ref-id,title,url,parent_key
L48,Google books,http://books.google.com/books?id=iadLoXoQkWEC&pg=PA440,DB00001
L10310,FDA Approved Drug Products: Lupaneta Pack for intramuscular and oral use,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203696s001lbl.pdf,DB00007
L13781,FDA Approved Drug Products: Lupron Depot (leuprolide acetate) depot suspension,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020517s042,019732s044lbl.pdf",DB00007
L13784,FDA Approved Drug Products: Lupron Depot-Ped (leuprolide acetate) depot suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020263s046lbl.pdf,DB00007
L13787,FDA Approved Drug Products: Fensolvi (leuprolide acetate) suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213150s000lbl.pdf,DB00007
L13790,FDA Approved Drug Products: Eligard (leuprolide acetate) suspension,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021343s039,021379s041,021488s036,021731s037lbl.pdf",DB00007
L13814,FDA Approved Drug Products: Lupron Depot 3.75mg (leuprolide acetate) depot suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019943s034lbl.pdf,DB00007
L13850,FDA Approved Drug Products: Lupron (leuprolide) injection; discontinued,https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019010Orig1s000rev.pdf,DB00007
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB00008
L12138,FDA Approved Drug Products: Kinlytic Urokinase Injection (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021846s101lbl.pdf,DB00013
L12141,Health Canada Approved Drug Products: Urokinase Injection,https://pdf.hres.ca/dpd_pm/00009157.PDF,DB00013
L2784,FDA News Release: FDA approves first epoetin alfa biosimilar for the treatment of anemia,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607703.htm,DB00016
L9746,Neulasta (pegfilgrastim) - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125031s189s191lbl.pdf,DB00019
L9761,Neulasta Safety Data Sheet - Amgen,https://www.msds.amgen.com/~/media/amgen/repositorysites/msds-amgen-com/neulasta_sds.ashx,DB00019
L9779,Biosimilars of pegfilgrastim,http://gabionline.net/Biosimilars/General/Biosimilars-of-pegfilgrastim,DB00019
L9782,Pegfilgrastim - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK532893/,DB00019
L9785,EMA approval for pegfilgrastim biosimilar Grasustek,http://gabionline.net/Biosimilars/News/EMA-approval-for-pegfilgrastim-biosimilar-Grasustek,DB00019
L9974,Biosimilar and Interchangeable Products | FDA,https://www.fda.gov/drugs/biosimilars/biosimilar-and-interchangeable-products,DB00019
L10022,pegfilgrastim | Cancer Care Ontario,https://www.cancercareontario.ca/en/node/43921,DB00019
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB00022
L1439,"UniProtKB - V6FYV8 (V6FYV8_ECOLX): E. coli L-asparaginase, type II FASTA sequence ",http://www.uniprot.org/uniprot/V6FYV8,DB00023
L12516,FDA Approved Drug Products: Humulin R (insulin human),https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018780s126s134lbl.pdf,DB00030
L1182,DDVAP Nasal Spray FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/017922s038,018938s027,019955s013lbl.pdf",DB00035
L1183,Stimate (desmopressin acetate) nasal spray FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020355s020lbl.pdf,DB00035
L1184,UKPAR for Desmopressin acetate 100mcg and 200mcg Tablets,http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2033807.pdf,DB00035
L12681,FDA Approved Drug Products: Sevenfact (coagulation factor VIIa (recombinant)-jncw) for intravenous use,https://www.fda.gov/media/136610/download,DB00036
L12687,Health Canada Product Monograph: NiaStase RT (eptacog alfa (activated) ) powder for injection,https://pdf.hres.ca/dpd_pm/00042076.PDF,DB00036
L7631,FDA Approved Drug Products: Glucagon Hydrochloride Injection (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012122,DB00040
L7634,FDA Approved Drug Products: Glucagon Intravenous or Intramuscular Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/201849s002lbl.pdf,DB00040
L7637,FDA Approved Drug Products: Glucagon for Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020928s056lbl.pdf,DB00040
L7640,"FDA Approved Drug Products: Glucagon Subcutaneous, Intramuscular, or Intravenous Injection",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020918s052lbl.pdf,DB00040
L7643,FDA Approved Drug Products: Glucagon Nasal Powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210134s000lbl.pdf,DB00040
L7658,Medsafe New Zealand: Glucagon Data Sheet,https://www.medsafe.govt.nz/profs/Datasheet/g/GlucaGeninj.pdf,DB00040
L8519,FDA Approved Drug Products: Glucagon Subcutaneous Auto-Injector and Pre-Filled Syringe,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212097s000lbl.pdf,DB00040
L13422,FDA Approved Products: Alecensa (alectinib) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208434s003lbl.pdf,DB00041
L4670,FDA Approves Genentech’s Xolair® (omalizumab) for Allergic Asthma in Children,https://www.gene.com/media/press-releases/14632/2016-07-07/fda-approves-genentechs-xolair-omalizuma,DB00043
L4671,FDA Approves Genentech's Xolair (omalizumab) Prefilled Syringe Formulation,https://www.drugs.com/newdrugs/fda-approves-genentech-s-xolair-omalizumab-prefilled-syringe-formulation-4830.html,DB00043
L4672,"Omalizumab properties, THPdb Database",http://crdd.osdd.net/raghava/thpdb/display_thppid_sub.php?details=Th1038,DB00043
L10298,HUMALOG FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020563s196s198s199,205747s022s025s026lbl.pdf",DB00046
L12474,FDA Approved Drug Products: Lantus (Insulin glargine) for subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021081s034lbl.pdf,DB00047
L1306,Patent: Methods related to adalimumab,https://patents.google.com/patent/US20150158943,DB00051
L4799,"Sandoz received US FDA approval for bio similar, Hyrimoz",https://www.novartis.com/news/media-releases/sandoz-receives-us-fda-approval-biosimilar-hyrimoztm-adalimumab-adaz,DB00051
L4805,HUMIRA website,https://www.humira.com/hidradenitis-suppurativa,DB00051
L4806,Abbvie Website,https://www.abbvie.com/our-science/pipeline/humira.html,DB00051
L941,FDA Press Announcements: FDA approves Mylotarg for treatment of acute myeloid leukemia,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574507.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery,DB00056
L3101,BLA APPROVAL,https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM611260.pdf,DB00062
L3102,ALBUMIN (HUMAN)- albumin human solution DailyMed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ddaae99-05e1-e05c-e63c-0c58965d157d,DB00062
L3104,PDR-Human Albumin,http://www.pdr.net/drug-summary/Human-Albumin-Grifols-25--albumin--human--1765,DB00062
L3108,Alburx,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad74b7f5-b380-47ab-b19d-eef92c8eb7a4,DB00062
L3109,Human Albumin,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90f0c351-3977-2b84-0a6a-e9cb091430ca,DB00062
L3110,Plasbumin,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ead60f3e-9dcc-7afe-2220-4f2381f3c140,DB00062
L50,Link,http://web.b.ebscohost.com/dynamed/detail?vid=15&sid=c9ea9657-342a-4b9b-a3bb-bf363d5d58c4%40sessionmgr112&hid=110&bdata=JnNpdGU9ZHluYW1lZC1saXZlJnNjb3BlPXNpdGU%3d#db=dme&AN=232803&anchor=Mechanism-of-Action-Pharmacokinetics,DB00065
L43,Link,http://www.google.co.in/patents/US8524217,DB00065
L1091,"FDA Label: INFLECTRA (infliximab-dyyb) for Injection, for Intravenous Use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125544s000lbl.pdf,DB00065
L1092,"FDA Label: IXIFI (infliximab-qbtx) for injection, for Intravenous Use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761072s000lbl.pdf,DB00065
L44,Link,http://www.kegg.jp/entry/D00746,DB00068
L45,Link,http://www.google.com/patents/EP0422697A1?cl=en,DB00069
L3069,US Patent US6870034B2 (includes Trastuzumab heavy chain sequence),https://patents.google.com/patent/US6870034,DB00072
L6214,Health Canada Product Monograph: Ogivri (trastuzumab) powder for intravenous infusion,https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=96453,DB00072
L14015,FDA Approved Drug Products: Herceptin (trastuzumab) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103792s5345lbl.pdf,DB00072
L14126,FDA Approved Drug Products: Ogivri (trastuzumab-dkst) for intravenous infusion,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761074s004lbl.pdf,DB00072
L14129,FDA Approved Drug Products: Herzuma (trastuzumab-pkrb) for intravenous infusion,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761091s001s002lbl.pdf,DB00072
L14132,FDA Approved Drug Products: Herceptin Hylecta (trastuzumab and hyaluronidase-oysk) for subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761106Orig1s000lbl.pdf,DB00072
L14135,FDA Approved Drug Products: Kanjinti (trastuzumab-anns) for intravenous infusion,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761073Orig1s000lbl.pdf,DB00072
L14138,FDA Approved Drug Products: Ontruzant (trastuzumab-dttb) for intravenous infusion,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761100s000lbl.pdf,DB00072
L14141,FDA Approved Drug Products: Trazimera (trastuzumab-qyyp) for intravenous infusion,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761081s000lbl.pdf,DB00072
L14150,Genentech: Herceptin(R) MSDS,https://www.gene.com/download/pdf/MSDS_herceptin_vials440mg.pdf,DB00072
L14510,FDA News Release: FDA Approves Breast Cancer Treatment That Can Be Administered At Home By Health Care Professional,https://www.fda.gov/news-events/press-announcements/fda-approves-breast-cancer-treatment-can-be-administered-home-health-care-professional,DB00072
L14531,FDA Approved Drug Products: Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf) for subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761170s000lbl.pdf,DB00072
L4808,FDA approves first biosimilar for treatment of adult patients with non-Hodgkin’s lymphoma,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm627009.htm,DB00073
L4811,FDA Approves Two New Indications for Rituxan in Patients With Non-Hodgkin's Lymphoma,https://www.gene.com/media/press-releases/10047/2006-09-29/fda-approves-two-new-indications-for-rit,DB00073
L8920,FDA approves first treatment for children with rare diseases that cause inflammation of small blood vessels,https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-rare-diseases-cause-inflammation-small-blood-vessels,DB00073
L51,Link,http://web.b.ebscohost.com/dynamed/detail?vid=6&sid=48a6db20-234e-4280-b18e-dcd0e2fed388%40sessionmgr198&hid=102&bdata=JnNpdGU9ZHluYW1lZC1saXZlJnNjb3BlPXNpdGU%3d#db=dme&AN=232878,DB00078
L47,Link,http://www.google.com/patents/WO2002059322A2?cl=en,DB00080
L2509,Creon monograph,http://www.rxabbvie.com/pdf/creon_PI.pdf,DB00085
L2510,FDA approval,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022523_pancreaze_toc.cfm,DB00085
L2521,FDA reports,https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM308286.pdf,DB00085
L1770,CENTER FOR DRUG EVALUATION AND RESEARCH- 20755,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/020725s000PharmR.pdf,DB00085
L2528,EMA reports,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002070/WC500210680.pdf,DB00085
L52,Link,http://www.google.com/patents/WO2013006706A1?cl=en,DB00089
L53,Link,http://www.google.ca/patents/US4741900,DB00089
L54,Link,http://www.google.com/patents/US5162504,DB00089
L5149,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065004,DB00091
L5158,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=48c3d8a3-4289-4b52-9189-58b48596095c,DB00091
L3002,Cyclosporine Product Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050573s039,050574s047,050625s053lbl.pdf",DB00091
L11085,Cayman Chem: Cyclosporine MSDS,https://www.caymanchem.com/msdss/12088m.pdf,DB00091
L11088,NIH Stat Pearls: Cyclosporine,https://www.ncbi.nlm.nih.gov/books/NBK482450/,DB00091
L11097,Novartis Monograph: Apo-Cyclosporine,https://pdf.hres.ca/dpd_pm/00014004.PDF,DB00091
L3734,Neoral (Cyclosporine) FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050715s027,050716s028lbl.pdf",DB00091
L11118,NY times: Drug that reduces risk in transplants gets early approval,https://www.nytimes.com/1983/09/03/us/drug-that-reduces-risk-in-transplants-gets-early-approval.html,DB00091
L14345,FDA Approved Products: Restasis (cyclosporine ophthalmic emulsion),https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050790s020lbl.pdf,DB00091
L11094,Health Canada Product Monograph: Raptiva (efalizumab) for subcutaneous injection,https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/efalizumab-marketed-raptiva-information,DB00095
L3735,"FDA Approves Second Neupogen Biosimilar, Nivestym",https://www.centerforbiosimilars.com/news/fda-approves-second-neupogen-biosimilar-nivestym,DB00099
L3739,FDA Approves Radiation Medical Countermeasure,https://www.fda.gov/emergencypreparedness/counterterrorism/medicalcountermeasures/aboutmcmi/ucm443245.htm,DB00099
L3742,Zarxio,http://www.zarxio.com/patient/,DB00099
L3744,Drugs Approved by the FDA document,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103353,DB00099
L58,Link,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000212/WC500050140.pdf,DB00102
L14495,"Bioworld: Chiasma carries new oral acromegaly treatment, Mycapssa, to FDA approval",https://www.bioworld.com/articles/436089-chiasma-carries-new-oral-acromegaly-treatment-mycapssa-to-fda-approval?v=preview,DB00104
L14501,NIH StatPearls: Acromegaly,https://www.ncbi.nlm.nih.gov/books/NBK431086/,DB00104
L14507,FDA approval letter: Mycapssa,https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/208232Orig1s000ltr.pdf,DB00104
L14513,Product monograph: Sandostatin (octreotide acetate) injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19667scm044_Sandostatin_lbl.pdf,DB00104
L14519,NIH StatPearls: Octreotide,https://www.ncbi.nlm.nih.gov/books/NBK544333/,DB00104
L14528,FDA Approved products: Mycapssa (octreotide) oral delayed-release capsules,https://label.mycapssa.com/wp-content/uploads/sites/4/2020/06/prescribinginformation.pdf,DB00104
L1738,U.S. Food & Drug Administration: FDA working with manufacturers to withdraw Zinbryta from the market in the United States,https://www.fda.gov/Drugs/DrugSafety/ucm600999.htm,DB00111
L1744,"European Medicines Agency: Public state on Zenapax (daclizumab), Withdrawal of the marketing authorization in the European Union",http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/2009/11/WC500011995.pdf,DB00111
L1746,U.S. FDA Zinbryta (daclizumab)  Prescribing Information,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761029s000lbl.pdf,DB00111
L12648,FDA Approved Drug Products: Avastin (bevacizumab) injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125085s331lbl.pdf,DB00112
L12699,ClinicalTrials.gov: Bevacizumab in Severe or Critical Patients with COVID-19 Pneumonia (BEST-CP),https://clinicaltrials.gov/ct2/show/NCT04275414,DB00112
L60,Link,http://www.google.ca/patents/US8420081,DB00113
L61,Link,http://www.google.ca/patents/US7790142,DB00113
L62,Link,http://www.google.ca/patents/US8226949,DB00113
L2074,Methylcobalamin vs cyanocobalamin,https://thetastyorange.wordpress.com/2013/04/02/methylcobalamin-versus-cyanocobalamin/,DB00115
L5542,"B12, cyanocobalamin tablets, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed824d40-79f8-4a76-a102-813ab85f7c6a&audience=consumer,DB00115
L5545,"Cyanocobalamin injection, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fb653d6-e2b2-4969-831b-c0dc37b9c0cc,DB00115
L2063,Vitamin B12,https://ods.od.nih.gov/factsheets/VitaminB12-Consumer/,DB00115
L5554,The metabolic processes of folic acid and Vitamin B12 deficiency,http://www.jhrr.org/article.asp?issn=2394-2010;year=2014;volume=1;issue=1;spage=5;epage=9;aulast=Mahmood,DB00115
L5557,University of Virginia: Megaloblastic anemia,https://www.med-ed.virginia.edu/courses/path/innes/rcd/mega.cfm,DB00115
L2064,Vitamin B 12 Health Professional Fact Sheet,https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/,DB00115
L12210,FDA Approved Drug Products: Ascor Ascorbic Acid Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209112s000lbl.pdf,DB00126
L892,Endari Approval Article,https://www.drugs.com/newdrugs/fda-approves-endari-l-glutamine-oral-powder-sickle-cell-4555.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+July+8%2C+2017&utm_content=FDA+Approves+Endari+%28L-glutamine+oral+powder%29+for+Sickle+Cell+Disease,DB00130
L12231,FDA Approved Drug Products: Endari L-Glutamine Oral Powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208587s001lbl.pdf,DB00130
L5653,"1,25-DIHYDROXYCHOLECALCIFEROL - National Library of Medicine HSDB Database - ToxNet - NIH",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3482,DB00136
L12237,FDA Approved Drug Products: Glycine Irrigation Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016784s035lbl.pdf,DB00145
L6058,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=003444,DB00153
L6082,Endocrine Web,https://www.endocrineweb.com/conditions/hypoparathyroidism/hypoparathyroidism,DB00153
L6085,NORD,https://rarediseases.org/rare-diseases/familial-hypophosphatemia/,DB00153
L6088,Pediatric Pharmacotherapy,https://med.virginia.edu/pediatrics/wp-content/uploads/sites/237/2015/12/200906.pdf,DB00153
L6091,Pubmed books,https://www.ncbi.nlm.nih.gov/books/NBK56061/,DB00153
L6094,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87e80b1f-e376-45ba-825b-a6fda4b82325,DB00153
L5744,Health Canada Prenatal Nutrition Guidelines for Health Professionals - Folate Contributes to a Healthy Pregnancy,https://www.canada.ca/en/health-canada/services/publications/food-nutrition/prenatal-nutrition-guidelines-health-professionals-folate-contributes-healthy-pregnancy-2009.html,DB00158
L3063,NIH ODS Vitamin E Fact Sheet for Health Professionals,https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/,DB00163
L5725,Vitamin E | Linus Pauling Institute | Oregon State University,https://lpi.oregonstate.edu/mic/vitamins/vitamin-E,DB00163
L12408,DailyMed: Pyridoxine hydrochloride tablets,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cca3c335-f43c-4053-b757-5ec48cf103c5,DB00165
L12411,FDA Approved Products: Diclegis (doxylamine succinate and pyridoxine hydrochloride),https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021876s002lbl.pdf,DB00165
L12414,Vitamin B6: Health professionals fact sheet,https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/,DB00165
L4437,"Pyridoxine, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a56d11c0-b033-4201-85ff-fc710506481a,DB00165
L5689,"Cholecalciferol (Vitamin D3) – Pharmacological Properties, Therapeutic Utility and Potential New Fields of Clinical Application by Yulian Voynikov, Georgi Momekov, Plamen Peikov",https://www.researchgate.net/publication/312164408_Cholecalciferol_Vitamin_D3_-_Pharmacological_Properties_Therapeutic_Utility_and_Potential_New_Fields_of_Clinical_Application,DB00169
L1782,Vitamin D Supplementation: An Update,https://www.uspharmacist.com/article/vitamin-d-supplementation-an-update,DB00169
L5771,NIH Vitamin D Fact Sheet for Health Professionals,https://ods.od.nih.gov/factsheets/Vitamind-HealthProfessional/,DB00169
L6142,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019898,DB00175
L6028,Chemocare,http://chemocare.com/chemotherapy/side-effects/cardiovascular-events.aspx,DB00175
L6025,Merck Manuals,https://www.merckmanuals.com/en-ca/professional/endocrine-and-metabolic-disorders/lipid-disorders/dyslipidemia,DB00175
L11305,FDA Approved Drug Products: Diovan (valsartan) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021283s053lbl.pdf,DB00177
L12798,FDA Approved Products: Altace (ramipril) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019901s060lbl.pdf,DB00178
L5098,Baclofen tablets,https://www.medicines.org.uk/emc/product/5728/smpc,DB00181
L6130,"Baclofen powder, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a32d8e8-a89a-40c1-8889-b3de5a2d839e,DB00181
L5194,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=083900,DB00182
L5197,JAMA network,https://jamanetwork.com/journals/jama/article-abstract/659694,DB00182
L5206,Australian Health Department,http://www.health.gov.au/internet/publications/publishing.nsf/Content/drugtreat-pubs-modpsy-toc~drugtreat-pubs-modpsy-2~drugtreat-pubs-modpsy-2-3~drugtreat-pubs-modpsy-2-3-pamp,DB00182
L5209,Inchem,http://www.inchem.org/documents/pims/pharm/pimg009.htm#PartTitle:6.%20%20KINETICS,DB00182
L5212,D-amphetamine sulfate information,http://www.acutetox.eu/pdf_human_short/35-Amphetamine%20revised.pdf,DB00182
L5095,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=070472,DB00186
L6403,Lorazepam monograph,https://pdf.hres.ca/dpd_pm/00026294.PDF,DB00186
L14177,"FDA Approved Drug Products: Bortezomib for Injection, for subcutaneous or intravenous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021602s044lbl.pdf,DB00188
L14195,Thermo Fisher Scientific: Bortezomib Safety Data Sheet,https://www.fishersci.com/store/msds?partNumber=AAJ60378LB0&productDescription=BORTEZOMIB%2C+99%25+5MG&vendorId=VN00024248&countryCode=US&language=en,DB00188
L14198,Cayman Chemical: Bortezomib Safety Data Sheet,https://www.caymanchem.com/msdss/10008822m.pdf,DB00188
L14180,BC Cancer: Bortezomib Monograph,http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Bortezomib_monograph.pdf,DB00188
L5110,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203261,DB00190
L5113,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=073589,DB00190
L5116,Glown,https://www.glowm.com/resources/glowm/cd/pages/drugs/kl021.html,DB00190
L5233,EmpowerPharmacy,https://www.empowerpharmacy.com/drugs/phentermine-hcl-capsules.html,DB00191
L5236,Inchem,http://www.inchem.org/documents/pims/pharm/pim415.htm#SectionTitle:6.5%20%20Elimination%20and%20excretion,DB00191
L5239,FDA reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202088Orig1s000PharmR.pdf,DB00191
L5125,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=075960,DB00193
L5128,WHO reports,https://www.who.int/medicines/areas/quality_safety/6_1_Update.pdf,DB00193
L9257,FDA Approved Drug Products: Ultram (tramadol hydrochloride) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020281s045lbl.pdf,DB00193
L6505,"Fluconazole, Medsafe NZ data sheet",https://www.medsafe.govt.nz/profs/Datasheet/f/fluconazolecapmylan.pdf,DB00196
L11034,EMA Summary of Product Characteristics: Diflucan (fluconazole) oral capsules,https://www.ema.europa.eu/en/documents/referral/diflucan-article-30-referral-annex-iii_en.pdf,DB00196
L11043,FDA Approved Drug Products: Diflucan (fluconazole),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019949s065,020090s047lbl.pdf",DB00196
L5161,Electronic Medicines Compendium: Tamiflu (oseltamivir phosphate) 30 mg Hard Capsules Monograph,https://www.medicines.org.uk/emc/product/8050/smpc,DB00198
L5182,Lupin launches US Tamiflu generic amid worst flu season in recent memory: Press Release,https://www.pharmaceutical-technology.com/comment/lupin-launches-us-tamiflu-generic-amid-worst-flu-season-recent-memory/,DB00198
L6571,Dailymed - Oseltamivir (FDA),https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d306e22c-0cb8-46cb-9a40-8194a2bc9e85,DB00198
L7264,CDC Influenza Antiviral Medications: Summary for Clinicians,https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm,DB00198
L7267,Canadian Paediatric Society - The use of antiviral drugs for influenza: Guidance for practitioners,https://www.cps.ca/en/documents/position/antiviral-drugs-for-influenza,DB00198
L5245,NIH StatPearls: Erythromycin,https://www.ncbi.nlm.nih.gov/books/NBK532249/,DB00199
L7261,FDA Approved Drug Products: Ery-Ped (erythromycin ethylsuccinate) granules for oral suspension,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050207s074,050611s036lbl.pdf",DB00199
L7270,MedSafe NZ: ERA (erythromycin stearate) oral filmtabs,https://www.medsafe.govt.nz/Profs/Datasheet/e/ERAcaptab.pdf,DB00199
L7279,Pfizer: Erythromycin MSDS,https://www.pfizer.com/system/files/products/material_safety_data/PZ00645.pdf,DB00199
L9827,Highly Concentrated Caffeine in Dietary Supplements: Guidance for Industry,https://www.fda.gov/media/112363/download,DB00201
L9851,Caffeine citrate injection FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20793s1lbl.pdf,DB00201
L9854,DailyMed Search: Caffeine,https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=caffeine&audience=consumer,DB00201
L9857,PDB reference,https://www.rcsb.org/ligand/CFF,DB00201
L9863,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020793,DB00201
L9869,"Alcohol and Drug Foundation, Australia",https://adf.org.au/drug-facts/caffeine/,DB00201
L9872,"Migergot, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a31ad0c-7bdd-544b-f5df-a99d04cf541c,DB00201
L9896,Caffeine pathway: Pharm GKB,https://www.pharmgkb.org/pathway/PA165884757,DB00201
L9899,Caffeine and sodium benzoate injection,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2c6b352-f837-4903-8e4c-fb0a2b20bb60,DB00201
L5611,"Electronic Medicines Compendium: Sildenafil 25mg, 50mg, 100mg film-coated tablets Monograph",https://www.medicines.org.uk/emc/product/3172/smpc,DB00203
L5614,Electronic Medicines Compendium: Revatio (sildenafil citrate) 20 mg film-coated tablets Monograph,https://www.medicines.org.uk/emc/product/181/smpc,DB00203
L5656,"Forbes: With Viagra Now Available Over-The-Counter In The U.K., Will The U.S. Follow Suit?",https://www.forbes.com/sites/johnlamattina/2018/05/01/with-viagra-now-available-over-the-counter-in-the-uk-will-the-us-follow-suit/#9f64aee75b65,DB00203
L6208,Trospium,https://medlineplus.gov/druginfo/meds/a604037.html,DB00209
L6211,FDA drug approval: Trospium,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022103s000TOC.cfm,DB00209
L12873,FDA Approved Drug Products: Differin (adapalene) gel,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021753s004lbl.pdf,DB00210
L12897,FDA: Pharmacology/Toxicology Review and Evaluation (adapalene),https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022502s000PharmR.pdf,DB00210
L12927,DPD Monograph: Differin (adapalene) topical cream/gel/lotion,https://pdf.hres.ca/dpd_pm/00048625.PDF,DB00210
L12930,"FDA Approved Drug Products: Epiduo (adapalene and benzoyl peroxide), gel",https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207917Orig1s000lbl.pdf,DB00210
L5248,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076110,DB00214
L5251,Cleveland Clinic,https://my.clevelandclinic.org/health/diseases/12564-edema,DB00214
L5254,Hypertension Canada,https://hypertension.ca/,DB00214
L5257,Indian Journal of Clinical Practice,http://medind.nic.in/iaa/t13/i9/iaat13i9p385.pdf,DB00214
L5260,EMC,https://www.medicines.org.uk/emc/product/6665/smpc,DB00214
L1355,MSDS  citalopram,https://www.spectrumchemical.com/MSDS/C2408ANSI-C2408AGHS.pdf,DB00215
L5224,NIH Stat Pearls: Citalopram,https://www.ncbi.nlm.nih.gov/books/NBK482222/,DB00215
L5227,AAFP: Off-label Applications for SSRIs,https://www.aafp.org/afp/2003/0801/p498.html,DB00215
L5230,"Celexa Information, FDA",https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020822a.cfm,DB00215
L8132,Nelfinavir FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021503s006lbl.pdf,DB00220
L10319,AMARYL (glimepiride) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020496s027lbl.pdf,DB00222
L10322,Amaryl (glimepiride) Product Monograph - Sanofi in Canada,http://products.sanofi.ca/en/amaryl.pdf,DB00222
L12561,FDA Approved Drug Products: Altoprev (lovastatin extended-release) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021316s035lbl.pdf,DB00227
L12564,FDA Approved Drug Products: Mevacor (lovastatin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019643s088lbl.pdf,DB00227
L13643,NIH StatPearls: Enflurane,https://www.ncbi.nlm.nih.gov/books/NBK554595/,DB00228
L13646,FDA Approved Products: Efrane (enflurane) liquid for inhalation,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017087s048lbl.pdf,DB00228
L13649,"FDA approval status, Enflurane",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017087,DB00228
L13871,Matheson Gas MSDS: Enflurane,https://www.mathesongas.com/pdfs/msds/MAT08601.pdf,DB00228
L1006,Pfizer,http://www.pfizer.com/news/press-release/press-release-detail/u_s_fda_approves_lyrica_cr_pregabalin_extended_release_tablets_cv,DB00230
L7066,FDA Label Pregabalin,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021446s036,022488s014lbl.pdf",DB00230
L9052,Pfizer Medical Information - Lyrica,https://www.pfizermedicalinformation.ca/en-ca/lyrica/overdosage#,DB00230
L5539,Electronic Medicines Compendium: Temazepam 10mg Tablets Monograph,https://www.medicines.org.uk/emc/product/8792/smpc,DB00231
L13613,FDA Approved Drug Products: Butabarbital Oral Tablets and Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/000793s026lbl.pdf,DB00237
L6121,Butalbital - National Library of Medicine HSDB Database,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7853,DB00241
L10370,"Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules - FDA Label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020232s041lbl.pdf,DB00241
L5437,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201046,DB00243
L5440,FDA approvals,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021526_s000_Ranexa.cfm,DB00243
L5473,Australian Assessment Report,https://www.tga.gov.au/sites/default/files/auspar-ranolazine-180220.pdf,DB00243
L3580,Ranolazine FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021526s007lbl.pdf,DB00243
L10965,Angina: Mayo clinic,https://www.mayoclinic.org/diseases-conditions/angina/symptoms-causes/syc-20369373,DB00243
L5101,Electronic Medicines Compendium: Asacol (mesalazine) 400mg MR Tablets Monograph,https://www.medicines.org.uk/emc/product/2217/smpc,DB00244
L5107,Electronic Medicines Compendium: Pentasa (Mesalazine) Sachet 2g Monograph,https://www.medicines.org.uk/emc/product/6309/smpc,DB00244
L5122,NIH Toxnet: Mesalazine Profile,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7512,DB00244
L5500,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040103,DB00245
L5509,Parkinson,https://www.parkinson.org/sites/default/files/attachments/Parkinsons-Disease-vs-Parkinsonisms.pdf,DB00245
L5431,Ziprasidone Black Box Warning,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020825s035,020919s023lbl.pdf",DB00246
L7342,FDA Approved Drug Products: Geodon (ziprasidone HCl),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020825s059,020919s047lbl.pdf",DB00246
L7348,Zeldox Pfizer Canada Product Monograph,https://www.pfizer.ca/sites/g/files/g10050796/f/201810/ZELDOX_PM_E_217496_28Sep2018.pdf,DB00246
L11668,FDA Approved Drug Products: Geodon (ziprasidone),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020825s058,020919s045lbl.pdf",DB00246
L9362,FDA Approved Drugs: Dilantin,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/084349s085lbl.pdf,DB00252
L10740,CEREBYX® FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020450s039lbl.pdf,DB00252
L10941,Dilantin® FDA Label (injectable formulation),https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/010151s047s048lbl.pdf,DB00252
L10980,Phenytoin: A Guide to Therapeutic Drug Monitoring,https://journals.sagepub.com/doi/pdf/10.1177/201010581302200307,DB00252
L12420,FDA Approved Drug Products: Allergan Medrysone Ophthalmic Suspension (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/16624s41lbl.pdf,DB00253
L13880,EMC: Tetralysal 300mg Hard Capsules,https://www.medicines.org.uk/emc/product/926/pil,DB00256
L13883,New Zealand data sheet: Tetralysal (lymecycline) oral capsules,https://www.medsafe.govt.nz/Profs/Datasheet/t/Tetralysalcap.pdf,DB00256
L13913,ClearSynth: Lymecycline MSDS,http://www.t3db.ca/system/msds/attachments/000/002/587/original/T3D3952.pdf?1414204380,DB00256
L5164,Clotrimazole Drug Summary,https://www.pdr.net/drug-summary/Clotrimazole-Cream-clotrimazole-704,DB00257
L5167,HMDB Database,http://www.hmdb.ca/metabolites/HMDB0001922,DB00257
L5170,The binding of Clotrimazole to the proteins of human serum,https://www.researchgate.net/publication/225525540_The_binding_of_Clotrimazole_to_the_proteins_of_human_serum,DB00257
L5173,"Clotrimazole Cream, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1fa2664f-955d-4ae1-85ff-186e4aebba49,DB00257
L14153,FDA Approved Drug Products: Agrylin (anagrelide) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020333s026lbl.pdf,DB00261
L14243,CaymanChem: Anagrelide MSDS,https://www.caymanchem.com/msdss/21411m.pdf,DB00261
L14300,Health Canada Product Monograph: Agrylin (anagrelide hydrochloride) capsules for oral use,https://pdf.hres.ca/dpd_pm/00053558.PDF,DB00261
L14159,FDA Approved Drug Products: BiCNU (carmustine) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017422s055lbl.pdf,DB00262
L5527,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017963,DB00264
L5530,Researchgate publications,https://www.researchgate.net/publication/257614687_Chemical_stability-indicating_HPLC_study_of_fixed-dosage_combination_containing_metoprolol_tartrate_and_hydrochlorothiazide,DB00264
L5533,Heart,https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease,DB00264
L5536,FDA reports,https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/019962s032lbl.pdf,DB00264
L5272,"Drug Approval Package, FDA",https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022008_requip_toc.cfm,DB00268
L5548,Merck,https://www.merckmanuals.com/en-ca/professional/neurologic-disorders/seizure-disorders/seizure-disorders,DB00273
L10541,"Topamax, manufacturer's website",https://www.topamax.com,DB00273
L10544,"FDA label, topiramate",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020505s057_020844s048lbl.pdf,DB00273
L10547,"MSDS, Topiramate",https://www.caymanchem.com/msdss/13623m.pdf,DB00273
L10550,Qsymia approval information,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022580Orig1s000_qsymia_toc.cfm,DB00273
L12876,Health Canada Product Monograph: Olmesartan medoxomil oral tablets,https://pdf.hres.ca/dpd_pm/00048843.PDF,DB00275
L12882,FDA Approved Drug Products: Benicar (olmesartan medoxomil) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021286s040lbl.pdf,DB00275
L88,Link,http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Amsacrine.htm,DB00276
L5578,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010379,DB00279
L5587,FDA reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202231Orig1s000ClinPharm.pdf,DB00279
L5930,Electronic Medicines Compendium: Lidocaine 1% w/v solution for injection Monograph,https://www.medicines.org.uk/emc/product/8737/smpc,DB00281
L5948,StatPearls Internet: Lidocaine Profile,https://www.ncbi.nlm.nih.gov/books/NBK539881/#article-24262.s2,DB00281
L6055,World Health Organization Model Lists of Essential Medicines,https://www.who.int/medicines/publications/essentialmedicines/en/,DB00281
L13835,FDA Approved Drug Products: Aredia Pamidronate Intravenous Injection (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020036s041lbl.pdf,DB00282
L13838,FDA Approved Drug Products: Aredia Pamidronate Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20927lbl.pdf,DB00282
L13892,Pfizer Canada: Pamidronate Disodium Injection,https://www.pfizer.ca/sites/default/files/201812/Pamidronate_PM_E_220092_11Dec2018.pdf,DB00282
L10454,FDA Approved Drug Products: Effexor XR® extended-release capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020699s110s111lbl.pdf,DB00285
L10460,FDA Approved Drug Products: Venlafaxine oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/076690s020lbl.pdf,DB00285
L5605,NIH,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/conjugated-estrogens,DB00286
L5608,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021396,DB00286
L5632,Pfizer,https://www.pfizermedicalinformation.com/en-us/premarin/clinical-pharmacology,DB00286
L5146,Electronic Medicines Compendium: Travatan (travoprost) Monograph,https://www.medicines.org.uk/emc/product/1556/smpc,DB00287
L5152,Alcon treatment Travatan® receives EU approval for pediatric glaucoma patients: Press Release,https://www.novartis.com.cn/xin-wen-zhong-xin/xin-wen-fa-bu/pediatric-glaucoma-patients,DB00287
L5155,Alcon receives FDA approval for first-line use of Travatan Z: Press Release,https://www.healio.com/ophthalmology/ophthalmic-business/news/online/%7B92fe9833-e3b4-4d2f-9e51-13ca6603d5a8%7D/alcon-receives-fda-approval-for-first-line-use-of-travatan-z,DB00287
L5644,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021411,DB00289
L5665,NIH,https://www.nimh.nih.gov/health/publications/attention-deficit-hyperactivity-disorder-adhd-the-basics/index.shtml,DB00289
L6037,CADDRA - Canadian ADHD Practice Guidelines,https://www.caddra.ca/pdfs/caddraGuidelines2011.pdf,DB00289
L12492,FDA Approved Drug Products: Strattera (atomoxetine) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021411s049lbl.pdf,DB00289
L5692,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021187,DB00294
L5695,PMC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683610/,DB00294
L5698,NIH,https://www.nichd.nih.gov/health/topics/contraception/conditioninfo/types,DB00294
L5701,NIH,https://drugs.ncats.io/drug/304GTH6RNH,DB00294
L5713,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018565,DB00295
L5728,NIH,https://medlineplus.gov/magazine/issues/spring11/articles/spring11pg9.html,DB00295
L12108,FDA Approved Drug Products: Infumorph Morphine Sulfate Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018565s024lbl.pdf,DB00295
L12114,FDA Approved Drug Products: Morphine Sulfate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022207s009lbl.pdf,DB00295
L103,Link,http://www.emedicine.com/ent/topic20.htm,DB00297
L11734,FDA Approved Products: Dapiprazole kit,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b0fde24-9549-11cf-e053-2a95a90a9338,DB00298
L14339,FDA Approved Drug Products: Invanz (ertapenem) for injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021337s048lbl.pdf,DB00303
L5762,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020071,DB00304
L5698,NIH,https://www.nichd.nih.gov/health/topics/contraception/conditioninfo/types,DB00304
L14039,FDA Approved Drug Products: DESOGEN Tablets (desogestrel and ethinyl estradiol tablets USP),https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020071s025lbl.pdf,DB00304
L12867,FDA Approved Drug Products: Jelmyto (mitomycin) pyelocalyceal solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211728s000lbl.pdf,DB00305
L12489,FDA Approved Drug Products: Thalitone (chlorthalidone),https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019574s017lbl.pdf,DB00310
L6151,Depacon FDA Label (2006),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018081s42,18082s26,18723s32,19680s19,20593s11,21168s9lbl.pdf",DB00313
L6190,Depakene FDA,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018081,DB00313
L6196,Depakene FDA Label (2019),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018081s069,018082s052lbl.pdf",DB00313
L12978,FDA Approved Drug Products: ZOMIG/ZOMIG-ZMT (zolmitriptan) oral tablets and nasal spray,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020768s023,021231s014,021450s010lbl.pdf",DB00315
L5756,"Acetaminophen tablet, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3b408ff-f47b-4fee-ade5-5db6e25f4ee0,DB00316
L5774,"Acetaminophen effervescent tablets, Cleveland Clinic",https://my.clevelandclinic.org/health/drugs/18282-acetaminophen-effervescent-tablets,DB00316
L5777,FDA safety communication: FDA has reviewed possible risks of pain medicine use during pregnancy,https://www.fda.gov/Drugs/DrugSafety/ucm429117.htm,DB00316
L5780,U.S. National Medical Library: MedlinePlus- Acetaminophen dosing for children,https://medlineplus.gov/ency/patientinstructions/000783.htm,DB00316
L5783,FDA consumer health information: Acetaminophen,https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm263989.htm,DB00316
L5786,FDA : Acetaminophen Information,https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm165107.htm,DB00316
L5789,Using Acetaminophen and Nonsteroidal Anti-inflammatory Drugs Safely,https://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/UnderstandingOver-the-CounterMedicines/SafeUseofOver-the-CounterPainRelieversandFeverReducers/ucm164977.htm,DB00316
L4396,Acetaminophen FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204767s000lbl.pdf,DB00316
L5506,"Codeine phosphate tablets, 30mg",https://www.medicines.org.uk/emc/product/5753/smpc,DB00318
L5521,DailyMed: Codeine and promethazine syrup,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a5215931-3385-4d8e-b121-47aa1c20420c&audience=consumer,DB00318
L5524,"Codittusin, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99f53fa4-98e0-4f0c-9bb2-4c7163f841ec,DB00318
L5308,"Amitriptyline FDA information, Approval",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=085971,DB00321
L5795,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019034,DB00327
L5798,Clinical trials,https://clinicaltrials.gov/ct2/show/NCT01123486,DB00327
L6778,Indomethacin Capsules (25 mg) - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016059s100lbl.pdf,DB00328
L10553,Indocin I.V. (indomethacin for injection) - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018878s027lbl.pdf,DB00328
L13269,"FDA Approved Drug Products: INDOCIN (indomethacin) Suppositories, for rectal use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/017814s041s042lbl.pdf,DB00328
L4087,Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program,https://www.bmj.com/content/350/bmj.h454/rr-0,DB00331
L5753,UptoDate: Pathogenesis of type 2 diabetes mellitus,https://www.uptodate.com/contents/pathogenesis-of-type-2-diabetes-mellitus,DB00331
L11479,FDA Approved Drug Products: Trijardy XR (empagliflozin/linagliptin/metformin) extended-release tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212614s000lbl.pdf,DB00331
L12207,FDA approved products: Glumetza (metformin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021748s010lbl.pdf,DB00331
L5891,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019085,DB00332
L5894,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020291,DB00332
L5900,Journal of Investigational Allergology and Clinical Immunology,http://www.jiaci.org/issues/vol20s1/7.pdf,DB00332
L5903,The differential diagnosis of rhinorrhea,https://www.jacionline.org/article/S0091-6749(95)70211-3/pdf,DB00332
L5906,COPD Foundation,https://www.copdfoundation.org/What-is-COPD/Understanding-COPD/What-is-COPD.aspx,DB00332
L5909,EMC,https://www.medicines.org.uk/emc/product/3213/smpc,DB00332
L5936,Canadian Mental Health Association,https://cmha.ca/mental-health/understanding-mental-illness/schizophrenia,DB00334
L5939,NIH,https://www.nimh.nih.gov/health/topics/bipolar-disorder/index.shtml,DB00334
L5945,Mylan-Olanzapine. Product monograph,https://pdf.hres.ca/dpd_pm/00038283.PDF,DB00334
L12591,FDA Approved Drug Products: Zyprexa (olanzapine),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020592s072,021086s047,021253s060lbl.pdf",DB00334
L13059,FDA Approved Drug Products: Zyprexa (olanzapine) tablets and powder,https://pi.lilly.com/us/zyprexa-pi.pdf,DB00334
L6313,LactMed: Atenolol,http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+283,DB00335
L6316,ChemIDplus: Atenolol,https://chem.nlm.nih.gov/chemidplus/rn/29122-68-7,DB00335
L12804,FDA Approved Products: Tenormin (atenolol) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018240s032lbl.pdf,DB00335
L9743,"FDA Approved Drug Products: Talicia Amoxicillin, Omeprazole, and Rifabutin Oral Delayed Release Capsules",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213004lbl.pdf,DB00338
L12309,NIH StatPearls: Omeprazole,https://www.ncbi.nlm.nih.gov/books/NBK539786/,DB00338
L12933,FDA Approved Products: Prilosec (omeprazole) delayed release capsules,https://s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/003/712/original/Prilosec_FDA.pdf?1551285648,DB00338
L5,Link,http://newdruginformation.com/Trest.htm,DB00340
L6289,Diltiazem - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK532937/,DB00343
L6292,Diltiazem Hydrochloride Injection Label - Bedford Laboratories,https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Ben%20Venue_Bedford%20Labs/55390-565-10%20DLT%2050MG/5539056510,DB00343
L6298,Cardizem (diltiazem hydrochloride) Drug Summary - PDR.net,https://www.pdr.net/drug-summary/Cardizem-diltiazem-hydrochloride-2077,DB00343
L10556,CARDIZEM® LA (diltiazem hydrochloride) extended-release tablets - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021392s019lbl.pdf,DB00343
L10559,CARDIZEM® CD (diltiazem HCl) Capsules - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020062s040lbl.pdf,DB00343
L9251,FDA Approved Drug Products: Alfuzosin Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021287s021lbl.pdf,DB00346
L6217,FDA approval: Buclizine,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=010911,DB00354
L6220,HMDB: Buclizine,http://www.hmdb.ca/metabolites/HMDB0014498,DB00354
L1998,Vinorelbine Tartrate,https://www.pfizer.ca/sites/g/files/g10037206/f/201710/VINORELBINE_TARTRATE_FOR_INJECTION_PM.pdf,DB00361
L2000,"Vinorelbine, Ontario Cancer Care",https://www.cancercareontario.ca/en/system/.../vinorelbine.pdf,DB00361
L2002,Predictors of Vinorelbine Pharmacokinetics and Pharmacodynamics in Patients With Cancer,http://ascopubs.org/doi/abs/10.1200/jco.2005.02.1295,DB00361
L2004,"Vinorelbine injection, Daily Med",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06eeaab8-a00d-4b41-b46b-40163f09ecb8,DB00361
L2005,Metabolism pathway of vinorelbine (Navelbine®) in human: Characterisation of the metabolites by HPLC–MS/MS,https://www.sciencedirect.com/science/article/abs/pii/S0731708507007625,DB00361
L2006,Vinca Alkaloid Pharmacokinetics,https://www.pharmgkb.org/pathway/PA150981002,DB00361
L2007,"Vinorelbine, a clinical review",https://www.nature.com/articles/6691203.pdf?origin=ppub,DB00361
L2009,Vinorelbine FDA pharmacology review,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-388S008_Navelbine_biopharmr.pdf,DB00361
L2010,Drug Approval Package,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-388s008_Navelbine.cfm,DB00361
L2011,"Navelbine, PDR",http://www.pdr.net/drug-summary/Navelbine-vinorelbine-tartrate-2360,DB00361
L6073,"FDA approval, Sucralfate suspension",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019183,DB00364
L6076,Sucralfate tablet FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018333,DB00364
L7760,Levonorgestrel FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021998lbl.pdf,DB00367
L7766,Alesse 28 FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020683s012lbl.pdf,DB00367
L7778,"FDA label, Mirena IUD",https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021225s019lbl.pdf,DB00367
L7781,Kyleena IUD FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208224s000lbl.pdf,DB00367
L7787,Jaydess monograph,https://www.bayer.ca/omr/online/jaydess-pm-pt3-en.pdf,DB00367
L7790,Levonorgestrel MSDS,http://datasheets.scbt.com/sc-205731.pdf,DB00367
L7793,"Medicines UK, levonorgestrel",https://www.medicines.org.uk/emc/product/7308/smpc,DB00367
L7796,"Birth control pill overdose, Medline",https://medlineplus.gov/ency/article/002599.htm,DB00367
L7805,Climara pro FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021885lbl.pdf,DB00367
L7808,Cleveland clinic: hormone therapy,https://my.clevelandclinic.org/health/treatments/15245-hormone-therapy,DB00367
L7823,Norplant FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020544s010lbl.pdf,DB00367
L6223,Cidofovir FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020638,DB00369
L6139,Bioavailability of mirtazapine from Remeron® tablets after single and multiple oral dosing,https://onlinelibrary.wiley.com/doi/pdf/10.1002/hup.470100803,DB00370
L6157,"Remeron approval, 1997",https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20-415S003_Remeron_Prntlbl.pdf,DB00370
L6160,"Mirtazapine: A Newer Antidepressant, American Family Physician (AFP)",https://www.aafp.org/afp/1999/0101/p159.html,DB00370
L4433,Remeron (Mirtazapine) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020415s023s024.pdf,DB00370
L6724,Timolol FDA Label (Ophthalmic),https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021516s005lbl.pdf,DB00373
L6727,Timolol maleate tablet,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57c62928-63d8-4505-9b9e-c085a3a12c95,DB00373
L6730,"Monograph, GD-LATANOPROST/TIMOLOL",https://www.pfizer.ca/sites/g/files/g10050796/f/201710/GD-latanoprost_and_timolol_PM_E_210086_17Oct2017.pdf,DB00373
L6733,CV Pharmacology,https://www.cvpharmacology.com/cardioinhibitory/beta-blockers,DB00373
L6736,"Approval information, FDA",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207556,DB00373
L6742,FDA summary review,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/761077Orig1s000SumR.pdf,DB00373
L6,Link,http://www.inchem.org/documents/pims/pharm/timolol.htm,DB00373
L6757,"MedSafe NZ, Timolol",https://medsafe.govt.nz/Profs/Datasheet/a/ArrowTimololeyedrops.pdf,DB00373
L6115,Electronic Medicines Compendium: Colestid (colestipol hydrochloride) Orange 5g Monograph,https://www.medicines.org.uk/emc/product/129/smpc,DB00375
L6118,NCBI LactMed@NIH Drugs and Lactation Database (LactMed) [Internet]: Colestipol Profile,https://www.ncbi.nlm.nih.gov/books/NBK501393/#LM514.admin-info,DB00375
L6262,Colestipol ScienceDirect Profile,https://www.sciencedirect.com/topics/medicine-and-dentistry/colestipol,DB00375
L7598,Colestid® (colestipol hydrochloride for oral suspension) - FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017563s023,020222s005lbl.pdf",DB00375
L104,Link,http://www.patient.co.uk/showdoc/30003042/,DB00378
L9314,FDA Approved Drug Products: Amlodipine Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf,DB00381
L9317,FDA Approved Drug Products: Amlodipine Oral Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211340s000lbl.pdf,DB00381
L6163,Triamterene - International Agency for Research on Cancer (IARC) Monographs,https://monographs.iarc.fr/wp-content/uploads/2018/06/mono108-10.pdf,DB00384
L6169,DYAZIDE (hydrochlorothiazide and triamterene) - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016042s077lbl.pdf,DB00384
L6193,PRO-TRIAZIDE (Triamterene 50 mg and Hydrochlorothiazide 25 mg) - Product Monograph,https://pdf.hres.ca/dpd_pm/00026038.PDF,DB00384
L6166,DailyMed - DYRENIUM- triamterene capsule,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af,DB00384
L9416,FDA Approved Drug Products: Phenylephrine Solution for Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204300lbl.pdf,DB00388
L9413,FDA Approved Drug Products: Phenylephrine Ophthalmic Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207926s002lbl.pdf,DB00388
L9410,FDA Approved Drug Products: Phenylephrine Intravenous Injection (Ready to Use),https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212909s000lbl.pdf,DB00388
L6253,Digoxin pharmacokinetics,https://sepia2.unil.ch/pharmacology/index.php?id=84,DB00390
L6274,MedSafe NZ: Lanoxin,https://medsafe.govt.nz/profs/Datasheet/l/Lanoxintabelixinj.pdf,DB00390
L9143,FDA Approved Drug Products: Lanoxin (digoxin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020405s015lbl.pdf,DB00390
L6871,QVAR® (beclomethasone dipropionate HFA) for oral inhalation use - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020911s029s030lbl.pdf,DB00394
L6880,"BECONASE AQ® (beclomethasone dipropionate, monohydrate) for intranasal use only - FDA Label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019389s027lbl.pdf,DB00394
L6886,DIPROSONE® (Betamethasone Dipropionate Cream) - Product Monograph - Merck Canada Inc.,https://pdf.hres.ca/dpd_pm/00042539.PDF,DB00394
L10782,"DIPROLENE® (augmented betamethasone dipropionate) ointment, for topical use - FDA Label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018741s040lbl.pdf,DB00394
L5074,Drug Scheduling: United States Drug Enforcement Administration (DEA),https://www.dea.gov/drug-scheduling,DB00395
L5719,"Muscle relaxants for lower back pain: What is the evidence (article, Journal of Pain Management)",https://journals.lww.com/topicsinpainmanagement/Citation/2007/07000/Muscle_Relaxants_for_Low_Back_Pain__What_Is_the.1.aspx,DB00395
L5629,Drug approval package FDA,https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020843_s000_PrometriumTOC.cfm,DB00396
L5638,Merck Manuals: Abnormal Uterine Bleeding Due to Ovulatory Dysfunction (AUB-O),https://www.merckmanuals.com/en-ca/professional/gynecology-and-obstetrics/menstrual-abnormalities/abnormal-uterine-bleeding-due-to-ovulatory-dysfunction-aub-o,DB00396
L5641,AAFP: Abnormal uterine bleeding,https://www.aafp.org/afp/1999/1001/p1371.html,DB00396
L13712,FDA Approved Drug Products: Zometa Zoledronic Acid Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021223s041lbl.pdf,DB00399
L13715,FDA Approved Drug Products: Reclast Zoledronic Acid Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022080lbl.pdf,DB00399
L13721,FDA Approved Drug Products: Reclast Zoledronic Acid Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021817s028lbl.pdf,DB00399
L6769,Eszopiclone FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021476s030lbl.pdf,DB00402
L6802,"FDA review, Eszopiclone",https://www.fda.gov/media/84679/download,DB00402
L6850,"Pubchem, Eszopiclone",https://pubchem.ncbi.nlm.nih.gov/compound/Eszopiclone,DB00402
L6853,"MSDS, Eszopiclone",https://www.chemblink.com/MSDS/MSDSFiles/138729-47-2_Clear%20Synth.pdf,DB00402
L6868,Lunesta label 2019,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021476s037lbl.pdf,DB00402
L6874,FDA news,https://www.fda.gov/news-events/press-announcements/fda-requires-stronger-warnings-about-rare-serious-incidents-related-certain-prescription-insomnia,DB00402
L6148,FDA Approved Drug Products: Xanax,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018276,DB00404
L6172,FDA Pregnancy Categories,https://chemm.nlm.nih.gov/pregnancycategories.htm,DB00404
L162,Flockhart Table of Drug Interactions,https://drug-interactions.medicine.iu.edu/Main-Table.aspx,DB00404
L4265,FDA Approved Drug Products: XANAX (Alprazolam) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018276s052lbl.pdf,DB00404
L6349,"MUPIROCIN OINTMENT USP, 2% - DailyMed",https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=2eba98c3-2cc8-143f-824e-c7ec90011f0b&type=display,DB00410
L10580,MUPIROCIN OINTMENT - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/50788_Mupirocin_Prntlbl.pdf,DB00410
L10586,"BACTROBAN (mupirocin) ointment, for topical use - FDA Label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050591s034lbl.pdf,DB00410
L5882,"FDA Approval package, Mirapex",https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/020667.cfm,DB00413
L4447,Mirapex® (pramipexole dihydrochloride) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020667s014s017s018lbl.pdf,DB00413
L6382,Phenoxymethylpenicillin (Penicillin V) Monograph - Government of Western Australia Child and Adolescents Health Service,https://pch.health.wa.gov.au/~/media/Files/Hospitals/PCH/General%20documents/Health%20professionals/ChAMP%20Monographs/Phenoxymethylpenicillin.pdf,DB00417
L6412,Phenoxymethyl Penicillin 250mg/5ml Oral Solution Sugar Free (syringe) - eMC,https://www.medicines.org.uk/emc/product/2994/smpc,DB00417
L6415,phenoxymethylpenicillin (penicillin v) - King Edward Memorial Hospital,https://www.kemh.health.wa.gov.au/~/media/Files/Hospitals/WNHS/For%20health%20professionals/Clinical%20guidelines/Pharmacy/medications/phenoxymethylpenicillin.pdf,DB00417
L6418,Penicillin V potassium - GLOWM,https://www.glowm.com/resources/glowm/cd/pages/drugs/p016.html,DB00417
L6187,FDA Approved Drug Products: Spironolactone,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012151,DB00421
L4449,FDA Approved Drug Products: Aldactone (spironolactone) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/012151s062lbl.pdf,DB00421
L6037,CADDRA - Canadian ADHD Practice Guidelines,https://www.caddra.ca/pdfs/caddraGuidelines2011.pdf,DB00422
L10073,Concerta FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021121s038lbl.pdf,DB00422
L10442,FDA Approved Drug Products: Daytrana® transdermal system,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021514s030lbl.pdf,DB00422
L6265,FDA Approved Drug Products: Robaxin,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011011,DB00423
L6268,FDA Approved Drug Products: Robaxin Intramuscular Injection,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011790,DB00423
L6295,Pfizer Canada: Robax,https://www.pfizer.ca/non-prescription-products/robax,DB00423
L5581,FDA Drug Safety Communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR,https://www.fda.gov/Drugs/DrugSafety/ucm352085.htm,DB00425
L5584,"NIH Stat Pearls, Internet: Zolpidem",https://www.ncbi.nlm.nih.gov/books/NBK442008/,DB00425
L5590,"Questions and Answers: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist)",https://www.fda.gov/drugs/drugsafety/ucm334041.htm,DB00425
L90,Link,http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Streptozocin.htm,DB00428
L6631,Prochlorperazine Tablets BP 5mg - Summary of Product Characteristics,https://www.medicines.org.uk/emc/product/4553/smpc,DB00433
L6634,Prochlorperazine - FDA Approval Package,https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21019A_Compazine_appltrs_prntlbl.pdf,DB00433
L6637,Prochlorperazine - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK537083/,DB00433
L6640,Prochlorperazine - LiverTox - NIH,https://livertox.nih.gov/Prochlorperazine.htm,DB00433
L6643,Prochlorperazine — the forgotten antiemetic - UF Health,http://cdn.webservices.ufhealth.org/wp-content/blogs.dir/358/files/2011/11/0609-drugs-therapy-bulletin.pdf,DB00433
L6646,Prochlorperazine Prescribing Information - AA Pharma,https://www.aapharma.ca/downloads/en/PIL/Prochlorazine_PI.pdf,DB00433
L6649,Prochlorperazine - National Library of Medicine HSDB Database,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3171,DB00433
L5674,"Allopurinol approval package, FDA label",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016084,DB00437
L5677,"Allopurinol, DailyMed",https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=allopurinol,DB00437
L11887,Health Canada Product Monograph: Polyrimethoprim (polymyxin B/trimethoprim) ophthalmic solution,https://pdf.hres.ca/dpd_pm/00016847.PDF,DB00440
L11890,Health Canada Product Monograph: Trimethoprim oral tablets,https://pdf.hres.ca/dpd_pm/00025165.PDF,DB00440
L11893,FDA Approved Drug Products: Trimethoprim oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018679s044lbl.pdf,DB00440
L11896,FDA Approved Drug Products: Primsol (trimethoprim) oral solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/074973s008lbl.pdf,DB00440
L11830,FDA Approved Drug Products: Bactrim (sulfamethoxazole/trimethoprim) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017377s074lbl.pdf,DB00440
L11851,Health Canada Product Monograph: Septra (sulfamethoxazole/trimethoprim) for intravenous injection,https://pdf.hres.ca/dpd_pm/00043890.PDF,DB00440
L11917,CaymanChem: Trimethoprim MSDS,https://www.caymanchem.com/msdss/16473m.pdf,DB00440
L11863,FDA Approved Drug Products: Sulfamethoxazole/Trimethoprim oral suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/077612s005lbl.pdf,DB00440
L91,Link,http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Gemcitabine.htm,DB00441
L11991,FDA Approved Drug Products: Diprosone (Betamethasone dipropionate) ointment,https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/17691s19lbl.pdf,DB00443
L11994,FDA Approved Drug Products: Celestone Soluspan (betamethasone sodium phosphate and betamethasone acetate) injectable suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/014602s062lbl.pdf,DB00443
L10782,"DIPROLENE® (augmented betamethasone dipropionate) ointment, for topical use - FDA Label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018741s040lbl.pdf,DB00443
L11997,FDA Approved Drug Products: Luxiq (betamethasone valerate) Foam,https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20934lbl.pdf,DB00443
L12000,FDA Approved Drug Products: Enstilar (calcipotriene and betamethasone dipropionate) foam,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207589s005s006s007lbl.pdf,DB00443
L6340,Lansoprazole - Drugs and Lactation Database,https://www.ncbi.nlm.nih.gov/books/NBK501283/,DB00448
L12432,FDA Approved Drug Products: Prevacid (lansoprazole),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020406s087s088,021428s034s035lbl.pdf",DB00448
L10562,FDA Approved Drug Products: Synthroid® oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021402s024s028lbl.pdf,DB00451
L8486,Health Canada Product Monograph: Claritin (loratadine),https://pdf.hres.ca/dpd_pm/00051759.PDF,DB00455
L8618,Comparative Pharmacology of the H1 Antihistamines,http://www.jiaci.org/issues/vol16s1/2.pdf,DB00455
L5828,"FDA approval information, Prazosin",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=071745,DB00457
L5831,"Cardiac anesthesiology, University of Toronto",http://pie.med.utoronto.ca/CA/CA_content/CA_cardiacPhys_peripheralResistance.html,DB00457
L5837,The pharmacology of adrenergic receptors,http://www.uky.edu/~mtp/OBI836AR.html,DB00457
L12987,FDA Approved Drug Products: Minipress (prazosin) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017442%20s043lbl.pdf,DB00457
L1348,AACAP: Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/ Hyperactivity Disorder,http://www.aacap.org/App_Themes/AACAP/docs/practice_parameters/jaacap_adhd_2007.pdf,DB00458
L1349,APA: Practice Guideline for the Treatment of Patients with Panic Disorder,https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf,DB00458
L1351,APA: Practice Guideline for the Treatment of Patients with Schizophrenia Second Edition,https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/schizophrenia.pdf,DB00458
L1352,APA: Practice Guideline for the Treatment of Patients with Bipolar Disorder Second Edition,https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/bipolar.pdf,DB00458
L1353,APA: Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder,https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/acutestressdisorderptsd.pdf,DB00458
L1360,TOXNET: Imipramine,http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+3100,DB00458
L6466,Nabumetone Health Canada Monograph,https://pdf.hres.ca/dpd_pm/00042393.PDF,DB00461
L6565,ChemIDplus: Nabumetone,https://chem.nlm.nih.gov/chemidplus/rn/42924-53-8,DB00461
L6568,FDA: Relafen,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019583,DB00461
L12807,FDA Approved Products: Relafen (nabumetone) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019583s023lbl.pdf,DB00461
L6358,Acular FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019700s028lbl.pdf,DB00465
L6508,Ketorolac Tromethamine IV/IM,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=bb3cb6eb-5f5e-4389-81df-2095198c0565&type=display,DB00465
L6511,Ketorolac: A Reappraisal of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Use In Pain Management,https://link.springer.com/article/10.2165/00003495-199753010-00012,DB00465
L6520,Ketorolac for Pain Management: A Review of the Clinical Evidence),https://www.ncbi.nlm.nih.gov/books/NBK254117/pdf/Bookshelf_NBK254117.pdf,DB00465
L11055,FDA Approved Drug Products: Ketorolac tromethamine oral tablets,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1191f151-ab29-1f7e-e054-00144ff88e88&type=display,DB00465
L3674,FDA Approved Drug Products: Toradol (ketorolac tromethamine) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019645s019lbl.pdf,DB00465
L11070,FDA Approved Drug Products: Sprix (ketorolac tromethamine) nasal spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022382s018lbl.pdf,DB00465
L63,Link,http://yosemite.epa.gov/oswer/CeppoEHS.nsf/Profiles/124-87-8?OpenDocument,DB00466
L6301,Singulair (montelukast sodium) US FDA Label 2019,https://www.merck.com/product/usa/pi_circulars/s/singulair/singulair_pi.pdf,DB00471
L6304,Apo-Montelukast Canadian Product Monograph,https://pdf.hres.ca/dpd_pm/00049133.PDF,DB00471
L6307,Electronic Medicines Compendium: Montelukast 10 mg Film Coated Tablets Monograph,https://www.medicines.org.uk/emc/product/1243/smpc,DB00471
L6310,NCBI StatPearls [Internet]: Montelukast Profile,https://www.ncbi.nlm.nih.gov/books/NBK459301/,DB00471
L6325,Electronic Medicines Compendium: Montelukast 4mg Chewable Tablets Monograph,https://www.medicines.org.uk/emc/product/6098/smpc,DB00471
L6328,Montelukast sodium tablets and chewable tablets Canadian Product Monograph,https://pdf.hres.ca/dpd_pm/00035313.PDF,DB00471
L6331,Electronic Medicines Compendium: Montelukast 5 mg Chewable Tablets Monograph,https://www.medicines.org.uk/emc/product/2710/smpc,DB00471
L7664,Prozac FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018936s103,021235s023lbl.pdf",DB00472
L7721,Fluoxetine: A case history of its discovery and preclinical development,https://pdfs.semanticscholar.org/b3f2/73276b41415c203b19627f2a29d70a32a5d2.pdf,DB00472
L8441,The Distribution of Fluoxetine in Human Fluids and Tissues,https://watermark.silverchair.com/31-7-409.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAlswggJXBgkqhkiG9w0BBwagggJIMIICRAIBADCCAj0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMxq-BdA0pD4hBv9fbAgEQgIICDi9e5SvYdtSTd4n3-ojFsd3phOj6pqFzsbalEBbPOpwULSMguJn_LLSPIgFAyvDZTzElshjv7v1lNiLqb8oVellZb22LL5Zt_sMLZsh6BITXlS-jG-MAQrwGnqi-ExPTlUm-aehAYMpw7Nx9JHGpAXKF1AkHxZ9EMNd5U24o8BBQLvPbykxmSRb0NRhxqz3lAhGzQHQNzYprgkznEu4MX5QwUYuTmxBgZusq9Actqtixc3hcxmsnygZY5CHQzC2u8lIr6GB8vDT5Pc9rDnYMHRzBlNRAYmxcL-UphitDIKgQ3GGxLDhM6kNaaZGBZpA0zTWUJuXs9YulpoviYcDHkwEae5fclzgF902nxuz7XSYli9cY-mqAnntE8jFn8NVrqVbxFzKr0IRb_MzQCD-WU1XE122FsoG0jKpvhpSOJ0VF2BzuHetWI7y1FiB1BJ8-xtNEf_d_0oIsQbmDhJjjgw7P0H_J6I-Xba3WouJx_cay7oQyTr5B6f_dO9oAoeaHaatNci2zlHoWmsNNRCmMMdwlOAs45z63wihln_w0-PlBppn63qgRMUo-7BFytjAVUl6pyf0JG2MkvtqVHfFQU3n8cYNrfGuYN_VirR4yfviv8c3QpYVHkG56bKuOCRYeGevdftSprL8MWpsOV7kiiYEJEaaJTOgg-BOwAIuXpcQUPcC3xULFqRECDCjuBA0,DB00472
L8468,DailyMed - Fluoxetine,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59de2889-c3d3-4ebf-8826-13f30a3fa439,DB00472
L162,Flockhart Table of Drug Interactions,https://drug-interactions.medicine.iu.edu/Main-Table.aspx,DB00472
L12297,Health Canada Product Monograph: Fluoxetine oral capsules,https://pdf.hres.ca/dpd_pm/00038615.PDF,DB00472
L6364,Cymbalta Health Canada Monograph,https://pdf.hres.ca/dpd_pm/00035593.PDF,DB00476
L6367,Yentreve EMA SmPC,https://www.ema.europa.eu/en/documents/product-information/yentreve-epar-product-information_en.pdf,DB00476
L6370,EAU Stress Urinary Incontinence Guidelines,https://uroweb.org/guideline/urinary-incontinence/#1,DB00476
L6454,Original FDA Label Cymbalta,https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21427lbl.pdf,DB00476
L12810,FDA Approved Products: Cymbalta (duloxetine) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021427s049lbl.pdf,DB00476
L4673,FDA Approves Arikayce,https://www.drugs.com/newdrugs/fda-approves-arikayce-amikacin-liposome-inhalation-suspension-mycobacterium-avium-complex-mac-lung-4829.html,DB00479
L4680,Stat Pearls: Amikacin,https://www.ncbi.nlm.nih.gov/books/NBK430908/,DB00479
L4681,FDA approves a new antibacterial drug to treat a serious lung disease using a novel pathway to spur innovation,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm622048.htm,DB00479
L10662,EVISTA (raloxifene hydrochloride) Tablet for Oral Use - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022042lbl.pdf,DB00481
L3293,"FDA drug safety, June 28 2018",https://www.fda.gov/Drugs/DrugSafety/ucm611959.htm,DB00482
L3294,Medscape drug reference,https://www.medscape.com/viewarticle/895722,DB00482
L3296,Pfizer Medical Information,https://www.pfizermedicalinformation.ca/en-ca/celebrex/action-and-clinical-pharmacology,DB00482
L7592,"Medicines UK, Celebrex 200mg capsule",https://www.medicines.org.uk/emc/product/2945/smpc,DB00482
L7604,"FDA approvals, Celebrex",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020998,DB00482
L7607,Bpac NZ: Celecoxib,https://bpac.org.nz/2018/celecoxib.aspx,DB00482
L7610,CaymanChem: Celecoxib MSDS,https://www.caymanchem.com/msdss/10008672m.pdf,DB00482
L7622,US Pharmacist: Cardiovascular risk associated with NSAIDS and COX2 inhibitors,https://www.uspharmacist.com/article/cardiovascular-risk-associated-with-nsaids-and-cox2-inhibitors,DB00482
L7646,FDA Approved Drug Products: Celebrex (celecoxib) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020998s050lbl.pdf,DB00482
L6535,MIRVASO (brimonidine) topical gel - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204708lbl.pdf,DB00484
L6538,Brimonidine (brimonidine tartrate) ophthalmic solution - Product Monograph,https://www.sandoz.ca/sites/www.sandoz.ca/files/Brimonidine%20Product%20Monograph.pdf,DB00484
L6544,Mirvaso (brimonidine) topical gel - EU Summary of Product Characteristics,https://www.ema.europa.eu/en/documents/product-information/mirvaso-epar-product-information_en.pdf,DB00484
L10674,ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020613s031lbl.pdf,DB00484
L6334,FDA Approved Drug Products: Sotalol,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019865,DB00489
L6373,FDA Approved Drug Products: Sotalol Intravenous,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022306,DB00489
L6376,FDA Approved Drug Products: Sotalol Oral Solution,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205108,DB00489
L6379,Dailymed: Sotalol Tablets,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62a71c8c-d92d-4122-848f-9ae35f8bbe2b,DB00489
L7375,Buspirone - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK531477/,DB00490
L7381,Buspirone (hydrochloride) Safety Data Sheet - Cayman Chemical,https://www.caymanchem.com/msdss/22028m.pdf,DB00490
L7384,Buspirone hydrochloride (B7148) - Sigma Aldrich Product Information Sheet,https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/b7148pis.pdf,DB00490
L4478,BuSpar® (buspirone HCl) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18731s39s45lbl.pdf,DB00490
L6460,FDA Approved Drug Products: Percodan,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007337,DB00497
L106,Link,http://www.patient.co.uk/showdoc/30002156/,DB00498
L92,Link,http://www.bccancer.bc.ca/HPI/DrugDatabase/DrugIndexPro/Flutamide.htm,DB00499
L2018,Clinical pharmacology of atypical antipsychotics: an update,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464358/,DB00502
L2021,"Mechanism of Action of Antipsychotics, Haloperidol and Olanzapine in vitro",https://vtechworks.lib.vt.edu/handle/10919/31133,DB00502
L2022,Haloperidol Overview,https://www.sciencedirect.com/topics/neuroscience/haloperidol,DB00502
L2028,Haldol Decanoate,https://www.medicines.org.uk/emc/product/968,DB00502
L12525,FDA Approved Drug Products: Haldol (haloperidol) for injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/015923s095lbl.pdf,DB00502
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB00503
L3513,"FDA Approved Drug Products: NORVIR (ritonavir) Capsules, Soft Gelatin for Oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020945s033lbl.pdf,DB00503
L12357,FDA Approved Drug Products: Norvir (ritonavir) for oral use,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020659s071,%20209512s006,%20022417s023lbl.pdf",DB00503
L12363,CaymanChem: Ritonavir MSDS,https://www.caymanchem.com/msdss/13872m.pdf,DB00503
L1416,"Nitazoxanide, Pub Chemistry",https://pubchem.ncbi.nlm.nih.gov/compound/nitazoxanide#section=Top,DB00507
L1417,EPA Chemistry Dashboard: Nitazoxanide,https://comptox.epa.gov/dashboard/dsstoxdb/results?search=DTXSID5033757,DB00507
L1422,Nitazoxanide: A New Thiazolide Antiparasitic Agent,https://academic.oup.com/cid/article/40/8/1173/320667,DB00507
L1424,"Validated and optimized high-performance liquid chromatographic determination of tizoxanide, the main active metabolite of nitazoxanide in human urine, plasma and breast milk.",https://watermark.silverchair.com/bms041.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAa8wggGrBgkqhkiG9w0BBwagggGcMIIBmAIBADCCAZEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM-kpbjlKq5U2lFyDhAgEQgIIBYtw6PzXSgZ5bAcaADgK2chDdauq8S51YHhYRw2Y7CIqmEeNFeLDH-rPr1iU638KpXjSSSF4fxBrEqou8j3cmjinfNQE6HzzUfT1TW-mw2FG6HRriDDfPiAtqmYjqfHnj1uoWLgg9akVMmPkY9wzidxGUnBnkVUSeRFt2OCyUmPnB4jgKL-rn-0xMBo-jQtYEFjbZQe4yDLXsCVGzj_gOvGh6p_jYdqHBmqiSC77yOgylIcZ_OGn_RkHOnUNM66W0MIjnQb4mWYa_hRTYffMU2OX2oYVkrmOUkkDEmxeF2J3mL-xz3SKmGZ0JtwyBc_bkblRXVNt8ci9BESlTsIvnQlFY6ZP0eF21RF3IRwxZp4T5D6yZOUR9o9FLP51YoOiXvzNra-NL7gonkbC0zM32XUNXL8d2d6IB0gcGl81HVTjSjNJJ-HJKM4eI-ZUNNFu4vIVwlNA7WetsoU8aZsrzZ6w4zg,DB00507
L1425,"Pharmacology review, Nitazoxanide",https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-497_Alinia_Pharmr_P1.pdf,DB00507
L1196,CutisPharma Announces FDA Approval of Firvanq (vancomycin) for Treatment of Clostridium Difficile Associated Diarrhea and Staphylococcus Aureus Colitis,https://www.drugs.com/newdrugs/cutispharma-announces-fda-approval-firvanq-vancomycin-clostridium-difficile-associated-diarrhea-4687.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+January+30%2C+2018&utm_content=CutisPharma+Announces+FDA+Approval+of+Firvanq+%28vancomycin%29+for+Treatment+of+Clostridium+Difficile+Associated+Diarrhea+and+Staphylococcus+Aureus+Colitis,DB00512
L14363,FDA Approved Drug Products: Neudexta Dextromethorphan Hydrobromide and Quinidine Sulfate Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021879s014lbl.pdf,DB00514
L14366,"Dailymed: Brompheniramine, Pseudoephedrine, and Dextromethorphan Oral Syrup",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e241d83e-996c-494d-b3fe-97f1ef4809ed,DB00514
L14369,Dailymed: Guaifenesin and Dextromethorphan Oral Extended Release Tablets,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=70987d06-d206-445f-bd0d-5e1345b8465c,DB00514
L9218,FDA Approved Drugs Products: Albendazole Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020666s012lbl.pdf,DB00518
L7330,FDA Approved Drug Products: Omnicef (cefdinir),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050739s015,050749s021lbl.pdf",DB00535
L7336,"Pfizer MSDS, Cefdinir",https://www.pfizer.com/system/files/products/material_safety_data/PD012.pdf,DB00535
L7339,Omnicef,https://www.rxlist.com/omnicef-drug.htm,DB00535
L7351,Appropriate prescribing of beta-lactamase antibiotics,https://www.aafp.org/afp/2000/0801/p611.html,DB00535
L7354,Dailymed: Cefdinir capsule,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=145e4a41-286e-4033-97c4-92d674d7bb89,DB00535
L6463,FDA Approved Drug Products: Cipro,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019537,DB00537
L6469,FDA Approved Drug Products: Cetraxal Solution/Drops;Otic,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021918,DB00537
L6472,FDA Approved Drug Products: Ciloxan Solution/Drops; Opthmalmic,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019992,DB00537
L6475,FDA Approved Drug Products: Ciloxan Ointment; Opthalmic,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020369,DB00537
L6478,FDA Approved Drug Products: Cipro Injection,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019847,DB00537
L6481,FDA Approved Drug Products: Cipro Oral Suspension,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020780,DB00537
L6484,FDA Approved Drug Products: Cipro HC Suspension/Drops; Otic,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020805,DB00537
L6487,FDA Approved Drug Products: Cipro XR Extended Release Tablet,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021554,DB00537
L6490,FDA Approved Drug Products: Ciprodex Suspension/Drops; Otic,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021537,DB00537
L6493,FDA Approved Drug Products: Otiprio Injection,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207986,DB00537
L6529,Pfizer: Ciprofloxacin MSDS,https://www.pfizer.com/sites/default/files/products/material_safety_data/PZ01031.pdf,DB00537
L11875,EMC Summary of product characteristics: Nortriptyline,https://www.medicines.org.uk/emc/product/4090/smpc,DB00540
L11878,FDA Approved Products: Nortriptyline oral capsules and oral solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018012s27lbl.pdf,DB00540
L11881,NIH StatPearls: Nortriptyline,https://www.ncbi.nlm.nih.gov/books/NBK482214/,DB00540
L11899,Product monograph: Nortriptyline tablets,https://pdf.hres.ca/dpd_pm/00001266.PDF,DB00540
L11911,MedSafe NZ data sheet: Nortriptyline tablets,https://www.medsafe.govt.nz/profs/datasheet/n/nortriptylinenrimtab.pdf,DB00540
L11920,CaymanChem MSDS: Nortriptyline,https://www.caymanchem.com/msdss/15904m.pdf,DB00540
L7,Link,http://www.medicinenet.com/acetohydroxamic_acid-oral/article.htm,DB00551
L9404,Lamictal FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020241s060,020764s053,022251s024lbl.pdf",DB00555
L12183,FDA Approved Products: Lamictal (lamotrigine) chewable dispersible tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020241s10s21s25s26s27,020764s3s14s18s19s20lbl.pdf",DB00555
L9680,Health Canada Product Monograph: Hydroxyzine HCl oral capsules,https://www.aapharma.ca/downloads/en/PIL/2018/Hydroxyzine-Pr_Info_Mono-ENG-Jul_09_2018.pdf,DB00557
L9722,CaymanChem: Hydroxyzine MSDS,https://www.caymanchem.com/msdss/24039m.pdf,DB00557
L11007,FDA Approved Drug Products: Hydroxyzine HCl oral tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/088617Orig1s043,088618Orig1s043,088619Orig1s044lbl.pdf",DB00557
L9677,FDA Approved Drug Products: Vistaril (hydroxyzine pamoate),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/011459s048,011795s025lbl.pdf",DB00557
L7144,FDA Approved Drug Products: Methotrexate Oral Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208004s002lbl.pdf,DB00563
L7147,FDA Approved Drug Products: Methotrexate Subcutaneous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205776s002lbl.pdf,DB00563
L7150,FDA Approved Drug Products: Methotrexate Prefilled Syringe for Subcutaneous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204824s009lbl.pdf,DB00563
L7180,FDA Approved Drug Products: Methotrexate Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011719s125lbl.pdf,DB00563
L7198,FDA Approved Drug Products: Methotrexate Sodium Oral Tablets,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008085,DB00563
L7204,Cayman Chemicals: Methotrexate MSDS,https://www.caymanchem.com/msdss/13960m.pdf,DB00563
L10457,FDA Approved Drug Products: RediTrex Methotrexate Subcutaneous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210737s000lbl.pdf,DB00563
L1335,Carbamazepine FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021710s11s012lbl.pdf,DB00564
L7195,"Pharm KGB, carbamazepine pathway, pharmacokinetics",https://www.pharmgkb.org/pathway/PA165817070,DB00564
L7156,Carbamazepine MSDS,https://www.caymanchem.com/msdss/15422m.pdf,DB00564
L7216,"ipolar Disorders and Carbamazepine: Pharmacokinetics,Pharmacodynamics, Therapeutic Effects and Indications of Carbamazepine: Review of Articles",https://www.omicsonline.org/open-access/bipolar-disorders-and-carbamazepine-pharmacokineticspharmacodynamics-therapeutic-effects-and-indications-ofcarbamazepine-review-of-2472-095X-1000112.php?aid=79291,DB00564
L995,GlaxoSmithKline: NIMBEX injection product information,http://www.gsk.com.au/resources.ashx/prescriptionmedicinesproductschilddataproinfo/78/FileName/3B9D6BE9E90F11117038850DBCAFE2A1/PI_Nimbex.pdf,DB00565
L6541,Cephalexin Product Monograph,https://pdf.hres.ca/dpd_pm/00043813.PDF,DB00567
L6547,FDA Approved Drug Products: Cephalexin Oral Capsule,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050405,DB00567
L6550,FDA Approved Drug Products: Cephalexin Oral Suspension,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050406,DB00567
L6553,FDA Approved Drug Products: Cephalexin Oral Tablet,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=063024,DB00567
L6901,FDA Approved Drug Products: Propranolol Oral Solution,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205410,DB00571
L6904,FDA Approved Drug Products: Propranolol Oral Tablet,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016762,DB00571
L6907,FDA Approved Drug Products: Propranolol Extended Release Capsule,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021438,DB00571
L14522,FDA Approved Drug Products: Fintepla (fenfluramine) oral solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212102s000lbl.pdf,DB00574
L7237,FDA Approved Drug Products: Catapres Clonidine Hydrochloride Oral Tablets,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017407,DB00575
L7240,FDA Approved Drug Products: Catapres Clonidine Transdermal System,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018891s028lbl.pdf,DB00575
L7243,FDA Approved Drug Products: Duraclon Clonidine Hydrochloride Injection Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020615s003lbl.pdf,DB00575
L7246,FDA Approved Drug Products: Kapvay Clonidine Hydrochloride Oral Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022331s013lbl.pdf,DB00575
L7276,Cayman Chemicals: Clonidine MSDS,https://www.caymanchem.com/msdss/15949m.pdf,DB00575
L5668,Valacyclovir: AAFP,https://www.aafp.org/afp/2003/0215/p757.html,DB00577
L5671,Valacyclovir approval package,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-550S012_Valacyclovir.cfm,DB00577
L12324,FDA Approved Drug Products: Betra (valdecoxib) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21341lbl.pdf,DB00580
L6199,Lactulose Canadian Product Monograph,https://pdf.hres.ca/dpd_pm/00031381.PDF,DB00581
L6202,NCBI StatPearls [Internet]: Lactulose,https://www.ncbi.nlm.nih.gov/books/NBK536930/#article-24004.s1,DB00581
L6205,WHO Model List of Essential Medicines 19th List (April 2015 - Amended November 2015),https://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1,DB00581
L6586,Enalapril Oral Tablets - Product Monograph,https://pdf.hres.ca/dpd_pm/00035279.PDF,DB00584
L6619,Angiotensin Converting Enzyme Inhibitors (ACEI) - StatPearls,https://www.ncbi.nlm.nih.gov/books/NBK431051/,DB00584
L10734,VASOTEC® (Enalapril Maleate) Tablets - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/018998s076lbl.pdf,DB00584
L7360,Drugs@FDA: Voltaren Delayed Release,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019201,DB00586
L12693,Health Canada Product Monograph: Diclofenac oral tablets,https://pdf.hres.ca/dpd_pm/00054964.PDF,DB00586
L5962,FDA Approved Drug Products December 1990,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process&rptName=2&reportSelectMonth=12&reportSelectYear=1990&nav,DB00588
L8309,FDA Approved Drugs: Dymista nasal spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202236s010lbl.pdf,DB00588
L7282,Doxazosin FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019668s021lbl.pdf,DB00590
L7285,"FDA approval package, Cardura",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019668,DB00590
L7288,"MSDS, Pfizer",https://www.pfizer.com/sites/default/files/products/material_safety_data/PZ01040.pdf,DB00590
L7294,Cardura XL label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021269s011lbl.pdf,DB00590
L7297,Cardura monograph,https://www.pfizer.ca/sites/g/files/g10050796/f/201710/CARDURA_PM_Eng_201486_4Apr2017.pdf,DB00590
L4676,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202368,DB00591
L4682,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a52763d0-7024-48a8-9cca-3127333dfb01,DB00591
L4683,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be70a464-f936-4721-8cbb-b106075bfd4d,DB00591
L4684,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4400e471-7402-11df-93f2-0800200c9a66,DB00591
L4685,Drugs.com,https://www.drugs.com/newdrugs/fda-approves-yutiq-fluocinolone-acetonide-intravitreal-implant-chronic-non-infectious-posterior-4845.html,DB00591
L4686,Retina today,http://retinatoday.com/pdfs/0609_12.pdf,DB00591
L7724,FDA Approved Drug Products: Normodyne Labetalol Hydrochloride Injection (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018686,DB00598
L7727,FDA Approved Drug Products: Labetalol Hydrochloride Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019425s021lbl.pdf,DB00598
L7730,FDA Approved Drug Products: Labetalol Hydrochloride Tablet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018716s026lbl.pdf,DB00598
L8657,FDA Approved Drug Products: Provera Medroxyprogesterone Acetate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/011839s071lbl.pdf,DB00603
L8660,FDA Approved Drug Products: Conjugated Estrogens and Medroxyprogesterone Acetate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020527s065lbl.pdf,DB00603
L8663,FDA Approved Drug Products: Medroxyprogesterone Acetate Subcutaneous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021583s023lbl.pdf,DB00603
L8666,FDA Approved Drug Products: Medroxyprogesterone Acetate Intramuscular Injection 150mg/mL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020246s058lbl.pdf,DB00603
L8669,FDA Approved Drug Products: Medroxyprogesterone Acetate Intramuscular Injection 400mg/mL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/012541s086lbl.pdf,DB00603
L8696,Pfizer Canada: Depo-Provera Monograph,https://www.pfizer.ca/sites/default/files/201803/DEPO-PROVERA_PM_E_210121_13Feb2018.pdf,DB00603
L8738,Cayman Chemicals: Medroxyprogesterone Acetate MSDS,https://www.caymanchem.com/msdss/23664m.pdf,DB00603
L12051,FDA Approved Drug Products: Chloroquine Phosphate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/083082s050lbl.pdf,DB00608
L12054,FDA Approved Drug Products: Aralen Chloroquine Oral Tablets (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=006002,DB00608
L14312,FDA: Emergency use Authorization for Hydroxychloroquine and Chloroquine Revoked,https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and,DB00608
L7219,Bisoprolol monograph,https://www.sandoz.ca/sites/www.sandoz.ca/files/Bisoprolol_TAB_Monograph.pdf,DB00612
L7222,Summary of product characteristics,https://www.medicines.org.uk/emc/product/6126/smpc,DB00612
L7228,"Bisoprolol, health links AU",http://secure.healthlinks.net.au/content/apo/index_pi_apo.cfm?product=txpbisop,DB00612
L7231,CaymanChem: Bisoprolol MSDS,https://www.caymanchem.com/msdss/23827m.pdf,DB00612
L7234,"Monograph, Bisoprolol",http://www.labriva.com/monographies/02471272eng.pdf,DB00612
L9743,"FDA Approved Drug Products: Talicia Amoxicillin, Omeprazole, and Rifabutin Oral Delayed Release Capsules",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213004lbl.pdf,DB00615
L8243,FDA Approved Drug Products: Aristocort Triamcinolone Oral Tablets (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011161,DB00620
L8246,FDA Approved Drug Products: Triamcinolone Hexacetonide Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/016466s046lbl.pdf,DB00620
L8249,FDA Approved Drug Products: Triamcinolone Acetonide Topical Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/012104s032lbl.pdf,DB00620
L8252,FDA Approved Drug Products: Triamcinolone Acetonide 10mg/mL Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012041s045lbl.pdf,DB00620
L8255,FDA Approved Drug Products: Triamcinolone Acetonide 40mg/mL Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/014901s045lbl.pdf,DB00620
L8258,FDA Approved Drug Products: Triamcinolone Acetonide Topical Cream,https://www.accessdata.fda.gov/drugsatfda_docs/label/pre96/011601s036lbl.pdf,DB00620
L8261,FDA Approved Drug Products: Triamcinolone Acetonide Intravitreal Injection,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022223,022048lbl.pdf",DB00620
L8264,FDA Approved Drug Products: Triamcinolone Acetonide Intraarticular Extended Release Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208845s000lbl.pdf,DB00620
L8285,Cayman Chemicals: Triamcinolone Acetonide MSDS,https://www.caymanchem.com/msdss/18026m.pdf,DB00620
L8983,FDA Approved Drug Products: Vogelxo Testosterone Gel,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204399s000lbl.pdf,DB00624
L8935,FDA Approved Drugs: Natesto,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205488s002lbl.pdf,DB00624
L8938,FDA Approved Drugs: Testim,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021454s027lbl.pdf,DB00624
L8986,FDA Approved Drug Products: Fortesta Testosterone Topical Gel,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021463s020lbl.pdf,DB00624
L8989,FDA Approved Drug Products: Androgel 1.62% Testosterone Topical Gel,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022309s020lbl.pdf,DB00624
L8992,FDA Approved Drug Products: Androgel 1% Testosterone Topical Gel,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021015s045lbl.pdf,DB00624
L8995,FDA Approved Drug Products: Androderm Testosterone Transdermal System,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020489s034lbl.pdf,DB00624
L7748,FDA Approved Drug Products: Bacitracin Injection,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=060733,DB00626
L7769,"FDA Approved Drug Products: Bacitracin, Neomycin, and Polymyxin B Ophthalmic Ointment",https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50417slr011_neosporin_lbl.pdf,DB00626
L7772,"FDA Approved Drug Products: Bacitracin, Neomycin, Polymyxin B, and Hydrocortisone Topical Ointment",https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50168slr078_cotisporin_lbl.pdf,DB00626
L7775,Pfizer: Corticosporin Safety Data Sheet,https://www.pfizer.com/sites/default/files/products/material_safety_data/Cortisporin_Ointment_1-Sep-2015.pdf,DB00626
L7784,FDA Briefing Document: Bacitracin for Intramuscular Injection,https://www.fda.gov/media/123641/download,DB00626
L7550,FDA Approved Drug Products: Niacin Film Coated Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020381s048lbl.pdf,DB00627
L7553,FDA Approved Drug Products: Niacin Oral Tablet,https://www.accessdata.fda.gov/drugsatfda_docs/anda/2000/40378_Niacor_Prntlbl.pdf,DB00627
L7556,FDA Approved Drug Products: M.V.I. Pediatric Multivitamin Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018920s038lbl.pdf,DB00627
L7559,FDA Approved Drug Products: Infuvite Pediatric Multivitamin Intravenous Injection,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021265s030,021646s022lbl.pdf",DB00627
L7562,FDA Approved Drug Products: Infuvite Adult Multivitamin Intravenous Injection,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021163s032,021559s025lbl.pdf",DB00627
L7565,FDA Approved Drug Products: M.V.I. Adult Multivitamin Intravenous Injection,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021625s023,021643s019lbl.pdf",DB00627
L7580,Jubilant Life Sciences: Niacin MSDS,https://www.jubl.com/lsi/uploads/files/133msds_Niacin.pdf,DB00627
L9182,FDA Approved Drugs: Alendronate,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020560s070lbl.pdf,DB00630
L10496,FDA Approved Drug Products: Meticorten Prednisone Oral Tablets (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009766,DB00635
L10502,FDA Approved Drug Products: Rayos Prednisone Delayed-Release Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/202020s003lbl.pdf,DB00635
L10583,ZOCOR FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019766s100lbl.pdf,DB00641
L10686,FDA Approved Drug Products: Nystatin oral suspension,https://www.accessdata.fda.gov/drugsatfda_docs/anda/98/64142ap_appltr_prntlbl_chemr.pdf,DB00646
L10728,DPD Approved Drugs: Nystatin,https://pdf.hres.ca/dpd_pm/00010205.PDF,DB00646
L10731,DPD Approved Drugs: Viaderm K.C.®,https://pdf.hres.ca/dpd_pm/00046265.PDF,DB00646
L10743,ThermoFisher Scientific: Nystatin MSDS,https://www.fishersci.com/store/msds?partNumber=BP29495&productDescription=NYSTATIN+5+G&vendorId=VN00033897&countryCode=US&language=en,DB00646
L10749,MedSafe NZ: Nystatin,https://www.medsafe.govt.nz/Profs/Datasheet/n/nilstatcapdrpowdtabcrointvagcr.pdf,DB00646
L10776,DPD Approved Drugs: Flagystatin® vaginal ovules,https://pdf.hres.ca/dpd_pm/00046934.PDF,DB00646
L342,FDA data,http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/Darvocet-N_July2009.pdf,DB00647
L350,Drug Information,http://www.rxlist.com/darvon-drug.htm,DB00647
L351,Drugs.com,https://www.drugs.com/propoxyphene.html,DB00647
L8357,Xalatan FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020597s044lbl.pdf,DB00654
L8360,Caymanchem MSDS,https://www.caymanchem.com/msdss/16812m.pdf,DB00654
L8363,"Latanoprost, drugs.com",https://www.drugs.com/mtm/latanoprost-ophthalmic.html,DB00654
L8366,"Xalatan, Canadian monograph",https://www.pfizer.ca/sites/default/files/201710/xalatan-non-annotated-pm-195072-E.pdf,DB00654
L8369,Rocklatan FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208259s000lbl.pdf,DB00654
L8402,Sandoz Latanoprost monograph,https://www.sandoz.ca/sites/www.sandoz.ca/files/Sandoz%20Latanoprost%20Product%20Monograph.pdf,DB00654
L3484,Trazodone,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018207s032lbl.pdf,DB00656
L7483,"Monograph, Trazodone",https://pdf.hres.ca/dpd_pm/00030282.PDF,DB00656
L7486,"Trazodone overdose, NIH Medline",https://medlineplus.gov/ency/article/002559.htm,DB00656
L7492,"Rapid structure determination of microgram-level drug metabolites using HPLC-MS, fraction collection and NMR spectroscopy",https://pubs.rsc.org/en/content/articlelanding/2010/ay/c0ay00290a#!divAbstract,DB00656
L7547,"FDA application review, Trazodone",https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022411s000MedR.pdf,DB00656
L10478,FDA Approved Drug Products: Verelan® PM extended-release capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020943s035lbl.pdf,DB00661
L10481,FDA Approved Drug Products: Verapamil HCl for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018925s010lbl.pdf,DB00661
L8791,Verapamil FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018817s033lbl.pdf,DB00661
L10517,FDA Approved Drugs: Tarka® extended-release tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020591s030lbl.pdf,DB00661
L10523,CaymanChem: Verapamil MSDS,https://www.caymanchem.com/msdss/14288m.pdf,DB00661
L10637,FDA Approved Drug Products: Calan SR tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019152s044lbl.pdf,DB00661
L4353,Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths.,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm617173.htm,DB00668
L4354,"Epinephrine, by Injection: NIH",https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010119/?report=details,DB00668
L4355,Symjepi Approval History,https://www.drugs.com/history/symjepi.html,DB00668
L4356,FDA approves Auvi-Q,https://www.drugs.com/newdrugs/sanofi-announces-fda-approval-auvi-q-first-voice-guided-epinephrine-auto-injector-patients-3424.html,DB00668
L4358,Epipen.ca,https://www.epipen.ca,DB00668
L4361,Medicines UK document,https://www.medicines.org.uk/emc/product/4289/smpc#PHARMACOKINETIC_PROPS,DB00668
L4824,Croup: American Family Physician Document,https://www.aafp.org/afp/2011/0501/p1067.html,DB00668
L4825,NIH STAT pearls,https://www.ncbi.nlm.nih.gov/books/NBK482160/,DB00668
L4827,PubChem: Epinephrine,https://pubchem.ncbi.nlm.nih.gov/compound/epinephrine#section=Absorption-Distribution-and-Excretion,DB00668
L6793,FDA Approved Drug Products: Sumatriptan and Naproxen Oral Tablets,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021926,DB00669
L6796,FDA Approved Drug Products: Sumatriptan Nasal Powder,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206099,DB00669
L6799,FDA Approved Drug Products: Sumatriptan Nasal Spray,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210884,DB00669
L6805,FDA Approved Drug Products: Sumatriptan Subcutaneous Injection,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020080,DB00669
L6808,FDA Approved Drug Products: Sumatriptan Subcutaneous Solution,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208223,DB00669
L6811,FDA Approved Drug Products: Sumatriptan Oral Tablets,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020132,DB00669
L6844,"Sumatriptan Tablets, USP monograph",https://pdf.hres.ca/dpd_pm/00036027.PDF,DB00669
L9332,FDA Approved Drug Products: Aprepitant Oral Capsules,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021549s031,207865s004lbl.pdf",DB00673
L9335,FDA Approved Drug Products: Aprepitant Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209296s003lbl.pdf,DB00673
L13571,"FDA Approved Drug Products: RAZADYNE (galantamine hydrobromide), for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021615s021lbl.pdf,DB00674
L13694,"DailyMed Label: RAZADYNE - galantamine hydrobromide CAPSULE, EXTENDED RELEASE RAZADYNE - galantamine hydrobromide TABLET, FILM COATED",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec9b5a9c-8caf-4f9b-8c1b-209b2de556dc,DB00674
L13709,Fisher Scientific: Galantamine hydrobromide MSDS,https://www.fishersci.com/store/msds?partNumber=AAJ6248203&productDescription=GALANTHAMINE+HYDROBROMIDE+1G&vendorId=VN00024248&countryCode=US&language=en,DB00674
L7799,FDA Approved Drug Products: Tamoxifen Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/17970s37s44s49lbl.pdf,DB00675
L7802,FDA Approved Drug Products: Tamoxifen Oral Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf,DB00675
L7423,FDA Approved Drug Products: Losartan Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020386s062lbl.pdf,DB00678
L7426,FDA Approved Drug Products: Losartan and Hydrochlorothiazide Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020387s063lbl.pdf,DB00678
L7441,Cayman Chemicals: Losartan Potassium MSDS,https://www.caymanchem.com/msdss/10006594m.pdf,DB00678
L6616,Warfarin DPD Monograph,https://pdf.hres.ca/dpd_pm/00047189.PDF,DB00682
L6622,ChemIDplus: Warfarin,https://chem.nlm.nih.gov/chemidplus/rn/81-81-2,DB00682
L6625,HSDB: Warfarin,http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+1786,DB00682
L6628,LactMed: Warfarin,http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+lactmed:@term+@DOCNO+279,DB00682
L4333,FDA Approved Drug Products: COUMADIN (warfarin sodium),https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/009218s107lbl.pdf,DB00682
L5074,Drug Scheduling: United States Drug Enforcement Administration (DEA),https://www.dea.gov/drug-scheduling,DB00683
L5092,DailyMed: Midazolam,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=9a443652-6aff-4e27-83fe-90c65fa0f3c1&type=display,DB00683
L6559,NAYZILAM® (midazolam) nasal spray - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211321s000lbl.pdf,DB00683
L11740,Dailymed: Trovan (trovafloxacin mesylate) oral tablet,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875,DB00685
L8971,DPD Approved Drugs: Florinef,https://pdf.hres.ca/dpd_pm/00050125.PDF,DB00687
L8974,MedSafe NZ: Florinef,https://www.medsafe.govt.nz/profs/Datasheet/f/Florineftab.pdf,DB00687
L8977,UK Approved Drugs: Fludrocortisone,https://www.medicines.org.uk/emc/product/2266,DB00687
L9055,CaymanChem: Fludrocortisone acetate MSDS,https://www.caymanchem.com/msdss/24032m.pdf,DB00687
L7363,"FDA label, Mycophenolate mofetil","https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050722s021,050723s019,050758s019,050759s024lbl.pdf",DB00688
L7366,"MSDS, Mycophenolate mofetil",http://datasheets.scbt.com/sc-200971.pdf,DB00688
L8,Link,http://www.inchem.org/documents/pims/pharm/pim640.htm,DB00690
L7958,Furosemide - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018667s036lbl.pdf,DB00695
L7961,Furosemide - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK499921/,DB00695
L7964,Furosemide SAFETY DATA SHEET - Cayman Chemical,https://www.caymanchem.com/msdss/17273m.pdf,DB00695
L9659,Lasix Oral (furosemide) Product Monograph,http://products.sanofi.ca/en/lasix.pdf,DB00695
L6064,Reflexes: Components of a Reflex Arc,https://courses.lumenlearning.com/boundless-ap/chapter/reflexes/,DB00697
L6856,FDA Approved Drug Products: Macrocrystalline Nitrofurantoin Oral Capsule,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016620,DB00698
L6859,FDA Approved Drug Products: Nitrofurantoin and Macrocrystalline Nitrofurantoin Oral Capsule,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020064,DB00698
L6862,FDA Approved Drug Products: Nitrofurantoin Oral Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/009175s046lbl.pdf,DB00698
L6895,FDA Approved Drug Products: Nitrofurantoin Oral Tablet,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008693,DB00698
L6238,FDA Approved Drug Products: Flomax,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020579,DB00706
L6259,Urology Times: Urologists no longer primary initiator of tamsulosin,https://www.urologytimes.com/modern-medicine-feature-articles/urologists-no-longer-primary-initiator-tamsulosin,DB00706
L4717,FDA approves Dsuvia,https://www.drugs.com/newdrugs/fda-approves-dsuvia-sufentanil-sublingual-severe-pain-4855.html,DB00708
L4718,"Noting Military Potential, FDA Approves Powerful Painkiller Dsuvia",https://www.wsj.com/articles/noting-military-potential-fda-approves-powerful-painkiller-dsuvia-1541200765,DB00708
L13805,FDA Approved Drug Products: Boniva Ibandronate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021455s021lbl.pdf,DB00710
L13808,FDA Approved Drug Products: Boniva Ibandronate Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021858s022lbl.pdf,DB00710
L13919,FDA Approved Drug Products: Apomorphine Subcutaneous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021264s018lbl.pdf,DB00714
L13922,FDA Approved Drug Products: Apomorphine Sublingual Film,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210875lbl.pdf,DB00714
L14012,Cayman Chemical: Apomorphine MSDS,https://www.caymanchem.com/msdss/16094m.pdf,DB00714
L7700,Paxil CR FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020936s053lbl.pdf,DB00715
L3358,Paroxetine FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020031s067,020710s031.pdf",DB00715
L7703,Brisdelle FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204516s000lbl.pdf,DB00715
L7706,"GSK monograph, Paxil",https://ca.gsk.com/media/530543/paxil_pm-2014-11-13.pdf,DB00715
L7712,Paxil,https://www.drugs.com/paxil.html,DB00715
L7715,Putting GlaxoSmithKline to the test over paroxetine,https://www.bmj.com/bmj/section-pdf/749788?path=/bmj/347/7933/Feature.full.pdf,DB00715
L7718,Annotation of CPIC Guideline for paroxetine and CYP2D6,https://www.pharmgkb.org/guidelineAnnotation/PA166127636,DB00715
L7733,Sandoz paroxetine tablets,https://www.sandoz.ca/sites/www.sandoz.ca/files/Sandoz%20Paroxetine%20tablets%20PMe%2020170315.pdf,DB00715
L7742,"Paroxetine, psychopharmacology institute",https://psychopharmacologyinstitute.com/section/paroxetine-moa-indications-pharmacokinetics-and-dosing-2051-4053#%20Pharmacokinetics,DB00715
L9527,DPD Approved Drugs: Jencycla oral tablets,https://pdf.hres.ca/dpd_pm/00051107.PDF,DB00717
L10301,FDA Approved Drug Products: CombiPatch® transdermal system,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020870s023lbl.pdf,DB00717
L10304,FDA Approved Drug Products: Femhrt® tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021065s024lbl.pdf,DB00717
L10310,FDA Approved Drug Products: Lupaneta Pack for intramuscular and oral use,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203696s001lbl.pdf,DB00717
L10313,FDA Approved Drug Products: Generess Fe chewable tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022573s008lbl.pdf,DB00717
L10307,FDA Approved Drug Products: Lo Loestrin Fe oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022501s000lbl.pdf,DB00717
L10433,CaymanChem: Norethisterone MSDS,https://www.caymanchem.com/msdss/20941m.pdf,DB00717
L10439,The Embryo Project Encyclopedia: Progestin,https://embryo.asu.edu/pages/progestin-synthetic-progesterone,DB00717
L13910,Health Canada Approved Drug Products: Clodronate Oral Capsules,https://pdf.hres.ca/dpd_pm/00041216.PDF,DB00720
L1215,Clinical Trial NCT00299897,https://www.clinicaltrials.gov/ct2/show/NCT00299897,DB00721
L12438,FDA Approved Drug Products: Novocain Procain Hydrochloride Injection,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=c80c810a-60e0-49bd-139c-95aec3a286fc&type=display,DB00721
L8384,FDA Approved Drug Products: Lisinopril Oral Tablet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019558s062lbl.pdf,DB00722
L8387,FDA Approved Drug Products: Lisinopril Oral Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208401s002lbl.pdf,DB00722
L8390,FDA Approved Drug Products: Lisinopril and Hydrochlorothiazide Oral Tablet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019888s067lbl.pdf,DB00722
L8399,Cayman Chemicals: Lisinopril MSDS,https://www.caymanchem.com/msdss/16833m.pdf,DB00722
L4429,Nitrostat® (Nitroglycerin) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021134s007lbl.pdf,DB00727
L7096,Rectiv FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021359s000lbl.pdf,DB00727
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB00727
L7099,Nitroglycerin in Dextrose FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019970s015lbl.pdf,DB00727
L7102,Nitroglycerin pump spray monograph,http://products.sanofi.ca/en/nitrolingual-pumpspray.pdf,DB00727
L7105,"Nitroglycerin MSDS, Pfizer",https://www.pfizer.com/sites/default/files/products/material_safety_data/Nitroglycerin_in_Dextrose_Injection_(hospira)060214.pdf,DB00727
L7138,"MSDS, Nitroglycerin",https://www.restek.com/documentation/msds/31498_useng.pdf,DB00727
L7141,Transdermal nitroglycerin,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020145s027lbl.pdf,DB00727
L1213,Risperidone in the Treatment of Schizophrenia,https://www.researchgate.net/publication/15685471_Marder_SR_Meibach_RC_Risperidone_in_the_treatment_of_schizophrenia_Am_J_Psychiatry_151_825-835,DB00734
L1214,Pharmacokinetics of Risperidone: Clinical Summary,https://psychopharmacologyinstitute.com/antipsychotics/risperidone/pharmacokinetics-risperidone/,DB00734
L12885,FDA Approved Drug Products: Risperdal (risperidone) for oral use,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020272s085,020588s072,021444s058lbl.pdf",DB00734
L12900,FDA Approved Drug Products: Risperdal Consta (risperidone) long-acting intramuscular injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021346s063lbl.pdf,DB00734
L12903,FDA Approved Drug Products: Perseris (risperidone) extended-release suspension for subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210655s004lbl.pdf,DB00734
L12906,Health Canada Product Monograph: Risperdal (risperidone) oral tablets,https://pdf.hres.ca/dpd_pm/00047330.PDF,DB00734
L6760,Antivert (meclizine hydrochloride) - Drug Summary - PDR.net,https://www.pdr.net/drug-summary/Antivert-meclizine-hydrochloride-1822,DB00737
L6766,"BONAMINE® (Meclizine Hydrochloride Tablets 25 mg, USP) - Product Monograph",https://pdf.hres.ca/dpd_pm/00013453.PDF,DB00737
L6772,ANTIVERT® - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/010721s058lbl.pdf,DB00737
L10529,FDA Approved Drug Products: Vosol Hydrocortisone and Glacial Acetic Acid Otic Drops,https://www.accessdata.fda.gov/drugsatfda_docs/label/1997/012770s024lbl.pdf,DB00741
L10532,"FDA Approved Drug Products: Casporyn Neomycin Sulfate, Polymixin B Sulfate, and Hydrocortisone Otic Drops",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/060613s013lbl.pdf,DB00741
L10535,FDA Approved Drug Products: Cortef Hydrocortisone Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/008697s036lbl.pdf,DB00741
L10538,FDA Approved Drug Products: Cortenema Hydrocortisone Rectal Enema,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/016199s035lbl.pdf,DB00741
L7772,"FDA Approved Drug Products: Bacitracin, Neomycin, Polymyxin B, and Hydrocortisone Topical Ointment",https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50168slr078_cotisporin_lbl.pdf,DB00741
L7321,FDA Approved Drug Products: Xerese Topical Cream With Hydrocortisone,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022436s004lbl.pdf,DB00741
L10574,FDA Approved Drug Products: Hydrocortone Hydrocortisone Oral Tablets (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008506,DB00741
L64,Link,http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/203185.html,DB00746
L7213,FDA Approved Drug Products: Clopidogrel Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020839s072lbl.pdf,DB00758
L8333,CaymenChem: Methimazole MSDS,https://www.caymanchem.com/msdss/23718m.pdf,DB00763
L8336,FDA Approved Drugs: Methimazole,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/040320s005lbl.pdf,DB00763
L8339,DPD Approved Drugs: Methimazole,http://www.paladin-labs.com/our_products/tapazole_en.pdf?ver=4.0,DB00763
L7877,Augmentin drug summary,https://www.pdr.net/drug-summary/Augmentin-XR-amoxicillin-clavulanate-potassium-2206,DB00766
L7880,FDA Approved Drug Products: Augmentin Amoxicillin and Clavulanate Oral Tablets and Suspension,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050564s053s055,050575s040s042,050597s047s049,050720s026s028,050725s028s030,050726s022s024lbl.pdf",DB00766
L7886,Public assessment report: CO-AMOXCOO,http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con059922.pdf,DB00766
L7898,"EMA, Clavulanic acid summary report",https://www.ema.europa.eu/en/documents/mrl-report/clavulanic-acid-summary-report-1-committee-veterinary-medicinal-products_en.pdf,DB00766
L7904,"Augmentin IV, Medicines UK",https://www.medicines.org.uk/emc/medicine/2025,DB00766
L7907,Timentin FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050658s022lbl.pdf,DB00766
L7910,"Monograph, Clavulin",https://ca.gsk.com/media/590864/clavulin.pdf,DB00766
L6781,PAZEO (olopatadine hydrochloride ophthalmic solution) - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206276s000lbl.pdf,DB00768
L6784,PATANASE (olopatadine hydrochloride) Nasal Spray - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021861lbl.pdf,DB00768
L6787,"Opatanol, INN-olopatadine - European Medicines Agency - Europa EU",https://www.ema.europa.eu/en/documents/product-information/opatanol-epar-product-information_en.pdf,DB00768
L6790,OLOPATADINE - Product Monograph - Sandoz Canada Inc.,https://www.sandoz.ca/sites/www.sandoz.ca/files/Olopatadine%200_2%25%20Product%20Monograph.pdf,DB00768
L10761,Patanol (olopatadine hydrochloride ophthalmic solution) 0.1% - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20688slr016_patanol_lbl.pdf,DB00768
L12462,FDA Approved Drug Products: Saluron Hydroflumethiazide Oral Tablets,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6153ef9e-77f0-4233-a5bc-3e3d1f732323,DB00774
L8627,FDA Approved Drugs: Oxcarbazepine,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021014s043lbl.pdf,DB00776
L8630,DPD Approved Drugs: Oxcarbazepine,https://pdf.hres.ca/dpd_pm/00048247.PDF,DB00776
L8633,MedSafe NZ: Oxcarbazepine,https://www.medsafe.govt.nz/profs/Datasheet/t/Trileptaltab.pdf,DB00776
L8672,CaymenChem: Oxcarbazepine MSDS,https://www.caymanchem.com/msdss/17340m.pdf,DB00776
L10121,FDA Approved Drug Products: Oxtellar XR extended-release oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202810s010lbl.pdf,DB00776
L9,Link,http://home.intekom.com/pharm/hmr/rulide.html,DB00778
L1356,Nardil monograph,https://davisplus.fadavis.com/3976/meddeck/pdf/phenelzine.pdf,DB00780
L1365,New Zealand report,http://www.medsafe.govt.nz/profs/Datasheet/n/nardiltab.pdf,DB00780
L11485,FDA Approved Products: Estrace (Estradiol) oral tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/081295s014,084499s042,084500s044lbl.pdf",DB00783
L11488,FDA Approved Products: Evamist (Estradiol) transdermal spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022014s001lbl.pdf,DB00783
L11491,FDA Approved Products: Depo-Estradiol (estradiol cypionate) for injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/085470s015lbl.pdf,DB00783
L11494,FDA Approved Products: Estring (Estradiol vaginal ring),https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020472s007lbl.pdf,DB00783
L11497,FDA Approved Products: Climara (estradiol) transdermal system,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020375s026lbl.pdf,DB00783
L11500,FDA approved products: Estrace (estradiol vaginal cream),https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/86069s018lbl.pdf,DB00783
L11503,Estra-50 (Estradiol pellet) implantable,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=596a20bd-d93d-4c48-e053-2991aa0ad4ca,DB00783
L11530,FDA Approved Products: Esclim (Estradiol) transdermal system,https://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20847lblpt.pdf,DB00783
L11560,NIH StatPearls: Estradiol,https://www.ncbi.nlm.nih.gov/books/NBK549797/,DB00783
L11563,Pfizer MSDS: Estradiol tablets MSDS,https://www.pfizer.com/sites/default/files/products/material_safety_data/PZ00638.pdf,DB00783
L11566,CaymanChem: Ethinyl estradiol safety data sheet,https://www.caymanchem.com/msdss/10006486m.pdf,DB00783
L11662,FDA Approved Products: Premarin (conjugated estrogens) vaginal cream,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020216s073s074s075lbl.pdf,DB00783
L7303,FDA Approved Drug Products: Zovirax Topical Cream,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021478s007lbl.pdf,DB00787
L7315,"FDA Drug Approval Package: Zovirax Oral Capsules, Oral Tablets, Oral Suspension",https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/018828s031lbl.pdf,DB00787
L7318,FDA Approved Drug Products: Zovirax Topical Ointment,https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/018604s018lbl.pdf,DB00787
L7321,FDA Approved Drug Products: Xerese Topical Cream With Hydrocortisone,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022436s004lbl.pdf,DB00787
L7324,FDA Approved Drug Products: Sitavig Buccal Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203791s000lbl.pdf,DB00787
L7327,FDA Approved Drug Products: Avaclyr Ophthalmic Ointment (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/0202408s000lbl.pdf,DB00787
L10328,FDA Approved Drug Products: Zovirax Acyclovir Intravenous Infusion (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018603s030lbl.pdf,DB00787
L6582,Naprelan FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020353s034lbl.pdf,DB00788
L6583,Naprosyn FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017581s113,018164s063,020067s020lbl.pdf",DB00788
L6595,Over-the-counter Medications in Pregnancy,https://www.aafp.org/afp/2003/0615/p2517.html,DB00788
L7309,Treximet FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021926s013lbl.pdf,DB00788
L7312,Vimovo FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022511s023lbl.pdf,DB00788
L4645,Electronic Medicines Compendium: Primidone 50 mg Tablet Monograph,https://www.medicines.org.uk/emc/product/2941/smpc,DB00794
L11112,FDA Approved Drug Products: Mysoline Primidone Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/009170s035lbl.pdf,DB00794
L11199,Cayman Chemical: Primidone MSDS,https://www.caymanchem.com/msdss/19277m.pdf,DB00794
L6226,"Paxipam approval, FDA",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017736,DB00801
L6229,"Federal drug register, FDA",https://www.federalregister.gov/documents/2004/05/05/04-10194/schering-corp-et-al-withdrawal-of-approval-of-92-new-drug-applications-and-49-abbreviated-new-drug,DB00801
L9239,FDA Approved Drug Products: Alfentanil Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019353s023lbl.pdf,DB00802
L7967,"FDA Approved Drug Products: Dicyclomine Oral Capsules, Oral Tablets, and Intramuscular Injections","https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/007409s042,008370s033lbl.pdf",DB00804
L7982,"Canadian Agency for Drugs and Technologies in Health: Dicyclomine for Gastrointestinal Conditions: A Review of the Clinical Effectiveness, Safety, and Guidelines",https://www.ncbi.nlm.nih.gov/books/NBK350056/pdf/Bookshelf_NBK350056.pdf,DB00804
L2899,Thiazide Diruetics in Hypertension- European Journal of Cardiology,https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-8/Thiazide-diuretics-in-hypertension,DB00808
L2900,Significant Drug–Drug Interactions with Antineoplastics,https://www.ebi.ac.uk/chembl/target/inspect/CHEMBL1876,DB00808
L13982,FDA Approved Drug Products: Lozol (Indapamide),https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/018538s028lbl.pdf,DB00808
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB00811
L11019,FDA Approved Drug Products: Rebetol (ribavirin) oral capsules,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020903s055,021546s011lbl.pdf",DB00811
L6598,FDA Approved Drug Products: Abstral Sublingual Tablet,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022510,DB00813
L6601,FDA Approved Drug Products: Actiq Transmucosal Lozenge,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020747,DB00813
L6604,FDA Approved Drug Products: Fentora Buccal Tablet,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021947,DB00813
L6607,FDA Approved Drug Products: Subsys Sublingual Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202788s016lbl.pdf,DB00813
L922,FDA Approved Drug Products: Duragesic Transdermal System,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019813,DB00813
L6610,FDA Approved Drug Products: Lazanda Metered Nasal Spray,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022569,DB00813
L6613,FDA Approved Drug Products: Sublimaze Preservative Free Intramuscular and Intravenous Injection,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016619,DB00813
L6748,CDC Drug Overdose Deaths 2017,https://www.cdc.gov/drugoverdose/data/statedeaths.html,DB00813
L6751,Government of Canada: Canada's opioid crisis,https://www.canada.ca/en/services/health/campaigns/drug-prevention.html,DB00813
L11398,FDA approved products: Mobic (meloxicam) oral tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020938s024s025,021530s014s015lbl.pdf",DB00814
L11470,Medsafe NZ: Mobictab (meloxicam) oral tablets,https://www.medsafe.govt.nz/profs/Datasheet/m/Mobictab.pdf,DB00814
L11473,American College of Cardiology: Meloxicam,https://www.cardiosmart.org/Healthwise/d045/32/d04532,DB00814
L14240,FDA Approved Drug Products: DIAMOX SEQUELS (acetazolamide extended release) oral capsules,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/12945s037,038lbl.pdf",DB00819
L14492,AA Pharma Inc.: ACETAZOLAMIDE Product Monograph,https://pdf.hres.ca/dpd_pm/00045130.PDF,DB00819
L5188,Electronic Medicines Compendium: Diazepam Tablets BP 2mg Monograph,https://www.medicines.org.uk/emc/product/4523/smpc,DB00829
L5200,"Xeris Pharmaceuticals Awarded Phase I-II NIH SBIR Fast Track Grant to Advance a Stable, Non-Aqueous Diazepam, Subcutaneous Injection for Treatment of Acute Repetitive Seizures in Patients with Epilepsy: Press Release",https://globenewswire.com/news-release/2015/10/01/772768/0/en/Xeris-Pharmaceuticals-Awarded-Phase-I-II-NIH-SBIR-Fast-Track-Grant-to-Advance-a-Stable-Non-Aqueous-Diazepam-Subcutaneous-Injection-for-Treatment-of-Acute-Repetitive-Seizures-in-Pat.html,DB00829
L11247,FDA Approved Drug Products Valtoco Diazepam Nasal Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211635s000lbl.pdf,DB00829
L13895,FDA Approved Drug Products: Oxazepam oral capsules,https://genesight.com/wp-content/uploads/2017/05/Serax-FDA-Label.pdf,DB00842
L13898,Health Canada Product Monograph: Oxazepam oral tablets,https://pdf.hres.ca/dpd_pm/00038954.PDF,DB00842
L13904,CaymanChem: Oxazepam MSDS,https://www.caymanchem.com/msdss/15909m.pdf,DB00842
L7916,Donepezil FDA label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf",DB00843
L7919,"Australian monograph, Donepezil",https://www.sunpharma.com/australia-pi-download/50508/Donepezil,DB00843
L7928,"Pfizer MSDS, Donepezil hydrochloride",https://www.pfizer.com/sites/default/files/products/material_safety_data/PZ00471.pdf,DB00843
L7937,"FDA label, Namzaric",https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206439lbl.pdf,DB00843
L7952,"Pfizer monograph, donepezil",https://www.pfizer.ca/sites/default/files/201612/ARICEPT_PM_E_177353_18Dec2014_R.pdf,DB00843
L13802,FDA Approved Drug Products: Lamprene (clofazimine) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019500s014lbl.pdf,DB00845
L13820,CaymanChem: Clofazimine MSDS,https://www.caymanchem.com/msdss/23301m.pdf,DB00845
L6232,FDA approval: Levamisole,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020035,DB00848
L11031,FDA Approved Drug Products: Zyrtec Cetirizine and Pseudoephedrine Oral Tablets (OTC),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/19835slr016,21150slr005,30346slr011_zyrtec_lbl.pdf",DB00852
L11037,FDA Approved Drug Products: Motrin Cold and Sinus Ibuprofen and Pseudoephedrine Oral Caplets (OTC),https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019899Orig1s019lbl.pdf,DB00852
L11040,FDA Approved Drug Products: Semprex Avacristine and Pseudoephedrine Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019806s013lbl.pdf,DB00852
L11046,FDA Approved Drug Products: Mucinex Guaifenesin and Pseudoephedrine Oral Extended Release Tablets (OTC),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021620Orig1s038,021585Orig1s033lbl.pdf",DB00852
L11052,FDA Approved Drug Products: Loratadine and Pseudoephedrine Oral Extended Release Tablets (OTC),https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/75706_Loratadine%20And%20Pseudoephedrine%20Sulfate_Prntlbl.pdf,DB00852
L11058,FDA Approved Drug Products: Clarinex 12 Hour Desloratadine and Pseudoephedrine Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021313s012lbl.pdf,DB00852
L11061,FDA Approved Drug Products: Clarinex 24 Hour Desloratadine and Pseudoephedrine Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021605s017lbl.pdf,DB00852
L9064,FDA Approved Drug Products: Lamisil Terbinafine Hydrochloride Topical Cream (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020192,DB00857
L9065,FDA Approved Drug Products: Lamisil Terbinafine Hydrochloride Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020539s033lbl.pdf,DB00857
L9068,"Health Canada Approved Drug Products: Lamisil Terbinafine Oral Tablets, Topical Cream, and Topical Spray",https://pdf.hres.ca/dpd_pm/00035035.PDF,DB00857
L10487,Cayman Chemicals: Terbinafine MSDS,https://www.caymanchem.com/msdss/10011619m.pdf,DB00857
L9431,FDA Approved Drug Products: Delta-Cortef Prednisolone Oral Tablets (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009987,DB00860
L9542,FDA Approved Drug Products: Prednisolone Oral Syrup,https://www.accessdata.fda.gov/drugsatfda_docs/anda/99/40287_Prednisolone_Prntlbl.pdf,DB00860
L9545,Cayman Chemicals: Prednisolone MSDS,https://www.caymanchem.com/msdss/20866m.pdf,DB00860
L9449,FDA Approved Drug Products: Prednisolone Acetate Oral Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022067s007lbl.pdf,DB00860
L9452,FDA Approved Drug Products: Prednisolone Acetate Ophthalmic Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017100s045lbl.pdf,DB00860
L9440,FDA Approved Drug Products: Orapred Prednisolone Sodium Phosphate Orally Disintegrating Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021959s004lbl.pdf,DB00860
L9437,FDA Approved Drug Products: Pediapred Prednisolons Sodium Phosphate Oral Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019157s021lbl.pdf,DB00860
L5861,FDA drug approval package: Zantac,https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/18703S56_zantac.cfm,DB00863
L10818,FDA Approved Drug Products: ZANTAC (ranitidine hydrochloride) injection,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019090s053,019593s042lbl.pdf",DB00863
L10821,GlaxoSmithKline Canada Inc. Product Monograph: Zantac (ranitidine),https://ca.gsk.com/media/592906/zantac.pdf,DB00863
L10923,Ranitidine product monograph,https://pdf.hres.ca/dpd_pm/00043712.PDF,DB00863
L8162,FDA Approved Drug Products: Tacrolimus Oral Capsules,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050708s050,050709s042,210115s002lbl.pdf",DB00864
L11193,FDA Approved Drug Products: TESSALON (benzonatate) Perle and Capsule,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/011210s053lbl.pdf,DB00868
L11196,Cayman Chemical: Benzonatate MSDS,https://www.caymanchem.com/msdss/23936m.pdf,DB00868
L11377,FDA Approved Drug Products: TRUSOPT (dorzolamide hydrochloride) ophthalmic solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020408s050lbl.pdf,DB00869
L11380,"FDA Approved Drug Products: COSOPT PF (dorzolamide hydrochloride, timolol maleate) ophthalmic solution",https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202667s000lbl.pdf,DB00869
L11386,Cayman Chemical Safety Data Sheet: Dorzolamide (hydrochloride),https://www.caymanchem.com/msdss/14616m.pdf,DB00869
L12435,NIH DailyMed: Suprofen,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8de2c303-5d99-46b6-ad6d-a4caadea3604,DB00870
L4539,Electronic Medicines Compendium: Loteprednol etabonate Monograph,https://www.medicines.org.uk/emc/product/6212,DB14596
L4545,Inveltys FDA Approval Press Release,https://www.drugs.com/newdrugs/fda-approves-inveltys-loteprednol-etabonate-post-operative-inflammation-pain-following-ocular-4808.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+August+24%2C+2018&utm_content=FDA+Approves+Inveltys+%28loteprednol+etabonate%29+for+Post-Operative+Inflammation+and+Pain+Following+Ocular+Surgery,DB14596
L6079,MyHealth.Alberta.ca Network: Guaifenesin - Oral Profile,https://myhealth.alberta.ca/Health/medications/Pages/conditions.aspx?hwid=fdb0118&,DB00874
L6100,Electronic Medicines Compendium: Robitussin Chesty Cough Medicine Monograph,https://www.medicines.org.uk/emc/product/3879/smpc,DB00874
L13011,FDA Approved Drug Products: Teveten HCT (eprosartan mesylate/hydrochlorothiazide) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021268s019lbl.pdf,DB00876
L11464,Health Canada Product Monograph: Peridex (chlorhexidine gluconate) oral rinse,https://pdf.hres.ca/dpd_pm/00004798.PDF,DB00878
L11512,FDA Approved Drug Products: Peridex (chlorhexidine gluconate) oral rinse,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019028s020lbl.pdf,DB00878
L11518,FDA Approved Drug Products: Avagard (chlorhexidine/ethyl alcohol) topical solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021074Orig1s012lbl.pdf,DB00878
L11521,FDA Approved Drug Products: Pre-Scrub (chlorhexidine gluconate) topical scrub,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019822Orig1s008lbl.pdf,DB00878
L11527,FDA Approved Drug Products: ChloraPrep One-Step (chlorhexidine/isopropyl alcohol) topical swab,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/21555Orig1s024lbl.pdf,DB00878
L11533,FDA Approved Drug Products: Chlorhexidine gluconate topical cloth,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021669Orig1s023lbl.pdf,DB00878
L11536,FDA Approved Drug Products: PerioChip (chlorhexidine gluconate) chip for oral insertion,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020774s012lbl.pdf,DB00878
L11539,CaymanChem: Chlorhexidine MSDS,https://www.caymanchem.com/msdss/17343m.pdf,DB00878
L11572,WHO Guidelines on Hand Hygiene in Health Care (2009),https://apps.who.int/iris/bitstream/handle/10665/44102/9789241597906_eng.pdf;jsessionid=E945C08B4281AF2C17706CBFAA43FD18?sequence=1,DB00878
L9010,FDA Press Announcements: FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic,https://www.fda.gov/news-events/press-announcements/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic,DB00879
L9019,FDA Approved Drug Products: Emtriva (Emtricitabine) Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021500s029lbl.pdf,DB00879
L4388,FDA Approved Drug Products: Descovy (Emtricitabine and Tenofovir Alafenamide) Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208215s012lbl.pdf,DB00879
L9818,Cayman Chemicals: Emtricitabine MSDS,https://www.caymanchem.com/msdss/16879m.pdf,DB00879
L9833,FDA Approved Drug Products: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021752s055lbl.pdf,DB00879
L9836,"FDA Approved Drug Products: Symtuza (Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210455s004lbl.pdf,DB00879
L9587,"FDA Approved Drug Products: Stribild (Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate) Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203100s034lbl.pdf,DB00879
L9839,"FDA Approved Drug Products: Odefsey (Emtricitabine, Rilpivirine, and Tenofovir Alafenamide)",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208351s006lbl.pdf,DB00879
L9647,"FDA Approved Drug Products: Genvoya (Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/207561s023lbl.pdf,DB00879
L9842,"FDA Approved Drug Products: Complera (Emtricitabine, Rilpivirine, Tenofovir Disoproxil Fumarate) Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202123s029lbl.pdf,DB00879
L9845,"FDA Approved Drug Products: Biktarvy (Bictegravir, Emtricitabine, and Tenofovir Alafenamide) Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210251s006lbl.pdf,DB00879
L9848,"FDA Approved Drug Products: Atripla (Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate) oral tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021937s044lbl.pdf,DB00879
L8420,FDA Approved Drug Products: Quinapril Oral Tablet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019885s043lbl.pdf,DB00881
L8423,FDA Approved Drug Products: Quinapril and Hydrochlorothiazide Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020125s022lbl.pdf,DB00881
L8429,Cayman Chemicals: Quinapril MSDS,https://www.caymanchem.com/msdss/21439m.pdf,DB00881
L8432,Pfizer Canada: Quinapril Oral Tablets,https://pdf.hres.ca/dpd_pm/00038674.PDF,DB00881
L5864,Risedronate Sodium Tablet MSDS,https://www.greenstonellc.com/sites/default/files/pdfs/MSDS/RISEDRONATE%20SODIUM%20TABLETS%20MSDS_0.pdf,DB00884
L9179,FDA Approved Drugs: Risedronic Acid Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020835s048lbl.pdf,DB00884
L9644,FDA Approved Drug Products: Risedronic Acid Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022560s007lbl.pdf,DB00884
L10226,Iron dextran FDA LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017441s171lbl.pdf,DB00893
L5203,Electronic Medicines Compendium: Zofran (ondansetron hydrochloride dihydrate) Tablets 4mg and 8mg Monograph,https://www.medicines.org.uk/emc/product/195/smpc,DB00904
L5221,"Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US: Press Release",https://www.cnbc.com/2016/04/11/globe-newswire-midatechas-commercial-launch-of-zuplenza-ondansetron-oral-soluble-film-to-prevent-post-operative-chemotherapy-and-radiation.html,DB00904
L6877,FDA Approved Drug Products: Lumigan (bimatoprost) ophthalmic solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022184s006lbl.pdf,DB00905
L6892,"Allergen monograph, Bimatoprost",https://allergan-web-cdn-prod.azureedge.net/allergancanadaspecialty/allergancanadaspecialty/media/actavis-canada-specialty/en/products/pms/lumigan-rc-pm-2016-05-11_e.pdf,DB00905
L6898,Bitamaprost MedSafe NZ,https://medsafe.govt.nz/Profs/Datasheet/b/BimatoprostMultichemeyedrops.pdf,DB00905
L6910,Latisse FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022369s005lbl.pdf,DB00905
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB00905
L6913,"Bimataprost metabolism, MDPI",https://www.mdpi.com/1420-3049/12/3/373/htm,DB00905
L11079,CaymanChem: Bimatoprost MSDS,https://www.caymanchem.com/msdss/10008027m.pdf,DB00905
L12069,FDA Approved Products: Durysta (bimatoprost) implant for intracameral administration,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211911s000lbl.pdf,DB00905
L12342,FDA Approved Products: Numbrino (cocaine hydrochloride) nasal solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209575s000lbl.pdf,DB00907
L12345,FDA Approved Products: Goprelto (cocaine hydrochloride) nasal solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209963lbl.pdf,DB00907
L12351,DailyMed: Cocaine hydrochloride solution,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=24faa247-fe12-4574-881d-445b078b3e87&type=display,DB00907
L65,Link,http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/500541.html,DB00911
L3754,Flagyl (Metronidazole) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/12623slr059_flagyl_lbl.pdf,DB00916
L7429,"FDA approvals, Metronidazole",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012623,DB00916
L7432,"Canadian monograph, Flagyl",http://products.sanofi.ca/en/flagyl.pdf,DB00916
L7474,Flagyl,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/012623s061lbl.pdf,DB00916
L12828,DailyMed: Flagyl (metronidazole) oral tablets,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b39cc0e4-57ad-4d70-a105-44ebccf201f8,DB00916
L9269,FDA Approved Drug Products: Almotriptan Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021001s015lbl.pdf,DB00918
L8405,CaymenChem: Cyclobenzaprine hydrochloride MSDS,https://www.caymanchem.com/msdss/15885m.pdf,DB00924
L8408,FDA Approved Drugs: Cyclobenzaprine,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017821s051lbl.pdf,DB00924
L8411,DPD Approved Drugs: Cyclobenzaprine,https://pdf.hres.ca/dpd_pm/00038944.PDF,DB00924
L11139,"FDA Approved Drug Products: PEPCID (famotidine) tablets, for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019462s039lbl.pdf,DB00927
L11142,"Mylan Pharmaceuticals Product Monograph: Famotidine, for intravenous injection",https://pdf.hres.ca/dpd_pm/00025674.PDF,DB00927
L11157,Cayman Chemical: Famotidine MSDS,https://www.caymanchem.com/msdss/23828m.pdf,DB00927
L11166,Famotidine - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK534778/,DB00927
L11172,Prophylaxis and management of stress ulceration - NCBI,https://www.ncbi.nlm.nih.gov/books/NBK6992/,DB00927
L7613,Cayman Chemicals: Misoprostol MSDS,https://www.caymanchem.com/msdss/13820m.pdf,DB00929
L7616,FDA Approved Drug Products: Misoprostol Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019268s051lbl.pdf,DB00929
L7619,FDA Approved Drug Products: Misoprostol and Diclofenac Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020607s031lbl.pdf,DB00929
L11542,FDA Approved Drug Products: Serevent Salmeterol Xinafoate Inhaled Metered Aerosol (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020236,DB00938
L11545,FDA Approved Drug Products: Wixela Inhub Fluticasone and Salmeterol Inhalation Powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208891Orig1s000lbl.pdf,DB00938
L11548,FDA Approved Drug Products: Serevent Diskus Salmeterol Inhalation Powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020692s047lbl.pdf,DB00938
L11551,FDA Approved Drug Products: Airduo Respiclick Fluticasone and Salmeterol Inhalation Powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208799s001lbl.pdf,DB00938
L11554,FDA Approved Drug Products: Advair HFA Fluticasone and Salmeterol Inhalation Aerosol,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021254s028lbl.pdf,DB00938
L11557,FDA Approved Drug Products: Advair Diskus Fluticasone and Salmeterol Inhalation Powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021077s061lbl.pdf,DB00938
L11569,Cayman Chemical: Salmeterol MSDS,https://www.caymanchem.com/msdss/16009m.pdf,DB00938
L5968,Mayo Clinic website: Salicylate,https://www.mayoclinic.org/drugs-supplements/salicylate-oral-route-rectal-route/proper-use/drg-20070551,DB00945
L12282,FDA Approved Products: Aspirin (acetylsalicylic acid) oral tablets,https://s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00945.pdf?1555434420,DB00945
L10779,DPD Approved Drugs: Allegra® oral tablets,https://pdf.hres.ca/dpd_pm/00053954.PDF,DB00950
L4269,Allegra (Fexofenadine Hydrochloride) FDA Label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020872s018,021963s002lbl.pdf",DB00950
L10800,FDA Approved Drug Products: Allegra-D® extended-release tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020786s026lbl.pdf,DB00950
L7913,FDA Label: Hydrocodone Tab ER,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206627s007s008lbl.pdf,DB00956
L7991,DPD Monograph: Dimetane Syrup,https://pdf.hres.ca/dpd_pm/00045954.PDF,DB00956
L9025,Drugs@FDA: Hycodan,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005213,DB00956
L11842,FDA Approved Drug Products: Ortho Cyclen Norgestimate and Ethinyl Estradiol Oral Tablets (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019653,DB00957
L11845,FDA Approved Drug Products: Ortho Tri-Cyclen Norgestimate and Ethinyl Estradiol Oral Tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019653s058,019697s054lbl.pdf",DB00957
L11848,FDA Approved Drug Products: Ortho Tri-Cyclen Lo Norgestimate and Ethinyl Estradiol Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021241s027lbl.pdf,DB00957
L10785,FDA Approved Drug Products: Medrol Methylprednisolone Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011153s075lbl.pdf,DB00959
L10788,FDA Approved Drug Products: Depo-Medrol Methylprednisolone Acetate Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011757s114lbl.pdf,DB00959
L10824,Cayman Chemicals: Methylprednisolone MSDS,https://www.caymanchem.com/msdss/15013m.pdf,DB00959
L12666,Efficacy and Safety of Corticosteroids in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04273321,DB00959
L108,Link,http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=355795,DB00965
L8240,FDA Approved Drugs: Azelastine nasal spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020114s028lbl.pdf,DB00972
L8270,FDA Approved Drugs: Azelastine ophthalmic solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021127s013lbl.pdf,DB00972
L8276,CaymenChem: Azelastine MSDS,https://www.caymanchem.com/msdss/20873m.pdf,DB00972
L8309,FDA Approved Drugs: Dymista nasal spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202236s010lbl.pdf,DB00972
L11347,FDA Approved Drug Products: Zetia (ezetimibe) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021445s033lbl.pdf,DB00973
L11401,FDA Approved Drug Products: Liptruzet (ezetimibe/atorvastatin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/200153s005lbl.pdf,DB00973
L11404,FDA Approved Drug Products: Vytorin (ezetimibe/simvastatin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021687s062lbl.pdf,DB00973
L11407,CaymanChem: Ezetimibe MSDS,https://www.caymanchem.com/msdss/16331m.pdf,DB00973
L11410,Health Canada Product Monograph: Ezetimibe oral tablets,https://pdf.hres.ca/dpd_pm/00028732.PDF,DB00973
L11884,FDA Approved Drug Products: Estinyl Ethinylestradiol Oral Tablets (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=005292,DB00977
L11944,FDA Approved Drug Products: Yaz Ethinylestradiol and Drospirenone Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021676s019lbl.pdf,DB00977
L11947,FDA Approved Drug Products: Taytulla Ethinylestradiol and Norethindrone Acetate Oral Capsules and Ferrous Fumarate Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204426s007lbl.pdf,DB00977
L11950,"FDA Approved Drug Products: Safyral Ethinylestradiol, Drospirenons, and Levomefolate Calcium Oral Tablets and Levomefolate Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022574s009lbl.pdf,DB00977
L9806,FDA Approved Drugs: Nuvaring® vaginal ring,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021187s037lbl.pdf,DB00977
L11953,FDA Approved Drug Products: Lo Ovral 28 Ethinylestradiol and Norgestrel Oral Tablets and Ferrous Fumarate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018206s020lbl.pdf,DB00977
L10304,FDA Approved Drug Products: Femhrt® tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021065s024lbl.pdf,DB00977
L11956,FDA Approved Drug Products: Estrostep Fe Ethinylestradiol and Norethindrone Oral Tablets and Ferrous Fumarate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020130s018lbl.pdf,DB00977
L11959,FDA Approved Drug Products: Cyclessa Ethinylestradiol and Desogestrel Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021090s008lbl.pdf,DB00977
L11962,FDA Approved Drug Products: Annovera Ethinylestradiol and Segesterone Acetate Vaginal System,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209627s000lbl.pdf,DB00977
L11845,FDA Approved Drug Products: Ortho Tri-Cyclen Norgestimate and Ethinyl Estradiol Oral Tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019653s058,019697s054lbl.pdf",DB00977
L11965,FDA Approved Drug Products: Seasonale Ethinylestradiol and Levonorgestrel Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021544s013lbl.pdf,DB00977
L11746,FDA Approved Products: Maxaquin (lomeafloxacin hydrochloride) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20013s015lbl.pdf,DB00978
L66,Link,http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202173.html,DB00979
L6574,FDA Approved Drug Products: Accutane Oral Capsule,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018662,DB00982
L6577,FDA Approved Drug Products: Absorica,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021951,DB00982
L6579,iPLEDGE Program Home Page,https://www.ipledgeprogram.com/iPledgeUI/home.u,DB00982
L6589,New Zealand Drug Data Sheet: Oratane,https://medsafe.govt.nz/profs/Datasheet/o/oratanecap.pdf,DB00982
L6592,Isotretinoin MSDS,https://www.caymanchem.com/msdss/21648m.pdf,DB00982
L10986,FDA Approved Drug Products: Perforomist® inhalation solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022007s015lbl.pdf,DB00983
L10989,FDA Approved Drug Products: Bevespi Aerosphere inhalation aerosol,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208294s005lbl.pdf,DB00983
L10992,FDA Approved Drug Products: Duaklir® Pressair® inhalation powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210595lbl.pdf,DB00983
L10995,FDA Approved Drug Products: Dulera® inhalation aerosol,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022518s026lbl.pdf,DB00983
L10998,FDA Approved Drug Products: Foradil® Aerolizer inhalation powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20831s2lbl.pdf,DB00983
L10619,FDA Approved Drug Products: Symbicort (budesonide/formoterol fumarate) inhalation aerosol,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021929s042lbl.pdf,DB00983
L11223,Health Canada Product Monograph: Oxeze (formoterol) dry powder inhaler,https://pdf.hres.ca/dpd_pm/00044980.PDF,DB00983
L11241,CaymanChem: Formoterol MSDS,https://www.caymanchem.com/msdss/15584m.pdf,DB00983
L11256,Global Initiative for Asthma: 2019 Guidelines Pocket Guide,https://ginasthma.org/wp-content/uploads/2019/04/GINA-2019-main-Pocket-Guide-wms.pdf,DB00983
L10,InChem Data Sheet,http://www.inchem.org/documents/pims/pharm/pim909.htm,DB00984
L12984,Health Canada Product Monograph: Cytarabine injection,https://pdf.hres.ca/dpd_pm/00041024.PDF,DB00987
L11214,FDA Approved Drug Products: Imuran Azathioprine Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/016324s039lbl.pdf,DB00993
L11979,FDA Approved Drug Products: Neo-Fradin (Neomycin Sulfate) Oral Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065010s002lbl.pdf,DB00994
L10532,"FDA Approved Drug Products: Casporyn Neomycin Sulfate, Polymixin B Sulfate, and Hydrocortisone Otic Drops",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/060613s013lbl.pdf,DB00994
L10716,"FDA Approved Drug Products: Maxitrol Neomycin, Polymyxin B, and Dexamethasone Ophthalmic Suspension",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050023s036lbl.pdf,DB00994
L11982,Cayman Chemical: Neomycin sulfate Safety Data Sheet,https://www.caymanchem.com/msdss/14287m.pdf,DB00994
L11985,Neomycin - LiverTox - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK547874/,DB00994
L8717,FDA Approved Drug Products: Neurontin (gabapentin) for oral use,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf,DB00996
L8720,DPD Approved Drugs: Gabapentin,https://pdf.hres.ca/dpd_pm/00044022.PDF,DB00996
L8726,MedSafe NZ: Gabapentin,https://www.medsafe.govt.nz/profs/Datasheet/a/arrowgabapentincap.pdf,DB00996
L8732,EMA Approved Drugs: Gabapentin,https://www.ema.europa.eu/en/documents/referral/neurontin-article-30-referral-annex-i-ii-iii_en.pdf,DB00996
L8741,FDA Approved Drugs: Gabapentin XR,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022399s008lbl.pdf,DB00996
L8765,CaymenChem: Gabapentin MSDS,https://www.caymanchem.com/msdss/10008346m.pdf,DB00996
L8444,FDA Approved Drug Products: Esidrix Hydrochlorothiazide Oral Tablets (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011793,DB00999
L8447,FDA Approved Drug Products: Hydrochlorothiazide Oral Tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/040735s004,040770s003lbl.pdf",DB00999
L8450,FDA Approved Drug Products: Hydrochlorothiazide Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020504s018lbl.pdf,DB00999
L7426,FDA Approved Drug Products: Losartan and Hydrochlorothiazide Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020387s063lbl.pdf,DB00999
L7459,FDA Approved Drug Products: Irbesartan and Hydrochlorothiazide Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020758s073lbl.pdf,DB00999
L8390,FDA Approved Drug Products: Lisinopril and Hydrochlorothiazide Oral Tablet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019888s067lbl.pdf,DB00999
L8423,FDA Approved Drug Products: Quinapril and Hydrochlorothiazide Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020125s022lbl.pdf,DB00999
L11623,FDA Approved Drug Products: Femara Letrozole Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020726s035lbl.pdf,DB01006
L11626,FDA Approved Drug Products: Kisquali Femara Co-Pack Letrozole and Ribociclib Succinate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209935s006lbl.pdf,DB01006
L11809,FDA Approved Drug Products: Temovate Clobetasol Propionate Topical Cream (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019322,DB01013
L11815,FDA Approved Drug Products: Olux-E Clobetasol Propionate Topical Aerosol Foam,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022013s013lbl.pdf,DB01013
L11818,FDA Approved Drug Products: Olux Clobetasol Propionate Topical Aerosol Foam,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021142s022lbl.pdf,DB01013
L11821,FDA Approved Drug Products: Impoyz Clobetasol Propionate Topical Cream,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209483s000lbl.pdf,DB01013
L11824,FDA Approved Drug Products: Clobex Clobetasol Propionate Topical Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021835s015lbl.pdf,DB01013
L11827,FDA Approved Drug Products: Clobex Clobetasol Propionate Topical Lotion,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021535Orig1s003,%20021644Orig1s003lbl.pdf",DB01013
L11833,Health Canada Approved Drug Products: Clobetasol Propionate Topical Spray,https://pdf.hres.ca/dpd_pm/00044987.PDF,DB01013
L11830,FDA Approved Drug Products: Bactrim (sulfamethoxazole/trimethoprim) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/017377s074lbl.pdf,DB01015
L11851,Health Canada Product Monograph: Septra (sulfamethoxazole/trimethoprim) for intravenous injection,https://pdf.hres.ca/dpd_pm/00043890.PDF,DB01015
L11863,FDA Approved Drug Products: Sulfamethoxazole/Trimethoprim oral suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/077612s005lbl.pdf,DB01015
L11866,CaymanChem: Sulfamethoxazole MSDS,https://www.caymanchem.com/msdss/23613m.pdf,DB01015
L8117,FDA Approved Drug Products: Micronase (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017498,DB01016
L8120,FDA Approved Drug Products: Glucovance (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021178s018lbl.pdf,DB01016
L8123,FDA Approved Drug Products: Glyburide Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020051s022lbl.pdf,DB01016
L8135,Pfizer: Glyburide Tablets MSDS,https://www.pfizer.com/system/files/products/material_safety_data/MICRONASE.pdf,DB01016
L11695,FDA Approved Drug Products: Minocin Minocycline Oral Capsules (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050315,DB01017
L11701,FDA Approved Drug Products: Ximino Minocycline Oral Extended Release Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/201922s002lbl.pdf,DB01017
L11704,FDA Approved Drug Products: Solodyn Minocycline Oral Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050808s023lbl.pdf,DB01017
L11707,FDA Approved Drug Products: Minocycline Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/anda/99/65-005_Minocycline%20Hydrochloride_prntlbl.pdf,DB01017
L11710,FDA Approved Drug Products: Minocin Minocycline Oral Pellet-Filled Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050649s027lbl.pdf,DB01017
L11713,FDA Approved Drug Products: Minocin Minocycline Powder for Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050444s049lbl.pdf,DB01017
L11716,FDA Approved Drug Products: Arestin Minocycline Subgingival Microspheres,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050781s020lbl.pdf,DB01017
L11719,FDA Approved Drug Products: Amzeeq Minocycline Topical Foam,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212379s000lbl.pdf,DB01017
L11722,Cayman Chemical: Minocycline MSDS,https://www.caymanchem.com/msdss/14454m.pdf,DB01017
L11274,FDA Approved Drug Products: Tenex Guanfacine Hydrochloride Oral Tablets (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019032s021lbl.pdf,DB01018
L11277,FDA Approved Drug Products: Intuniv Guanfacine Hydrochloride Extended Release Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022037s019lbl.pdf,DB01018
L11299,Cayman Chemical: Guanfacine MSDS,https://www.caymanchem.com/msdss/22907m.pdf,DB01018
L11698,FDA Approved Drug Products: Monoket (isosorbide mononitrate) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020215s024lbl.pdf,DB01020
L11728,Spectrum Chemical: 5-Isosorbide Mononitrate MSDS,https://www.spectrumchemical.com/MSDS/TCI-I0403.pdf,DB01020
L11737,DailyMed Label: Isosorbide Mononitrate (ISMN) extended-release tablets,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=897a0327-25d4-4769-bd6a-0e674264017f,DB01020
L11743,Organic Nitrates - LiverTox - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK547928/,DB01020
L7736,EMA SmPC: Ketoconazole,https://www.ema.europa.eu/en/documents/product-information/ketoconazole-hra-epar-product-information_en.pdf,DB01026
L7739,FDA Label: Ketoconazole Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018533s041lbl.pdf,DB01026
L10292,HSDB: Ketoconazole,http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+7447,DB01026
L3637,Ketoconazole FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018533s040lbl.pdf,DB01026
L7456,FDA Approved Drug Products: Irbesartan Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020757s069lbl.pdf,DB01029
L7459,FDA Approved Drug Products: Irbesartan and Hydrochlorothiazide Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020758s073lbl.pdf,DB01029
L7477,Cayman Chemicals: Irbesartan MSDS,https://www.caymanchem.com/msdss/11952m.pdf,DB01029
L7480,Sandoz Canada: Irbesartan Product Monograph,https://www.sandoz.ca/sites/www.sandoz.ca/files/Irbesartan%20Product%20Monograph.pdf,DB01029
L8585,FDA Approved Drug Products: Lipidil Fenofibrate Oral Capsules (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019304,DB01039
L8588,FDA Approved Drug Products: Fenofibrate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022118s010lbl.pdf,DB01039
L8591,FDA Approved Drug Products: Fenofibrate Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021612s020lbl.pdf,DB01039
L8651,Cayman Chemicals: Fenofibrate MSDS,https://www.caymanchem.com/msdss/10005368m.pdf,DB01039
L5953,135 million people will live with dementia worldwide by 2050,https://www.alzheimersresearchuk.org/135-million-people-will-live-with-dementia-worldwide-by-2050/,DB01043
L12285,Sandoz Monograph: Memantine hydrochloride oral tablets,https://s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/004/375/original/Memantine_FCT_PM_English20150916.pdf?1555348927,DB01043
L96,Link,http://pharmgkb.org/pathway/PA166104634#,DB01048
L2639,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009087,DB01049
L2640,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=081113,DB01049
L2637,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf973160-d467-4192-a432-04c8c2140369,DB01049
L2681,Kegg,http://www.genome.jp/dbget-bin/www_bget?dr:D02268,DB01049
L4614,Current issues in pharmacy and medical sciences,https://www.degruyter.com/downloadpdf/j/cipms.2014.27.issue-1/cipms-2014-0003/cipms-2014-0003.pdf,DB01050
L229,article,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC444435/pdf/aac00346-0019.pdf,DB01053
L230,Webmd,http://www.webmd.com/drugs/2/drug-3781/penicillin-g-benzathine-intramuscular/details,DB01053
L231,monograph,https://www.drugs.com/cdi/penicillin-g-benzathine-suspension.html,DB01053
L12576,FDA Approved Drug Products: Penicillin G Potassium Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050638s020lbl.pdf,DB01053
L12579,FDA Approved Drug Products: Penicillin G Sodium Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065068s013lbl.pdf,DB01053
L9743,"FDA Approved Drug Products: Talicia Amoxicillin, Omeprazole, and Rifabutin Oral Delayed Release Capsules",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213004lbl.pdf,DB01060
L11644,FDA Approved Drug Products: Amoxil Amoxicillin Oral Capsules (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050459,DB01060
L11647,FDA Approved Drug Products: Omeclamox-Pak Oral Capsules and Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/050824s007lbl.pdf,DB01060
L11650,FDA Approved Drug Products: Augmentin XR Amoxicillin and Clavulanate Oral Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050785s015lbl.pdf,DB01060
L7880,FDA Approved Drug Products: Augmentin Amoxicillin and Clavulanate Oral Tablets and Suspension,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050564s053s055,050575s040s042,050597s047s049,050720s026s028,050725s028s030,050726s022s024lbl.pdf",DB01060
L11653,FDA Approved Drug Products: Amoxicillin and Clavulanate Oral Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/065162s021lbl.pdf,DB01060
L11656,FDA Approved Drug Products: Amoxicillin Oral Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/065119s020lbl.pdf,DB01060
L11659,FDA Approved Drug Products: Amoxicillin Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/065056s017lbl.pdf,DB01060
L8645,"HMDB MSDS, Oxybutinin",http://www.hmdb.ca/system/metabolites/msds/000/013/858/original/HMDB15195.pdf?1358895165,DB01062
L8648,Ditropan XL FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020897s037lbl.pdf,DB01062
L6712,Clinical Practice Guidelines - 2018 Full Guidelines - Diabetes Canada - Chapter 13: Pharmacologic Glycemic Management of Type 2 Diabetes in Adults,http://guidelines.diabetes.ca/cpg/chapter13,DB01067
L6739,Glipizide - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK459177/,DB01067
L6745,Glipizide 5 mg Tablets - Summary of Product Characteristics (SmPC) - European Medicines Agency,https://www.medicines.org.uk/emc/product/8543/smpc,DB01067
L3825,Glucotrol (Glipizide) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017783s021lbl.pdf,DB01067
L10746,GLUCOTROL XL® (glipizide) extended release tablets - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020329s029lbl.pdf,DB01067
L10752,METAGLIP (glipizide and metformin HCl) Tablets - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021460s010lbl.pdf,DB01067
L5572,Electronic Medicines Compendium: Clonazepam Rosemont 2mg/5ml Oral Solution,https://www.medicines.org.uk/emc/product/6022/smpc,DB01068
L4000,FDA Approved Drug Products: Phenergran Promethazine Oral Tablets (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/07935s030lbl.pdf,DB01069
L11326,FDA Approved Drug Products: Promethazine with Phenylephrine and Codeine Oral Syrup,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/088764Orig1s084lbl.pdf,DB01069
L11338,Cayman Chemical: Promethazine MSDS,https://www.caymanchem.com/msdss/16478m.pdf,DB01069
L5263,StatPearls [Internet]: Diphenhydramine,https://www.ncbi.nlm.nih.gov/books/NBK526010/#article-20535.s1,DB01075
L5266,Electronic Medicines Compendium: Histergan (diphenhydramine hydrochloride) Tablets Patient Information,https://www.medicines.org.uk/emc/product/8071/pil,DB01075
L5269,Electronic Medicines Compendium: Histergan (diphenhydramine hydrochloride) Cream Monograph,https://www.medicines.org.uk/emc/product/2303/smpc,DB01075
L5281,Electronic Medicines Compendium: Boots Sleepeaze (diphenhydramine hydrochloride) 50mg Tablets Monograph,https://www.medicines.org.uk/emc/product/6568/smpc,DB01075
L5287,Electronic Medicines Compendium: Nytol One-A-Night (diphenhydramine hydrochloride) Monograph,https://www.medicines.org.uk/emc/product/340/smpc,DB01075
L6025,Merck Manuals,https://www.merckmanuals.com/en-ca/professional/endocrine-and-metabolic-disorders/lipid-disorders/dyslipidemia,DB01076
L6028,Chemocare,http://chemocare.com/chemotherapy/side-effects/cardiovascular-events.aspx,DB01076
L6031,Laguna Treatment,https://lagunatreatment.com/lipitor/,DB01076
L12588,FDA Approved Drug Products: Lipitor (atorvastatin calcium) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020702s074lbl.pdf,DB01076
L13901,FDA Approved Drug Products: Didronel Etidronate Oral Tablet (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017831s058lbl.pdf,DB01077
L5918,FDA approves the reintroduction of Zelnorm™ (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in women under 65,https://www.erienewsnow.com/story/40228826/fda-approves-the-reintroduction-of-zelnorm-tegaserod-for-irritable-bowel-syndrome-with-constipation-ibs-c-in-women-under-65,DB01079
L13616,FDA Approved Drug Products: Sabril (vigabatrin) for oral use,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020427s021,022006s023lbl.pdf",DB01080
L13652,Health Canada Product Monograph: Sabril (vigabatrin) for oral use,https://pdf.hres.ca/dpd_pm/00051654.PDF,DB01080
L13661,Vigabatrin REMS Program,https://vigabatrinrems.com/#Main,DB01080
L4275,Crestor (Rosuvastatin Calcium) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021366s016lbl.pdf,DB01098
L1373,EMA Label: Zoloft; INN: sertraline,http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Zoloft_30/WC500007023.pdf,DB01104
L9016,Zoloft FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/019839S74S86S87_20990S35S44S45lbl.pdf,DB01104
L9022,"Zoloft, PDR",https://www.pdr.net/drug-summary/Zoloft-sertraline-hydrochloride-474.3608,DB01104
L5227,AAFP: Off-label Applications for SSRIs,https://www.aafp.org/afp/2003/0801/p498.html,DB01104
L9058,"Sertraline, pubchem",https://pubchem.ncbi.nlm.nih.gov/compound/sertraline,DB01104
L9061,"Sertraline, Pfizer SDS",https://pfe-pfizercom-prod.s3.amazonaws.com/products/material_safety_data/sertraline_hydrochloride_capsules_2-June-2016.pdf,DB01104
L9188,Sertraline pathway,https://www.pharmgkb.org/pathway/PA166181117,DB01104
L10677,Psychology Today article,https://www.psychologytoday.com/ca/blog/the-superhuman-mind/201702/number-one-reason-ssris-take-four-six-weeks-work,DB01104
L14021,FDA Approved Drug Products: Oravig (miconazole) buccal tablet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022404s005lbl.pdf,DB01110
L14024,"FDA Approved Drug Products: Vusion (miconazole nitrate, zinc oxide, white petrolatum) topical ointment",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021026s013lbl.pdf,DB01110
L14027,FDA Approved Drug Products: miconazole nitrate suppositories and cream,https://www.accessdata.fda.gov/drugsatfda_docs/anda/99/75-329_Miconazole%20Nitrate_prntlbl.pdf,DB01110
L14033,DailyMed miconazole nitrate,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=745242b5-c10f-4c59-8037-e7e0e4c948d6,DB01110
L14396,FDA Approved Drug Products: Monistat (miconazole nitrate) suppositories and cream,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/017450Orig1s056lbl.pdf,DB01110
L12,MSDS,http://msds.orica.com/pdf/shess-en-cds-010-000000033835.pdf,DB01114
L11383,FDA Approved Drug Products: Procardia Nifedipine Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018482s052lbl.pdf,DB01115
L11389,FDA Approved Drug Products: Procardia XL Nifedipine Oral Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019684s029lbl.pdf,DB01115
L1245,FDA Approved Drug Products: Adalat CC Nifedipine Oral Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020198s023lbl.pdf,DB01115
L11428,Cayman Chemical: Nifedipine MSDS,https://www.caymanchem.com/msdss/11106m.pdf,DB01115
L2908,Electronic Medicines Compendium Amiodarone 100mg Tablets,https://www.medicines.org.uk/emc/product/6019/smpc,DB01118
L8087,Nexterone FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022325lbl.pdf,DB01118
L3561,FDA Approved Drug Products: Cordarone (amiodarone HCl) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/018972s042lbl.pdf,DB01118
L11265,NIH StatPearls: Amiodarone,https://www.ncbi.nlm.nih.gov/books/NBK482154/,DB01118
L11286,AAFP: Medication Guide for Amiodarone,https://www.aafp.org/afp/2005/0401/p1434.html,DB01118
L11509,FDA Approved Drug Products: Proglycem Diazoxide Oral Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/017453s020lbl.pdf,DB01119
L6256,Avodart (dutasteride capsules) - Product Monograph,https://ca.gsk.com/media/588688/avodart.pdf,DB01126
L10568,AVODART (dutasteride) Capsules - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021319s028s029lbl.pdf,DB01126
L11416,FDA Approved Drug Products: Actos (pioglitazone) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021073s049lbl.pdf,DB01132
L11419,FDA Approved Drug Products: Actoplus Met (pioglitazone/metformin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021842s022lbl.pdf,DB01132
L11422,FDA Approved Drug Products: Duetact (pioglitazone/glimepiride) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021925s017lbl.pdf,DB01132
L11425,FDA Approved Drug Products: Oseni (pioglitazone/alogliptin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022426s012lbl.pdf,DB01132
L11431,CaymanChem: Pioglitazone MSDS,https://www.caymanchem.com/msdss/22263m.pdf,DB01132
L11461,Diabetes Canada: Clinical Practice Guidelines for Diabetes 2018,http://guidelines.diabetes.ca/docs/CPG-2018-full-EN.pdf,DB01132
L4763,FDA Approved Drug Products: Skelid Tiludronate Disodium Oral Tablets (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020707s006lbl.pdf,DB01133
L7889,FDA Approved Drug Products: Carvedilol Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020297s038lbl.pdf,DB01136
L7892,FDA Approved Drug Products: Carvedilol Oral Extended Release Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022012s022lbl.pdf,DB01136
L11638,FDA Approved Drug Products: Levaquin (levofloxacin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020634s071lbl.pdf,DB01137
L11641,FDA Approved Drug Products: Quixin (levofloxacin) ophthalmic solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021199s014lbl.pdf,DB01137
L10043,Health Canada Product Monograph: Levofloxacin oral tablets,https://pdf.hres.ca/dpd_pm/00050865.PDF,DB01137
L11689,Health Canada Product Monograph: Quinsair (levofloxacin hemihydrate) solution for inhalation,https://pdf.hres.ca/dpd_pm/00051502.PDF,DB01137
L11692,Health Canada Product Monograph: Levofloxacin in 5% dextrose for injection,https://pdf.hres.ca/dpd_pm/00053176.PDF,DB01137
L11725,CaymanChem: Levofloxacin MSDS,https://www.caymanchem.com/msdss/20382m.pdf,DB01137
L1347,FDA Label: SilenorTM (doxepin) tablets for oral administration,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022036lbl.pdf,DB01142
L5971,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016798,DB01142
L5974,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022036,DB01142
L5977,Encyclopedia,https://www.encyclopedia.com/medicine/drugs/pharmacology/doxepin,DB01142
L5980,American Psychiatric Association,https://www.psychiatry.org/patients-families/depression/what-is-depression,DB01142
L5983,Canadian Mental Health Association,https://cmha.ca/documents/anxiety-disorders,DB01142
L5986,HealthLink BC,https://www.healthlinkbc.ca/health-topics/uh1001,DB01142
L5989,Cleveland Clinic,http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/dermatology/pruritus-itch/,DB01142
L5992,Merck Manuals,https://www.merckmanuals.com/en-ca/professional/neurologic-disorders/pain/neuropathic-pain,DB01142
L5995,Dehli Psychiatry Journal paper,http://medind.nic.in/daa/t12/i2/daat12i2p402.pdf,DB01142
L5998,Novo-doxepin product monograph,https://pdf.hres.ca/dpd_pm/00024530.PDF,DB01142
L6562,Dailymed: Contrave (bupropion + naltrexone),https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed2da3a6-0614-4bea-8e82-962cbaae6428,DB01156
L10589,FDA Approved Drug Products: Wellbutrin XL® extended-release tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021515s040lbl.pdf,DB01156
L10592,FDA Approved Drug Products: Wellbutrin immediate-release tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/018644s054lbl.pdf,DB01156
L12453,FDA Approved Products: Neutrexin (trimetrexate glucuronate) for injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020326s015lbl.pdf,DB01157
L9602,FDA Approved Drug Products: Terazosin Oral Capsules,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/19057Orig1s021,%2020347Orig1s009%20lbl.pdf",DB01162
L10007,European Public Assessment Report: Trisenox,https://www.ema.europa.eu/en/documents/product-information/trisenox-epar-product-information_en.pdf,DB01169
L1350,Monamine Oxidase Inhibitors,https://books.google.ca/books?id=iUi5ErxyhVYC&pg=PA191&lpg=PA191&dq=moclobemide+clearance&source=bl&ots=9-XcLmfB1Y&sig=jKPdSO_2hzyh2adnG3Ap73GqEZQ&hl=en&sa=X&ved=0ahUKEwiPxOSHgrXZAhUY5WMKHeVgCk44ChDoAQgoMAA#v=onepage&q=moclobemide%20clearance&f=false,DB01171
L1357,Citalopram ,https://comptox.epa.gov/dashboard/dsstoxdb/results?search=DTXSID8022826,DB01171
L8513,FDA Approved Drug Products: Lexapro (escitalopram) for oral use,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021323s051,021365s036lbl.pdf",DB01175
L8516,DPD Approved Drugs: Escitalopram,https://www.lundbeck.com/upload/ca/en/files/pdf/pm/Cipralex%20JUN2018_PM_E_clean.pdf,DB01175
L8522,Medsafe NZ: Escitalopram,https://www.medsafe.govt.nz/profs/Datasheet/l/loxalatetab.pdf,DB01175
L8549,CaymenChem: Escitalopram MSDS,https://www.caymanchem.com/msdss/22405m.pdf,DB01175
L67,Link,http://www.medscape.com/viewarticle/441915_3,DB01183
L12741,FDA Approved Products: Permax (pergolide),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/19385slr030,031,035_permax_lbl.pdf",DB01186
L11584,FDA Approved Drug Products: Onexton (clindamycin phosphate/benzoyl peroxide) topical gel,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050819s012lbl.pdf,DB01190
L11590,FDA Approved Drug Products: Ziana (clindamycin phosphate/tretinoin) topical gel,https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/050802lbl.pdf,DB01190
L11593,FDA Approved Drug Products: Evoclin (clindamycin phosphate) topical foam,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050801s018lbl.pdf,DB01190
L11596,FDA Approved Drug Products: Clindesse (clindamycin phosphate) vaginal cream,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050793s015lbl.pdf,DB01190
L11599,FDA Approved Drug Products: Clindamycin in 0.9% NaCl for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208083s003lbl.pdf,DB01190
L11602,FDA Approved Drug Products: Cleocin (clindamycin hydrochloride) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050162s101lbl.pdf,DB01190
L11605,FDA Approved Drug Products: Cleocin T (clindamycin phosphate) topical gel/solution/lotion,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050537s041,050600s018,050615s019lbl.pdf",DB01190
L11608,FDA Approved Drug Products: Cleocin (clindamycin phosphate) vaginal suppositories,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/050767s016lbl.pdf,DB01190
L11611,Health Canada Product Monograph: Clindets (clindamycin phosphate) topical swabs,https://pdf.hres.ca/dpd_pm/00036879.PDF,DB01190
L11614,CaymanChem: Clindamycin MSDS,https://www.caymanchem.com/msdss/15006m.pdf,DB01190
L11629,Health Canada Product Monograph: Clindamycin oral capsules,https://pdf.hres.ca/dpd_pm/00054159.PDF,DB01190
L8875,FDA Approved Drug Products: Tambocor Flecainide Acetate Oral Tablets,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018830,DB01195
L8878,Medsafe New Zealand Approved Drug Products: Tambocor Oral Tablets and Capsules,https://www.medsafe.govt.nz/profs/datasheet/t/tambocortabcap.pdf,DB01195
L5056,Flecainide Acetate,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f6b78d4-8ac8-464b-bb78-ee70cbc97898,DB01195
L8923,Cayman Chemicals: Flecainide MSDS,https://www.caymanchem.com/msdss/20388m.pdf,DB01195
L8606,FDA Approved Drugs: Levetiracetam Tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021035s100,021505s040lbl.pdf",DB01202
L8609,FDA Approved Drugs: Levetiracetam ODT,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207958s008lbl.pdf,DB01202
L8600,DPD Approved Drugs: Levetiracetam,https://pdf.hres.ca/dpd_pm/00047496.PDF,DB01202
L8612,CaymenChem: Levetiracetam MSDS,https://www.caymanchem.com/msdss/9001820m.pdf,DB01202
L8615,MedSafe NZ: Levetiracetam,https://www.medsafe.govt.nz/profs/Datasheet/k/Keppratab.pdf,DB01202
L7922,FDA Approved Drug Products: Nadolol Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018063s063lbl.pdf,DB01203
L7925,FDA Approved Drug Products: Nadolol and Bendroflumethiazide Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/018647s025lbl.pdf,DB01203
L7934,The Human Metabolome Database: Nadolol MSDS,http://www.hmdb.ca/system/metabolites/msds/000/013/997/original/HMDB15334.pdf?1358895036,DB01203
L6235,PROPECIA® (finasteride) tablets for oral use - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020s021s023lbl.pdf,DB01216
L6244,Finasteride - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK513329/,DB01216
L10565,Proscar (finasteride) tablets label - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020180s037lbl.pdf,DB01216
L8863,FDA Approved Drug Products: Arimidex (anastrozole) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020541s031lbl.pdf,DB01217
L8866,EMA Approved Drugs: Anastrozole,https://www.ema.europa.eu/en/documents/referral/arimidex-article-30-referral-annex-iii_en.pdf,DB01217
L8869,DPD Approved Drugs: Anastrozole,https://pdf.hres.ca/dpd_pm/00037304.PDF,DB01217
L8872,Medsafe NZ: Anastrozole,https://www.medsafe.govt.nz/profs/Datasheet/r/rolintab.pdf,DB01217
L8887,CaymenChem: Anastrozole MSDS,https://www.caymanchem.com/msdss/11987m.pdf,DB01217
L1332,Ketamine ,http://ketamine.com/history-of-ketamine/,DB01221
L1336,Ketamine monograph,https://www.sandoz.ca/sites/www.sandoz.ca/files/Ketamine_HCl_PMe_20150506.pdf,DB01221
L1337,Time magazine,http://time.com/4876098/new-hope-for-depression/,DB01221
L10598,FDA Approved Drug Products: Rhinocort Budesonide Nasal Metered Aerosol (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020233,DB01222
L10601,FDA Approved Drug Products: Entocort Budesonide Oral Extended Release Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021324s018lbl.pdf,DB01222
L10604,FDA Approved Drug Products: Ortikos Budesonide Oral Extended Release Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211929s000lbl.pdf,DB01222
L10607,FDA Approved Drug Products: Pulmicort Budesonide Inhalation Powder,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021949s013lbl.pdf,DB01222
L10613,FDA Approved Drug Products: Pulmicort Budesonide Inhalation Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020929s052lbl.pdf,DB01222
L10616,FDA Approved Drug Products: Rhinocort Budesonide Nasal Metered Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020746Orig1s037lbl.pdf,DB01222
L10619,FDA Approved Drug Products: Symbicort (budesonide/formoterol fumarate) inhalation aerosol,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021929s042lbl.pdf,DB01222
L10622,FDA Approved Drug Products: Uceris Budesonide Oral Extended Release Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203634s000lbl.pdf,DB01222
L10625,FDA Approved Drug Products: Uceris Budesonide Rectal Aerosol Foam,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205613s000lbl.pdf,DB01222
L8546,Quetiapine fumarate fda label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022047s033s037lbl.pdf,DB01224
L8594,Astrazenica: quetiapine,https://www.astrazeneca.com.au/content/dam/az-au/Material%20Safety%20Data/2018/MSDS_Seroquel%20Tablets_SDS1010_12.17_v3.0.pdf,DB01224
L13,Link,http://www.medicinenet.com/diphenidol_hcl-oral/article.htm,DB01231
L3450,FDA Approved Drug Products: Invirase (saquinavir mesylate) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021785s024lbl.pdf,DB01232
L14351,Health Canada Product Monograph: Invirase (saquinavir mesylate) for oral administration,https://pdf.hres.ca/dpd_pm/00055570.PDF,DB01232
L14354,CaymanChem: Saquinavir MSDS,https://www.caymanchem.com/msdss/9001893m.pdf,DB01232
L8414,Metoclopramide FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/017854s062lbl.pdf,DB01233
L8417,Reglan injection FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/017862s063lbl.pdf,DB01233
L8465,Metoclopramide MSDS,https://pfe-pfizercom-prod.s3.amazonaws.com/products/material_safety_data/Metoclopramide_Inj(Hospira)_4-jan-2017.pdf,DB01233
L14381,FDA Approved Drug Products: Gimoti Metoclopramide Nasal Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209388s000lbl.pdf,DB01233
L10695,FDA Approved Drug Products: Decadron Dexamethasone Oral Tablet (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011664,DB01234
L10698,FDA Approved Drug Products: Ciprodex Dexamethasone and Ciprofloxacin Otic Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021537s017lbl.pdf,DB01234
L10701,FDA Approved Drug Products: Dexamethasone Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/40572s002lbledt.pdf,DB01234
L10704,FDA Approved Drug Products: Dextenza Dexamethasone Ophthalmic Insert,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208742s001lbl.pdf,DB01234
L10707,FDA Approved Drug Products: Dexycu Dexamethasone Intraocular Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208912s000lbl.pdf,DB01234
L10710,FDA Approved Drug Products: Hemady Dexamethasone Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211379s000lbl.pdf,DB01234
L10713,FDA Approved Drug Products: Maxidex Dexamethasone Ophthalmic Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/013422s045lbl.pdf,DB01234
L10716,"FDA Approved Drug Products: Maxitrol Neomycin, Polymyxin B, and Dexamethasone Ophthalmic Suspension",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050023s036lbl.pdf,DB01234
L10719,FDA Approved Drug Products: Ozurdex Dexamethasone Intravitreal Implant,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022315s012lbl.pdf,DB01234
L10722,"FDA Approved Drug Products: Maxitrol Neomycin, Polymyxin B, and Dexamethasone Ophthalmic Ointment",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050065s064lbl.pdf,DB01234
L10725,FDA Approved Drug Products: Tobradex Tobramycin and Dexamethasone Ophthlamic Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/050818s001lbl.pdf,DB01234
L14318,RECOVERY trial news release: dexamethasone,https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf,DB01234
L6133,FDA Approved Drug Products: Sinemet,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=017555,DB01235
L6136,FDA Drug Approval Package: Aripiprazole,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-436_Abilify.cfm,DB01238
L6145,Clinicaltrails.gov: National Pregnancy Registry for Atypical Antipsychotics,https://clinicaltrials.gov/ct2/show/NCT01246765,DB01238
L8525,FDA Approved Drug Products: Gemfibrozil Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018422s058lbl.pdf,DB01241
L8576,Cayman Chemicals: Gemfibrozil MSDS,https://www.caymanchem.com/msdss/14835m.pdf,DB01241
L1372,Validus pharma news,http://validuspharma.com/blog/marplan-acquisition/,DB01247
L1375,National Institute of Mental Health,https://www.nimh.nih.gov/health/topics/depression/index.shtml,DB01247
L109,Link,http://www.centerwatch.com/patient/drugs/dru946.html,DB01256
L6916,FDA: Eculizumab New Indication,https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-neuromyelitis-optica-spectrum-disorder-rare-autoimmune-disease-central,DB01257
L6919,FDA Approved Drug Products: Eculizumab Intravenous Infusion,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125166,DB01257
L6922,Alexion Pharma: Soliris Product Monograph,https://alexion.com/Documents/Canada/Product-Monograph-Soliris-English.aspx,DB01257
L6061,FDA Drug Approval Package: Sitagliptin,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021995s000TOC.cfm,DB01261
L6067,Merck Pregnancy Registry: Sitagliptin,http://www.merckpregnancyregistries.com/januvia.html,DB01261
L14,Link,http://www.medilexicon.com/drugs/prezista.php,DB01264
L9227,FDA Approved Drug Products: Prezista (darunavir) oral tablets/suspension,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021976s056,202895s027lbl.pdf",DB01264
L11988,Medicines UK: Zentiva 800mg film coated tablets,https://www.medicines.org.uk/emc/product/10124/smpc,DB01264
L12066,Clinicaltrials.gov: Efficacy and Safety of Darunavir and Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV (DACO-nCoV),https://clinicaltrials.gov/ct2/show/NCT04252274,DB01264
L8779,FDA Approved Drug Products: Apresoline Hydralazine Hydrochloride Tablets and Injections (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008303,DB01275
L8782,FDA Approved Drug Products: Hydralazine Hydrochloride Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/1996/008303s068lbl.pdf,DB01275
L8785,FDA Approved Drug Products: Hydralazine and Isosorbide Dinitrate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020727s010lbl.pdf,DB01275
L6106,FDA Drug Approval Package: Exenatide,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021773_byettatoc.cfm,DB01276
L6112,FDA Pharmacology Review: Exenatide,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/021919s000pharmr.pdf,DB01276
L12249,FDA Approved Drug Products: Increlex Mecasermin Subcutaneous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021839s024lbl.pdf,DB01277
L12273,FDA Approved Drug Products: Novolog (insulin aspart) for SC/IV injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020986s090s091lbl.pdf,DB01306
L12279,FDA Approved Drug Products: Levemir (insulin detemir) for subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021536s057s058lbl.pdf,DB01307
L12519,FDA Approved Drug Products: Apidra (insulin glulisine),https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021629s030lbl.pdf,DB01309
L894,ILO: Lithium,http://www.ilo.org/dyn/icsc/showcard.display?p_card_id=0710,DB01356
L12603,FDA Approved Drug Products: OMNIPAQUE (iohexol) injection and oral solution.,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018956s101lbl.pdf,DB01362
L12972,FDA Approved Drug Products: Emerphed Ephedrine Sulfate Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213407s000lbl.pdf,DB01364
L12975,FDA Approved Drug Products: Akovaz Ephedrine Sulfare Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208289s005lbl.pdf,DB01364
L12990,Cayman Chemical: Ephedrine MSDS,https://www.caymanchem.com/msdss/14143m.pdf,DB01364
L12993,Dailymed: Ephedrine Nasal Spray,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0bf3e120-ac51-4b14-8584-ab561f6ed446,DB01364
L12996,"Dailymed: Ephedrine Intravenous, Intramuscular, and Subcutaneous Injection",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e4a4021c-c092-41bf-91ed-ef483fd52732,DB01364
L8138,Colchicine FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022352s017lbl.pdf,DB01394
L8141,Colchicine: Up to Date,https://www.uptodate.com/contents/management-of-familial-mediterranean-fever,DB01394
L8189,Cayman chem MSDS,https://www.caymanchem.com/msdss/9000760m.pdf,DB01394
L8192,"Pharmacology review, FDA",https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204820Orig1s000PharmR.pdf,DB01394
L12291,Medline NIH: Colchicine,https://medlineplus.gov/druginfo/meds/a682711.html,DB01394
L7973,YAZ fda label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021676s009lbl.pdf,DB01395
L7976,Yaz Bayer monograph,https://www.bayer.ca/omr/online/yaz-pm-en.pdf,DB01395
L7979,"2012 FDA safety statement, YAZ",https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-updated-information-about-risk-blood-clots-women-taking-birth-control,DB01395
L7994,"FDA pharmacology review, Drospirenone",https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022532Orig1s000PharmR.pdf,DB01395
L7997,Angeliq EU label,http://mri.cts-mrp.eu/download/NL_H_0380_001_FinalSPC.pdf,DB01395
L8000,drospirenone/ethinyl estradiol - Drug Summary,https://www.pdr.net/drug-summary/Yaz-drospirenone-ethinyl-estradiol-98,DB01395
L8075,Angeliq FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021355s003lbl.pdf,DB01395
L8078,Safyral FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022574s001lbl.pdf,DB01395
L15,Link,http://www.doctissimo.fr/medicament-NOZINAN.htm,DB01403
L7084,FDA Drug Approval Package: Tiotropium Bromide Powder for Inhalation,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021395,DB01409
L7087,FDA Approved Drug Products: Tiotropium and Olodaterol Metered Inhalation Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206756s011lbl.pdf,DB01409
L7090,FDA Approved Drug Products: Tiotropium Inhalation Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207070s000lbl.pdf,DB01409
L7093,FDA Approved Drug Products: Tiotropium Metered Inhalation Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021936s012lbl.pdf,DB01409
L1159,Steroidal,https://www.steroidal.com/steroid-profiles/testosterone-propionate/testosterone-propionate-cycle/,DB01420
L1160,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cdef530-023e-4d34-8e97-77f143b0068f,DB01420
L1161,Steroidal,https://www.steroidal.com/steroid-profiles/testosterone-propionate/testosterone-propionate-dosage/,DB01420
L1162,Empowerpharmacy,https://www.empowerpharmacy.com/drugs/testosterone-propionate-injection.html,DB01420
L1163,Fittness uncovered,http://www.fitnessuncovered.co.uk/performance-drugs/profiles/testosterone-propionate,DB01420
L7826,Phenazopyridine Hydrochloride,https://pdf.hres.ca/dpd_pm/00011122.PDF,DB01438
L7829,Drug summary: phenazopyridine,https://www.pdr.net/drug-summary/Pyridium-phenazopyridine-hydrochloride-3457.101,DB01438
L7832,FDA information Phenazopyridine,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019358,DB01438
L7841,"HMDB, phenazopyridine",http://www.hmdb.ca/metabolites/HMDB0015506,DB01438
L7844,Phenazopyridine DailyMed,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=da0a825f-329d-ae56-b834-eeaf65ff596c&type=display,DB01438
L7847,"MSDS, Phenazopyridine",https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_FSHSCI_REAGENT_PHENAZOPYRIDINE_HCL_50MG.pdf,DB01438
L7850,UPMC: Final Diagnosis -- Suicide Attempt with Ingestion of Pyridium Tablets,https://path.upmc.edu/cases/case311/dx.html,DB01438
L7856,Intracellular Drug Bioavailability: Effect of Neutral Lipids and Phospholipids,https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b00064,DB01438
L7865,O Factors Affecting Drug Metabolism,https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/o-factors-affecting-drug-metabolism.html,DB01438
L7871,Phenazopyridine hydrochloride,https://ntp.niehs.nih.gov/ntp/roc/content/profiles/phenazopyridinehydrochloride.pdf,DB01438
L4996,"Huecker MR, Marraffa J. Heroin. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan.",https://www.ncbi.nlm.nih.gov/books/NBK441876/,DB01452
L4999,Electronic Medicines Compendium: Diamorphine Hydrochloride BP 100 mg Lyophilisate for Solution for Injection Monograph,https://www.medicines.org.uk/emc/product/2040/smpc,DB01452
L5005,"Murphy PB, Barrett MJ. Morphine. [Updated 2018 Oct 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan",https://www.ncbi.nlm.nih.gov/books/NBK526115/,DB01452
L16,Link,http://home.intekom.com/pharm/merckp/reactivn.html,DB01463
L68,Link,http://isomerdesign.com/PiHKAL/read.php?domain=tk&id=11,DB01546
L6010,FDA Drug Approval Package for Dextroamphetamine,https://www.accessdata.fda.gov/drugsatfda_docs/anda/2001/040361_dextroamphetamine_toc.cfm,DB01576
L13062,FDA Approved Drug Products: Adderall (dextroamphetamine) capsule,https://pi.shirecontent.com/PI/PDFs/AdderallXR_USA_ENG.PDF,DB01576
L7511,FDA Approved Drug Products: Solifenacin Succinate Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021518s018lbl.pdf,DB01591
L7520,Cayman Chemicals: Solifenacin MSDS,https://www.caymanchem.com/msdss/17320m.pdf,DB01591
L2092,Zinc and its importance for human health: An integrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724376/,DB01593
L2093,The Essential Toxin: Impact of Zinc on Human Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872358/,DB01593
L2094,Dietary factors affecting Zinc bioavailability,http://journals.sagepub.com/doi/pdf/10.1177/156482650102200204,DB01593
L2095,Zinc,https://www.mayoclinic.org/drugs-supplements-zinc/art-20366112,DB01593
L2096,"Zinc Transporters, Mechanisms of Action and Therapeutic Utility: Implications for Type 2 Diabetes Mellitus",https://www.hindawi.com/journals/jnme/2012/173712/,DB01593
L2097,"Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action",https://www.sciencedirect.com/science/article/abs/pii/S1734114015000274,DB01593
L2098,MeSH Zinc,https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=%22Zinc%22%5BMeSH+Terms%5D,DB01593
L2099,Agency for Toxic Substances and Disease Registry: Toxicological Profile for Zinc,https://www.atsdr.cdc.gov/toxprofiles/tp60-c3.pdf,DB01593
L1887,ZINC COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6912,DB01593
L2100,"Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394467/,DB01593
L2101,Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia,https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.2830310203,DB01593
L2102,Zinc Therapy in Dermatology: A review ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120804/,DB01593
L2103,Treatment of Wilson’s Disease with Zinc. I. Oral Zinc Therapy Regimens,https://pdfs.semanticscholar.org/896f/03dae9396d9463c552aff6e9ab78dcd44f06.pdf,DB01593
L2104,Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394849/,DB01593
L2106,Zinc Supplementation in treating diarrhea in children,http://www.cochrane.org/CD005436/INFECTN_oral-zinc-supplementation-treating-diarrhoea-children,DB01593
L2107,Zinc homeostasis in humans,https://academic.oup.com/jn/article/130/5/1360S/4686372,DB01593
L2172,"ZINC: Uses, Side Effects, Interactions and Warnings - WebMD",https://www.webmd.com/vitamins.../ingredientmono-982-zinc.aspx?...982...zinc,DB01593
L2091,Zinc Toxicity in Humans,https://pdfs.semanticscholar.org/a9e2/8321ae506e646f32ce59d87b7589851aa7e4.pdf,DB01593
L2208,Chapter 16. Zinc,http://www.fao.org/docrep/004/y2809e/y2809e0m.htm,DB01593
L2210,Zinc metabolism,http://flipper.diff.org/app/pathways/3503,DB01593
L2211,"Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance",https://www.omicsonline.org/copper-and-zinc-biological-role-and-significance-of-copper-zincimbalance-2161-0495.S3-001.php?aid=3055,DB01593
L2213,The emerging role of zinc transporters,https://www.nature.com/articles/sigtrans201729,DB01593
L7568,FDA: Recarbrio Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212819s000lbl.pdf,DB01597
L7526,FDA: Primaxin Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050587s081lbl.pdf,DB01597
L7625,ChemSpider: Cilastatin,http://www.chemspider.com/Chemical-Structure.4940183.html?rid=95b4e0e3-45f3-40b1-ab49-455b5e0f4b98,DB01597
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB01597
L7628,Drugs@FDA: Primaxin,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050587,DB01597
L7526,FDA: Primaxin Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050587s081lbl.pdf,DB01598
L7568,FDA: Recarbrio Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212819s000lbl.pdf,DB01598
L7628,Drugs@FDA: Primaxin,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050587,DB01598
L11163,FDA Approved Drug Products: Kaletra (lopinavir/ritonavir) for oral use,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021251s058,021906s053lbl.pdf",DB01601
L12012,Nature Biotechnology: Coronavirus puts drug repurposing on the fast track,https://www.nature.com/articles/d41587-020-00003-1,DB01601
L12060,CaymanChem: Lopinavir MSDS,https://www.caymanchem.com/msdss/13854m.pdf,DB01601
L12063,Health Canada Product Monograph: Kaletra (lopinavir/ritonavir) for oral use,https://pdf.hres.ca/dpd_pm/00053305.PDF,DB01601
L4417,Zosyn (Piperacillin and Tazobactam) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050684s055s061_050750s016s020lbl.pdf,DB01606
L6661,Medsafe NZ: Tazocin,https://medsafe.govt.nz/profs/Datasheet/t/Tazocininj.pdf,DB01606
L6664,Pfizer medical information,https://www.pfizermedicalinformation.com/en-us/zosyn/warnings,DB01606
L6673,"FDA approval information, Zerbaxa",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206829,DB01606
L11788,FDA Approved Drug Products: TIMENTIN (sterile ticarcillin disodium and clavulanate potassium) for Intravenous Administration,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050590s069,050658s031lbl.pdf",DB01607
L8072,FDA Approved Drug Products: Hydroxychloroquine Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/009768Orig1s051lbl.pdf,DB01611
L14312,FDA: Emergency use Authorization for Hydroxychloroquine and Chloroquine Revoked,https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and,DB01611
L17,Spasmonal Package Insert,http://www.medicines.org.uk/EMC/medicine/24562/SPC/,DB01616
L7649,Pheniramine/Naphazoline Eye Drop Monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5649c6e2-966f-44d9-b57e-5bb988eb373d,DB01620
L7652,Acetaminophen/Pheniramine/Phenylephrine Solution Monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49ada090-e70e-476f-89ce-9647c064e1e6,DB01620
L7682,Cameo Chemicals: Pheniramine maleate,https://cameochemicals.noaa.gov/chemical/20879,DB01620
L69,Link,http://medicaid.alabama.gov/documents/2.0_Newsroom/2.4_Procurement/2.4.3_Pharm_Support_ITB/2.4.3_Antipsychotic_Agents_Class_Review_8-10-11.pdf,DB01624
L70,Link,http://www.mentalhealth.com/drug/p30-z03.html,DB01624
L97,US Biological,http://www.usbio.net/item/O8070-50,DB01669
L867,Pharmaceuticals and Medical Devices Agency (PMDA): Topiroxostat review,https://www.pmda.go.jp/files/000153624.pdf,DB01685
L71,The NIH National Library of Medicine,http://www.nlm.nih.gov/medlineplus/druginfo/natural/patient-dhea.html,DB01708
L10295,INTRAROSA™ FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208470s001lbl.pdf,DB01708
L786,Baxter Health GLUCOSE INTRAVENOUS INFUSION BP Product information,http://www.baxterhealthcare.com.au/downloads/healthcare_professionals/cmi_pi/glucose%20IVI_pi.pdf,DB01914
L787,Glucose injection (Viaflex bag) Product information,http://www.medsafe.govt.nz/profs/Datasheet/g/glucoseinjviaflex.pdf,DB01914
L1058,FDA GRAS,https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm465256.pdf,DB01956
L1060,KEGG metabolism,http://www.genome.jp/kegg-bin/show_pathway?hsa00430,DB01956
L2729,HMDB: Pyroglutamic Acid Metabocard,http://www.hmdb.ca/metabolites/HMDB0000267,DB03088
L2731,Pyroglutamic acid: throwing light on a lightly studied metabolite,https://pdfs.semanticscholar.org/c50e/3ad15345b8901709d52d89f38c1c0fb6080c.pdf,DB03088
L18,eMedicine,http://www.emedicinehealth.com/drug-acetic_acid_otic/article_em.htm,DB03166
L933,European Medicines Agency (EMA): TEYSUNO (tegafur/gimeracil/oteracil) Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001242/WC500104415.pdf,DB03209
L9071,WHO: Critically Important Antimicrobials for Human Medicine 6th Revision,https://apps.who.int/iris/bitstream/handle/10665/312266/9789241515528-eng.pdf?ua=1,DB03615
L2710,RXmed.com: AMINO-CERV Monograph,https://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/cps-_monographs/CPS-_(General_Monographs-_A)/AMINO.html,DB03766
L2715,FDA Listing of Propionic Acid,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1081,DB03766
L2716,EFSA Journal: Safety of the extension of use of sodium propionate (E 281) as a food additive,https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2016.4546,DB03766
L2722,"INCHEM Propionic Acid and its Calcium, Potassium, and Sodium Salts (WHO Food Additive Series 5)",http://www.inchem.org/documents/jecfa/jecmono/v05je16.htm,DB03766
L2724,PROPIONIC ACID IS AN ALTERNATIVE TO ANTIBIOTICS IN POULTRY DIET,https://pdfs.semanticscholar.org/0f06/ef56b8d936245c4c0d4e124f0c4dc3c6bfda.pdf,DB03766
L2725,PubChem Propionic Acid Profile,https://pubchem.ncbi.nlm.nih.gov/compound/propionic_acid#section=Pharmacology-and-Biochemistry,DB03766
L2728,NIH Toxnet: Propionic Acid Profile,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1192,DB03766
L2896,OLEIC ACID - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1240,DB04224
L14120,Drugs.com: Phexxi Approval History,https://www.drugs.com/history/phexxi.html,DB04272
L14123,"FDA Approved Drug Products: PHEXXI (lactic acid, citric acid, and potassium bitartrate) vaginal gel",https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208352s000lbl.pdf,DB04272
L14120,Drugs.com: Phexxi Approval History,https://www.drugs.com/history/phexxi.html,DB04398
L14123,"FDA Approved Drug Products: PHEXXI (lactic acid, citric acid, and potassium bitartrate) vaginal gel",https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208352s000lbl.pdf,DB04398
L72,Trimesta,http://www.syntheticbiologics.com/trimesta,DB04573
L98,Link,http://www.hybrigenics.com/Pharma/Pharma-Content/Inecalcitol-Development.html,DB04796
L13532,FDA Approved Drug Products: Ixempra (ixabepilone) kit for intravenous infusion,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022065s006lbl.pdf,DB04845
L157,Link,https://clinicaltrials.gov/ct2/show/NCT01516203,DB04850
L13056,FDA Approved Products: Uloric (febuxostat) oral tablets,https://www.takeda.com/siteassets/en-ca/home/what-we-do/our-medicines/product-monographs/uloric/uloric-dhcpl-04nov2019--en.pdf,DB04854
L8684,MULTAQ® (dronedarone hydrochloride) Product Monograph,http://products.sanofi.ca/en/multaq.pdf,DB04855
L8687,MULTAQ® (dronedarone) Safety Data Sheet - Van Wert Health,https://www.vanwerthospital.org/docs/default-source/SDS/dronedarone-sds.pdf?sfvrsn=2,DB04855
L8800,Health Canada Endorsed Important Safety Information on Multaq,http://www.healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/14651a-eng.php,DB04855
L8980,Atrial Fibrillation (A Fib) - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK526072/,DB04855
L8699,FDA Approved Drug Products: Multaq (dronedarone) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022425s025lbl.pdf,DB04855
L7985,FDA Approved Drug Products: Nebivolol Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021742s022lbl.pdf,DB04861
L7988,FDA Approved Drug Products: Nebivolol and Valsartan Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206302s000lbl.pdf,DB04861
L14162,FDA Approved Drug Products: Bepreve (bepotastine besilat) ophthalmic solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022288s008lbl.pdf,DB04890
L5659,Brain Uses Serotonin To Perpetuate Chronic Pain Signals In Local Nerves,https://www.hopkinsmedicine.org/news/media/releases/brain_uses_serotonin_to_perpetuate_chronic_pain_signals_in_local_nerves,DB04896
L19,Link,http://www.freshpatents.com/Anti-cd80-antibody-having-adcc-activity-for-adcc-mediated-killing-of-b-cell-lymphoma-cells-alone-or-in-combination-with-other-therapies-dt20070322ptan20070065436.php?type=description,DB04901
L8492,FDA Approved Drug Products: Orbactiv (oritavancin) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206334s005lbl.pdf,DB04911
L12858,"Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran",https://www.novartis.com/news/media-releases/novartis-successfully-completes-acquisition-medicines-company-adding-potentially-first-class-investigational-cholesterol-lowering-therapy-inclisiran,DB04911
L12861,DailyMed: Orbactiv (oritavancin) powder for injection,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=085d6d1a-21c2-11e4-8c21-0800200c9a66,DB04911
L12870,Mckesson: Oritavancin diphosphate MSDS,https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/SDS_9ICS_ORBACTIV_VL_400MG_3ML_3CT.pdf,DB04911
L12879,Orbactiv website,http://www.orbactiv.com/dosing-and-administration.html,DB04911
L9086,EMA Approved Drugs: Afamelanotide,https://www.ema.europa.eu/en/documents/product-information/scenesse-epar-product-information_en.pdf,DB04931
L9092,FDA News Release: Scenesse,https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-increase-pain-free-light-exposure-patients-rare-disorder,DB04931
L9098,CaymanChem: Afamelanotide MSDS,https://www.chemblink.com/MSDS/MSDSFiles/75921-69-6_Cayman.pdf,DB04931
L9119,EMA Summary for the Public: Afamelanotide,https://www.ema.europa.eu/en/documents/overview/scenesse-epar-summary-public_en.pdf,DB04931
L9122,FDA Orphan Drugs: Afamelanotide,https://www.accessdata.fda.gov/scripts/opdlisting/oopd/listResult.cfm,DB04931
L9125,EMA Orphan Drugs: Afamelanotide,https://www.ema.europa.eu/en/documents/orphan-designation/eu/3/08/541-public-summary-positive-opinion-orphan-designation-nle4-d-phe7-alpha-melanocyte-stimulating_en.pdf,DB04931
L9134,FDA Approved Drugs: Afamelanotide,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210797s000lbl.pdf,DB04931
L2794,FDA News,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607884.htm,DB04948
L2801,FDA reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM602419.pdf,DB04948
L73,Link,http://www.wipo.int/pctdb/en/wo.jsp?WO=2004061120&IA=WO2004061120&DISPLAY=DESC,DB04950
L9518,Definition of rimiducid - NCI Drug Dictionary - National Cancer Institute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/rimiducid,DB04974
L9521,"Technology - Bellicum Pharmaceuticals, Inc.",https://www.bellicum.com/technology/,DB04974
L20,Link,http://meeting.ascopubs.org/cgi/content/abstract/24/18_suppl/4080,DB04978
L110,Link,http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=453546,DB04979
L925,EMA Product Label,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002720/WC500171813.pdf,DB05016
L4263,"Migalastat for the treatment of Fabry Disease: Sunder-Plassmann G., Schiffmann R., and Nicholls K.",https://www.tandfonline.com/doi/abs/10.1080/21678707.2018.1469978?journalCode=ieod20,DB05018
L4274,Amicus Therapeutics News Release: FDA Approves Galafold™ (migalastat) for the Treatment of Certain Adult Patients with Fabry Disease,http://ir.amicusrx.com/news-releases/news-release-details/fda-approves-galafoldtm-migalastat-treatment-certain-adult,DB05018
L4278,Drugs.com: FDA Approves Galafold (migalastat) for the Treatment of Fabry Disease,https://www.drugs.com/newdrugs/fda-approves-galafold-migalastat-fabry-4797.html,DB05018
L740,TYMLOS (abaloparatide) injection Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208743lbl.pdf,DB05084
L741,"Radius Health, Inc. Pipeline",http://radiuspharm.com/pipeline/,DB05084
L8048,"Pretomanid FDA label, August 2019",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212862s000lbl.pdf,DB05154
L8051,"MSDS, Pretomanid",https://www.sigmaaldrich.com/catalog/product/sigma/sml1290?lang=en&region=US,DB05154
L8057,"Pretomanid briefing document, FDA",https://www.fda.gov/media/127592/download,DB05154
L8066,TB Alliance,https://www.tballiance.org/news/fda-approves-new-treatment-highly-drug-resistant-forms-tuberculosis,DB05154
L8069,TB Alliance presentation slides,https://www.fda.gov/media/128001/download,DB05154
L22,Link,http://www.geminx.com/en/research/gmx1777.php,DB05217
L99,Link,http://www.medicalnewstoday.com/articles/71766.php,DB05218
L100,Link,http://www.exelixis.com/eortc/posters/AACR_NCI_EORTC2007_XL765_preclin.pdf,DB05241
L23,Link,http://www.freepatentsonline.com/6235316.html,DB05257
L1458,"Kalbitor, INN-ecallantide - European Medicines Agency - Europa EU",http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/human/002200/WC500122745.pdf,DB05311
L74,Link,http://www.google.com/patents/US6835809,DB05332
L12495,FDA Approved Drug Products: Dexilant (dexlansoprazole) delayed-release oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022287s029s030lbl.pdf,DB05351
L12909,DailyMed: Histamine positive test control injection,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5c20f3f4-65f8-4cdb-bdd1-5774da1c551b,DB05381
L12321,DailyMed: CVS Iodine,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b11db4e5-6a6d-4d4a-b980-600692b54176,DB05382
L12327,Drugs.com: Iodine tincture information,https://www.drugs.com/otc/590514/iodine-tincture-rojo.html,DB05382
L12330,Mayo Clinic: Topical iodine side effects,https://www.mayoclinic.org/drugs-supplements/iodine-topical-route/side-effects/drg-20064375?p=1,DB05382
L12336,"NIH Statpearls: Physiology, thyroid hormone",https://www.ncbi.nlm.nih.gov/books/NBK500006/,DB05382
L12339,NIH StatPearls: Skin (integument) antiseptics,https://www.ncbi.nlm.nih.gov/books/NBK507853/,DB05382
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB05521
L9293,FDA Approved Drug Products: Incivek (telaprevir) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/201917s012lbl.pdf,DB05521
L760,Briviact FDA Approval,http://www.ucb.com/stories-media/press-releases/article/U-S-FDA-approves-UCB-s-new-epilepsy-treatment-BRIVIACT-for-patients-with-partial-onset-seizures,DB05541
L2917,Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid,https://clinicaltrials.gov/ct2/show/NCT00381433,DB05620
L75,Link,http://clinicaltrials.gov/show/NCT00320502,DB05631
L111,Link,http://www.diobex.com/dio902,DB05667
L7495,"FDA approvals, Otezla",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205437,DB05676
L7498,Otezla product information,http://www.guildlink.com.au/gc/ws/celgene/pi.cfm?product=cjpaprem,DB05676
L7501,"FDA label, Otezla",https://media.celgene.com/content/uploads/otezla-pi.pdf,DB05676
L7502,Medsafe NZ,https://medsafe.govt.nz/profs/Datasheet/o/otezlatab.pdf,DB05676
L7505,"EMA label, Otezla",https://www.ema.europa.eu/en/documents/assessment-report/otezla-epar-public-assessment-report_en.pdf,DB05676
L9383,STELARA® (ustekinumab) injection - FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761044lbl.pdf,DB05679
L9386,STELARA® (ustekinumab) injection -Janssen Full Prescribing Information,http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/STELARA-pi.pdf,DB05679
L9392,Janssen Announces FDA Approval of Stelara (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis,https://www.drugs.com/newdrugs/janssen-announces-fda-approval-stelara-ustekinumab-adults-moderately-severely-active-ulcerative-5084.html,DB05679
L9491,STELARA® (ustekinumab) Product Monograph - Janssen Inc.,https://www.janssen.com/canada/sites/www_janssen_com_canada/files/prod_files/live/stelara_cpm.pdf,DB05679
L112,Link,http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=486259,DB05698
L113,Link,http://www.alkermes.com/newsroom/showArticle.aspx?id=407,DB05723
L416,TOXNET,https://chem.nlm.nih.gov/chemidplus/rn/120313-91-9,DB05777
L417,Bloodjournal,http://www.bloodjournal.org/content/bloodjournal/80/5/1254.full.pdf?sso-checked=1,DB05777
L76,Link,http://clinicaltrials.gov/ct2/show/NCT00004890?term=AIDS&lup_s=03%2F06%2F2013&lup_d=30,DB05851
L24,Link,http://www.abcam.com/Substance-P-protein-ab9608.html,DB05875
L938,European Medicines Agency (EMA): BESPONSA Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004119/WC500231261.pdf,DB05889
L12684,CytoDyn: Treatment with CytoDyn's Leronlimab Indicates Significant Trend Toward Immunological Restoration in Severely Ill COVID-19 Patients,https://www.cytodyn.com/newsroom/press-releases/detail/405/treatment-with-cytodyns-leronlimab-indicates-significant,DB05941
L275,MSDS,http://www.selleckchem.com/msds/MSDS_S7660.pdf,DB05990
L12633,FDA Approved Products: Ocaliva (obeticholic acid) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207999s003lbl.pdf,DB05990
L12636,FDA Accepts Intercept’s NDA for OCA for the Treatment of Liver Fibrosis Due to NASH and Grants Priority Review,http://ir.interceptpharma.com/news-releases/news-release-details/fda-accepts-intercepts-nda-oca-treatment-liver-fibrosis-due-nash,DB05990
L12720,"EMA Summary of product characteristics, Ocaliva (obeticholic acid) 5 and 10 mg oral tablets",https://www.ema.europa.eu/en/documents/product-information/ocaliva-epar-product-information_en.pdf,DB05990
L12735,Product Monograph: Ocaliva (obeticholic acid) oral tablets,https://pdf.hres.ca/dpd_pm/00045776.PDF,DB05990
L12738,NIH InXight Drugs: Obeticholic acid,https://drugs.ncats.io/substance/0462Z4S4OZ,DB05990
L10860,CAPLYTA®,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209500s000lbl.pdf,DB06077
L10902,24. The Clinical Development of Lumateperone (ITI-007) for the Treatment of Schizophrenia,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475480/,DB06077
L10908,S44. Lumateperone (ITI-007) for the Treatment of Schizophrenia: Placebo-Controlled Clinical Trials and an Open-Label Safety Switching Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888500/,DB06077
L5302,FDA news,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm630866.htm,DB06081
L5305,Guide to Pharmacology,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=9123,DB06081
L5314,Clinical trials,https://clinicaltrials.gov/ct2/show/NCT03172208,DB06081
L10653,FDA Approved Drug Products: Xcopri Cenobamate Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212839s000lbl.pdf,DB06119
L77,Link,http://clinicaltrials.gov/show/NCT00525330,DB06127
L269,article,http://jac.oxfordjournals.org/content/22/Supplement_B/13.abstract,DB06145
L270,article,https://www.ncbi.nlm.nih.gov/pubmed/9571302,DB06145
L271,article,http://www.medicinenet.com/spiramycin-oral_capsule/article.htm,DB06145
L272,product info,https://www.drugs.com/mmx/spiramycin.html,DB06145
L2279,"PubChem, Nylidrin",https://pubchem.ncbi.nlm.nih.gov/compound/nylidrin,DB06152
L2280,Nylidrin (Oral),https://www.drugs.com/cons/nylidrin.html,DB06152
L2283,Nylidrin - Oral,https://myhealth.alberta.ca/Health/medications/Pages/conditions.aspx?hwid=fdb0207,DB06152
L2284,Nylidrin,https://reference.medscape.com/drug/nylidrin-342462#10,DB06152
L2285,Drug monograph,http://www.druginfosys.com/drug.aspx?drugcode=2016&type=1,DB06152
L2286,ToxNet Nylidrin,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3137,DB06152
L2288,Central cardiovascular effects of nylidrin (buphenine),https://www.sciencedirect.com/science/article/pii/0014299980903362,DB06152
L2289,"Buphenine, MIMS",http://www.mims.com/india/drug/info/buphenine?type=full&mtype=generic,DB06152
L2291,Central cardiovascular effects of nylidrin (buphenine).,https://www.ncbi.nlm.nih.gov/m/pubmed/6105964/,DB06152
L2294,Nylidrin,http://decs.bvs.br/cgi-bin/wxis1660.exe/decsserver/?IsisScript=../cgi-bin/decsserver/decsserver.xis&task=exact_term&previous_page=homepage&interface_language=i&search_language=i&search_exp=nylidrin,DB06152
L2296,Beta-Adrenergic Agonists,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034018/,DB06152
L2297,Local and systemic hemodynamic effects of nylidrin,https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt196455569,DB06152
L2298,Nylidrin Hydrochloride,https://drugs.ncats.io/ginas/app/substance/EC69E3PW7E,DB06152
L2299,Specific blockade of spasmogens by β‐receptor stimulation with nylidrin and isoprenaline,https://www.researchgate.net/publication/18774229_Specific_blockade_of_spasmogens_by_b-receptor_stimulation_with_nylidrin_and_isoprenaline,DB06152
L2300,NyIidrin HCL: A BETA-SYMPATHETIC STIMULANT IN THE MANAGEMENT OF HAEMORRHAGIC SHOCK,https://pdfs.semanticscholar.org/1a78/f56fd773ac5e0c0a624812090e41ca12a7cd.pdf,DB06152
L2292,Paladin Labs - Product Monograph: SANDOMIGRAN (Pizotifen hydrogen malate 0.5 mg and 1 mg tablets),http://www.paladin-labs.com/our_products/Sandomigran_en.pdf,DB06153
L2392,Pentaerythritol tetranitrate,https://pubchem.ncbi.nlm.nih.gov/compound/pentaerythritol_tetranitrate,DB06154
L2393,CheBi - Pentaerythritol,https://www.ebi.ac.uk/chebi/searchId.do?chebiId=25879,DB06154
L2394,PETN,https://www.britannica.com/science/PETN,DB06154
L2395,OSHA document,https://www.osha.gov/dts/chemicalsampling/data/CH_260110.html,DB06154
L2396,Pentaerythritol tetra nitrate,https://www.drugs.com/international/pentaerythritol-tetranitrate.html,DB06154
L2397,Determination of Pentaerythritol Tetranitrate in Pharmaceuticals by High Performance Liquid Chromatography,https://www.tandfonline.com/doi/abs/10.1080/01483918808076749,DB06154
L2398,Pentaerythrityl tetranitrate (PETN): a better nitrate? ,https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/eht403/3056872,DB06154
L2399,Pentaerythritol tetranitrate,http://www.genome.jp/dbget-bin/www_bget?dr:D01721,DB06154
L2412,Pentaerythritol tetranitrate,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6313,DB06154
L2413,Medscape- Pentaerythritol tetra nitrate,https://reference.medscape.com/drug/duotrate-pentylan-pentaerythritol-tetranitrate-342279#10,DB06154
L2414,Characterization of the Antioxidant Properties of Pentaerithrityl Tetranitrate (PETN)-Induction of the Intrinsic Antioxidative System Heme Oxygenase-1 (HO-1),http://www.springerprotocols.com/Abstract/doi/10.1007/978-1-60761-411-1_22?verPrint=print,DB06154
L2402,Pentaerythritol tetranitrate,http://www.t3db.ca/toxins/T3D0265,DB06154
L2408,Pentaerythritoltetranitrate (PETN) EPA document,https://cfpub.epa.gov/ncea/pprtv/documents/PentaerythritoltetranitratePETN.pdf,DB06154
L2415,PENTAERYTHRITE TETRANITRATE,http://nj.gov/health/eoh/rtkweb/documents/fs/1474.pdf,DB06154
L2416,Pentaerithrityl tetranitrate improves angiotensin II induced vascular dysfunction via induction of heme oxygenase-1,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080599/,DB06154
L12126,FDA Approved Drug Products: Yervoy Ipilimumab Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125377s108lbl.pdf,DB06186
L12642,BC Cancer Agency: Yervoy Monograph,http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Ipilimumab_monograph.pdf,DB06186
L25,Link,http://www.lasofoxifene.com/,DB06202
L759,Fablyn development history,http://www.drugdevelopment-technology.com/projects/lasofoxifene/,DB06202
L761,FDA Reproductive Health Drugs Advisory Committee Briefing Document,https://www.fda.gov/ohrms/dockets/ac/08/briefing/2008-4381b1-02-Pfizer.pdf,DB06202
L762,EMA Summary of product characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000977/WC500020092.pdf,DB06202
L13338,FDA Approved Drug Products: Vitrase Hyaluronidase Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021640s025lbl.pdf,DB06205
L2173,Feraheme Product Info,http://www.feraheme.com,DB06215
L2178,FDA Orders Stricter Warnings for Ferumoxytol (Feraheme ),https://www.medscape.com/viewarticle/842309,DB06215
L2179,EMA label,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002215/WC500129751.pdf,DB06215
L2181,Ferumoxytol,https://link.springer.com/article/10.2165%2F11209880-000000000-00000,DB06215
L2182,Ferumoxytol pubChem,https://pubchem.ncbi.nlm.nih.gov/compound/49868115#section=Top,DB06215
L2183,Plasma Pharmacokinetics of Two Consecutive Doses of Ferumoxytol in Healthy Subjects,https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1038/clpt.2010.80,DB06215
L2184,Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412424/,DB06215
L2185,"Ferumoxytol, Davisplus",https://davisplus.fadavis.com/3976/meddeck/pdf/ferumoxytol.pdf,DB06215
L2186,Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD,https://www.researchgate.net/publication/290788673_Ferumoxytol-Enhanced_Magnetic_Resonance_Imaging_in_Late-Stage_CKD,DB06215
L2187,Feraheme-ferumoxytol,https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1035/feraheme-ferumoxytol,DB06215
L2188,Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213428/,DB06215
L2189,"T1 and T2 images, Radiology Masterclass",https://www.radiologymasterclass.co.uk/tutorials/mri/t1_and_t2_images,DB06215
L2190,Feraheme PDR,http://www.pdr.net/drug-summary/Feraheme-ferumoxytol-1201,DB06215
L765,European Medicines Agency Summary of product characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001215/WC500097154.pdf,DB06217
L115,Link,http://www.isispharm.com/product_pipeline.html,DB06224
L12819,FDA Approved Products: Xarelto (rivaroxaban) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/202439s001lbl.pdf,DB06228
L1024,European Medicines Agency (EMA) Summary of product characteristics: Selincro,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002583/WC500140255.pdf,DB06230
L117,Link,http://www.viropharma.com/Pipeline/Camvia.aspx,DB06234
L78,Link,http://www.antisoma.com/asm/media/press/pr2007/2007-08-22/,DB06235
L1709,Amrubicin,http://www.lookchem.com/Amrubicin/,DB06263
L1710,Amrubicin for the Treatment of Small Cell Lung Cancer: Does Effectiveness Cross the Pacific?,https://www.sciencedirect.com/science/article/pii/S1556086415300460,DB06263
L1713,Pharmacokinetics of amrubicin in lung cancer patients with impaired hepatic function,https://www.sciencedirect.com/science/article/pii/S2213089616300603,DB06263
L1714,Amrubicin® Receives FDA Orphan Drug Designation for the Treatment of Small Cell Lung Cancer,https://www.businesswire.com/news/home/20080325005495/en/Amrubicin-Receives-FDA-Orphan-Drug-Designation-Treatment,DB06263
L1715, Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer ,https://academic.oup.com/annonc/article/16/3/430/159840,DB06263
L1716," randomized, open-label, phase III trial comparing amrubicin versus docetaxel in patients with previously treated non-small-cell lung cancer",https://academic.oup.com/annonc/article/28/2/285/2676905,DB06263
L12789,FDA Approved Drug Products: Actemra Tocilizumab Intravenous or Subcutaneous Injection,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125276s127,125472s040lbl.pdf",DB06273
L12837,Clinical Trials: TOCIVID-19,https://clinicaltrials.gov/ct2/show/study/NCT04317092,DB06273
L12843,Clinical Trials: COVACTA,https://clinicaltrials.gov/ct2/show/NCT04320615,DB06273
L118,Link,http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm194328.htm,DB06274
L7694,FDA Approved Drug Products: Levocetirizine Dihydrochloride Tablets and Oral Solution,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022064s038,022157s020lbl.pdf",DB06282
L13389,FDA Approved Drug Products: Prialt (ziconotide) solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021060s006lbl.pdf,DB06283
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB06290
L6034,FDA Drug Approval Package: Dapagliflozin,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/202293Orig1s000TOC.cfm,DB06292
L119,Link,http://www.medicalnewstoday.com/articles/104218.php,DB06307
L122,Link,http://www.medicalnewstoday.com/articles/84205.php,DB06309
L26,Link,http://www.bionomics.com.au/page.php?page=188&section=103,DB06313
L124,Link,http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=575732,DB06318
L27,Link,http://www.orthologic.com/research-development/AZX100modeofaction.php,DB06323
L126,Link,http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=574048,DB06342
L11350,FDA News Release: Teprotumumab approval,https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-thyroid-eye-disease,DB06343
L11359,FDA Approved Drug Products: Tepezza (teprotumumab-trbw) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761143s000lbl.pdf,DB06343
L127,Link,http://ir.rigel.com/phoenix.zhtml?c=120936&p=irol-newsArticle&ID=1077812&highlight=,DB06347
L131,Link,http://www.micromet.de/index.php?id=117,DB06356
L1039,Recombinant soluble prostate-specific membrane antigen (rsPSMA) vaccine,http://ascopubs.org/doi/10.1200/jco.2004.22.14_suppl.2584,DB06361
L216,Pertuzumab protein sequence,http://www.freepatentsonline.com/20110117097.pdf,DB06366
L14510,FDA News Release: FDA Approves Breast Cancer Treatment That Can Be Administered At Home By Health Care Professional,https://www.fda.gov/news-events/press-announcements/fda-approves-breast-cancer-treatment-can-be-administered-home-health-care-professional,DB06366
L30,"Report on Carcinogens, Thirteenth Edition",http://ntp.niehs.nih.gov/ntp/roc/content/profiles/oxymetholone.pdf,DB06412
L31,Link,http://www.medilexicon.com/drugs/nuvigil.php,DB06413
L13988,FDA Orphan Drug Designations and Approvals,https://www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm,DB06419
L14003,Human Disposition and Metabolism of Orally Administered (14C)ABT-773,http://www.digitalconference.net/ICAAC2001/ICAAC2001/Poster/P_ABT773-942.pdf,DB06419
L14006,Clinical Trial NCT00336505,https://clinicaltrials.gov/ct2/show/results/NCT00336505,DB06419
L132,Link,http://www.prnewswire.co.uk/cgi/news/release?id=48518,DB06421
L32,Link,http://scripts.iucr.org/cgi-bin/paper?S1600536802017683,DB06422
L4880,FDA reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/GastrointestinalDrugsAdvisoryCommittee/UCM623493.pdf,DB06480
L4882,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210166,DB06480
L4883,Canadian Society of Intestinal Research,https://www.badgut.org/information-centre/a-z-digestive-topics/serious-toll-of-chronic-constipation-overlooked/,DB06480
L1236,Alzheimer’s Therapy: GABA Receptor Inverse Agonists,http://cnsdiseases.com/alzheimers-therapy-gaba-receptor-inverse-agonists,DB06504
L5191,NCI Drug Dictionary: MVA-MUC1-IL2 vaccine,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mva-muc1-il2-vaccine,DB06584
L742,Abmole Midostaurin MSDS,http://www.abmole.com/literature/midostaurin-msds.html,DB06595
L743,Alfa Aesar Midostaurin MSDS,https://www.alfa.com/en/content/msds/british/J62917.pdf,DB06595
L744,Cayman Midostaurin MSDS,http://www.chemblink.com/MSDS/MSDSFiles/120685-11-2_Clear%20Synth.pdf,DB06595
L1133,FDA approves Cinqair to treat severe asthma,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm491980.htm,DB06602
L133,Link,http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm435296.htm,DB06603
L217,Drugs of the Future - Panobinostat,https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=1094476&p_IsPs=N,DB06603
L6043,FDA Drug Approval Package: Apixaban,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202155orig1s000toc.cfm,DB06605
L1122,EMA: Removab Withdrawal from Market,http://www.ema.europa.eu/docs/en_GB/document_library/Public_statement/human/000972/WC500231226.pdf,DB06607
L3770,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=210795,DB06608
L6676,DRUG NAME: Axitinib - BC Cancer,http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Axitinib_monograph_1March2014.pdf,DB06626
L135,Link,https://www.google.com/patents/US20110305694?pg=PA27&dq=AMG-162&hl=en&sa=X&ei=4IzKUZbLMeGqiQKhvoHAAQ&ved=0CDYQ6AEwAA,DB06643
L136,Link,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001120/WC500093529.pdf,DB06643
L12612,"FDA Approved Drug Products: ARZERRA (ofatumumab) injection, for intravenous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125326s062lbl.pdf,DB06650
L12753,"Novartis announces FDA and EMA filing acceptance of ofatumumab, a novel B-cell therapy for patients with relapsing forms of multiple sclerosis (RMS)",https://www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptance-ofatumumab-novel-b-cell-therapy-patients-relapsing-forms-multiple-sclerosis-rms,DB06650
L12771,Arzerra (ofatumumab) FDA Approval History - Drugs.com,https://www.drugs.com/history/arzerra.html,DB06650
L6070,FDA Drug Approval Package: Liraglutide,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022341s000TOC.cfm,DB06655
L6718,FDA News Release: Liraglutide Indication,https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-pediatric-patients-type-2-diabetes,DB06655
L6046,FDA Drug Approval Package: Vilazodone,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022567Orig1s000TOC.cfm,DB06684
L33,Chemspider,http://www.chemspider.com/Chemical-Structure.58262.html,DB06693
L138,Pubchem,http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=49896293&viewopt=PubChem,DB06693
L6022,FDA Drug Approval Package for Dabigatran Etexilate,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022512orig1s000toc.cfm,DB06695
L139,Antimicrobial agents and Chemotherapy,http://aac.asm.org/cgi/content/full/44/7/1925,DB06696
L6016,FDA Drug Approval Package for Desvenlafaxine,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/021992s000TOC.cfm,DB06700
L12957,FDA Approved Drug Products: AdreView (Iobenguane I 123 Injection) for Intravenous Use,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022290s005lbl.pdf,DB06704
L4435,AZEDRA® (iobenguane I 131) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209607s000lbl.pdf,DB06704
L5804,Naphazoline Hydrochloride Solution/Drops,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=eee62a16-5d68-4639-8aec-63189f3afe60&type=display,DB06711
L5807,Toxnet: Naphazoline Hydrochloride,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2174,DB06711
L141,Link,http://www.sanofi.ca,DB06719
L868,UK Medicines and Healthcare products Regulatory Agency: ACECLOFENAC 100MG TABLETS product information,http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2023359.pdf,DB06736
L869,"DailyMed: CLANZA CR- aceclofenac tablet, film coated ",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8a023942-01e8-4849-aa3c-1a640ffc7fd3,DB06736
L2482,The rise and fall of chemonucleolysis,http://eknygos.lsmuni.lt/springer/525/351-358.pdf,DB06752
L2486,Worthington,http://www.worthington-biochem.com/pcyp/default.html,DB06752
L2487,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018663,DB06752
L2496,Spine Health,https://www.spine-health.com/conditions/herniated-disc/whats-a-herniated-disc-pinched-nerve-bulging-disc,DB06752
L2191,FDA Code of Federal Regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1245,DB06755
L2192,FDA Code of Federal Regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=73.95,DB06755
L2193,FDA Code of Federal Regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=73.1095,DB06755
L2194,FDA Code of Federal Regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=73.2095,DB06755
L2202,UCSD lecture,http://jwhitesell.ucsd.edu/documents/Beta_Carotene.pdf,DB06755
L2214,AHFS,http://www.ahfsdruginformation.com/drug-information-fulltext-dif/,DB06755
L2226,Meeting the vitamin A requirements,https://www.hindawi.com/journals/tswj/2016/7393620/,DB06755
L1428,EMA Label: Vitravene (fomivirsen sodium) Summary of Product Characteristics,https://ec.europa.eu/health/documents/community-register/1999/199907293331/anx_3331_en.pdf,DB06759
L279,product info,https://pubchem.ncbi.nlm.nih.gov/compound/ammonium_chloride#section=Absorption-Distribution-and-Excretion,DB06767
L1944,Oleoresin Capsicum Toxicology Evaluation and Hazard Review,http://prod.sandia.gov/techlib/access-control.cgi/1995/952129.pdf,DB06774
L34,Carbaglu,http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000461/human_med_000685.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124&jsenabled=true,DB06775
L1190,"WikiDoc: Editor-In-Chief: C. Michael Gibson, M.S., M.D. ",https://www.wikidoc.org/index.php/Sodium_cellulose_phosphate,DB06776
L1817,Cupric Sulfate ,https://pubchem.ncbi.nlm.nih.gov/compound/Copper_II__sulfate_pentahydrate,DB06778
L1818,Copper Sulfate,http://npic.orst.edu/factsheets/cuso4gen.html,DB06778
L1819,Cupric Sulfate ToxNet,http://pmep.cce.cornell.edu/profiles/extoxnet/carbaryl-dicrotophos/copper-sulfate-ext.html,DB06778
L1820,"Cupric Sulfate, Britannica Online",https://www.britannica.com/science/cupric-sulfate,DB06778
L1821,Cupric Sulfate,http://www.mims.com/philippines/drug/info/copper%20sulfate?mtype=generic,DB06778
L1823,Wilson Disease,https://www.niddk.nih.gov/health-information/liver-disease/wilson-disease,DB06778
L1827,Complications and management of acute copper sulphate poisoning; a case discussion,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269987/,DB06778
L1828,Using Copper to Improve the Well-Being of the Skin,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556990/,DB06778
L1829,Veterinary Toxicology: Basic and Clinical Principals,https://books.google.ca/books?id=SB8wDwAAQBAJ&pg=PA426&lpg=PA426&dq=copper+sulfate+mechanism+of+action&source=bl&ots=Nlep4d-WrL&sig=eu1xNrHEagOkxMASrOKpWBpRR5Y&hl=fr&sa=X&ved=0ahUKEwj5u8Pj9ILaAhUKEHwKHZzHDMIQ6AEImAEwCQ#v=onepage&q=copper%20sulfate%20mechanism%20of%20action&f=false,DB06778
L1830,Abnormal Copper Homeostasis: Mechanisms and Roles  in Neurodegeneration,https://www.researchgate.net/publication/294424113_Abnormal_Copper_Homeostasis_Mechanisms_and_Roles_in_Neurodegeneration,DB06778
L1838,Copper,https://www.canada.ca/en/health-canada/services/publications/healthy-living/guidelines-canadian-drinking-water-quality-guideline-technical-document-copper.html,DB06778
L1839,Metallic Copper as an Antimicrobial Surface,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067274/,DB06778
L1841,Bacterial Killing by Dry Metallic Copper Surfaces,http://aem.asm.org/content/77/3/794.full,DB06778
L778,World Health Organization Model List of Essential Medicines (19th List),http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1,DB06783
L807,FERRIC HEXACYANOFERRATE Toxnet ,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7127,DB06783
L605,Gallium-Mechanism article,http://jnm.snmjournals.org/content/21/3/282.full.pdf,DB06784
L606,Gallium citrate,http://www.nuclearonline.org/PI/Du%20Pont%20Ga-67%20Citrate%20doc.pdf,DB06784
L607,Drugs.com,https://www.drugs.com/pro/gallium-citrate-ga-67.html,DB06784
L12705,FDA Approved Drug Products: Gallium Citrate Ga 67 Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017478s016lbl.pdf,DB06784
L876,WHOCC-ATC: Hexocyclium,https://www.whocc.no/atc_ddd_index/?code=A03AB10&showdescription=yes,DB06787
L143,Link,http://www.supprelinla.com/,DB06788
L874,European Medicines Agency (EMA): TESLASCAN Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000137/WC500036336.pdf,DB06796
L875,European Medicines Agency (EMA): TESLASCAN Scientific Discussion,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000137/WC500036332.pdf,DB06796
L11860,"Federal Register: Withdrawal of Approval of 29 NADA's (July 3, 1996)",https://www.govinfo.gov/content/pkg/FR-1996-07-03/html/96-16887.htm,DB06803
L144,Link,http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_113.pdf,DB06811
L290,The efficacy and risks of using povidone-iodine irrigation to prevent surgical site infection: an evidence-based review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386220/,DB06812
L291,"Iodophore activity, CDC",https://www.cdc.gov/hicpac/Disinfection_Sterilization/8_0Iodophors.html,DB06812
L1758,Pyrithione zinc - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+4498,DB06815
L879,HSDB: Pyrvinium,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3178,DB06816
L384,product info,https://www.drugs.com/cdi/sodium-phenylbutyrate.html,DB06819
L386,FDA label,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020572s016,020573s015lbl.pdf",DB06819
L227,article,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958522/,DB06826
L228,Monogragh,http://www.rxlist.com/rescula-drug/clinical-pharmacology.htm,DB06826
L12711,FDA Approved Drug Products: Chloramphenicol Sodium Succinate Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/050155s039lbl.pdf,DB07565
L14174,DailyMed: Chloramphenicol Succinate Powder for Injection,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aed29594-211d-49ef-813f-131975a8d0e3,DB07565
L145,ON THE FATE OF TRICLOSAN IN HUMANS,http://diss.kib.ki.se/2009/978-91-7409-510-4/thesis.pdf,DB08604
L35,Product Insert,http://home.intekom.com/pharm/hmr/roxit.html,DB08806
L1185,MIMS,http://www.mims.com/malaysia/drug/info/triflusal?mtype=generic,DB08814
L14201,FDA Approved Drug Products: Brilinta Ticagrelor Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022433s028lbl.pdf,DB08816
L14207,EMA Summary of Product Characteristics: Brilique Ticagrelor Oral Tablet,https://www.ema.europa.eu/en/documents/product-information/brilique-epar-product-information_en.pdf,DB08816
L768,"FDA Approval Update May 17, 2017",https://www.drugs.com/newdrugs/fda-expands-approved-kalydeco-additional-mutations-cystic-fibrosis-4534.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+May+18%2C+2017&utm_content=FDA+Expands+Approved+Use+of+Kalydeco+to+Treat+Additional+Mutations+of+Cystic+Fibrosis,DB08820
L6814,Symdeko FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210491lbl.pdf,DB08820
L6841,"Cystic Fibrosis, Canada",https://www.cysticfibrosis.ca/our-programs/advocacy/access-to-medicines/kalydeco,DB08820
L6847,"FDA label, Orkambi",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/211358s000lbl.pdf,DB08820
L9395,"FDA Approved Drug Products: Trikafta (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets)",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212273s000lbl.pdf,DB08820
L6979,FDA Approved Drug Products: Kalydeco (ivacaftor),"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203188s029,207925s008lbl.pdf",DB08820
L146,Link,http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5cd2bff8-40cd-4e63-9907-77b80d774cb7,DB08823
L147,Link,http://md.gehealthcare.com/files/pdfs/msds/datscan.pdf,DB08824
L214,Clearance of Temocapril and Enalapril during Haemodialysis Treatment,http://link.springer.com/article/10.2165%2F00044011-199509040-00008,DB08836
L12567,FDA Approved Drug Products: Livalo (pitavastatin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022363s017lbl.pdf,DB08860
L12864,FDA Approved Drug Products: Zypitamag (pitavastatin magnesium) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208379s003lbl.pdf,DB08860
L1632,cholecystokinin,http://www.vivo.colostate.edu/hbooks/pathphys/endocrine/gi/cck.html,DB08862
L1633,Cholecystokinin metabolism in man and dogs,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1344019/,DB08862
L1634,Cholecystokinin,https://www.drugs.com/mmx/cck.html,DB08862
L1635,Cholecystokinin- a review,https://www.sciencedirect.com/topics/chemistry/cholecystokinin,DB08862
L1636,Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839260/,DB08862
L1637,"Cholecystokinin receptors in brain: Effects of obesity, drug treatment, and lesions Author links open overlay panel",https://www.sciencedirect.com/science/article/abs/pii/0196978181900516,DB08862
L1638,"SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI",https://link.springer.com/article/10.1007/s00213-002-1214-z,DB08862
L1639,Physiology of CCK,https://www.uptodate.com/contents/physiology-of-cholecystokinin,DB08862
L1640,"Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.",https://www.ncbi.nlm.nih.gov/pubmed/12496267,DB08862
L1641,"Effect of Exogenous Cholecystokinin (CCK)-8 on Food Intake and Plasma CCK, Leptin, and Insulin Concentrations in Older and Young Adults: Evidence for Increased CCK Activity as a Cause of the Anorexia of Aging",https://watermark.silverchair.com/jcem5830.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAaowggGmBgkqhkiG9w0BBwagggGXMIIBkwIBADCCAYwGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQM8C4jETgsbOcKN1RJAgEQgIIBXby2TDMTqLoxgQ6ubmlN4HjHutX56ZK5YSit8uXY_SxCH-FeJHHRd96DO6Xelfs_AWHgOkwYiSjyYiuJ6R5G75IuAh7TqXiqfShWHfHPGcr6jbX8N95S0Q25p6CTV_9-3_c8L1bA6AmtrsINgJbKbocjEZYJz0Dw51NqiUsO8g8f8Junna_pmyfUuz8j4wEmV7mywP_MWfvtH85E-gZ1XvGsQ7CiBLVtSW2g_4VGxNQgySqQqOqwvwdBXWNGFaIdAEDcvTqNslGyKbBNDf9OG_vZdli5fQXImHAhuyg1MGK4DKqzXh1FLuaRnRpOILyQrw5Wdw9pmiH_t6LxvC4RDlG5gi_fhjlAbLBZSLFxxefkX9NV8s9_sjKTpGFpVRDLooh6_luWVvHcFmS8OyEbaj-Jy8E0d_n_JndMakMvJT1ijVQpi4RbOrA6zCGeAvlPoDhBVT5IfTTQ61uJSsQ,DB08862
L1642,Comparison of Gallbladder Function Obtained with Regular CCK-8 and Pharmacy-Compounded CCK-8,http://jnm.snmjournals.org/content/44/4/499.full,DB08862
L1643,Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo,https://link.springer.com/article/10.1007%2FBF02779509,DB08862
L1644,Cholecystokinin Octapeptide ,https://pubchem.ncbi.nlm.nih.gov/compound/16219094,DB08862
L1645,"Cholecystokinin Octapeptide, [125I]-, Bolton-Hunter Labeled, 10µCi",http://www.perkinelmer.ca/en-ca/product/cholecystokinin-octapeptide-125i-bolt-nex203010uc,DB08862
L1646,"Alfa Aesar™ Cholecystokinin, CCK Octapeptide (26-33)",https://www.fishersci.ca/shop/products/cholecystokinin-cck-octapeptide-26-33-2/p-5384644,DB08862
L1647,Cholecystokinin-Pancreozymin Peptides Products,http://www.biosyn.com/catalog-peptides/cholecystokinin-pancreozymin-peptides.aspx,DB08862
L1648,CCK Octapeptide sulfated,https://www.tocris.com/products/cck-octapeptide-sulfated_1166,DB08862
L1649,Cholecystokinin Octapeptide,https://www.perkinelmer.com/Content/MSDSDatabase/MSDS_NEX203010UC_AU_EN.pdf,DB08862
L148,Lexicomp 2013,http://lexicomp.com,DB08864
L1030,J&J News,https://www.jnj.com/media-center/press-releases/fda-approves-edurant-rilpivirine-for-use-in-treatment-naive-adults-with-hiv-1,DB08864
L1031,FDA News and Events,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm586305.htm,DB08864
L1032,Australian report,https://www.tga.gov.au/sites/default/files/auspar-rilpivirine-120327.pdf,DB08864
L1033,J&J News,https://www.jnj.com/media-center/press-releases/janssen-announces-us-fda-approval-of-first-and-only-complete-single-pill-two-drug-regimen-juluca-dolutegravir-and-rilpivirine-for-the-treatment-of-hiv-1-infection,DB08864
L5575,Electronic Medicines Compendium: ellaOne (ulipristal acetate) 30 mg Monograph,https://www.medicines.org.uk/emc/product/6657/smpc,DB08867
L12651,FDA Approved Products: Gilenya (fingolimod) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022527s031lbl.pdf,DB08868
L12654,Clinicaltrials.gov: Fingolimod in COVID-19,https://clinicaltrials.gov/ct2/show/NCT04280588,DB08868
L12657,Clinical trials on drug repositioning for COVID-19 treatment,https://www.paho.org/journal/sites/default/files/2020-03/40-20-249-Rosa-prelim.pdf?ua=1,DB08868
L12690,European Medicines Agency Public Assessment Report: Gilenya (fingolimod),https://www.ema.europa.eu/en/documents/assessment-report/gilenya-epar-public-assessment-report_en.pdf,DB08868
L1737,FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm601935.htm,DB08870
L1739,Seattle Genetics Announces FDA Approval of ADCETRIS® (Brentuximab Vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Stage III or IV Classical Hodgkin Lymphoma  Read more: http://www.digitaljournal.com/pr/3703005#ixzz5AKAaxmbe,http://www.digitaljournal.com/pr/3703005,DB08870
L1740,NCCN Flash UpdatesTM: NCCN Guidelines® and NCCN Compendium® Updated,https://www.nccn.org/about/news/ebulletin/ebulletindetail.aspx?ebulletinid=472,DB08870
L1741,EMA label,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002455/WC500135055.pdf,DB08870
L1742,Cancer Care Ontario Formulary,https://www.cancercareontario.ca/sites/ccocancercare/files/brentuximab%20vedotin.pdf,DB08870
L1743,"Merck Manuals, Progressive Multifocal Leukoencephalopathy","https://www.merckmanuals.com/en-ca/home/brain,-spinal-cord,-and-nerve-disorders/brain-infections/progressive-multifocal-leukoencephalopathy-pml",DB08870
L1745,Seattle genetics Brentuximab Vedotin,http://www.seattlegenetics.com/pipeline/brentuximab-vedotin,DB08870
L1747,Brentuximab vedotin: clinical updates and practical guidance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762734/,DB08870
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB08873
L11575,"FDA Approved Drug Products: DIFICID (fidaxomicin) tablets, for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213138lbl.pdf,DB08874
L11578,"Santa Cruz Biotechnology, Inc.: Fidaxomicin Safety Data Sheet",http://datasheets.scbt.com/sds/wpna/en/sc-362739.pdf,DB08874
L1012,Roche news,https://www.roche.com/media/store/releases/med-cor-2011-08-17.htm,DB08881
L1013,FDA News and Events,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm583931.htm,DB08881
L1014,FDA  Vemurafenib application,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/202429Orig1s000ClinPharmR.pdf,DB08881
L9557,FDA Approved Drug Products: Linagliptin Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201280s018lbl.pdf,DB08882
L11479,FDA Approved Drug Products: Trijardy XR (empagliflozin/linagliptin/metformin) extended-release tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212614s000lbl.pdf,DB08882
L149,Link,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125359lbl.pdf,DB08886
L150,Link,http://webprod5.hc-sc.gc.ca/dpd-bdpp/info.do?code=61174&lang=eng,DB08886
L1447,"Electronic Medicines Compendium ERWINASE (Erwinia L-asparaginase), 10000 Units/vial, Lyophilisate for Solution for Injection Monograph",https://www.medicines.org.uk/emc/product/4979,DB08886
L1448,BC Cancer Asparaginase Monograph,http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Asparaginase_monograph_1June2013_formatted.pdf,DB08886
L1452,Pegylated l-asparaginase: Protein Sequence of Erwinia Asparaginase,https://patents.google.com/patent/EP2451486A1,DB08886
L1453,Genbank Accession No. CAA32884: L-asparaginase [Dickeya chrysanthemi],https://www.ncbi.nlm.nih.gov/protein/CAA32884.1,DB08886
L151,Link,http://www.accessdata.fda.gov/spl/data/34f69a09-8707-42ca-8cd1-33dabe698756/34f69a09-8707-42ca-8cd1-33dabe698756.xml,DB08895
L5819,FDA news,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm634671.htm,DB08904
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB08904
L5825,Pubmed books,https://www.ncbi.nlm.nih.gov/pubmed/30222277,DB08904
L5840,Nature,https://www.nature.com/subjects/inflammatory-diseases,DB08904
L5965,FDA Fluticasone Furoate Approval 2007,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022051_veramyst_toc.cfm,DB08906
L5897,"U.S. FDA Approves INVOKANA® (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease",https://www.janssen.com/us-fda-approves-invokanar-canagliflozin-reduce-risk-heart-attack-stroke-or-cardiovascular-death,DB08907
L5933,"Diabetes, Heart Disease, and Stroke: NIDDK",https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/heart-disease-stroke,DB08907
L8917,FDA Approved Drug Products: Invokana (canagliflozin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/204042s032lbl.pdf,DB08907
L2726,FDA approves new uses for two drugs administered together for the treatment of BRAF-positive anaplastic thyroid cancer,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm606686.htm,DB08911
L2727,Drugs@FDA: FDA Approved Drug Products,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=204114,DB08911
L2711,Dabrafenib,https://pubchem.ncbi.nlm.nih.gov/compound/Dabrafenib,DB08912
L2712,"Drug Duo, Tafinlar and Mekinist, Approved for Aggressive Thyroid Cancer",https://www.drugs.com/news/duo-tafinlar-mekinist-approved-aggressive-thyroid-cancer-74098.html?utm_source=ddc&utm_medium=email&utm_campaign=Today%27s+news+summary+-+May+5%2C+2018&utm_content=Drug+Duo%2C+Tafinlar++and+Mekinist%2C+Approved+for+Aggressive+Thyroid+Cancer,DB08912
L2713,FDA grants regular approval to dabrafenib and trametinib combination for metastatic NSCLC with BRAF V600E mutation,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm564331.htm,DB08912
L2714,Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma,https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-tafinlarr-mekinistr-adjuvant-treatment-braf-v600-mutant-melanoma,DB08912
L2717,Dabrafenib,https://www.rcsb.org/ligand/P06,DB08912
L2718,Cancer. gov Dabrafenib,https://www.cancer.gov/about-cancer/treatment/drugs/fda-dabrafenib,DB08912
L2723,Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600–Mutant Anaplastic Thyroid Cancer,http://ascopubs.org/doi/abs/10.1200/JCO.2017.73.6785,DB08912
L2937,Electronic Medicines Compendium: Giotrif 30 mg film-coated tablets Monograph,https://www.medicines.org.uk/emc/product/7701/smpc,DB08916
L2939,Boehringer Ingelheim: FDA approves new indication for Gilotrif® in EGFR mutation-positive NSCLC,https://www.boehringer-ingelheim.us/press-release/fda-approves-new-indication-gilotrif-egfr-mutation-positive-nsclc,DB08916
L1035,ViiV Healthcare News,https://www.viivhealthcare.com/media/press-releases/2013/august/viiv-healthcare-announces-us-approval-of-tivicay-dolutegravir-for-the-treatment-of-hiv-1.aspx,DB08930
L1031,FDA News and Events,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm586305.htm,DB08930
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB08934
L154,Link,http://clinicaltrials.gov/ct2/show/NCT01607957,DB08937
L215,Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999,http://dij.sagepub.com/content/35/1/293.abstract,DB08942
L810,SCIENTIFIC OPINION Inositol hexanicotinate,http://www.efsa.europa.eu/sites/default/files/scientific_output/files/main_documents/949.pdf,DB08949
L842,"Vitamin and Mineral Safety 3rd Edition (2013) Council for Responsible Nutrition (CRN); Niacin: Nicotinic Acid, Nicotinamide, and Inositol Hexanicotinate",https://www.crnusa.org/sites/default/files/files/resources/13-CRNVMS3-NIACIN.pdf,DB08949
L878,CERVAGEM (Gemeprost) Product information,https://gp2u.com.au/static/pdf/C/CERVAGEM-PI.pdf,DB08964
L155,Link,http://www.catalog.md/drugs/tinoran.html,DB08998
L156,Link,http://chem.sis.nlm.nih.gov/chemidplus/rn/486-17-9,DB09014
L13994,FDA Approved Products: Tekturna (Aliskiren) oral tablets and pellets,https://www.tekturna.com/wp-content/uploads/2017/11/Tekturna_PCR-1.pdf,DB09026
L14018,The Pharmaletter: Novartis and Speedel,https://www.thepharmaletter.com/article/novartis-and-speedel,DB09026
L14030,"NIH StatPearls: Physiology, Renin Angiotensin System",https://www.ncbi.nlm.nih.gov/books/NBK470410/,DB09026
L14168,FDA Approved Products: Tekamlo (amlodipine and aliskiren) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022545s014lbl.pdf,DB09026
L14171,FDA Approved Products: Tekturna HCT (aliskiren and hydrochlorothiazide) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022107s023lbl.pdf,DB09026
L14294,Product monograph: Rasilez HCT (Aliskiren fumarate and hydrochlorothiazide oral tablets),https://www.novartis.ca/sites/www.novartis.ca/files/rasilez%20hct_scrip_e.pdf,DB09026
L14297,NIH StatPearls: Aliskiren,https://www.ncbi.nlm.nih.gov/books/NBK507868/,DB09026
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB09027
L12129,FDA Approved Drug Products: Opvido Nivolumab Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125554s078lbl.pdf,DB09035
L12618,BC Cancer Agency: Opdivo Monograph,http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Nivolumab_monograph.pdf,DB09035
L2954,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=125514,DB09037
L2955,FDA news,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm610572.htm,DB09037
L11479,FDA Approved Drug Products: Trijardy XR (empagliflozin/linagliptin/metformin) extended-release tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212614s000lbl.pdf,DB09038
L13670,FDA Summary Review: Empagliflozin,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204629Orig1s000SumR.pdf,DB09038
L13673,FDA Approved Drug Products: Glyxambi (empagliflozin/linagliptin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206073s021lbl.pdf,DB09038
L13679,FDA Approved Drug Products: Synjardy (empagliflozin/metformin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/206111s022lbl.pdf,DB09038
L13685,FDA Approved Drug Products: Synjardy XR (empagliflozin/metformin) extended-release tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208658s009lbl.pdf,DB09038
L13688,FDA Approved Drug Products: Jardiance (empagliflozin) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/204629s023lbl.pdf,DB09038
L13916,Health Canada Product Monograph: Jardiance (empagliflozin) oral tablets,https://pdf.hres.ca/dpd_pm/00055667.PDF,DB09038
L13964,CaymanChem: Empagliflozin MSDS,https://www.caymanchem.com/msdss/17375m.pdf,DB09038
L11232,FDA Approved Products: Sivextro (tedizolid phosphate) tablet and injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205435s000lbl.pdf,DB09042
L6685,Ceftolozane Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/53234134,DB09050
L6688,Zerbaxa MedSafe NZ data sheet,https://medsafe.govt.nz/profs/Datasheet/z/zerbaxainj.pdf,DB09050
L6691,FDA news,https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-hospital-acquired-and-ventilator-associated-bacterial-pneumonia,DB09050
L937,FDA: Ibrutinib cGVHD approval,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm569710.htm,DB09053
L1926,FDA approved drugs,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205552,DB09053
L1929,Canadian cancer society,http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/mantle-cell-lymphoma/?region=on,DB09053
L1931,National Cancer Institute,https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq,DB09053
L1934,American Cancer Society,https://www.cancer.org/cancer/waldenstrom-macroglobulinemia/about/what-is-wm.html,DB09053
L2469,EMA: Tractocile Product Information,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000253/WC500040495.pdf,DB09059
L886,Health Canada Product Label,https://pdf.hres.ca/dpd_pm/00016162.PDF,DB09061
L2719,New York Times: F.D.A. Panel Recommends Approval of Cannabis-Based Drug for Epilepsy (April 2018),https://www.nytimes.com/2018/04/19/health/epidiolex-fda-cannabis-marajuana.html,DB09061
L2720,GW Pharmaceuticals Announces Positive Phase 3 Pivotal Study Results for Epidiolex (cannabidiol),https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-announces-positive-phase-3-pivotal-study-results-epidiolex,DB09061
L2721,"FDA Briefing Document - Peripheral and Central Nervous System Drugs Advisory Committee Meeting (April 19, 2018)",https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PeripheralandCentralNervousSystemDrugsAdvisoryCommittee/UCM604736.pdf,DB09061
L2269,Corifollitropin alfa vs recombinant FSH for controlled ovarian stimulation in women aged 35–42 years with a body weight ≥50 kg: a randomized controlled trial,https://academic.oup.com/hropen/article/2017/3/hox023/4670555,DB09066
L2270,EMA label,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/001106/WC500074787.pdf,DB09066
L2271,Impact of patient characteristics on the pharmacokinetics of corifollitropin alfa during controlled ovarian stimulation,https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.12939,DB09066
L2272,Corifollitropin alfa approval,https://www.drugs.com/history/corifollitropin-alfa.html,DB09066
L2273,"Australian  APA report document, corifollitropin alfa",https://www.tga.gov.au/sites/default/files/auspar-elonva.pdf,DB09066
L2274,"Corifollitropin alfa, a long-acting follicle-stimulating hormone agonist for the treatment of infertility.",https://www.jove.com/visualize/abstract/19337959/corifollitropin-alfa-long-acting-follicle-stimulating-hormone-agonist,DB09066
L2275,Ovarian hyperstimulation syndrome,https://www.mayoclinic.org/diseases-conditions/ovarian-hyperstimulation-syndrome-ohss/symptoms-causes/syc-20354697,DB09066
L2276,Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465305/,DB09066
L2277,Gonadotrophins: The future,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296397/,DB09066
L1720,Tibolone for Postmenopausal Women: Systematic Review of Randomized Trials,https://academic.oup.com/jcem/article/87/1/16/2846489,DB09070
L1722,Tibolone Approval Status,https://www.drugs.com/history/tibolone.html,DB09070
L1723,WHO DRUG INFORMATION,http://apps.who.int/medicinedocs/pdf/s5407e/s5407e.pdf,DB09070
L1724,Livial,https://www.news-medical.net/drugs/Livial.aspx,DB09070
L1725,Postmenopausal hormonal therapy: Current status,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830366/,DB09070
L1727,LIVIAL- Drug sheet NZ,http://www.medsafe.govt.nz/profs/Datasheet/l/Livialtab.pdf,DB09070
L1748,Tibolone Drug Monograph,http://www.druginfosys.com/drug.aspx?drugcode=1070&type=1,DB09070
L1874,Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603018/,DB09070
L1876,The Effects of Tibolone in Older Postmenopausal Women,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684062/,DB09070
L1877,Tibolone Metabolism in Human Liver Is Catalyzed by 3α/3β-Hydroxysteroid Dehydrogenase Activities of the Four Isoforms of the Aldo-Keto Reductase (AKR)1C Subfamily,https://doi.org/10.1359/jbmr.2001.16.9.1651,DB09070
L1879,Tibolone: A Unique Version of Hormone Replacement Therapy,http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.919.2384&rep=rep1&type=pdf,DB09070
L1881,Cardiovascular Effects of Tibolone: A Selective Tissue Estrogenic Activity Regulator,https://onlinelibrary.wiley.com/doi/full/10.1111/j.1527-3466.2007.00007.x,DB09070
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB09073
L5867,Pfizer history,https://www.pfizer.com/sites/default/files/news/Palbociclib_Timeline.pdf,DB09073
L5870,Canadian cancer society,http://www.cancer.ca/en/cancer-information/cancer-type/breast/breast-cancer/?region=on,DB09073
L5873,Canadian cancer society,http://www.cancer.ca/en/cancer-information/cancer-type/breast/breast-cancer/breast-cancer-in-men/?region=on,DB09073
L5876,Clinical trials,https://clinicaltrials.gov/ct2/show/NCT02499146,DB09073
L5086,FDA Approves Olaparib as Frontline Maintenance Therapy in Ovarian Cancer Press Release,https://www.targetedonc.com/news/fda-approves-olaparib-as-frontline-maintenance-therapy-in-ovarian-cancer,DB09074
L5089,Olaparib New Zealand Data Sheet,https://medsafe.govt.nz/profs/Datasheet/l/lynparzacap.pdf,DB09074
L8453,FDA Approved Drugs: Nintedanib,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205832s010lbl.pdf,DB09079
L8459,EMA Approved Drugs: Nintedanib,https://www.ema.europa.eu/en/documents/product-information/vargatef-epar-product-information_en.pdf,DB09079
L8462,FDA New Indication Approval: Nintedanib,https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/205832Orig1s012ltr.pdf,DB09079
L885,EMA Product Label,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003834/WC500193836.pdf,DB09081
L2909,hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes,http://journals.sagepub.com/doi/abs/10.1177/2042098615595546,DB09083
L1120,Electronic Medicines Compedium Difflam (Benzydamine Hydrochloride) Spray Monograph,https://www.medicines.org.uk/emc/medicine/13#PRODUCTINFO,DB09084
L1121,Electronic Medicines Compedium Benzydamine Hydrochloride 0.15% w/v Mouthwash Monograph,https://www.medicines.org.uk/emc/product/3347,DB09084
L1123,Electronic Medicines Compedium Difflam (Benzydamine Hydrochloride) 3% Cream Monograph,https://www.medicines.org.uk/emc/product/825,DB09084
L2466,Benzydamine - Tantum Verde,https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=6&ved=0ahUKEwiF3q-XvdPaAhVCWq0KHUz4BQYQFghdMAU&url=http%3A%2F%2Fwww.tantum-verde.de%2Fpflichtangaben.html%3Ffile%3Dfiles%2Fpflichtangaben_upload%2FTANTUM_VERDE_Benzydamin.pdf&usg=AOvVaw2r3MBiTXb2XWY8xYv3SfGs,DB09084
L1070,FDA GRAS,https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260848.htm,DB09087
L1071,Homepathic label,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e93e2938-5c91-4dff-8346-7faa154ed0cc,DB09087
L1072,EWG's skin deep,https://www.ewg.org/skindeep/ingredient/705178/POTASSIUM_ALUM/#.WirqskriY2w,DB09087
L1073,Cosmetics info,http://www.cosmeticsinfo.org/ingredient/potassium-alum-0,DB09087
L1074,FDA OTC ingredients,https://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM135688.pdf,DB09087
L1075,Encyclopaedia Britannica,https://www.britannica.com/science/astringent,DB09087
L1076,What is alum?,https://www.thoughtco.com/what-is-alum-608508,DB09087
L1882,The Wood Library-Museum: Stovaine Profile,https://www.woodlibrarymuseum.org/museum/item/504/stovaine,DB09088
L872,AA Pharma Inc.: TRIMEBUTINE product monograph,http://www.aapharma.ca/downloads/en/PIL/Trimebutine_PM.pdf,DB09089
L873,BGP Pharma ULC: DICETEL (Pinaverium Bromide) product monograph,http://www.mylan.ca/-/media/mylanca/documents/english/product%20pdf/pdfs%20dec%202015/dicetel-pm-2016.01.08.pdf,DB09090
L1077,Chemotechnique diagnostics,https://www.chemotechnique.se/get_pdf.php?l=en&p=386,DB09091
L1078,Clinical experience with tixocortol pivalate,http://downloads.hindawi.com/journals/cjgh/1988/819089.pdf,DB09091
L1079,Exercise,https://www.exercise.com/supplements/xanthinol-nicotinate,DB09092
L1080,Smart publications ,http://www.smart-publications.com/books/full-text/smart-drugs-and-nutrients/smart-drugs-and-nutrients-sec-5/smart-drugs-and-nutrients-sec5-xanthinol,DB09092
L1081,Xanthinol,https://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=7&cad=rja&uact=8&ved=0ahUKEwjIrefY-4TYAhWjyoMKHQmXAwoQFghIMAY&url=http%3A%2F%2Fwww.drugfuture.com%2Fmt%2Fxantinol-nicotinate.pdf&usg=AOvVaw2hzzAzSkuCgM5yKwbKzqnC,DB09092
L261,product info,http://www.inchem.org/documents/pims/pharm/pim427.htm,DB09094
L1082,FDA Submission,https://www.fda.gov/downloads/drugs/developmentapprovalprocess/formssubmissionrequirements/drugmasterfilesdmfs/ucm370723.txt,DB09095
L1083,Dokteronline,https://www.dokteronline.com/en/nerisone,DB09095
L1084,J-stage papers,https://www.jstage.jst.go.jp/article/dmpk1986/7/5/7_5_591/_article,DB09095
L1085,Diflucortolone monograph,https://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&cad=rja&uact=8&ved=0ahUKEwicvuWUtYfYAhWq34MKHd3kALMQFgg1MAI&url=https%3A%2F%2Fwww.old.health.gov.il%2Funits%2Fpharmacy%2Ftrufot%2Falonim%2FNeriderm_dr_1409827405542.pdf&usg=AOvVaw2ugd9AqSVOs5HlRGSO_I3r,DB09095
L1086,Medicine.ie,http://www.medicines.ie/medicine/1993/SPC,DB09095
L870,DRUG NAME: Quinagolide - BC Cancer Agency,http://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Quinagolide_monograph_1June2013_formatted.pdf,DB09097
L871,NORPROLAC® (quinagolide) Product information,http://www.medicines.org.au/files/fppnorpt.pdf,DB09097
L1896,Human Growth Hormone: Protropin,https://www.worldhealth.net/news/protropin/,DB09098
L11755,Health Canada Approved Drug Products: Desiccated Thyroid Oral Tablets,https://pdf.hres.ca/dpd_pm/00034857.PDF,DB09100
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB09102
L863,American Liver Foundation: Advances in Medications to Treat Hepatitis C,http://hepc.liverfoundation.org/treatment/the-basics-about-hepatitis-c-treatment/advances-in-medications/,DB09102
L1087,Health Canada,https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=63758,DB09103
L1088,Sobi,http://www.sobi.com/en/Healthcare-Professionals/Products-alphabetical-list/Stemgen/,DB09103
L1089,Stemgen monograph,https://pdf.hres.ca/dpd_pm/00007290.PDF,DB09103
L1090,Stemgen monograph,http://www.medicines.org.au/files/anpstemi.pdf,DB09103
L409,Drugs.com,https://www.drugs.com/ppa/magnesium-hydroxide.html,DB09104
L410,Glow,https://www.glowm.com/resources/glowm/cd/pages/drugs/m001.html,DB09104
L411,Medicines,https://www.medicines.org.uk/emc/medicine/17293,DB09104
L412,Drugs.com,https://www.drugs.com/mtm/milk-of-magnesia.html,DB09104
L362,MSDS,http://pss-polymer.com/fileadmin/custom_documents/MSDS_Hydroxyethyl_starch.pdf,DB09106
L495,Daily Med Micera Monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c6b7448-152f-435f-a672-7404b1bfe7eb,DB09107
L1115,Nuwiq Product Monograph,http://www.octapharma.ca/fileadmin/user_upload/octapharma.ca/Product_Monographs/NUWIQ-PM.pdf,DB09108
L1104,FiercePharma,https://www.fiercepharma.com/pharma/novoeight%C2%AE-turoctocog-alfa-receives-approval-from-fda,DB09109
L1105,EMA Reports,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002719/WC500157553.pdf,DB09109
L1106,NovoNordisk,http://www.novonordisk.ca/content/dam/Canada/AFFILIATE/www-novonordisk-ca/OurProducts/PDF/Zonovate_PM_English.pdf,DB09109
L1107,EU Reports,http://ec.europa.eu/health/documents/community-register/2013/20131113127003/anx_127003_en.pdf,DB09109
L1108,Australian report,https://www.tga.gov.au/sites/default/files/auspar-turoctocog-140507.pdf,DB09109
L219,DynaMed,http://www.dynamed.com/home/,DB09110
L1109,Pharmaintelligence,https://pink.pharmaintelligence.informa.com/PS017845/BURROUGHS-WELLCOMEs-EXOSURF-IS-APPROVED,DB09114
L1110,Access,http://www.syrianclinic.com/med/en/ProfDrugs/Print/ColfoscerilPalmitatepd.html,DB09114
L1111,Curoservice,http://www.curoservice.com/parents_visitors/surfactant/surfactant_composition_action.php,DB09114
L1112,Rob Holland,http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/C111.html,DB09114
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB09116
L1114,Encyclopedia,http://www.encyclopedia.com/education/encyclopedias-almanacs-transcripts-and-maps/calcium-carbimide,DB09116
L880,European Medicines Agency (EMA): DIACOMIT Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000664/WC500036518.pdf,DB09118
L4352,FDA approved Drugs,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process,DB09118
L877,Sanofi Canada: ZUACTA (zucapsaicin cream) product monograph,http://products.sanofi.ca/en/zuacta.pdf,DB09120
L1925,NLM Toxnet Toxicology Data Network: Aurothioglucose,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7174,DB09121
L1937,RXmed: Solganal (Aurothioglucose) Monograph,https://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/cps-_monographs/CPS-_(General_Monographs-_S)/SOLGANAL.html,DB09121
L1940,ChemIDplus: Aurothioglucose [USP],https://chem.nlm.nih.gov/chemidplus/rn/12192-57-3,DB09121
L1947,ScienceDirect: Aurothioglucose,https://www.sciencedirect.com/topics/neuroscience/aurothioglucose,DB09121
L1956,Arthritis Society: Rheumatoid Arthritis,https://www.arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/rheumatoid-arthritis,DB09121
L931,Bayer Inc: VISANNE (2mg dienogest tablets) Product Monograph,http://www.bayer.ca/static/documents/news/en/VISANNE-PM-EN-19JUN2015-182736.pdf,DB09123
L932,Bayer Inc: VISANNE (2mg dienogest tablets) Product Information,http://www.bayerresources.com.au/resources/uploads/pi/file10142.pdf,DB09123
L1118,Health Canada,https://health-products.canada.ca/dpd-bdpp/info.do?lang=en&code=759,DB09124
L253,Monograph,https://www.drugs.com/pro/potassium-citrate.html,DB09125
L254,safety data sheet,http://www.adm.com/en-US/worldwide/australia/Documents/Potassium%20Citrate%20AU.pdf,DB09125
L431,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/chromic_chloride,DB09129
L432,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/10025-73-7,DB09129
L433,DAILYMED,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4d01ebb-a36e-44b7-028c-43c0ab2d13b4,DB09129
L801,Product Monograph: Copper IUD,http://omr.bayer.ca/omr/online/nova-tpi-en-17feb2015.pdf,DB09130
L418,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/24014#section=Absorption-Distribution-and-Excretion,DB09131
L419,inChem,http://www.inchem.org/documents/ukpids/ukpids/ukpid53.htm,DB09131
L340,FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018310s011lbl.pdf,DB09136
L341,Drugs.com,https://www.drugs.com/pro/isosulfan-blue-injection.html,DB09136
L1137,WHO,http://www.who.int/medicines/publications/pharmacopoeia/Radgenmono.pdf,DB09139
L1138,IAEA,http://www-pub.iaea.org/MTCD/publications/PDF/trs466_web.pdf,DB09139
L1139,Human health IAEA,https://humanhealth.iaea.org/HHW/Radiopharmacy/VirRad/Selection_of_Labelling_Kit/index.html,DB09139
L1140,Doctissimo,http://www.doctissimo.fr/medicament-OSTEOCIS.htm,DB09139
L1141,Pubmedhealth,https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0024006/?report=details,DB09139
L1142,SNMjournals,http://jnm.snmjournals.org/content/22/7/local/advertising.pdf,DB09139
L1143,Tc-99m compounds,http://eknygos.lsmuni.lt/springer/439/173-337.pdf,DB09139
L745,British Thoracic Society: Guideline for emergency oxygen use in adult patients ,https://www.brit-thoracic.org.uk/document-library/clinical-information/oxygen/emergency-oxygen-use-in-adult-patients-guideline/emergency-oxygen-use-in-adult-patients-guideline/,DB09140
L747,Airgas SDS,https://www.airgas.com/msds/001043.pdf,DB09140
L748,Linde SDS,http://www.linde-gas.com/internet.global.lindegas.global/en/images/Compressed%20oxygen17_24367.pdf?v=1.0,DB09140
L387,Product info,"https://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=13&cad=rja&uact=8&sqi=2&ved=0ahUKEwjE44WH68fSAhWj24MKHSKCCzwQFghTMAw&url=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fprotamine-sulfate.html&usg=AFQjCNEZpum1VIHPgqSl9Z8J3a4w3RFkKQ&bvm=bv.149093890,d.amc",DB09141
L388,product info,http://www.rxlist.com/protamine-drug/indications-dosage.htm,DB09141
L5371,Dailymed: Protamine sulfate Monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1964129-33f4-4e4e-86e3-8e6a4e65bd83,DB09141
L5443,Prosulf (protamine sulfate) 10 mg/ml Solution for Injection,https://www.medicines.org.uk/emc/product/8/smpc,DB09141
L222,monograph,https://www.drugs.com/monograph/iron-sucrose.html,DB09146
L238,article,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805051/,DB09146
L12732,FDA Approved Drug Products: Velphoro Sucroferric Oxyhydroxide Oral Tablet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205109s008lbl.pdf,DB09146
L436,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/Iron_III__pyrophosphate#section=Pharmacology-and-Biochemistry,DB09147
L1419,Nippon,https://www.nippon.com/en/currents/d00106/,DB09147
L1420,KEGG,http://www.genome.jp/dbget-bin/www_bget?D04946,DB09147
L1423,FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206317orig1s000medr.pdf,DB09147
L1433,Sunactive,https://taiyogmbh.com/en/sunactive-en/,DB09147
L13014,"DailyMed: Unapproved label for liquid nitrogen, refrigerated",https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=8519f7b5-2fe2-42e9-8604-431a9ccfc420&type=display,DB09152
L12963,FDA Compliance Program Guidance Manual: Compressed Medical Gases,https://www.fda.gov/media/75194/download,DB09152
L13017,ATSDR: Medical Management Guidelines for Nitrogen Oxides,https://www.atsdr.cdc.gov/MMG/MMG.asp?id=394&tid=69,DB09152
L448,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/7647-14-5,DB09153
L449,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/sodium_chloride,DB09153
L788,FDA Monograph: Sodium Citrate Tablet,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a60660b2-c5db-45a0-885f-de93e655380d,DB09154
L789,FDA Monograph: Sodium Citrate Liquid,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb0bade0-fc86-4bfa-90cc-f0d5f7b4d3a8,DB09154
L790,TOXNET: Trisodium Citrate,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5201,DB09154
L795,SMPDB: Citric Acid Cycle,http://smpdb.ca/view/SMP00057,DB09154
L12963,FDA Compliance Program Guidance Manual: Compressed Medical Gases,https://www.fda.gov/media/75194/download,DB09155
L13020,DailyMed: Helium gas,https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cb33fc07-e122-4f66-aa43-b659ee150150,DB09155
L13023,FDA Approved Products: Heliox (helium and oxygen) gases for inhalation,https://www.accessdata.fda.gov/spl/data/1366bd51-4f64-48d6-baa1-1fb402553331/1366bd51-4f64-48d6-baa1-1fb402553331.xml,DB09155
L255,product leaflet,http://www.mhra.gov.uk/home/groups/spcpil/documents/spcpil/con1464324364725.pdf,DB09157
L256,product info,https://www.cdc.gov/niosh/idlh/124389.html,DB09157
L12963,FDA Compliance Program Guidance Manual: Compressed Medical Gases,https://www.fda.gov/media/75194/download,DB09157
L671,FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022278s003lbl.pdf,DB09158
L1146,Technetium radiopharmaceutical chemistry,https://pdfs.semanticscholar.org/bfa5/c1913650a8a23b0359c3d9d2f5710a243a27.pdf,DB09160
L1147,Monograph,http://www.nuclearcardiologyseminars.net/articles/Tetrofosmin.pdf,DB09160
L794,Dailymed Hepatolite product information (FDA Label),https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=32c493f8-c4fa-4564-911b-ca2e1146c754,DB09164
L883,US Drug Enforcement Administration: ETIZOLAM Drug information,https://www.deadiversion.usdoj.gov/drug_chem_info/etizolam.pdf,DB09166
L884,World Health Organization: Etizolam (INN) Pre-Review Report ,https://erowid.org/pharms/etizolam/etizolam_article1_who_2016.pdf,DB09166
L881,Co-pharma Ltd. SUMMARY OF PRODUCT CHARACTERISTICS:  Dosulepin hydrochloride tablets ,http://www.co-pharma.co.uk/downloads/v2/Approved%20Dosulepin%20Tablets%2075mg%20SPC%20updated%20section%206.5-%2023.01.13.pdf,DB09167
L882,Alphapharm: DOTHEP (Dothiepin hydrochloride) Product information,http://www.medicines.org.au/files/afpdothe.pdf,DB09167
L7811,World Health Organization: Butyrfentanyl Critical Review Report,https://www.who.int/medicines/access/controlled-substances/4.2_Butyrfentanyl_CritReview.pdf,DB09173
L7814,DEA: Temporary Placement of Butyryl Fentanyl and Beta-Hydroxythiofentanyl Into Schedule I,https://www.deadiversion.usdoj.gov/fed_regs/rules/2016/fr0512_2.htm,DB09173
L7817,Cayman Chemicals: Butyrylfentanyl MSDS,https://www.caymanchem.com/msdss/14728m.pdf,DB09173
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB09183
L1041,Patents,https://www.google.com/patents/US4132791,DB09194
L1042,Patents,https://www.google.com/patents/US4931445,DB09194
L1043,Not in Pubmed,https://www.researchgate.net/publication/230039847_Nefazodone_A_Review_of_Its_Neurochemical_Mechanisms_Pharmacokinetics_and_Therapeutic_Use_in_Major_Depressive_Disorder,DB09194
L1167,Molecules 2016,https://www.google.ca/url?sa=t&rct=j&q=&esrc=s&source=web&cd=10&cad=rja&uact=8&ved=0ahUKEwj6xNae0d_YAhUiY98KHejwBPcQFgheMAk&url=http%3A%2F%2Fwww.mdpi.com%2F1420-3049%2F21%2F1%2F75%2Fs1&usg=AOvVaw11fr7ZS00i-2hlOa7d5w8q,DB09195
L1168,Clinical trials,https://clinicaltrials.gov/ct2/show/record/NCT02612298?view=results,DB09204
L1172,FDA-orphan products,https://google2.fda.gov/search?q=cache:cqX7toRQhxQJ:www.fda.gov/downloads/forindustry/developingproductsforrarediseasesconditions/howtoapplyfororphanproductdesignation/ucm162066.xls+thymoxamine&client=FDAgov&proxystylesheet=FDAgov&output=xml_no_dtd&site=FDAgov&ie=UTF-8&access=p&oe=UTF-8,DB09205
L1173,Eye wiki,http://eyewiki.aao.org/Drug-induced_Acute_Angle_Closure_Glaucoma,DB09205
L1174,Opilon monograph,https://www.medicines.org.uk/emc/medicine/18553#PHARMACODYNAMIC_PROPS,DB09205
L1178,Jstage,https://www.jstage.jst.go.jp/article/jsma1939/45/6/45_6_739/_pdf,DB09205
L1200,Australian government ,https://www.tga.gov.au/otc-medicine-monograph-pholcodine#indications,DB09209
L1201,United Nations Office on Drugs and Crime,https://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1961-01-01_2_page004.html,DB09209
L1202,WHO,http://apps.who.int/iris/bitstream/10665/39030/3/Codeine_1970_eng_part2.pdf,DB09209
L1124,Nootropil tablets Drug Summary,http://www.e-lactancia.org/media/papers/Piracetam-DS-UCB2013.pdf,DB09210
L1125,electronic Medicines Compendium (eMC): Nootripil Summary of Product Characteristics,https://www.medicines.org.uk/emc/medicine/27470,DB09210
L1225,Loxoprofen,http://www.chemspider.com/Chemical-Structure.3828.html,DB09212
L1226,MIMS LOXOPROFEN,https://www.mims.com/malaysia/drug/info/loxoprofen?mtype=generic,DB09212
L1227,Mechanism of action of non steroidal anti-inflammatory drugs,https://www.intechopen.com/books/nonsteroidal-anti-inflammatory-drugs/mechanism-of-action-of-nonsteroidal-anti-inflammatory-drugs,DB09212
L1228,Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036661/,DB09212
L1230,"Loxoprofen Sodium, a Non-Selective NSAID, Reduces Atherosclerosis in Mice by Reducing Inflammation",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2935154/,DB09212
L1231,"Comparison of Pharmacokinetics between Loxoprofen and Its Derivative with Lower Ulcerogenic Activity, Fluoro-loxoprofen",https://www.sciencedirect.com/science/article/pii/S134743671530389,DB09212
L1233,"Comparison of Pharmacokinetics between Loxoprofen and Its Derivative with Lower Ulcerogenic Activity, Fluoro-loxoprofen",https://pdfs.semanticscholar.org/6f52/9ebb1b417438f2ca462c82d4720b30606a48.pdf,DB09212
L1234,"Aspirin, Non-Aspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and risk of ovarian cancer",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454462/,DB09212
L1235,LOXOPROFEN,http://www.druginfosys.com/drug.aspx?drugcode=909&type=1,DB09212
L1268,Loxoprofen Sodium,http://repository-tnmgrmu.ac.in/320/1/MAHESH%20KUMAR%20K.pdf,DB09212
L1269,Roxonin,http://www.meppo.com/pdf/drugs/3019-ROXONIN-1440574468.pdf,DB09212
L1298,Dexketoprofen,https://www.drugs.com/international/dexketoprofen.html,DB09214
L1299,Concise info Dexketoprofen,https://www.mims.com/philippines/drug/info/dexketoprofen?mtype=generic,DB09214
L1300,DEXKETOPROFEN,http://www.chemspider.com/Chemical-Structure.580922.html,DB09214
L1301,PRECLINICAL AND CLINCIAL DEVELOPMENT OF DEXOKETOPROFEN,https://link.springer.com/article/10.2165/00003495-199600525-00005,DB09214
L1302,Dexktoprofen drug insert,https://www.hpra.ie/img/uploaded/swedocuments/2153796.PA0865_002_002.fd883daf-dafe-4bb7-81bd-84144c3a5808.000001ProductLeaflet25.150508.pdf,DB09214
L1304,Dexketoprofen information,http://www.drugsupdate.com/generic/view/1132/Dexketoprofen,DB09214
L1305,Analgesic properties of dexketoprofen trometamol,https://www.researchgate.net/profile/Jean_Sebastien_Walczak/publication/260947943_Analgesic_properties_of_dexketoprofen_trometamol/links/571a523008aee3ddc568f435/Analgesic-properties-of-dexketoprofen-trometamol.pdf,DB09214
L1119,WHO: Droxicam,https://www.whocc.no/atc_ddd_index/?code=M01AC04&showdescription=yes,DB09215
L1291,EMA,http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2016/04/human_orphan_001714.jsp&mid=WC0b01ac058001d12b,DB09216
L1292,European Journal of Chemistry,https://www.degruyter.com/downloadpdf/j/chem.2013.11.issue-9/s11532-013-0284-6/s11532-013-0284-6.pdf,DB09216
L1293,Clotam leaflet,https://www.medicines.org.uk/emc/files/pil.3748.pdf,DB09216
L1303,EMA,http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015620.pdf,DB09216
L926,FAMPH: Bisoxatin Summary of Product Characteristics,https://drive.google.com/open?id=0B2K5buBGjy5rejZjMGRTb0dDTEk,DB09219
L887,IKOREL (Nicorandil) Product Information,http://www.medicines.org.au/files/swpikore.pdf,DB09220
L930,UK Medicines and Healthcare products Regulatory Agency (MHRA): Nicorandil Tablets_Scientific Discussion,http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con105865.pdf,DB09220
L1307,Promac,https://www.drugs.com/international/promac.html,DB09221
L1308,NCI dictionary,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/polaprezinc,DB09221
L1309,Applicability of Zinc Complex of L-Carnosine for Medical Use,http://www.protein.bio.msu.ru/biokhimiya/contents/v65/full/65070961.html,DB09221
L1311,Residence Time of Polaprezinc (Zinc L-Carnosine Complex) in the Rat Stomach and Adhesiveness to Ulcerous Sites,https://pdfs.semanticscholar.org/3b5d/be879f38fa7952fe6c6ff0c04dafe2cd3491.pdf,DB09221
L1312,Revision of Precautions for Poplaprezinc,https://www.pmda.go.jp/files/000219558.pdf,DB09221
L225,FDA label,http://www.fda.gov/downloads/Biolog...ionatedPlasmaProducts/ucm094006.pdf,DB09222
L1097,Blonanserin Approval Announcement,http://www.ds-pharma.com/ir/news/2017/20170228-2.html,DB09223
L1102,ChemIDPlus: Blonanserin,https://chem.nlm.nih.gov/chemidplus/rn/132810-10-7,DB09223
L1316,Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease,https://clinicaltrials.gov/ct2/show/NCT00125138,DB09224
L1317,"The effect of melperone, an atypical antipsychotic drug, on cognitive function in schizophrenia",https://www.sciencedirect.com/science/article/pii/S0920996401003292,DB09224
L1318,Melperone MSDS,http://www.chemicalbook.com/ChemicalProductProperty_US_CB81011889.aspx,DB09224
L1319,Melperone in Treatment-Refractory Schizophrenia: A Case Series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736899/,DB09224
L1321,Melperone in Treatment-Refractory Schizophrenia: A Case Series,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736899/#bibr5-2045125311399800,DB09224
L1322,Melperone,https://drugs.ncats.io/ginas/app/drug/a2ef4d17,DB09224
L1323,Quantification of selected antidepressants and antipsychotics in clinical samples using chromatographic methods combined with mass spectrometry: A review (2006-2015),https://pdfs.semanticscholar.org/7af2/95cd553c0def02c99d390fab51c7b5be8ff7.pdf,DB09224
L1346,Pharmacological data of the atypical neuroleptic compound melperone (Buronil),https://www.researchgate.net/publication/20583412_Pharmacological_data_of_the_atypical_neuroleptic_compound_melperone_Buronil,DB09224
L1345,Development of orally disintegrating tablets comprising controlled-release multiparticulate beads,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497912/,DB09224
L1082,FDA Submission,https://www.fda.gov/downloads/drugs/developmentapprovalprocess/formssubmissionrequirements/drugmasterfilesdmfs/ucm370723.txt,DB09225
L1313,FDA antipsychotics,https://www.fda.gov/downloads/advisorycommittees/committeesmeetingmaterials/drugs/psychopharmacologicdrugsadvisorycommittee/ucm493998.pdf,DB09225
L1314,EMA reports,http://www.ema.europa.eu/docs/en_GB/document_library/Report/2016/03/WC500203705.pdf,DB09225
L1320,NIMH,https://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml,DB09225
L1341,Zotepine monograph,http://www.drugfuture.com/mt/zotepine.pdf,DB09225
L1131,Vasexten (barnidipine hydrochloride modified release capsules) Summary of Product Characteristics,http://mri.cts-mrp.eu/download/NL_H_0199_002_FinalPI_2of3.pdf,DB09227
L1343,Researchgate,https://www.researchgate.net/publication/229817671_Aranidipine_MPC-1304_a_New_Dihydropyridine_Calcium_Antagonist_A_Review_of_Its_Antihypertensive_Action,DB09229
L1379,DRUG: Azelnidipine,http://www.genome.jp/dbget-bin/www_bget?D01145,DB09230
L1380,"Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study",https://www.nature.com/articles/hr2009179,DB09230
L1381,Azelnidipine MSDS,https://www.chemblink.com/MSDS/MSDSFiles/123524-52-7_Sigma-Aldrich.pdf,DB09230
L1382,Clinical use of azelnidipine in the treatment of hypertension in Chinese patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348133/,DB09230
L1383,Determination of azelnidipine by LC–ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteers,http://www.ingentaconnect.com/content/govi/pharmaz/2008/00000063/00000008/art00003?crawler=true,DB09230
L1384,Calcium Channel Blocker Poisoning,https://www.uptodate.com/contents/calcium-channel-blocker-poisoning,DB09230
L1385,IJBCP,http://www.ijbcp.com/index.php/ijbcp/article/download/1891/1616,DB09231
L1386,Springer,http://adisinsight.springer.com/drugs/800000001,DB09231
L1436,Centapres monograph,http://www.centaurpharma.com/newwebsite/downloads/CENTAPRES.pdf,DB09232
L1438,Hypertension Canada,https://hypertension.ca/hypertension-and-you/about-hypertension/what-is-high-blood-pressure/,DB09232
L1440,Kerala medical journal,http://journals.publishmed.com/index.php/KMJ/article/viewFile/265/282,DB09232
L1444,Lloyd healthcare,http://www.lloydhealthcare.org/cilidin-t.php,DB09232
L1454,Medfacts,http://factmed.com/study-CILNIDIPINE%20(CILNIDIPINE)-causing-DRUG%20TOXICITY.php,DB09232
L6124,ResearchGate article,https://www.researchgate.net/publication/315976376_POLYMERIC_NANOPARTICLES_FOR_IMPROVED_BIOAVAILABILITY_OF_CILNIDIPINE,DB09232
L1437,"Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, open-label pilot study☆",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053062/,DB09235
L1441,"Pharmaceutical Substances, 5th Edition, 2009",https://books.google.ca/books?id=4lCGAwAAQBAJ&pg=PA461&lpg=PA461&dq=ld50+of+efonidipine&source=bl&ots=rHGBcAgr4N&sig=Qk2sWFcDEkFvEsPPwhNE9nmEkyU&hl=en&sa=X&ved=0ahUKEwjjq7rIu8TZAhVE1mMKHZbSC18Q6AEILjAB#v=snippet&q=ld50%20efonidipine&f=false,DB09235
L1442,Pharmacokinetic Interaction between Warfarin and Efonidipine in Rats,https://pdfs.semanticscholar.org/058d/a3935a5736ea1244a3b6f2e1a6348c792146.pdf,DB09235
L1443,"Clinical Efficacy of Efonidipine Hydrochloride, a T-type Calcium Channel Inhibitor, on Sympathetic Activities Examination Using Spectral Analysis of Heart Rate/Blood Pressure Variabilities and 123I-Metaiodobenzylguanidine Myocardial Scintigraphy",https://www.omicsonline.org/open-access/development-and-validation-of-liquid-chromatography-rphplcmethodology-for-estimation-of-efonidipine-hcl-ethanolate-efd-2153-2435-1000547.pdf,DB09235
L1445,DORSET CARDIOLOGY WORKING GROUP GUIDELINE FOR CALCIUM CHANNEL BLOCKERS IN   HYPERTENSION                                  ,http://www.dorsetccg.nhs.uk/Downloads/aboutus/medicines-management/Other%20Guidelines/Calcium%20channel%20blockers%20for%20hypertension.pdf,DB09235
L1446,"Relationship between Lipophilicities of 1,4-Dihydropyridine Derivatives and Pharmacokinetic Interaction Strengths with Grapefruit Juice",https://www.researchgate.net/publication/5674263_Relationship_between_Lipophilicities_of_14-Dihydropyridine_Derivatives_and_Pharmacokinetic_Interaction_Strengths_with_Grapefruit_Juice,DB09235
L1449,Effect of an L- and T-Type Calcium Channel Blocker on 24-Hour Systolic Blood Pressure and Heart Rate in Hypertensive Patients,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341419/,DB09235
L1450,Efonidipine,http://www.maria-online.com/health/article.php?lg=en&q=Efonidipine,DB09235
L1456,Drug profile: Efonidipine,http://adisinsight.springer.com/drugs/800000179,DB09235
L1457,"Studies on the Metabolic Fate of NZ-105. (I). Absorption, Distribution, Metabolism and Excretion after a Single Administration to Rats.",https://www.researchgate.net/publication/273669636_Studies_on_the_Metabolic_Fate_of_NZ-105_I_Absorption_Distribution_Metabolism_and_Excretion_after_a_Single_Administration_to_Rats,DB09235
L1459,Efonidipine,https://www.revolvy.com/main/index.php?s=Efonidipine&sr=50,DB09235
L1460, CHEMICAL IDENTIFICATION ,http://www.drugfuture.com/toxic/q113-q507.html,DB09235
L1126,Lacidipine Summary of Product Characteristics,http://mri.cts-mrp.eu/download/NL_H_2992_002_FinalSPC.pdf,DB09236
L10833,FDA Approved Drug Products: Conjupri Levamlodipine Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212895s000lbl.pdf,DB09237
L1484,S-Amlodipine,https://pubchem.ncbi.nlm.nih.gov/compound/_S_-Amlodipine,DB09237
L586,product info,http://www.alzforum.org/therapeutics/rember-tm,DB09241
L587,Article,http://www.alzforum.org/papers/preventive-methylene-blue-treatment-preserves-cognition-mice-expressing-full-length-pro,DB09241
L588,article,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087269/#ref1,DB09241
L590,Drug info,https://www.drugs.com/monograph/methylene-blue.html,DB09241
L591,Monograph,https://monographs.iarc.fr/ENG/Monographs/vol108/mono108-06.pdf,DB09241
L610,msds,https://www.fishersci.com/shop/msdsproxy?productName=BP117100&productDescription=METHYLENE+BLUE+100G&catNo=BP117-100&vendorId=VN00033897&storeId=10652,DB09241
L3675,"FDA Approved Drug Products: PROVAYBLUE (methylene blue) injection, for intravenous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204630s000lbl.pdf,DB09241
L1025,Electronic Medicines Compedium Physiotens (Moxonidine) Monograph,https://www.medicines.org.uk/emc/medicine/22286,DB09242
L1390,Psychiatry: The State of the Art Volume 3 Pharmacopsychiatry,https://books.google.ca/books?id=IgraBwAAQBAJ&pg=PA209&lpg=PA209&dq=pirlindole+pharmacokinetics&source=bl&ots=lN64zZ3EEg&sig=UN0rzaFBQg_vqXbJHo2ls2BO2JA&hl=en&sa=X&ved=0ahUKEwj12av-kLjZAhVP0mMKHYXuCXYQ6AEIRzAE#v=onepage&q=pirlindole%20pharmacokinetics&f=false,DB09244
L1393,Chemistry Dashboard- Pirlindole,https://comptox.epa.gov/dashboard/dsstoxdb/results?search=Pirlindole,DB09244
L1394,Pirlindole in the Treatment of Depression and Fibromyalgia Syndrome,https://www.researchgate.net/publication/51605654_Pirlindole_in_the_Treatment_of_Depression_and_Fibromyalgia_Syndrome,DB09244
L1395,Hypertensive effect and cheese,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738414/,DB09244
L1398,Monamine oxide inhibitors,http://www.inchem.org/documents/pims/pharm/pimg025.htm,DB09244
L1387,"A reversible monoamine oxidase inhibitor, toloxatone: spectrophotometric and molecular orbital studies of the interaction with flavin adenine dinucleotide (FAD)",https://www.sciencedirect.com/science/article/pii/0223523494900965,DB09245
L1388,Comparative investigation of the effect of moclobemide and toloxatone on monoamine oxidase activity and psychometric performance in healthy subjects,https://link.springer.com/article/10.1007/BF02246239,DB09245
L1389,Tolaxatone,http://www.mims.com/india/drug/info/toloxatone?mtype=generic,DB09245
L1392,Chemistry ,https://comptox.epa.gov/dashboard/dsstoxdb/results?search=Toloxatone,DB09245
L643,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c273512-84e2-2cea-b201-12345a6bd1fe,DB09255
L644,Drugs.com,https://www.drugs.com/monograph/dextran-40.html,DB09255
L645,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/9004-54-0,DB09255
L1455,WHO,http://apps.who.int/medicinedocs/en/d/Jh2962f/9.2.html,DB09255
L1461,Tears naturale monograph,https://www.medicines.org.uk/emc/files/pil.843.pdf,DB09255
L1464,Military trauma research,http://www.dtic.mil/dtic/tr/fulltext/u2/a217721.pdf,DB09255
L933,European Medicines Agency (EMA): TEYSUNO (tegafur/gimeracil/oteracil) Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001242/WC500104415.pdf,DB09256
L934,UFT (uracil/tegafur) capsules_Product information,https://hemonc.org/docs/packageinsert/uraciltegafur.pdf,DB09256
L933,European Medicines Agency (EMA): TEYSUNO (tegafur/gimeracil/oteracil) Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001242/WC500104415.pdf,DB09257
L1462,Irish Medicines Board: Bemiparin,http://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_PA1388-001-003_27012012144048.pdf,DB09258
L1463,Hibor-Bemiparin Sodium,http://www.meppo.com/pdf/drugs/875-HIBOR-1444208315.pdf,DB09258
L1465,"Zibor 2,500 IU Solution for Injection",http://www.medicines.ie/printfriendlydocument.aspx?documentid=12319&companyid=38,DB09258
L1466,Injectable drugs guide ,https://books.google.ca/books?id=42TEmTJ0ewAC&pg=PA80&lpg=PA80&dq=bemiparin+pharmacokinetics&source=bl&ots=-7uU8qynV5&sig=Y7WH-fzi8PLB_YCA6T1_DjQOggc&hl=en&sa=X&ved=0ahUKEwi-oJem-cbZAhVI1WMKHQE8CII4ChDoAQhUMAk#v=onepage&q=bemiparin%20pharmacokinetics&f=false,DB09258
L1467,Thrombosis Advisors- Factor Xa inhibitor ,https://www.thrombosisadviser.com/factor-xa-inhibitors/,DB09258
L1468,Anti-tumor effects of bemiparin in HepG2 and MIA PaCa-2 cells,https://pdfs.semanticscholar.org/e190/2ca30f2548cfa7f02e2b815705137ace90e3.pdf,DB09258
L1470,"Bemiparin, an effective and safe low molecular weight heparin: a review",https://www.jove.com/visualize/abstract/24657810/bemiparin-an-effective-and-safe-low-molecular-weight-heparin-a-review,DB09258
L1472,Bemiparin sodium,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/bemiparin-sodium,DB09258
L1469,FDA orphan list,https://www.fda.gov/downloads/forindustry/developingproductsforrarediseasesconditions/howtoapplyfororphanproductdesignation/ucm162066.xls,DB09259
L763,Adlyxin FDA Approval Announcement,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm513602.htm,DB09265
L764,EMA Lixisenatide Assessment,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002445/WC500140449.pdf,DB09265
L1157,Electronic Medicines Compendium: Lymphoseek (technetium TC 99M tilmanocept) Monograph,https://www.medicines.org.uk/emc/product/2572/smpc,DB09266
L1127,Electronic Medicines Compedium Proteos (strontium ranelate) Monograph,https://www.medicines.org.uk/emc/product/5598/smpc,DB09267
L262,article,http://cancerres.aacrjournals.org/content/54/7/1690.short,DB09269
L505,MSDS,http://www.sciencelab.com/msds.php?msdsId=9927390,DB09269
L1062,FDA Reports,https://www.fda.gov/ohrms/dockets/dailys/02/May02/052902/02p-0244-cp00001-02-Exhibit_A-vol1.pdf,DB09270
L1063,Pubmedhealth,https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0032601/,DB09270
L1064,Diet supplement label,https://biomedicine.com/public_downloads/BiomedSupplements/Co-Q10%20Supreme%20monograph.pdf,DB09270
L1065,Coenzyme Q,http://fodsupport.org/pdf/Description_of_CoQ_10.pdf,DB09270
L1066,Journal of Health Science,http://jhs.pharm.or.jp/data/55(4)/55_540.pdf,DB09270
L1169,Doxofix Product Information,https://www.unilab.com.ph/assets/product-info/doxofix.pdf,DB09273
L1170,Cayman Chemical Doxofylline Product Information,https://www.caymanchem.com/pdfs/18746.pdf,DB09273
L1171,Ansimar tablets Product Information,http://oep.com.ph/assets/upload/images/Ansimar_200_mg_tablet_with_new_licensor.pdf,DB09273
L890,CDC: Artesunate,https://www.cdc.gov/malaria/diagnosis_treatment/artesunate.html,DB09274
L891,Artesunate Product Information,https://extranet.who.int/prequal/sites/default/files/documents/MA051part4v2.pdf,DB09274
L14099,FDA Approved Drug Products: Artesunate Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213036s000lbl.pdf,DB09274
L381,FDA Label,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050786s012lbl.pdf,DB09275
L239,product info,http://products.sanofi.ca/en/myochrysine.pdf,DB09276
L1492,Society of nuclear medicine and molecular imaging,http://snmmi.files.cms-plus.com/Choline%20chloride%20C-11%20(3).pdf,DB09277
L778,World Health Organization Model List of Essential Medicines (19th List),http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1,DB09278
L779,World Health Organization Model Formulary2008,http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf,DB09278
L936,The Canadian Drug Expert Committee (CDEC): Lumacaftor/Ivacaftor Recommendation,https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_SR0379_Kalydeco_Dec-23-14.pdf,DB09280
L592,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+589,DB09281
L593,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+211,DB09281
L594,Sciencedirect,http://www.sciencedirect.com/science/article/pii/B9780080552323620896,DB09281
L1366,Molsidomine,https://www.drugs.com/international/molsidomine.html,DB09282
L1367,Update: Molsidomine,http://neurocirugia.com/2017/02/07/update-molsidomine/,DB09282
L1368,EPA Chemistry Dashboard: Molsidomine ,https://comptox.epa.gov/dashboard/dsstoxdb/results?search=Molsidomine,DB09282
L1369,Molsidomine,http://www.druginfosys.com/drug.aspx?drugcode=492&type=1,DB09282
L1370,Molsidomide: an overview,https://www.sciencedirect.com/topics/medicine-and-dentistry/molsidomine,DB09282
L1371,Molsidomine,http://www.bertin-bioreagent.com/pr3010/molsidomine,DB09282
L1374,Relationship between pharmacokinetics and pharmacodynamics of molsidomine and its metabolites in humans,http://europepmc.org/abstract/med/3838400,DB09282
L1376,Molsidomine 2/4 mg tablets,https://pdfs.semanticscholar.org/3cb7/a1d396f6d523af253581daf8033e64a0cb3f.pdf,DB09282
L1377,Clinical Pharmacology of Antianginal Drugs,https://books.google.ca/books?id=nuXrCAAAQBAJ&pg=PA366&lpg=PA366&dq=molsidomine+liver+metabolism&source=bl&ots=qBCXm0vm5D&sig=lxa3AYTHHhiqJe-_8X94eUCSW_0&hl=en&sa=X&ved=0ahUKEwiXzM7rz7fZAhUD5mMKHcS0AmMQ6AEIczAJ#v=onepage&q=esterase&f=false,DB09282
L1493,Morniflumate,https://www.medkoo.com/products/10883,DB09285
L1494,Morniflumate,https://www.epharmapedia.com/medicine/profile/132115/Nifluril.html?lang=en&tab=druginfo,DB09285
L1495,Morniflumate induced urticaria and angioedema,https://dadospdf.com/download/morniflumate-induced-urticaria-angioedema-_5a4bbaccb7d7bcab67ea383c_pdf,DB09285
L1496,A gastroprotective anti-inflammatory agent: theβ-morpholinoethyl ester of niflumic acid (morniflumate),https://www.researchgate.net/publication/16587181_A_gastroprotective_anti-inflammatory_agent_theb-morpholinoethyl_ester_of_niflumic_acid_morniflumate,DB09285
L1497,Modulation of arachidonic acid metabolism by orally administered morniflumate in man,https://link.springer.com/article/10.1007/BF01986568,DB09285
L1498,The pharmacokinetics and availability of niflumic acid in humans,https://www.researchgate.net/publication/16346020_The_pharmacokinetics_and_availability_of_niflumic_acid_in_humans,DB09285
L1499,Niflumic acid,http://www.medchemexpress.com/niflumic-acid.html,DB09285
L1512,Pipamperone,https://pubchem.ncbi.nlm.nih.gov/compound/Pipamperone#section=Pharmacology-and-Biochemistry,DB09286
L1513,The Treatment of Autism with Pipamperone,https://www.sciencedirect.com/science/article/pii/S0924933816020319,DB09286
L1514,Pipamperone,https://www.kenniscentrum-kjp.nl/en/professionals/Medication-14/Antipsychotics-6/Pimpamperone,DB09286
L1515,Pipamperone: International drug information,http://cursoenarm.net/UPTODATE/contents/mobipreview.htm?17/10/17580?source=HISTORY,DB09286
L1516,Low dose pipamperone in treatment mood disorders,https://patents.google.com/patent/WO2010112529A1,DB09286
L1517,Pipamperone dihydrochloride,https://www.trc-canada.com/product-detail/?P475200,DB09286
L1518,The Pharmacological Role and Clinical Applications of Antipsychotics’ Active Metabolites: Paliperidone versus Risperidone,https://www.omicsonline.org/the-pharmacological-role-and-clinical-applications-of-antipsychotics-active-metabolites-paliperidone-versus-risperidone-2161-1459.1000117.pdf,DB09286
L1520,Pipamerone,https://chem.nlm.nih.gov/chemidplus/rn/1893-33-0,DB09286
L1521,Pipamperone and increased excercise/weight,https://databankws.lareb.nl/Downloads/Signals_2017_Pipamperone%20and%20increased%20appetite.pdf,DB09286
L1522,Current antipsychotics,https://books.google.ca/books?id=RpVtM_WVw64C&pg=PA258&lpg=PA258&dq=PIPAMPERONE+metabolism&source=bl&ots=jl4_fNIg92&sig=bBV2ZA-BLObu-ukpCv7fXsTOfvg&hl=en&sa=X&ved=0ahUKEwjFrtHr6NXZAhXFz1QKHeNPBnoQ6AEIczAJ#v=onepage&q=PIPAMPERONE%20metabolism&f=false,DB09286
L1524,Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders,https://www.researchgate.net/publication/6814909_Influence_of_the_antipsychotic_drug_pipamperone_on_the_expression_of_the_dopamine_D4_receptor,DB09286
L1525,PP232—Acute toxicity profile of pipamperone in overdose: A consecutive case series,https://www.researchgate.net/publication/270941129_PP232-Acute_toxicity_profile_of_pipamperone_in_overdose_A_consecutive_case_series,DB09286
L6421,"PLENVU (polyethylene glycol 3350, sodium sulfate, ascorbic acid, sodium chloride and potassium chloride for oral solution) US FDA 2018 Label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209381s000lbl.pdf,DB09287
L6424,PegaLAX (polyethylene glycol 3350) 2017 Canadian Prescribing Information,https://aralez.com/wp-content/uploads/2018/03/PEGALAX-Prescribing-Information-22-MARCH-2017.pdf,DB09287
L6433,NCBI StatPearls [Internet]: Bowel Preparation,https://www.ncbi.nlm.nih.gov/books/NBK535368/,DB09287
L11812,"DailyMed Label: GAVILAX (Polyethylene glycol 3350) powder, for solution",https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=267de1ce-baa2-5a0b-e054-00144ff8d46c,DB09287
L11854,Laxatives - StatPearls - NCBI Bookshelf,https://www.ncbi.nlm.nih.gov/books/NBK537246/#_article-24120_s2_,DB09287
L11857,Spectrum Chemical: POLYETHYLENE GLYCOL 3350 Safety Data Sheet,https://www.spectrumchemical.com/MSDS/PO125_AGHS.pdf,DB09287
L1505,"Anaesthesia, pain and intensive care",http://www.apicareonline.com/review-article-intravenous-paracetamol-in-pediatrics-a-global-perspective/,DB09288
L1509,New zealand perfalgan report,http://www.medsafe.govt.nz/profs/datasheet/p/Perfalganinf.pdf,DB09288
L1511,Sociedade brasileira de quimica,http://www.scielo.br/pdf/jbchs/v27n6/0103-5053-jbchs-27-06-1121.pdf,DB09288
L1519,Update in anaesthesia,http://e-safe-anaesthesia.org/e_library/03/Paracetamol_Update_2008.pdf,DB09288
L1523,Monograph,https://www.tga.gov.au/sites/default/files/foi-305-1112-1.pdf,DB09288
L1411,Tianeptine,https://www.tianeptine.com,DB09289
L1412,Tianeptine,https://www.drugs.com/international/tianeptine.html,DB09289
L1413,Tianeptine properties,http://datasheets.scbt.com/sds/aghs/en/sc-204345.pdf,DB09289
L1414,The neurobiological properties of Tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902200/,DB09289
L1415,Pharmacokinetic study of tianeptine and its active metabolite MC5 in rats following different routes of administration using a novel liquid chromatography tandem mass spectrometry analytical method,https://link.springer.com/article/10.1007/s00210-017-1448-2,DB09289
L1426,Effects of tianeptine on symptoms of fibromyalgia via BDNF signaling in a fibromyalgia animal model,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507774/,DB09289
L1427,Anxiety- rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety- and comorbid depression-like behavior,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565824/,DB09289
L1429,"Antidepressants: Past, Present and Future",https://books.google.ca/books?id=Ue3uCAAAQBAJ&pg=PA305&lpg=PA305&dq=metabolism+of+tianeptine&source=bl&ots=GQEZ5hNG5Z&sig=JyJ0MOjIFxArnFR3em7zXGo2Cbo&hl=en&sa=X&ved=0ahUKEwjRlvec_bzZAhUS22MKHTLMCqk4ChDoAQgoMAA#v=onepage&q=metabolism%20of%20tianeptine&f=false,DB09289
L1430,TIANEPTINE DRUG INFORMATION,http://cdn.neiglobal.com/content/pg/live/tianeptine.pdf,DB09289
L1434,Acute Toxicity From Intravenous Use of the Tricyclic Antidepressant Tianeptine,https://academic.oup.com/jat/article-abstract/41/6/547/3852120?redirectedFrom=fulltext,DB09289
L1435,Management of Respiratory Depression from Tianeptine Overdose with Naloxone,https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A5344,DB09289
L2946,"HMDB, Tianeptine Metabocard",http://www.hmdb.ca/metabolites/HMDB0042038,DB09289
L2947,Targeting opioid receptor signalling in depression: do we need selective kappa opioid receptor antagonists?,http://www.neuronalsignaling.org/content/early/2018/04/17/NS20170145,DB09289
L2948,"The kappa opioid receptor: from addiction to depression, and back",https://www.frontiersin.org/articles/10.3389/fpsyt.2014.00170/full,DB09289
L1399,Talniflumate,https://www.sigmaaldrich.com/catalog/product/sigma/sml1710?lang=en&region=CA,DB09295
L1400,Screening study for genetic polymorphisms af­fecting pharmacokinetics of talnifumate,http://www.tcpharm.org/Data/Journal/2/349.pdf,DB09295
L1401,"Pharmacokinetics of talniflumate, a prodrug of niflumic acid, following oral administration to man",https://link.springer.com/article/10.1007/BF02976244,DB09295
L1402,Talniflumate (Genaera),https://www.researchgate.net/publication/8504535_Talniflumate_Genaera,DB09295
L1403,Talniflunate,https://pubchem.ncbi.nlm.nih.gov/compound/Talniflumate,DB09295
L1404,Chemistry Dashboard: Talniflumate,https://comptox.epa.gov/dashboard/dsstoxdb/results?formula=1&isotopes=1&search=C21H13F3N2O4,DB09295
L1405,TALNIFLUMATE,https://drugs.ncats.io/ginas/app/substance/7c324c44,DB09295
L1406,Talniflumate Increases Survival in a Cystic Fibrosis Mouse Model of Distal Intestinal Obstructive Syndrome,https://pdfs.semanticscholar.org/5e51/25821836a281b38e976a20886bbd74048908.pdf,DB09295
L1408,TALNIFLUMATE,https://www.drugs.com/international/talniflumate.html,DB09295
L1409,KWANG DONG TARIFUL TAB,http://eng.ekdp.com/product/items_view.asp?s=202,DB09295
L1410,Talniflumate,http://www.drugfuture.com/chemdata/talniflumate.html,DB09295
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB09296
L866,Dailymed: Technivie,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85130606-e6a4-cf08-4bac-a460a30b0984,DB09296
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB09297
L6241,Pubmed books,https://www.ncbi.nlm.nih.gov/books/NBK533928/,DB09299
L6271,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207561,DB09299
L4388,FDA Approved Drug Products: Descovy (Emtricitabine and Tenofovir Alafenamide) Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/208215s012lbl.pdf,DB09299
L6277,"FDA Approved Drug Products: Bictegravir, Emtricitabine, and Tenofovir Alafenamide Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210251s000lbl.pdf,DB09299
L6280,"FDA Approved Drug Products: Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207561s000lbl.pdf,DB09299
L6283,"FDA Approved Drug Products: Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210455s000lbl.pdf,DB09299
L6286,Health Canada Approved Drug Products: Tenofovir Alafenamide Oral Tablets,https://pdf.hres.ca/dpd_pm/00046979.PDF,DB09299
L6337,European Medicines Agency Assessment Report: Tenofovir Alafenamide,https://www.ema.europa.eu/en/documents/assessment-report/vemlidy-epar-public-assessment-report_en.pdf,DB09299
L9010,FDA Press Announcements: FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic,https://www.fda.gov/news-events/press-announcements/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic,DB09299
L1527,Chemical selection summary,https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/chondroitin_508.pdf,DB09301
L1528,Arthritis foundation,https://www.arthritis.org/living-with-arthritis/treatments/natural/supplements-herbs/guide/chondroitin-sulfate.php,DB09301
L1536,Metafishnet,http://mummichog.org/shuzhao/mfn1.9/humanpngs2/mfn1v9path123.png,DB09301
L232,Monograph,http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/C012.html,DB09311
L233,webmd,http://www.webmd.com/drugs/2/drug-6278/calcium-polycarbophil-oral/details,DB09311
L1883,Loxaglic acid,https://pubchem.ncbi.nlm.nih.gov/compound/ioxaglic_acid#section=Top,DB09313
L1884,"Ioxaglic acid, NZ MedSAFE Data sheet",http://www.medsafe.govt.nz/profs/datasheet/h/Hexabrix320inj.pdf,DB09313
L1885,"FDA letter, Ioxaglic Acid",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018905s025lbl.pdf,DB09313
L1886,"HEXABRIX 320 (320 mg I/ml), solution for injection",https://www.old.health.gov.il/units/pharmacy/trufot/alonim/hexabrix_spc-_1460026610609.pdf,DB09313
L1888,Are low osmolality contrast media less neprotoxic?,https://watermark.silverchair.com/11-6-930.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAaIwggGeBgkqhkiG9w0BBwagggGPMIIBiwIBADCCAYQGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMwV4qlJ5SoXYTnm4nAgEQgIIBVf0gNR3GKaTsiazPlAUb40UrMgHGzcLxzK3HeR1RfzFpV5xfdDVAvE8oi9T_QWcAlmtHXVN5B9-F5PI1DS68buzsUItQsD9VCNs8OosJEOVY8jnLLRSvdkUduECUQ4ILNk3LgG1w8uGuyw8Fy1Ixk6FG-whN-1wKGQeIxdrZVsV7uxk34qs3lQoTgoV08sFTvlOVU0Jf9rN0aTDNo2pvRuS5Du3NrCwkZjdFzQhAgynFP5k1kK-ecxwZ4RWqOn3x695xkPdai2ivL_-erzmj6U8ruVZcCEgEMhHXBYIayG9jiWIpCZmtna069zETceXt8qCIs0IH3vypyOI-EfMfn6YX9ymsnN0K7LkhEJHrnPnEdJqqbm5dYfw8PmvzPa6yGOxmTtUPQc7CgZ2LAGw4ixA0tH1rUtE7AtDEuJgYXbNb1fE8uCGWEKST4J5GPSiJrRwzV3RA,DB09313
L1889,"Clinical Pharmacology, Uses, and Adverse Reactions of Iodinated Contrast Agents: A Primer for the Non-radiologist",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538464/,DB09313
L1890,Imaging-related medications: a class overview,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014815/,DB09313
L651,FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017284s012lbl.pdf,DB09315
L226,Monograph,https://www.drugs.com/sfx/thallous-chloride-tl-201-side-effects.html,DB09316
L332,product info,https://www.drugs.com/pro/penicillin-g-procaine.html,DB09320
L783,World Health Organization Model Prescribing Information: Drugs Used in Skin Diseases,http://apps.who.int/medicinedocs/en/d/Jh2918e/23.2.html,DB09320
L326,MSDS,http://www.sciencelab.com/msds.php?msdsId=9927329,DB09321
L327,product info,http://www.drugsupdate.com/generic/view/580/Zinc-Oxide,DB09321
L421,DRUGS.COM,https://www.drugs.com/pro/zinc-sulfate-injection.html,DB09322
L422,NCBI,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113371/,DB09322
L423,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/7733-02-0,DB09322
L428,WebMD,http://www.webmd.com/drugs/2/drug-4086/zinc-sulfate-oral/details,DB09322
L429,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/24424#section=Absorption-Distribution-and-Excretion,DB09322
L430,DAILYMED,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a03fe85-fdc9-4847-960f-1fc782d7d493,DB09322
L7661,"MSDS, sodium fluoride",http://www.inchem.org/documents/icsc/icsc/eics0951.htm,DB09325
L7670,"Daily med: Sodium fluoride tablet, chewable",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c868e459-33b6-47e9-af4d-3d421d91772d,DB09325
L7673,"Sodium fluoride F-18 injection, DailyMed",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96e61ba1-30ca-4844-b503-056afd247e69,DB09325
L7676,Medline NIH: Fluoride overdose information,https://medlineplus.gov/ency/article/002650.htm,DB09325
L7679,"MSDS, sodium fluoride, Fisher Scientific",https://fscimage.fishersci.com/msds/21230.htm,DB09325
L7685,What happens to sodium fluoride in your body? DG Health and Consumer Protection,https://ec.europa.eu/health/scientific_committees/opinions_layman/fluoridation/en/l-3/2.htm,DB09325
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB09325
L7688,Fluoride therapy APPD,https://www.aapd.org/media/Policies_Guidelines/BP_FluorideTherapy.pdf,DB09325
L7691,ADA guidelines on fluoride use,https://www.ada.org/en/member-center/oral-health-topics/fluoride-topical-and-systemic-supplements,DB09325
L7697,"Sodium fluoride, science direct",https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/sodium-fluoride,DB09325
L246,article,http://www.uth.tmc.edu/pet/Assets/pdf/cad/20-jnm-1996.pdf,DB09326
L264,product info,http://interactive.snm.org/docs/PET_PROS/ammonia.pdf,DB09326
L265,article,https://www.ncbi.nlm.nih.gov/books/NBK23075/,DB09326
L934,UFT (uracil/tegafur) capsules_Product information,https://hemonc.org/docs/packageinsert/uraciltegafur.pdf,DB09327
L1557,National Cancer Institute,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tegafur-uracil,DB09327
L1565,FDA presentations,https://www.fda.gov/ohrms/dockets/ac/99/slides/3540s1c/sld004.htm,DB09327
L1500,Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD),https://clinicaltrials.gov/ct2/show/NCT03115671,DB09328
L1501,Neurobiological Basis of Response to Vayarin in Adults With ADHD: an fMRI Study of Brain Activation Pre and Post Treatment (VAYA-fMRI),https://clinicaltrials.gov/ct2/show/NCT02473419,DB09328
L1502,"mproved Academic Performance and Medication Rebound in Patients with ADHD Following the Use of Vayarin®, a Multi-Year, Real-World Retrospective Study",https://globenewswire.com/news-release/2017/01/10/904861/0/en/Improved-Academic-Performance-and-Medication-Rebound-in-Patients-with-ADHD-Following-the-Use-of-Vayarin-a-Multi-Year-Real-World-Retrospective-Study.html,DB09328
L1503,"Pharmacokinetics Basics- Absorption, Distribution, Metabolism and Excretion",https://www.ndrugs.com/?s=vayarin&t=actions,DB09328
L1504,Vaya Direct,https://vayadirect.com,DB09328
L1506,Vayarin product label,https://vayadirect.com/wp-content/uploads/2018/01/RIN_PI_PA-Final_new-slip.pdf,DB09328
L1507,FDA label PS,https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm513828.pdf,DB09328
L1508,"Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of  EPA, DPA and DHA",https://www.frontiersin.org/articles/10.3389/fnagi.2015.00052/,DB09328
L1510,Drug Insert Vayarin,http://122.179.130.16/~vayarin/wp-content/uploads/2015/02/vayarin-60ct-outsert-ver-9.pdf,DB09328
L1529,Adynovate Pro,http://www.adynovatepro.com/science/how-it-works/,DB09329
L1530,Adynovate assessment report EMA,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004195/WC500243897.pdf,DB09329
L1531,Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients,http://www.bloodjournal.org/content/bloodjournal/119/13/3031.full.pdf,DB09329
L1532,Potential role of a new PEGylated recombinant factor VIII for hemophilia A,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920230/,DB09329
L1533,Potential role of a new PEGylated recombinant factor VIII for hemophilia A,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387834/,DB09329
L1534,PEGylation of a Factor VIII–Phosphatidylinositol Complex: Pharmacokinetics and Immunogenicity in Hemophilia A Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291190/,DB09329
L1535,"Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551361/,DB09329
L1538,"Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIII",https://www.sciencedirect.com/science/article/pii/S004938481400156X,DB09329
L1539,Antihemophilic Factor (Recombinant [Pegylated]),https://www.drugs.com/ppa/antihemophilic-factor-recombinant-pegylated.html,DB09329
L1540,EMA label Adate,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000520/WC500022464.pdf,DB09329
L1541,F8 gene coagulation factor VIII ,https://ghr.nlm.nih.gov/gene/F8,DB09329
L1542,Advate Product Monograph,https://www.shirecanada.com/-/media/shire/shireglobal/shirecanada/pdffiles/product%20information/advate-pm-en.pdf,DB09329
L13290,FDA Approved Drug Products: Darzalex Daratumumab Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761036s027lbl.pdf,DB09331
L13296,FDA Approved Drug Products: Darzalex Faspro Daratumumab and Hyaluronidase-fihj Subcutaneous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761145s000lbl.pdf,DB09331
L1543,Kappadione patent,https://www.drugpatentwatch.com/p/tradename/KAPPADIONE,DB09332
L1544,Endocrine Disrupters,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/menadione,DB09332
L1545,"Vitamin K, Systemic",https://www.drugs.com/mmx/menadiol-sodium-diphosphate.html,DB09332
L1546,Menadiol Sodium,https://www.medicines.org.uk/emc/product/1349,DB09332
L1561,Menadiol Sodium Pharmacology,https://www.ndrugs.com/?s=creatinine%20sulfate/esculoside/hesperidin%20methyl%20chalcone/menadiol%20sodium%20phosphate/tranexamic%20acid&t=actions#doctor_pharmacology,DB09332
L1562,Foye's Principles of Medicinal Chemistry,https://books.google.ca/books?id=Sd6ot9ul-bUC&pg=PA870&lpg=PA870&dq=menadiol+phosphate+pharmacodynamics&source=bl&ots=TNPwJHhGOo&sig=Flj9-vlEjeVhbswimLW8Tt5WXJ0&hl=en&sa=X&ved=0ahUKEwiEyL7OrdvZAhUEzGMKHQuBBeU4ChDoAQgmMAA#v=onepage&q=menadiol%20phosphate%20pharmacodynamics&f=false,DB09332
L1563,Drugs and haemostats,https://clinicalgate.com/drugs-and-haemostasis/,DB09332
L1566,Menadiol,http://www.drugfuture.com/chemdata/menadiol.html,DB09332
L1567,"Menadiol diphosphate, a new substrate for non-specific alkaline phosphatase in histochemistry and immunohistochemistry",https://www.semanticscholar.org/paper/Menadiol-diphosphate%2C-a-new-substrate-for-non-spec-Dikow-Gossrau/0bffb6a475339a3879f5cf99e15af5c355640e68,DB09332
L1568,Vitamin K metabolism,http://smpdb.ca/view/SMP00464,DB09332
L1572,A pharmacokinetic study with the high-dose anticancer agent menadione in rabbits,https://tmu.pure.elsevier.com/en/publications/a-pharmacokinetic-study-with-the-high-dose-anticancer-agent-menad,DB09332
L1570,Chapter 10. Vitamin K,http://www.fao.org/docrep/004/y2809e/y2809e0g.htm,DB09332
L1574,Menadione,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3354,DB09332
L1082,FDA Submission,https://www.fda.gov/downloads/drugs/developmentapprovalprocess/formssubmissionrequirements/drugmasterfilesdmfs/ucm370723.txt,DB09333
L1587,Up to date,https://www.uptodate.com/contents/iodinated-radiocontrast-agents-in-the-treatment-of-hyperthyroidism,DB09333
L1589,Radiologyinfo,https://www.radiologyinfo.org/en/info.cfm?pg=abdominrad,DB09333
L1590,Endocrinology association,https://www.thyroid.org/hyperthyroidism/,DB09333
L1146,Technetium radiopharmaceutical chemistry,https://pdfs.semanticscholar.org/bfa5/c1913650a8a23b0359c3d9d2f5710a243a27.pdf,DB09336
L1651,Cancer,https://www.cancer.org/cancer/small-cell-lung-cancer/about/what-is-small-cell-lung-cancer.html,DB09336
L1652,Pharmacopeia,http://www.pharmacopeia.cn/v29240/usp29nf24s0_m80698.html,DB09336
L1667,Pharmacological science,https://www.pharmacologicalsciences.us/pharmaceutical-chemistry/monoclonal-antibody-radionuclide-test-kits.html,DB09336
L1668,National Public library,http://www.nationalpubliclibrary.info/articles/eng/Technetium_(99mTc)_nofetumomab_merpentan,DB09336
L1650,FDA CDER list,https://www.fda.gov/downloads/forindustry/userfees/prescriptiondruguserfee/ucm164641.pdf,DB09336
L1082,FDA Submission,https://www.fda.gov/downloads/drugs/developmentapprovalprocess/formssubmissionrequirements/drugmasterfilesdmfs/ucm370723.txt,DB09336
L1575,Mersalyl,https://pubchem.ncbi.nlm.nih.gov/compound/23690449#section=Pharmacology-and-Biochemistry,DB09338
L1576,Mersalyl,http://www.mims.com/philippines/drug/info/mersalyl?mtype=generic,DB09338
L1577,Mersalyl,https://en.oxforddictionaries.com/definition/mersalyl,DB09338
L1578,Mercurial Diuretics Their Mechanism of Action and Application,https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/562756?redirect=true,DB09338
L1579,MIMS: Mersalyl,https://www.mims.com/hongkong/drug/info/mersalyl?mtype=generic,DB09338
L1580,Uncouplers and inhibitors,http://www.bmb.leeds.ac.uk/illingworth/oxphos/poisons.htm,DB09338
L1581,On the inhibitory action of mersalyl on microsomal drug oxidation: A rigid organization of the electron transport chain,https://www.sciencedirect.com/science/article/pii/000398617190213X,DB09338
L1582,Mersalyl acid,http://www.t3db.ca/toxins/T3D1362,DB09338
L1583, Pharmacokinetics and Toxicology of Aluminum in the Brain,https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1068&context=ps_facpub,DB09338
L1584,MERSALYL- AN ANTIVIRAL DIURETIC,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC429309/,DB09338
L1585,Salt and Water Balance,https://books.google.ca/books?id=T_cbBQAAQBAJ&pg=PA69&lpg=PA69&dq=mersalyl+blood+pressure&source=bl&ots=en5ogYEJet&sig=UJRLLTS-s6GAtlH4pL6hHQYGvPw&hl=en&sa=X&ved=0ahUKEwjI07_L4N3ZAhUD32MKHaGEBtgQ6AEITTAE#v=onepage&q=mersalyl%20blood%20pressure&f=false,DB09338
L1586,Metabolic adaptation of renal carbohydrate metabolism. V.In vivo response of rat renal-tubule gluconeogenesis to different diuretics,https://link.springer.com/article/10.1007/BF00944073,DB09338
L1601,Tyropanoic acid,https://pubchem.ncbi.nlm.nih.gov/compound/Tyropanoic_acid,DB09340
L1602,Iopanoic Acid,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3345,DB09340
L1603,Inhibition of Hepatic Binding of Thyroxine by Cholecystographic Agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC371433/,DB09340
L1604,Tyropanoate sodium,https://www.medkoo.com/products/10768,DB09340
L1605,Tyropanoate sodium,http://www.drugfuture.com/chemdata/tyropanoate-sodium.html,DB09340
L1606,Foreign Compound Metabolism in Mammals,https://books.google.ca/books?id=raKIFKRdi0AC&pg=PA423&lpg=PA423&dq=tyropanoic+acid&source=bl&ots=qASeCBztrt&sig=Ux3ZzP6AIeG9EQyKiq90uLdTUh8&hl=en&sa=X&ved=0ahUKEwjMs9PgjuDZAhUE6mMKHY3qA404ChDoAQhBMAY#v=onepage&q=tyropanoic%20acid&f=false,DB09340
L1607,Hormone resistance and other metabolic paradoxes,https://books.google.ca/books?id=KHQoBgAAQBAJ&pg=PT109&lpg=PT109&dq=tyropaque&source=bl&ots=DF-bIZuEq8&sig=rdB3GxcKY7SMBz4XBXhZwL7N84g&hl=en&sa=X&ved=0ahUKEwjA0vPIj-DZAhUEx2MKHcZGAcI4ChDoAQg1MAM#v=onepage&q=tyropaque&f=false,DB09340
L1608,ORAL CHOLECYSTOGRAPHY WITH IOPANOIC ACID (TELEPAQUE),https://sites.jamanetwork.com/jnc8//?utm_campaign=JNC8&utm_medium=banner&utm_source=house&utm_content=High_BP_Site&utm_term=728x90%5bgoogle.com%5d,DB09340
L1609,CHOLECYSTOGRAPHIC AGENT: A RE-EVALUATION OF ITS CLINICAL UTILITY,https://vdocuments.site/prolonged-treatment-of-hyperthyroidism-with-sodium-tyropanoate-an-oral-cholecystographic.html,DB09340
L1610,Diagnostic process using sodium tyropanoate,https://patents.google.com/patent/US4002731,DB09340
L1611,Drug dosing in renal insufficiency,https://books.google.ca/books?id=OavnCAAAQBAJ&pg=PA603&lpg=PA603&dq=tyropanoate+sodium+drug+information&source=bl&ots=lgdOlC83fh&sig=hX_ooOrR9qAoQvhVK-AMyJiP4ts&hl=en&sa=X&ved=0ahUKEwi80sKBouDZAhUT2WMKHRnDA3E4ChDoAQg4MAQ#v=onepage&q=tyropanoate%20sodium%20drug%20information&f=false,DB09340
L786,Baxter Health GLUCOSE INTRAVENOUS INFUSION BP Product information,http://www.baxterhealthcare.com.au/downloads/healthcare_professionals/cmi_pi/glucose%20IVI_pi.pdf,DB09341
L787,Glucose injection (Viaflex bag) Product information,http://www.medsafe.govt.nz/profs/Datasheet/g/glucoseinjviaflex.pdf,DB09341
L1588,PROPOXYCAINE,https://pubchem.ncbi.nlm.nih.gov/compound/Propoxycaine,DB09342
L1591,New local anesthetic solutions containing propoxycaine,https://www.sciencedirect.com/sdfe/pdf/download/eid/1-s2.0-S0002817755110042/first-page-pdf,DB09342
L1592,Handbook of Dental Anesthesia- Ebook,https://books.google.ca/books?id=3MfsAwAAQBAJ&pg=PA57&lpg=PA57&dq=dental+anesthetic+propoxycaine&source=bl&ots=83RGmRB2vJ&sig=EQcChwt3P5m2LM5yto8r8a5C-GI&hl=en&sa=X&ved=0ahUKEwjVt6-D1t_ZAhUB_2MKHaM4A6cQ6AEITTAD#v=onepage&q=dental%20anesthetic%20propoxycaine&f=false,DB09342
L1593,Essentials of local anesthetic pharmacology,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1693664/,DB09342
L1594,Propoxycaine Hydrochloride,http://www.pharmacopeia.cn/v29240/usp29nf24s0_m70480.html,DB09342
L1010,EMA.europa,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003897/WC500206246.pdf,DB09343
L1011,EMA.europa,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/003897/WC500206248.pdf,DB09343
L1691,DCP monograph,https://mri.cts-mrp.eu/Human/Downloads/DE_H_3724_001_FinalPI_1of3.pdf,DB09344
L633,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/Pramocaine#section=Substances-by-Category,DB09345
L1597,Metrizoic Acid,https://pubchem.ncbi.nlm.nih.gov/compound/Metrizoic_acid,DB09346
L1600,Metrizoic Acid,https://www.sciencedirect.com/topics/immunology-and-microbiology/metrizoic-acid,DB09346
L1702,Acetrizoic acid,https://www.scbt.com/scbt/product/acetrizoic-acid-85-36-9,DB09347
L1703,FDA Records,https://www.fda.gov/downloads/drugs/developmentapprovalprocess/formssubmissionrequirements/drugmasterfilesdmfs/ucm370722.xls,DB09347
L1704,Cilag ,http://www.cilag.ch/de/index.html,DB09347
L1705,ChemSrc,https://www.chemsrc.com/en/cas/85-36-9_701814.html,DB09347
L1707,Radiographic constrat agents,https://www.ranzcr.com/documents/593-notes-on-radiographic-contrast-rad-part-i-exam-ait/file,DB09347
L1708,Water soluble contrast media,https://pdfs.semanticscholar.org/a628/88f1f574e2d105aa9bd7b7c3a9f91b29b938.pdf,DB09347
L1717,EPA report,https://www.epa.gov/sites/production/files/2016-09/documents/beta-propiolactone.pdf,DB09348
L1718,Himedialabs,http://himedialabs.com/TD/TC223.pdf,DB09348
L1719,Monograph propiolactone,https://monographs.iarc.fr/ENG/Monographs/vol71/mono71-51.pdf,DB09348
L1721,Science alert,https://scialert.net/fulltext/?doi=jbs.2013.521.527,DB09348
L236,article,http://npic.orst.edu/factsheets/archive/pbotech.pdf,DB09350
L389,product info,https://www.drugs.com/cdi/hydroxyamphetamine-tropicamide.html,DB09352
L390,American Academy of Ophthalmology - Horner syndrome Article,https://www.aao.org/bcscsnippetdetail.aspx?id=0f6d09c9-8bee-4003-8652-0c4e062295a6,DB09352
L392,product info,http://reference.medscape.com/drug/paremyd-hydroxyamphetamine-tropicamide-999448,DB09352
L343,MSDS,http://pmep.cce.cornell.edu/profiles/extoxnet/pyrethrins-ziram/sulfur-ext.html,DB09353
L454,DRUGS.COM,https://www.drugs.com/pro/dexpanthenol.html,DB09357
L455,Webmd,http://www.webmd.com/drugs/2/drug-75143/dexpanthenol-topical/details,DB09357
L456,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/4678#section=Pharmacology-and-Biochemistry,DB09357
L457,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/81-13-0,DB09357
L1612,Rauwolfia in the Treatment of Hypertension,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566472/,DB09363
L1613,Rauwolfia,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97e4edf7-dca9-4d8b-8f04-da6fc202d40e,DB09363
L1614,Rauwolfia serpentina,https://www.drugs.com/mmx/rauwolfia-serpentina.html,DB09363
L1615,Human kidney proximal tubule cells are vulnerable to the effects of Rauwolfia serpentina.,http://europepmc.org/abstract/med/26838987,DB09363
L1616,Hyserpin/rauwolfia,https://www.drugpatentwatch.com/p/NDA/010581,DB09363
L1617,Reserpine,https://medlineplus.gov/druginfo/meds/a601107.html,DB09363
L1618,Review of Rauwolfia,https://www.sciencedirect.com/topics/medicine-and-dentistry/rauvolfia-serpentina,DB09363
L1619,"Prospecting for Novel Plant-Derived Molecules of Rauvolfia serpentina as Inhibitors of Aldose Reductase, a Potent Drug Target for Diabetes and Its Complications",http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0061327,DB09363
L1621,Rauwolfia Serpentina in the Treatment of High Blood Pressure A Review of the Literature,http://circ.ahajournals.org/content/12/2/220,DB09363
L1622,"Reserpine, Pub chem",https://pubchem.ncbi.nlm.nih.gov/compound/reserpine,DB09363
L1624,Sympatholytic therapy in primary hypertension: a user friendly role for the future,https://www.nature.com/articles/1001356.pdf?origin=publication_detail,DB09363
L1625,Reserpine,http://flipper.diff.org/app/items/3998,DB09363
L1626,"Reserpine, Drugs.com",https://www.drugs.com/pro/reserpine.html,DB09363
L1627,Differential Network Analysis Reveals Evolutionary Complexity in Secondary Metabolism of Rauvolfia serpentina over Catharanthus roseus,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4988974/,DB09363
L1628,Reserpine,http://www.inchem.org/documents/pims/pharm/reserpn.htm#SectionTitle:6.3%20%20Biological%20half-life%20by%20route%20of%20exposure,DB09363
L1629,MSDS,http://www.waters.com/webassets/cms/support/docs/700001673.pdf,DB09363
L1630,Severe depression caused by reserpine,https://www.semanticscholar.org/paper/Severe-depression-caused-by-reserpine./3e0338937c0882d799d2374efac9aa93c0515995,DB09363
L1631,Reserpine-induced Reduction in Norepinephrine Transporter Function Requires Catecholamine Storage Vesicles,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859979/,DB09363
L245,article,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1928430/pdf/canmedaj01105-0011.pdf,DB09372
L277,Book,https://books.google.ca/books?id=Ca3QAQAAQBAJ&pg=PA67&lpg=PA67&dq=tannic+acid+pharmacokinetics&source=bl&ots=Qc-poT_GSL&sig=QX2QfNbK4iFUDzd27L7_t8zf1YY&hl=ar&sa=X&ved=0ahUKEwil_MyY3IPSAhXD1IMKHemcD6AQ6AEIbDAJ#v=onepage&q=tannic%20acid%20pharmacokinetics&f=false,DB09372
L278,database ,http://naturaldatabase.therapeuticresearch.com/nd/PrintVersion.aspx?id=217&AspxAutoDetectCookieSupport=1,DB09372
L459,DRUGS.COM,https://www.drugs.com/pro/indocyanine-green.html,DB09374
L461,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/3599-32-4,DB09374
L462,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/indocyanine_green,DB09374
L796,ChemIDPlus: Lapyrium Chloride,https://chem.nlm.nih.gov/chemidplus/rn/6272-74-8,DB09376
L2368,FDA approval ,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=012828,DB09379
L2383,US Army Annual progress report,http://www.dtic.mil/dtic/tr/fulltext/u2/a021858.pdf,DB09379
L280,MSDS,http://www.pfizer.com/sites/default/files/products/material_safety_data/MENEST(esterified_estrogen)tablets_30-Jan-2017pdf.pdf,DB09381
L282,product info,https://www.drugs.com/ingredient/esterified-estrogens.html,DB09381
L283,product info,http://www.webmd.com/drugs/2/drug-6028/esterified-estrogens-oral/details,DB09381
L285,article,http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf,DB09381
L424,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/phosphoric_acid#section=Top,DB09394
L425,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/7664-38-2,DB09394
L426,inChem,http://www.inchem.org/documents/ukpids/ukpids/ukpid73.htm,DB09394
L248,rxlist,http://www.rxlist.com/sodium-acetate-drug/indications-dosage.htm,DB09395
L249,monograph,http://www.medsafe.govt.nz/Profs/datasheet/d/dblsodiumacetatesol.pdf,DB09395
L257,article,http://www.fda.gov/downloads/drugs/developmentapprovalprocess/manufacturing/ucm257994.pdf,DB09398
L258,drug label,https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=43688,DB09398
L259,article,http://www-pub.iaea.org/MTCD/Publications/PDF/TE-1782_web.pdf,DB09398
L260,article,https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/jat/31/8/10.1093/jat/31.8.526/2/31-8-526.pdf?Expires=1486832749&Signature=gYf2KeNoTFpEpHy47hbt2SYABrAEBn0WI6sSBPjBiYq0kJ0FQgtHC80j17QdOaKnplUbk2ATGEeyxIlsStlQyyvA-Zh9qrMJCy6EGfFx02RHJ0swLeZ8Yht2ES0LQBjPD9j3PWH-WEteQC29M94tIng9ps~k9yzkvoSVyM4VRhre8SxPeGiqotS6uaTiqqh1uS7npqKE6Npo6hjTAgRcakyCkPQVTf8jqyJWVXd-9suXIb5ZwKPVIyfE22KmGkB3zkPYOMTaaE8IrkaZ0aNpi1k8D8BSorprJR5mYKh~2fV85QsZUNJNLWDOzA98EZHoks4GeXbJPdA3vKIjj4mzug__&Key-Pair-Id=APKAIUCZBIA4LVPAVW3Q,DB09398
L12528,FDA Approved Products: Isordil titradose (isosorbide dinitrate) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/012093s052lbl.pdfFDA,DB09401
L12531,FDA Approved Products: Bidil (isosorbide dinitrate and hydralazine hydrochloride) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/020727lbl.pdf,DB09401
L11698,FDA Approved Drug Products: Monoket (isosorbide mononitrate) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020215s024lbl.pdf,DB09401
L468,DRUGS.COM,https://www.drugs.com/mtm/magnesium-chloride.html,DB09407
L469,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/magnesium_chloride#section=Pharmacology-and-Biochemistry,DB09407
L470,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+657,DB09407
L471,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/7791-18-6,DB09407
L750,Santa Cruz Biotechnology,https://www.scbt.com/scbt/product/magnesium-acetate-tetrahydrate-molecular-biology-grade-16674-78-5,DB09409
L751,"PLASMA-LYTE 56 and 5% Dextrose Injection  (Multiple Electrolytes and Dextrose Injection, Type 1, USP)  in VIAFLEX Plastic Container: Drug Label",https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=162726,DB09409
L752,Magnesium Absorption in Humans ,http://e-collection.library.ethz.ch/eserv/eth:26387/eth-26387-02.pdf,DB09409
L791,TOXNET Magnesium compounds,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7065,DB09409
L475,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/516951#section=Bionecessity,DB09413
L476,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/7778-77-0,DB09413
L477,DAILYMED,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b01eac95-dbe3-4b21-a922-187e0fc8ad23,DB09413
L481,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5046,DB09413
L483,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/24450#section=Bionecessity,DB09414
L484,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+935,DB09414
L485,MSDS,http://www.sciencelab.com/msds.php?msdsId=9924689,DB09414
L2364,POTASSIUM PERCHLORATE - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1222,DB09418
L2365,FDA is Revoking Food Additive Approval for the Use of Perchlorate in Sealing Gaskets for Food Containers Because its Use Has Been Abandoned,https://www.fda.gov/Food/NewsEvents/ConstituentUpdates/ucm555609.htm,DB09418
L2370,Perchlorate Toxicity and Risk Assessment,https://pdfs.semanticscholar.org/7974/fd30f936f33aecc961c24986018cd7e3f1b2.pdf,DB09418
L2372,Toxicological Profile For Perchlorates,https://www.atsdr.cdc.gov/toxprofiles/tp162-c3.pdf,DB09418
L2428,Sugar Alcohols (Polyols) and Polydextrose Used as Sweeteners in Foods - Food Safety - Health Canada,https://www.canada.ca/en/health-canada/services/food-nutrition/food-safety/food-additives/sugar-substitutes/sugar-alcohols-polyols-polydextrose-used-sweeteners-foods-food-safety.html,DB09419
L2429,U.S. Food & Drug Administration: High-Intensity Sweeteners,https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm397716.htm,DB09419
L2432,MedlinePlus: D-xylose absorption,https://medlineplus.gov/ency/article/003606.htm,DB09419
L853,SMOFLIPID (lipid injectable emulsion) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/207648lbl.pdf,DB09422
L855,NUTRILIPID® (lipid injectable emulsion) FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019531s002lbl.pdf,DB09422
L854,CLINOLEIC 20% (Lipid Emulsion for Intravenous Nutrition) FDA Label,http://www.baxter.ca/en_CA/assets/downloads/monographs/ClinOleic_PM_30Jul2014_EN.pdf,DB09422
L856,INTRALIPID (soybean oil emulsion) Dailymed drug label information,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b007eb60-e18e-4dbc-bf8d-1a3cf434a722,DB09422
L12780,DailyMed: Jeanatope (iodinated I-125 albumin) for injection,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b6f6a5e-f456-4db9-a3da-44d870ee6547,DB09429
L12783,DailyMed: Megatope (iodinated I-131 albumin) for injection,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62ca4278-8cc9-46b7-8f3c-303ce6a9c155,DB09430
L2465,SAFFLOWER OIL - National Library of Medicine HSDB Database - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5153,DB09446
L798,FDA Guide: Sodium Phosphate Tablet,https://www.fda.gov/downloads/drugs/drugsafety/ucm134684.pdf,DB09449
L799,ChemIDPlus: Sodium Phosphate,https://chem.nlm.nih.gov/chemidplus/rn/7558-80-7,DB09449
L10827,Beef Insulin Discontinuation Notice,https://www.iddt.org/wp-content/uploads/2017/07/Hypurin-Bovine-Discontinuation-Patient-announcement.pdf?x15779,DB09456
L487,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/444305#section=Pharmacology-and-Biochemistry,DB09459
L520,Glowm,https://www.glowm.com/resources/glowm/cd/pages/drugs/s014.html,DB09460
L521,Drugs.com,https://www.drugs.com/pro/sodium-bicarbonate.html,DB09460
L522,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/497-19-8,DB09460
L523,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/sodium_carbonate,DB09460
L596,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+492,DB09462
L597,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/56-81-5,DB09462
L598,DAILYMED,https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=GLYCERIN,DB09462
L654,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/sodium_sulfate#section=Top,DB09472
L655,DRUGS.COM,https://www.drugs.com/drp/sodium-sulfate.html,DB09472
L656,DAILYMED,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ca2803e-a4d6-4e57-a910-13237c93a4ce,DB09472
L657,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/7757-82-6,DB09472
L658,inChem,http://www.inchem.org/documents/sids/sids/7757826.pdf,DB09472
L492,Drug Information,http://www.nuclearonline.org/PI/Cardiogen.pdf,DB09479
L493,Daily med,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee95aa18-9f2f-40eb-9b4c-583bea6f36bf,DB09479
L781,CDC NIOSH: MgCO3,https://www.cdc.gov/niosh/npg/npgd0373.html,DB09481
L593,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+211,DB09481
L672,Safety Data Sheet,http://www.sigmaaldrich.com/MSDS/MSDS/DisplayMSDSPage.do?country=PL&language=EN-generic&productNumber=344443&brand=ALDRICH&PageToGoToURL=http%3A%2F%2Fwww.sigmaaldrich.com%2Fcatalog%2Fproduct%2Faldrich%2F344443%3Flang%3Dpl,DB09484
L674,Drug information,https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c40be43e-3da9-441b-8cde-82a471b94012,DB09484
L670,FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/in111med042403LB.pdf,DB09490
L1810,1-HEXADECANOL - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2643,DB09494
L1824,Synthetic Fatty Alcohols - FDA,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=172.864&SearchTerm=stearyl%20alcohol,DB09494
L1074,FDA OTC ingredients,https://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM135688.pdf,DB09494
L295,MSDS,https://toxnet.nlm.nih.gov/cgi-bin,DB09495
L297,article,http://www.thedermreview.com/avobenzone/,DB09495
L296,product info,https://www.drugs.com/mmx/avobenzone-octyl-methoxycinnamate-octyl-salicylate-and-oxybenzone.html,DB09495
L767,The Dermatology Review: Octinoxate,http://www.thedermreview.com/octinoxate/,DB09496
L286,MSDS,https://www.ch.ntu.edu.tw/~genchem99/msds/exp19/Na2S2O3.pdf,DB09499
L288,Monograph,https://www.drugs.com/mmx/sodium-thiosulfate.html,DB09499
L308,product info,https://www.drugs.com/pro/sodium-thiosulfate-injection.html,DB09499
L309,product info,https://pubchem.ncbi.nlm.nih.gov/compound/Sodium_thiosulphate#section=Use-and-Manufacturing,DB09499
L310,database ,http://www.medsafe.govt.nz/profs/Datasheet/d/DBL-SodiumThiosulfateinj.pdf,DB09499
L379,FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021870lbl.pdf,DB09502
L511,MSDS,http://www.sciencelab.com/msds.php?msdsId=9927617,DB09511
L513,product info,https://www.drugcenter.com/drugs/talcum-powder/,DB09511
L292,MSDS,http://www.pfizer.com/system/files/products/material_safety_data/PZ00809.pdf,DB09512
L293,product info,http://npra.moh.gov.my/images/reg-and-noti/PI/non-poison/Simethicone_Tablet_Capsule.pdf,DB09512
L993,TOXNET: 4-methoxyphenol,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+4258,DB09516
L2532,Drugs.com: Mequinol and Tretinoin (Topical),https://www.drugs.com/mmx/mequinol-and-tretinoin.html#citec50007323,DB09516
L2533,PucChem: Mequinol Fb,https://pubchem.ncbi.nlm.nih.gov/compound/4-Methoxyphenol#section=Synonyms,DB09516
L2534,ECHA: Mequinol ,https://echa.europa.eu/registration-dossier/-/registered-dossier/16005/7/2/2,DB09516
L666,SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE MONOGRAPH,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc374c01-f3ed-4920-920b-b19f20fd20a9,DB09517
L1875,21-256 Synthetic Human Secretin Pharmacology Review - FDA,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/21-256_Synthetic%20Human%20Secretin_Pharmr.pdf,DB09532
L546,Drug Information,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97628e66-1550-43b9-ba1c-c2202049e8f5,DB09535
L547,Skin care research,http://www.smartskincare.com/skinprotection/sunblocks/sunblock_octocylene.html,DB09535
L517,Drugs.com,https://www.drugs.com/inactive/titanium-dioxide-70.html,DB09536
L518,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/13463-67-7,DB09536
L519,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/26042#section=Biological-Half-Life,DB09536
L305,FDA label,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021586Orig1s005lbl.pdf,DB09537
L314,MSDS,http://www.mercedesmedical.com/customer/MEMESA/specpages/THR-8630.pdf,DB09537
L317,article,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812878/,DB09537
L5849,Omega-3-acid ethyl esters 90 (K85EE),https://products.basf.com/en/K85EE-Omega-3-acid-ethyl-esters.html,DB09539
L5852,Australian Public Assessment Report for Omega-3-acid ethyl esters 90,https://www.tga.gov.au/sites/default/files/auspar-omacor.pdf,DB09539
L2401,FDA reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205060Orig1s000PharmR.pdf,DB09539
L776,FDA SALONPAS® Pain Relief Patch Clinical Review,https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM453825.pdf,DB09543
L777,Norwegian Food Safety Authority: Methyl salicylate risk review,https://www.mattilsynet.no/kosmetikk/stoffer_i_kosmetikk/risk_profile_methyl_salicylate.9877/binary/Risk%20Profile%20Methyl%20Salicylate,DB09543
L612,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/11102#section=Drug-Labels-for-Ingredients,DB09552
L800,CORTISPORIN-TC Otic Suspension (Monarch) with Neomycin and Hydrocortisone,https://www.drugs.com/drp/thonzonium-bromide.html,DB09552
L579,Dexchlorpheniramine monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1950f4d6-7fc2-44cd-9f7d-1359315353fc,DB09555
L660,"FDA Approved Drug Products: Choline C 11 Injection, for intravenous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203155s000lbl.pdf,DB09563
L11091,FDA Approved Drug Products: Tresiba (insulin degludec) for subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203314s015s016lbl.pdf,DB09564
L857,ChemIDPlus: Olive Oil,https://chem.nlm.nih.gov/chemidplus/unii/6UYK2W1W1E,DB09567
L2386,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=205060,DB09568
L2387,Epanova,http://www.epanovahcp.com/,DB09568
L2390,FDA reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205060Orig1s000CrossR.pdf,DB09568
L2401,FDA reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205060Orig1s000PharmR.pdf,DB09568
L12795,DailyMed: Imovax rabies vaccine,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba8d4e72-f452-4859-ae6f-3644b4b0a78c,DB10062
L1007,Dailymed Label: ACTHIB- haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8143d01c-4911-40db-95b2-47f3ebea2a7d,DB10076
L1116,Rotateq FDA Label,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aaf3b24e-85fd-43ee-b657-2ee4df312ec3,DB10276
L1117,CDC: About Rotavirus,https://www.cdc.gov/rotavirus/about/index.html,DB10276
L1037,CDC - Clinical Overview of Shingles (Herpes Zoster),https://www.cdc.gov/shingles/hcp/clinical-overview.html,DB10318
L1038,CDC - What Everyone Should Know about Shingles Vaccine,https://www.cdc.gov/vaccines/vpd/shingles/public/index.html,DB10318
L1040,CDC - About Chickenpox,https://www.cdc.gov/chickenpox/about/index.html,DB10318
L668,Drug information,http://ballaratallergyclinic.com.au/public_documents/Sublingual%20Immunotherapy%20for%20House%20Dust%20Mite/(2016)%20ACTAIR%20HOUSE%20DUST%20MITE%20TABLET%20PI.pdf,DB10400
L667,FDA label,https://www.fda.gov/downloads/biologicsbloodvaccines/allergenics/ucm544382.pdf,DB10401
L668,Drug information,http://ballaratallergyclinic.com.au/public_documents/Sublingual%20Immunotherapy%20for%20House%20Dust%20Mite/(2016)%20ACTAIR%20HOUSE%20DUST%20MITE%20TABLET%20PI.pdf,DB10401
L2418,"FDA document,: SUMMARY OF SAFETY AND EFFECTIVENESS DATA",https://www.accessdata.fda.gov/cdrh_docs/pdf/P000036b.pdf,DB10770
L2419,"Apligraf document, FDA",https://www.accessdata.fda.gov/cdrh_docs/pdf/P950032c.pdf,DB10770
L2420,Three-Dimensional Human Tissue Models That Incorporate Diabetic Foot Ulcer-Derived Fibroblasts Mimic In Vivo Features of Chronic Wounds,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410281/,DB10770
L2421,Skin Substitutes for Treating Chronic Wounds [Internet],https://www.ncbi.nlm.nih.gov/books/NBK248357/,DB10770
L2423,Human foreskin fibroblast produces interleukin-6 to support derivation and self-renewal of mouse embryonic stem cells,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580467/,DB10770
L2424,IL6 interleukin 6 [ Homo sapiens (human) ],https://www.ncbi.nlm.nih.gov/gene/3569,DB10770
L2425,IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism,https://www.sciencedirect.com/science/article/pii/S0022202X15601658,DB10770
L2426,Fibronectin human foreskin fibroblasts,https://www.sigmaaldrich.com/catalog/product/sigma/f2518?lang=en&region=CA,DB10770
L2427,"SUMMARY OF SAFETY AND EFFECTIVENESS DATA, Orcel",https://www.accessdata.fda.gov/cdrh_docs/pdf/P010016b.pdf,DB10770
L2430,Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells,https://academic.oup.com/humrep/article/24/10/2567/774983,DB10770
L2434,Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,DB10770
L2438,SUMMARY OF SAFETY AND EFFECTIVENESS DATA (SSED),https://www.accessdata.fda.gov/cdrh_docs/pdf/P900033S042b.pdf,DB10770
L2439,Advancement of wound care from grafts to bioengineered smart skin substitutes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299852/,DB10770
L2440,Premarket Approval (PMA),https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=p000036,DB10770
L2481,Computational analysis of bovine alpha-1 collagen sequences,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563415/,DB10771
L2450,Gintuit,https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM295525.pdf,DB10771
L2427,"SUMMARY OF SAFETY AND EFFECTIVENESS DATA, Orcel",https://www.accessdata.fda.gov/cdrh_docs/pdf/P010016b.pdf,DB10771
L2483,Advances in Skin Substitutes—Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing,http://www.mdpi.com/2079-4983/6/3/547,DB10771
L2484,Development and utilization of a bovine type I collagen microfibril model,https://www.ars.usda.gov/ARSUserFiles/80720525/1-s2.0-s0141813012004266-main.pdf,DB10771
L2485,"CoMatryx wound dressing, FDA letters and documents",https://www.accessdata.fda.gov/cdrh_docs/pdf17/K171645.pdf,DB10771
L2488,Bovine Collagen Type I,https://rockland-inc.com/store/Collagen-Proteins-001-001-103-O4L_22962.aspx,DB10771
L2489,Type 1 Collagen,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/type-i-collagen,DB10771
L2490,Scielo,http://www.scielo.br/pdf/rbcp/v26n4/en_a28.pdf,DB10771
L2491,A Bovine Collagen Type I-Based Biodegradable Matrix as a Carrier for Tissue-Engineered Urothelium,https://www.omicsonline.org/open-access/a-bovine-collagen-type-ibased-biodegradable-matrix-as-a-carrier-for-tissueengineered-urothelium-2157-7633-1000275.php?aid=50701,DB10771
L2492,Collagen: A review on its sources and potential cosmetic applications,https://onlinelibrary.wiley.com/doi/pdf/10.1111/jocd.12450,DB10771
L2493,"Bovine type 1 Collagen, Santa Cruz Biology",https://www.scbt.com/scbt/product/collagen-i-bovine,DB10771
L2494,Updated Report and Scientific Opinion on the safety of hydrolysed proteins produced from bovine hides. Initially adopted by the Scientific Steering Committee at its meeting of 22-23 October 1998 and updated at its meeting of 25-26 May 2000,https://ec.europa.eu/food/sites/food/files/safety/docs/sci-com_ssc_out109_en.pdf,DB10771
L2497,WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies,http://www.who.int/bloodproducts/tse/WHO%20TSE%20Guidelines%20FINAL-22%20JuneupdatedNL.pdf,DB10771
L2498, Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products (EMA/410/01 rev.3),http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003700.pdf,DB10771
L2500,Excellagen,http://www.empr.com/excellagen/drug/7834/,DB10771
L2434,Pre-Clinical Demo Orcel,https://www.fda.gov/ohrms/dockets/ac/01/briefing/3771b1_01.pdf,DB10772
L2419,"Apligraf document, FDA",https://www.accessdata.fda.gov/cdrh_docs/pdf/P950032c.pdf,DB10772
L2452,Advances in Skin Substitutes—Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598670/,DB10772
L2453,Skin Substitutes: A Brief Review of Types and Clinical Applications,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269619/,DB10772
L2454,Foreskin‐isolated keratinocytes provide successful extemporaneous autologous paediatric skin grafts,https://onlinelibrary.wiley.com/doi/full/10.1002/term.1690,DB10772
L2456,Allogeneic cultured keratinocytes/fibroblasts in bovine collagen (Rx),https://reference.medscape.com/drug/formulary/gintuit-allogeneic-cultured-keratinocytes-fibroblasts-bovine-collagen-999735#3,DB10772
L2457,The importance of both fibroblasts and keratinocytes in a bilayered living cellular construct used in wound healing,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211362/,DB10772
L2439,Advancement of wound care from grafts to bioengineered smart skin substitutes,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299852/,DB10772
L2450,Gintuit,https://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM295525.pdf,DB10772
L2459,Orcel,https://www.ndrugs.com/?s=orcel,DB10772
L2460,Advances in keratinocyte delivery in burn wound care,https://www.sciencedirect.com/science/article/pii/S0169409X17300960,DB10772
L2461,Apligraf,http://www.apligraf.com/professional/clinical_data/index.html,DB10772
L2462,Molecular biology of keratinocyte differentiation.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567608/,DB10772
L1653,World Health Organization - Yellow Fever Fact Sheet,http://www.who.int/mediacentre/factsheets/fs100/en/,DB10805
L1654,World Health Organization - Yellow fever vaccination booster not needed,http://www.who.int/mediacentre/news/releases/2013/yellow_fever_20130517/en/,DB10805
L1655,CDC - Yellow Fever Symptoms and Treatment,https://www.cdc.gov/yellowfever/symptoms/index.html,DB10805
L1657,CDC - Yellow Fever Vaccine,https://www.cdc.gov/yellowfever/vaccine/index.html,DB10805
L334,MSDS,http://www.msds-gsk.com/Product.aspx?id=227,DB10989
L335,WHO website,http://www.who.int/ith/vaccines/hepatitisA/en/,DB10989
L336,product info,http://www.rxlist.com/havrix-drug/side-effects-interactions.htm,DB10989
L338,Havrix Monograph,http://healthsensetravelclinic.ca/wp-content/uploads/havrix.pdf,DB10989
L12756,FDA approved vaccines: Havrix (Hepatitis A) intramuscular injection,https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert---HAVRIX.pdf,DB10989
L12759,WHO: Vaccine immunology,https://www.who.int/immunization/documents/Elsevier_Vaccine_immunology.pdf,DB10989
L13371,GSK: Twinrix adult MSDS,https://www.vaxserve.com/image.cfm?doc_id=15077&image_type=msds_sheet,DB10989
L13392,NIH StatPearls: Hepatitis A Vaccine,https://www.ncbi.nlm.nih.gov/books/NBK554604/,DB10989
L11785,FDA Approved Drug Products: LAVIV (azficel-T) Suspension for Intradermal Injection,https://www.fda.gov/media/80838/download,DB11051
L12924,FDA Approved Products: Hemacord Human Cord Blood hematopoietic Progenitor Cell Injection,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bd9a5180-1773-11e0-980a-0002a5d5c51b,DB11054
L858,FDA Monograph: Petrolatum,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9164696-3128-4712-9276-e1d3e69dfd1b,DB11058
L2826,"Polyvinyl alcohol, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/Ethenol,DB11060
L2827,Polivinyl Alcohol Review,https://www.omicsonline.org/open-access/polyvinyl-alcohol-in-medicine-and-pharmacy-a-perspective-2329-6631.1000112.php?aid=21700,DB11060
L2828,"Daily Med, Artificial Tears",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=736f9577-d8ff-45c7-8205-dfdb7193492f,DB11060
L2829,HYPOTEARS - polyvinyl alcohol and polyehtylene glycol 400 solution/ drops,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c57d917-8114-03b5-0fa5-63dc420ae94d,DB11060
L2830,"MIMS, Polyvinyl Alcohol",http://www.mims.com/india/drug/info/polyvinyl%20alcohol?type=full&mtype=generic,DB11060
L2832,Pediatrics On Call: Polyvinyl Alcohol,https://www.pediatriconcall.com/drugs/polyvinyl-alcohol/1321,DB11060
L329,product info,http://www.smartskincare.com/skinprotection/sunblocks/sunblock_octisalate.html,DB11062
L331,MSDS,https://www.whatsinproducts.com/files/brands_pdf/1368132770.pdf,DB11062
L1842,Polysorbate 80,https://pubchem.ncbi.nlm.nih.gov/compound/5281955,DB11063
L1843,Code of Federal Regulation,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=172.840,DB11063
L1844,Common Ingredients in U.S. Licensed Vaccines,https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ucm187810.htm,DB11063
L1845,NTP Toxicology and Carcinogenesis Studies of Polysorbate 80 (CAS No. 9005-65-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).,https://www.ncbi.nlm.nih.gov/pubmed/12616296,DB11063
L1846,Polysorbate 80 and Helicobacter pylori: a microbiological and ultrastructural study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537525/,DB11063
L1847,Food Emulsifier Polysorbate 80 Increases Intestinal Absorption of Di-(2-Ethylhexyl) Phthalate in Rats,https://academic.oup.com/toxsci/article/139/2/317/2511598,DB11063
L1848,"Polysorbates, peroxides, protein aggregation, and immuno- genicity – a growing concern.",https://pdfs.semanticscholar.org/8b1b/e7f127f8a7ae1c71e62550f4e5a15639c91f.pdf,DB11063
L1851,In uence of excipients on drug absorption via modulation of intestinal transporters activity,https://www.asiapharmaceutics.info/index.php/ajp/article/viewFile/435/394,DB11063
L1852,Polysorbate 80,https://www.drugs.com/inactive/polysorbate-80-372.html,DB11063
L1853,Overview of pharmaceutical excipients used in tablets and capsules,http://biologicpharma.com/wp-content/uploads/Overview-of-pharmaceutical-excipients-used-in-tablets-and-capsules.pdf,DB11063
L1855,Effect of Polysorbate 80 Quality on Photostability of a Monoclonal Antibody,https://www.ncbi.nlm.nih.gov/pubmed/22362139,DB11063
L1856,Evaluation reports of Polysorbates,http://www.fsc.go.jp/english/evaluationreports/foodadditive/polysorbate_report.pdf,DB11063
L13053,DailyMed: Aviteras (Polysorbate 80.1%) drops,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dbb0d312-c79a-4c89-acb1-b895b52c05d5,DB11063
L311,MSDS,http://www.sciencelab.com/msds.php?msdsId=9924271,DB11064
L312,product info,http://www.cosmeticsinfo.org/ingredient/homosalate-0,DB11064
L2509,Creon monograph,http://www.rxabbvie.com/pdf/creon_PI.pdf,DB11065
L2510,FDA approval,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022523_pancreaze_toc.cfm,DB11065
L2512,Amylase product information,https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a3176pis.pdf,DB11065
L2521,FDA reports,https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM308286.pdf,DB11065
L1770,CENTER FOR DRUG EVALUATION AND RESEARCH- 20755,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/020725s000PharmR.pdf,DB11065
L2528,EMA reports,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002070/WC500210680.pdf,DB11065
L2509,Creon monograph,http://www.rxabbvie.com/pdf/creon_PI.pdf,DB11066
L2510,FDA approval,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022523_pancreaze_toc.cfm,DB11066
L2543,VIVO pathophysiology,http://www.vivo.colostate.edu/hbooks/pathphys/digestion/pancreas/exocrine.html,DB11066
L2547,EMBL-EBI,https://www.ebi.ac.uk/interpro/potm/2003_5/Page1.htm,DB11066
L2464,Phenyl Salicylate,https://www.drugs.com/drp/phenyl-salicylate.html,DB11071
L2467,Phenyl Salicylate,https://pubchem.ncbi.nlm.nih.gov/compound/Phenyl_salicylate,DB11071
L2468,"Phenyl Salicylate, CHeBi",http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:34918,DB11071
L2470,"HYOPHEN- methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate tablet ",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2c1f0f4c-e57b-4df5-9a58-41d39c3d8893,DB11071
L2471,"Methenamine, benzoic acid, phenyl salicylate, methylene blue, and hyoscyamine sulfate",https://www.hyophen.com,DB11071
L2472,"Phenyl Salicylate, Norway RISK PROFILE",https://www.mattilsynet.no/kosmetikk/stoffer_i_kosmetikk/risk_profile_phenyl_salicylate.9879/binary/Risk%20Profile%20Phenyl%20Salicylate,DB11071
L2473,The pharmacokinetics of salicylate,https://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2125.1980.tb01811.x,DB11071
L2474,A toxicologic and dermatologic assessment of salicylates when used as fragrance ingredients,https://pdfs.semanticscholar.org/130a/43234f7a843e67be3f2b518effabc54c9d46.pdf,DB11071
L2475,"Santa Cruz SDS sheet, Phenyl Salicylate",http://datasheets.scbt.com/sc-250695.pdf,DB11071
L2476,Phenyl Salicylate SDS,http://www.esciencelabs.com/sites/default/files/msds_files/Salol.pdf,DB11071
L2477,Phenyl salicylate (T3D4905),http://www.t3db.ca/toxins/T3D4905,DB11071
L2478,"Absorption, Biotransformation, and Pharmacokinetics of Salicylsalicylic Acid in Humans",https://www.researchgate.net/publication/15889003_Absorption_Biotransformation_and_Pharmacokinetics_of_Salicylsalicylic_Acid_in_Humans,DB11071
L2479,FDA Everything Added to Food Listing,https://www.accessdata.fda.gov/scripts/fcn/fcnNavigation.cfm?filter=118-55-8&sortColumn=&rpt=eafusListing,DB11071
L2480,Molecular Targets of Aspirin and Cancer Prevention,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090734/,DB11071
L2754,The Role of Cetylpyridinium Chloride Mouthwash In The Treatment of Periodontitis.,http://www.ijpsi.org/Papers/Vol2(12)/H0212036037.pdf,DB11073
L2755,Electronic Medicines Compendium: Cetylpyridinium chloride formulations,https://www.medicines.org.uk/emc/search?q=Cetylpyridinium+chloride,DB11073
L2756,Electronic Medicines Compendium: Covonia Cold & Flu Formula Monograph,https://www.medicines.org.uk/emc/product/4826/smpc,DB11073
L2757,IPCS INCHEM: Quaternary ammonium profile,http://www.inchem.org/documents/pims/chemical/pimg022.htm,DB11073
L2758,Pubchem: Cetylpyridinium Chloride Profile,https://pubchem.ncbi.nlm.nih.gov/compound/cetylpyridinium_chloride#section=Top,DB11073
L2760,Electronic Medicines Compendium: Lemsip Cough for Mucus Cough & Catarrh 100mg/2.5mg/5ml Oral Solution Monograph,https://www.medicines.org.uk/emc/product/7255/smpc,DB11073
L2761,Electronic Medicines Database: Calgel Teething Gel Monograph,https://www.medicines.org.uk/emc/product/259/smpc,DB11073
L1765,Dimethicone,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1808,DB11074
L1767,Safety and efficacy of a 100 % dimethicone pediculocide in school-age children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475297/,DB11074
L1769,"Public Assessment Report, Dimethicone",http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2023415.pdf,DB11074
L1770,CENTER FOR DRUG EVALUATION AND RESEARCH- 20755,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/020725s000PharmR.pdf,DB11074
L1771,Dimethicone,https://www.drugs.com/cdi/dimethicone-topical-products.html,DB11074
L1772,"Moisturel, Daily Med monograph",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cdbe0d25-f76b-4f5f-bfe6-8d6271eecfd1,DB11074
L1773,Guidelines of care for the management of atopic dermatitis,https://www.aad.org/File%20Library/Main%20navigation/.../AD-part-2.pdf,DB11074
L1774,"Product Monograph, NYDA",http://www.pedia-pharm.com/en/wp-content/uploads/sites/3/2014/03/NYDA-Product-Monograph-2012-09-11-EN.pdf,DB11074
L1775,POLYDIMETHYLSILOXANE,http://www.maria-online.com/health/article.php?lg=en&q=Polydimethylsiloxane,DB11074
L1779,Dimethicone,https://www.ewg.org/skindeep/ingredient/702011/DIMETHICONE/#.WrLbYrYZN-U,DB11074
L11782,"DailyMed Label: DIMETHICONE, skin protectant cream",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96886b33-44d4-5a2a-e053-2a95a90a505e,DB11074
L1803,BION TEARS,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e48d82f0-2f18-e514-4caa-e397d6713b99,DB11075
L1805,Hypromellose,https://www.drugs.com/mmx/hypromellose.html,DB11075
L1808,MIMS Hypromellose,http://www.mims.com/malaysia/drug/info/hypromellose?mtype=generic,DB11075
L1809,SUMMARY OF PRODUCT CHARACTERISTICS,http://mri.cts-mrp.eu/download/DE_H_0534_001_FinalSPC.pdf,DB11075
L1811,SUMMARY PRODUCT ASSESSMENT,http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2023972.pdf,DB11075
L1812,Hydroxypropyl methyl cellulose,http://www.lookchem.com/Hydroxypropyl-methyl-cellulose/,DB11075
L1781,Polyethylene glyco,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5159,DB11077
L1783,SIGMA-ALDRICH  PEG 400,https://www.sigmaaldrich.com/catalog/search?term=PEG+400&interface=All&N=0&mode=partialmax&lang=en&region=CA&focus=product,DB11077
L1784,Polyethylene glycol 400 (PEG400) affects the systemic exposure of oral drugs based on multiple mechanisms: taking berberine as an example,http://pubs.rsc.org/-/content/articlelanding/2017/ra/c6ra26284h#!divAbstract,DB11077
L1785,Polyethylene glycol,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15bc06ec-f3dc-3180-ca1a-106769a770ea,DB11077
L1786,Polyethylene Glycol ,http://www.abcam.com/primary-antibodies/polyethylene-glycol-peg-faqs,DB11077
L1787,Safety Evaluation of Polyethylene Glycol (PEG) Compounds for Cosmetic Use,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505343/,DB11077
L1788,PEG-400,https://www.drugs.com/inactive/polyethylene-glycol-400-272.html,DB11077
L1789,Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects,https://clinicaltrials.gov/ct2/show/NCT02260076,DB11077
L1790,PEGylated Proteins: Evaluation of Their Safety in the Absence of Definitive Metabolism Studies,http://dmd.aspetjournals.org/content/dmd/35/1/9.full.pdf,DB11077
L1792,The Absorption and Excretion of a Liquid Polyethylene Glycol,https://www.sciencedirect.com/science/article/pii/S0095955315319119,DB11077
L1795,Polyethylene Glycol 400 ,https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=POLYETHYLENE+GLYCOL+400&pagesize=100&page=2&vfile=,DB11077
L1796,Systane Mechanism of Action,http://www.systane.dk/professional/media/pdf/SYS_Ultra_MOA.pdf,DB11077
L1797,Ocular lubricants: what is the best choice?,http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782016001102055,DB11077
L1798,Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex vivo and Distribution in vivo,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890729/,DB11077
L1799,The different faces of poly(ethylene glycol),http://www.pnas.org/content/pnas/94/16/8378.full.pdf,DB11077
L1791,Health Canada: Triethanolamine Salicylate (Trolamine) Label,https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/triethanolamine-salicylate-trolamine.html,DB11079
L2012,"FDA CFR - Code of Federal Regulations Title 21, PART 350: ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE",https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=350&showFR=1,DB11081
L2013,ALUMINUM CHLORIDE - National Library of Medicine HSDB ... - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+607,DB11081
L347,product info,https://www.drugs.com/cdi/coal-tar-ointment.html,DB11082
L2744,NIH Toxnet: Resorcinol Profile,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+722,DB11085
L2745,Drugs.com: Resorcinol Profile,https://www.drugs.com/mmx/resorcinol.html,DB11085
L2746,Resorcinol Peel as a Part of a Facial Rejuvenation Program,http://journals.sagepub.com/doi/pdf/10.1177/074880689701400109,DB11085
L2747,INCHEM: Resorcinol Profile,http://www.inchem.org/documents/cicads/cicads/cicad71.htm#8.10,DB11085
L1801,Docusate sodium/Senna: Drug Information,https://davisplus.fadavis.com/3976/meddeck/pdf/docusatesodiumsenna.pdf,DB11089
L1804,Docusate sodium Drug Summary,http://www.pdr.net/drug-summary/Colace-Capsules-docusate-sodium-1023,DB11089
L5912,Alberta Health Services Drugs and Therapeutics Background- Stool Softeners: WHY Are They Still Used?,https://www.albertahealthservices.ca/assets/info/hp/pharm/if-hp-pharm-docusate-delisting-backgrounder.pdf,DB11089
L5915,World Health Organization List of Essential Medicines 2017,https://www.who.int/medicines/publications/essentialmedicines/20th_EML2017_FINAL_amendedAug2017.pdf,DB11089
L1735,Potassium Nitrate,https://pubchem.ncbi.nlm.nih.gov/compound/potassium_nitrate#section=Top,DB11090
L1736,COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS,http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500015775.pdf,DB11090
L1749,CHEBI:63043 - potassium nitrate,http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:63043,DB11090
L1750,POTASSIUM NITRATE,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1227,DB11090
L1751,Mechanism of Action of a Desensitizing Fluoride Toothpaste Delivering Calcium and Phosphate Ingredients in the Treatment of Dental Hypersensitivity,https://www.aegisdentalnetwork.com/cced/2009/10/mechanism-of-action-of-a-desensitizing-fluoride-toothpaste-delivering-calcium-and-phosphate-ingredients-in-the-treatment-of-dental-hypersensitivity,DB11090
L1752,EPA NITRATES DOCUMENT,https://www3.epa.gov/pesticides/chem_search/reg_actions/reregistration/fs_G-49_1-Sep-91.pdf,DB11090
L1753,Nitrates,https://rais.ornl.gov/tox/profiles/nitrates_f_V1.html,DB11090
L1754,Potassium Nitrate,https://www.drugs.com/drp/potassium-nitrate.html,DB11090
L1755,NITRATE,http://www.inchem.org/documents/jecfa/jecmono/v35je14.htm,DB11090
L1756,Guideline-Potassium Intake ,https://www.ncbi.nlm.nih.gov/books/NBK132460/,DB11090
L1757,Nitrates in the meat industry,http://www.mapleleaffoods.com/wp-content/themes/maplecorporate/pdf/food%20nutrition%20and%20the%20nitric%20oxide%20pathway%20(chapter%205).pdf,DB11090
L1759,POTASSIUM CHLORIDE,http://www.inchem.org/documents/sids/sids/kchloride.pdf,DB11090
L1760,"Reduction in Dental Hypersensitivity with Nano-Hydroxyapatite, Potassium Nitrate, Sodium Monoflurophosphate and Antioxidants",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378071/,DB11090
L1764,Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489477/,DB11090
L2023,HYDROGEN PEROXIDE - National Library of Medicine HSDB ... - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+547,DB11091
L2024,Chemical Summary for Hydrogen Peroxide - SSWM,https://www.sswm.info/sites/default/files/reference_attachments/OAK%20RIDGE%20NATIONAL%20LABORATORY%201995%20Chemical%20Summary%20of%20Hydrogen%20Peroxide.pdf,DB11091
L12768,FDA Approved Drug Products: Eskata Hydrogen Peroxide Topical Solution (Discontinued),https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209305s001lbl.pdf,DB11091
L811,HSDB: Calcium Compounds,https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+6931,DB11093
L1782,Vitamin D Supplementation: An Update,https://www.uspharmacist.com/article/vitamin-d-supplementation-an-update,DB11094
L302,Monograph,https://www.drugs.com/ppa/desirudin.html,DB11095
L303,FDA label,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021271s006lbl.pdf,DB11095
L2748,FDA,https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm079686.pdf,DB11096
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB11096
L2749,Dermapproved,http://dermapproved.com/active-ingredients/meradimate,DB11096
L1865,Electronic Medicines Compendium: Fybogel Orange Monograph,https://www.medicines.org.uk/emc/product/1447,DB11097
L1872,Sigma Aldrich: Psyllium Profile,https://www.sigmaaldrich.com/life-science/nutrition-research/learning-center/plant-profiler/plantago-ovata.html,DB11097
L1873,"European Medicines Agency: Community Herbal Monograph on Plantago afar L. et. Plantago indica L., semen",http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Community_herbal_monograph/2009/12/WC500018447.pdf,DB11097
L1836,FDA Code of Federal Regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=331&showFR=1,DB11098
L1837,Potassium Bicarbonate Handbook,http://www.armandproducts.com/content/pdfs/PotBiVs6.PDF,DB11098
L1840,Efferk monograph,http://www.efferk.com/images/PIEffer-K25.pdf,DB11098
L1834,Toxnet Toxicology Data Network: Allantoin,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7490,DB11100
L675,FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203684s001lbl.pdf,DB11104
L1806,DailyMed: Benzalkonium Chloride - antibacterial hand soap refill liquid  Monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e00ec76-8600-1091-e054-00144ff88e88,DB11105
L1814,NIH Toxnet Benzalkonium Chloride Compounds,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+234,DB11105
L1815,The National Institute for Occupational Safety and Health (NIOSH) Benzalkonium Chloride Chemical Safety Card,https://www.cdc.gov/niosh/ipcsneng/neng1584.html,DB11105
L1816,European Medicines Agency: Benzalkonium chloride used as an excipient,http://www.ema.europa.eu/docs/en_GB/document_library/Report/2017/10/WC500235907.pdf,DB11105
L1826,Food and Drug Administration: Safety and Effecrtiveness for Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening of Administrative Record,https://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/EconomicAnalyses/UCM447035.pdf,DB11105
L2732,FDA CFR - Code of Federal Regulations Title 21 Sec. 184.1077 Potassium acid tartrate,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1077,DB11107
L14120,Drugs.com: Phexxi Approval History,https://www.drugs.com/history/phexxi.html,DB11107
L14123,"FDA Approved Drug Products: PHEXXI (lactic acid, citric acid, and potassium bitartrate) vaginal gel",https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208352s000lbl.pdf,DB11107
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB11110
L2831,FDA Inactive ingredient search,https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browsebyletter.page&letter=m,DB11110
L2841,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50314e6b-c2bf-4e6e-94e8-220044c959d9,DB11110
L2842,Supplements manufacturer,https://www.nowfoods.com/supplements/magnesium-citrate-softgels,DB11110
L2576,Code of federal regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=347.10&SearchTerm=lanolin,DB11112
L2577,NIH: Lanolin on the skin,https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0018933/,DB11112
L2579,Lanolin Ointment,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=115af0c8-a6fa-4d8e-9b22-9912d7fbc9ba,DB11112
L2580,Lanolin MeSH,https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=%22Lanolin%22%5BMeSH+Terms%5D,DB11112
L2581,Lanolin synthesis reference,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/lanolin,DB11112
L2582,"Lanolin, Drugs.com",https://www.drugs.com/mtm/lanolin-topical.html,DB11112
L2583,NIH Toxnet Lanolin,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1817,DB11112
L2584,"Final Report of the Safety Assessment for PEG-75 Lanolin, PEG-20 Lanolin, PEG-27 Lanolin, PEG-30 Lanolin, PEG-40 Lanolin, PEG-50 Lanolin, PEG-60 Lanolin, and PEG-85 Lanolin",http://journals.sagepub.com/doi/pdf/10.3109/10915818209021263,DB11112
L2585,LipidBank Wax,http://lipidbank.jp/cgi-bin/detail.cgi?id=WWA2201,DB11112
L2586,"Lanolin Monograph, Epocrates",https://online.epocrates.com/u/1ba5356/Lansinoh+HPA+Lanolin,DB11112
L2587,"Lanolin, Web MD",https://www.webmd.com/drugs/2/drug-77393/lanolin-hydrophilic-cream-topical/details,DB11112
L2588,Contact allergy to lanolin: temporal changes in prevalence and association with atopic dermatitis,https://onlinelibrary.wiley.com/doi/abs/10.1111/cod.12872,DB11112
L2589,An evaluation of the effect ov lanolin in healing nipple injuries,http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21002008000100002,DB11112
L1854,Safety Assessment of Eucalyptus globulus (Eucalyptus) - Derived Ingredients as Used in Cosmetics,https://www.cir-safety.org/sites/default/files/eucalyptus.pdf,DB11114
L1857,Electronic Medicines Compendium: Eucalyptus Oil BP Monograph,https://www.medicines.org.uk/emc/product/4843,DB11114
L1860,Sigma-Aldrich: Eucalyptus oil Profile,https://www.sigmaaldrich.com/life-science/nutrition-research/learning-center/plant-profiler/eucalyptus0.html,DB11114
L1870,"ENSULIZOLE: material safety data sheet - Cymit Quimica, SL",http://www.cymitquimica.com/uploads/products/45/pdf/1530809-msds.pdf,DB11115
L1887,ZINC COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6912,DB11117
L1891,Arkema: Oleris® Undecylenic acid,https://www.arkema.com/en/products/product-finder/product-viewer/Oleris-Undecylenic-acid/,DB11117
L2033,Ammonia - National Library of Medicine HSDB Database - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+162,DB11118
L2061,SODIUM IODIDE - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+750,DB11119
L2065,"Dailymed - IODOPEN SODIUM IODIDE- sodium iodide injection, solution ",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a601734d-e6f4-414e-8a13-f4c0c391b30b,DB11119
L549,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+204,DB11120
L550,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/8006-64-2,DB11120
L1988,US EPA Reregistration Eligibility Decision (RED): Chloroxylenol,https://archive.epa.gov/pesticides/reregistration/web/pdf/3045.pdf,DB11121
L1989,Exponent FDA Consumer Antispetics Rule: FDA Request for Data on Safety and Efficacy of Chloroxylenol,http://www.cleaninginstitute.org/assets/1/Page/American%20Cleaning%20Institute%20Comments%20on%20chloroxylenolProposed%20FDA%20Amendment%20of%20TFM1.pdf,DB11121
L1992,Electronic Medicines Compendium: Dettol (Chloroxylenol) Antiseptic Cream Monograph,https://www.medicines.org.uk/emc/product/5621,DB11121
L1993,NLM Toxnet: Chloroxylenol,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7427,DB11121
L1999,Electronic Medicines Compendium: Dettol (chloroxylenol) Liquid Monograph,https://www.medicines.org.uk/emc/product/5633,DB11121
L2730,SODIUM HYPOCHLORITE - National Library of Medicine Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+748,DB11123
L1923,BENZETHONIUM CHLORIDE - National Library of Medicine HSDB Database,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+567,DB11125
L615,DRUGS.COM,https://www.drugs.com/pro/calcium-gluconate-injection.html,DB11126
L616,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/calcium_gluconate#section=Therapeutic-Uses,DB11126
L617,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/299-28-5,DB11126
L618,DRUGS.COM,https://www.drugs.com/mmx/calcium-gluceptate-and-calcium-gluconate.html,DB11126
L1910,Selenious Acid PubChem,https://pubchem.ncbi.nlm.nih.gov/compound/selenious_acid#section=Top,DB11127
L1911,Selenium (As selenious acid),https://www.drugs.com/ppa/selenium-as-selenious-acid.html,DB11127
L1912,Selenium overview,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/selenous-acid,DB11127
L1913,"EPA Label, Selenious Acid",https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0097_summary.pdf,DB11127
L1914,High-dose selenium for critically ill patients with systemic inflammation: Pharmacokinetics and pharmacodynamics of selenious acid: A pilot study,http://www.nutritionjrnl.com/article/S0899-9007(09)00297-4/pdf,DB11127
L1916,"Selenium, URMC Rochester encyclopedia",https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=19&contentid=selenium,DB11127
L1917,"Absorption, distribution, and retention of inhaled selenious acid and selenium metal aerosols in Beagle dogs",https://www.sciencedirect.com/science/article/pii/0041008X83903162,DB11127
L1918,"Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase",https://doi.org/10.1093/carcin/20.9.1657,DB11127
L1919,Distribution of Selenium in Plasma of French Women: Relation to Age and Selenium Status,http://clinchem.aaccjnls.org/content/46/5/731,DB11127
L1920,Interaction between SNPs in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2800981/,DB11127
L1921,Selenium in the prevention of atherosclerosis and its underlying mechanisms,http://pubs.rsc.org/en/content/articlelanding/2017/mt/c6mt00195e#!divAbstract,DB11127
L1922,Selenium Injection,https://www.drugs.com/pro/selenium-injection.html,DB11127
L1924,Selenious acid as a source of selenium added for nutritional purposes to food supplements ,https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2009.1009,DB11127
L1928,Pharmacokinetics and Toxicity of Sodium Selenite in the Treatment of Patients with Carcinoma in a Phase I Clinical Trial: The SECAR Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488827/,DB11127
L1930,Application of Sodium Selenite in the Prevention and Treatment of Cancers,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755498/,DB11127
L1984,Selenious Acid Injection,http://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/selenious_acid_injection-m74778.pdf,DB11127
L1985,Selenium Overview,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/hydrogen-selenide,DB11127
L1987,Selenoprotein P,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763998/,DB11127
L1974,electronic Medicines Compendium (eMC): Otex Ear Drops,https://www.medicines.org.uk/emc/product/299,DB11129
L1976,CFR - Code of Federal Regulations Title 21: Sec. 310.534 Drug products containing active ingredients offered over-the-counter (OTC) for human use as oral wound healing agents.,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=310.534,DB11129
L1761,Chemical and engineering news,https://pubs.acs.org/cen/coverstory/83/8325/8325morphine.html,DB11130
L1762,Encyclopedia ,https://www.britannica.com/science/opium,DB11130
L1766,WHO,http://www.who.int/substance_abuse/activities/opium_abuse_and_its_management.pdf,DB11130
L1780,NZIC,https://nzic.org.nz/ChemProcesses/biotech/12C.pdf,DB11130
L1802,FDA Reports,https://www.fda.gov/ohrms/dockets/ac/02/slides/3873S1_08_Katz.ppt,DB11130
L1807,Health partners,https://www.healthpartners.com/ucm/groups/public/@hp/@public/@ime/@content/documents/documents/cntrb_031044.pdf,DB11130
L1944,Oleoresin Capsicum Toxicology Evaluation and Hazard Review,http://prod.sandia.gov/techlib/access-control.cgi/1995/952129.pdf,DB11131
L784,National Institutes of Health (NIH) Office of Dietary Supplements: Omega-3 Fatty Acids Fact Sheet for Health Professionals,https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/,DB11133
L785,Lovaza FDA Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021654s034lbl.pdf,DB11133
L2422,COPPER(II) OXIDE - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+266,DB11134
L2437,European Food Safety Authority (EFSA): Copper(II) oxide as a source of copper added for nutritional purposes,https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2009.1089,DB11134
L1981,"CHROMIUM, ELEMENTAL - National Library of Medicine HSDB ... - Toxnet - NIH",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+910,DB11136
L1982,CHROMIUM COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6999,DB11136
L1983,Chromium Toxicological Overview - Health Protection Agency - Gov.uk,https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/338694/Chromium_toxicological_overview.pdf,DB11136
L1986,Dietary Supplement Fact Sheet: Chromium,https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/,DB11136
L1990,Dailymed Label: DIVISTA - chromium picolinate capsule ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06c485cd-ee30-44f2-be63-bb98f8d1a907,DB11136
L1005,Drugs.com Sodium Chromate CR 51 product label,https://www.drugs.com/pro/sodium-chromate-cr-51.html,DB11140
L992,TOXNET: Cresol,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+250,DB11143
L2015,"CDC NIOSH: Cresol (o, m, p isomers)",https://www.cdc.gov/niosh/idlh/cresol.html,DB11143
L2019,OCED SIDS UNEP Publications: M/P-Cresol Catgory,http://www.inchem.org/documents/sids/sids/m-p-cresols.pdf,DB11143
L2020,"Interim Specific Ground Water Criterion: o, m, p-Cresol",http://www.state.nj.us/dep/dsr/gw-criteria-pql-public-comment/Cresols.pdf,DB11143
L2038,International Programme On Chemical Safety (IPCS) INCHEM Environmental Health Criteria 168: Cresols,http://www.inchem.org/documents/ehc/ehc/ehc168.htm,DB11143
L2059,IPCS INCHEM: o-cresol,http://www.inchem.org/documents/icsc/icsc/eics0030.htm,DB11143
L2060,IPCS INCHEM: m-cresol,http://www.inchem.org/documents/icsc/icsc/eics0646.htm,DB11143
L2062,IPCS INCHEM: p-cresol,http://www.inchem.org/documents/icsc/icsc/eics0031.htm,DB11143
L2458,IARC Monographs Volume 13,http://monographs.iarc.fr/ENG/Monographs/vol1-42/mono13.pdf,DB11145
L2433,FDA code of federal regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=216.24,DB11148
L2445,Tesis ,https://openaccess.leidenuniv.nl/bitstream/handle/1887/12865/Thesis.pdf?sequence=1,DB11148
L1957,Barium Sulfate  PubChem,https://pubchem.ncbi.nlm.nih.gov/compound/barium_sulfate,DB11150
L1958,"Barium Sulfate, Drugs.com",https://www.drugs.com/mmx/barium-sulfate.html,DB11150
L1959,"NDA, Barium Sulfate",https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM489008.pdf,DB11150
L11776,FDA Approved Drug Products: E-Z-CAT DRY (barium sulfate) for oral suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208036s002lbl.pdf,DB11150
L1965,"Sodium Hydroxide, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/sodium_hydroxide,DB11151
L1967,"FDA document, Sodium Hydroxide",https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1763,DB11151
L1968,Sodium Hydroxide Solution,https://www.drugs.com/pro/sodium-hydroxide-solution.html,DB11151
L1970,"EPA, Sodium Hydroxide ",https://www3.epa.gov/pesticides/chem_search/reg_actions/reregistration/fs_PC-075603_1-Sep-92.pdf,DB11151
L1971,"Chemical Safety Facts, Sodium Hydroxide ",https://www.chemicalsafetyfacts.org/sodium-hydroxide/,DB11151
L1972,SODIUM HYDROXIDE,https://www.nap.edu/read/690/chapter/14#88,DB11151
L1975,Sodium Hydroxide,https://onlinelibrary.wiley.com/doi/pdf/10.1002/3527600418.mb131073e0012,DB11151
L1977,Chlorine and sodium hydroxide,http://scifun.chem.wisc.edu/CHEMWEEK/ChlorineSodiumHydroxide2017.pdf,DB11151
L1941,Evaluation of Topical Potassium Hydroxide Solution for Treatment of Plane Warts,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312655/,DB11153
L1942,Potassium Hydroxide,https://pubchem.ncbi.nlm.nih.gov/compound/potassium_hydroxide,DB11153
L1943,"FDA document, potassium hydroxide",https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1631&SearchTerm=potassium%20hydroxide,DB11153
L1945,Potassium,http://www.druginfosys.com/drug.aspx?drugcode=1964&type=1,DB11153
L1946,"NJ Gov Document, Potassium Hydroxide ",http://nj.gov/health/eoh/rtkweb/documents/fs/1571.pdf,DB11153
L1948,Comparison of 5% potassium hydroxide with 10% potassium hydroxide solution in treatment of molluscum contagiosum: A comparative study,http://applications.emro.who.int/imemrf/J_Pak_Assoc_Dermatol/J_Pak_Assoc_Dermatol_2014_24_4_337_341.pdf,DB11153
L1949,Potassium Hydroxide Liquid,https://www.drugs.com/pro/potassium-hydroxide-liquid.html,DB11153
L1950,Potassium hydroxide overview,https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/potassium-hydroxide,DB11153
L1951,Overview of KOH,https://www.sciencedirect.com/topics/medicine-and-dentistry/koh-test,DB11153
L1952,"NIH MeSH search, Potassium Hydroxide",https://www.ncbi.nlm.nih.gov/mesh/68002424,DB11153
L1953,"ECHA information page, Potassium Hydroxide",https://echa.europa.eu/substance-information/-/substanceinfo/100.013.802,DB11153
L1954,Potassium Hydroxide- Continental Chemical,http://continentalchemicalusa.com/oil-gas-exploration-production/potassium-hydroxide/,DB11153
L1955,"InCHEM, Potassium Hydroxide",http://www.inchem.org/documents/sids/sids/potassiumhyd.pdf,DB11153
L2672,FDA bans triclosan and triclocarban in consumer soaps,https://cen.acs.org/articles/94/web/2016/09/FDA-bans-triclosan-triclocarban-consumer.html,DB11155
L2673,FDA issues final rule on safety and effectiveness of antibacterial soaps,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm517478.htm,DB11155
L2674,Triclorcarban ToxNet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5009,DB11155
L2675,European Chemicals Agency - Triclorcarban,https://echa.europa.eu/substance-information/-/substanceinfo/100.002.659,DB11155
L2676,Temporal Development of Gut Microbiota in Triclocarban Exposed Pregnant and Neonatal Rats,https://www.nature.com/articles/srep33430,DB11155
L2678,Binding mechanism of triclocarban with human serum albumin: Effect on the conformation and activity of the model transport protein,https://www.sciencedirect.com/science/article/pii/S0167732217339946,DB11155
L2679,Triclocarban and Triclosan Inhibit Human Aromatase via Different Mechanisms,https://www.hindawi.com/journals/bmri/2017/8284097/,DB11155
L2680,Triclocarban,https://www.pharmacompass.com/chemistry-chemical-name/triclocarban,DB11155
L2682,"Investigation of human exposure, metabolism and biological effects of the antibacterial triclocarban",https://pdfs.semanticscholar.org/76e2/4869adc7cd1ca73e43a94b547d7cb42509f8.pdf,DB11155
L2684,"Effects of triclocarban on the transcription of estrogen, androgen and aryl hydrocarbon receptor responsive genes in human breast cancer cells",https://www.sciencedirect.com/science/article/pii/S0887233313000672,DB11155
L2685,"Triclocarban, PuBMED",https://pubchem.ncbi.nlm.nih.gov/compound/Triclocarban,DB11155
L1892,Pharmacokinetics of praziquantel and pyrantel pamoate combination following oral administration in cats,http://journals.sagepub.com/doi/abs/10.1177/1098612X17734065?journalCode=jfma,DB11156
L1893,Pyrantel Pamoate PDR,http://m.pdr.net/drug-summary/Reese--39-s-Pinworm-Medicine-pyrantel-pamoate-2158,DB11156
L1894,CDC  for healthcare professionals,https://www.cdc.gov/parasites/pinworm/health_professionals/index.html,DB11156
L1895,MSDS for pyrantel,http://www.sciencelab.com/msds.php?msdsId=9924756,DB11156
L1897,Strongidpaste,https://www.horse.com/ContentFiles/Associated_Content/strongidpaste.pdf,DB11156
L1898,Pyrantel Dosage,https://www.drugs.com/dosage/pyrantel.html,DB11156
L1899,Pyrantel Pamoate,https://reference.medscape.com/drug/pin-rid-pin-x-pyrantel-pamoate-342667,DB11156
L1900,"Pyrantel, Science Direct",https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/pyrantel,DB11156
L1901,Pediatric Ascaris Medication,https://emedicine.medscape.com/article/996482-medication,DB11156
L1902,Summary of product characteristics,http://mri.cts-mrp.eu/download/DE_V_0101_001_FinalSPC.pdf,DB11156
L1904,Pyrantel Pamoate Monograph,https://www.drugs.com/monograph/pyrantel-pamoate.html,DB11156
L1905,Pyrantel MeSH NIH,https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=D02.886.778.634%5BAll+Fields%5D,DB11156
L1906,Principles and Practice of Infectious Diseases,https://books.google.ca/books?id=BseNCgAAQBAJ&pg=PA525&lpg=PA525&dq=drug+target+for+pyrantel&source=bl&ots=0KHyn8g9MU&sig=UoubwY2uNKIu-jsFyOtQhIU2pwY&hl=fr&sa=X&ved=0ahUKEwi44OG3wo3aAhVPw2MKHacQAuo4ChDoAQhYMAg#v=onepage&q=pyrantel&f=false,DB11156
L1907,Pharmacotherapeutics For Advanced Practice Nurse Prescribers,https://books.google.ca/books?id=2Q5hCgAAQBAJ&pg=PA787&lpg=PA787&dq=pyrantel+excreted+feces+50%25&source=bl&ots=m4H2pjGjOF&sig=9lq5pMb3YdzEmePL4lGyzk-8maI&hl=fr&sa=X&ved=0ahUKEwjZl52Zy43aAhUS2mMKHQUmA1UQ6AEISjAF#v=onepage&q=pyrantel%20excreted%20feces%2050%25&f=false,DB11156
L1908,Delmar Nurse's Drug Handbook 2012 Edition,https://books.google.ca/books?id=bNNtCgAAQBAJ&pg=PA1469&lpg=PA1469&dq=pyrantel+absorption+1-3+h+peak&source=bl&ots=tSCNdeUZY5&sig=kR6IqlsjMSKn4df8SoSyAjibx8A&hl=fr&sa=X&ved=0ahUKEwiQpPrcy43aAhUFz2MKHX1tA1YQ6AEINjAD#v=onepage&q=pyrantel%20absorption%201-3%20h%20peak&f=false,DB11156
L1991,MSD vet manual,https://www.msdvetmanual.com/pharmacology/anthelmintics/pharmacokinetics-of-anthelmintics,DB11156
L1932,Anthralin,https://www.drugs.com/mmx/anthralin.html,DB11157
L1933,"Zithranol, PDR",http://www.pdr.net/drug-summary/Zithranol-RR-anthralin-2822,DB11157
L1935,Anthralin/dithranol in dermatology,https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-4632.2012.05611.x,DB11157
L1936,"PubChem, Anthralin",https://pubchem.ncbi.nlm.nih.gov/compound/anthralin#section=Top,DB11157
L1938,Zithranol-RR,http://www.empr.com/zithranol-rr/drug/3423/,DB11157
L1939,American Academy of Dermatology Recommendations,https://www.aad.org/practicecenter/quality/clinical-guidelines/psoriasis/topical-therapy/recommendations-for-anthralin,DB11157
L1979,NIH.gov Topical Therapies in psoriasis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518573/,DB11157
L1980,Prophase Definition,https://www.nature.com/scitable/definition/prophase-189,DB11157
L1960,FDA regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1588,DB11158
L1961,Dissolutiontech,http://www.dissolutiontech.com/DTresour/201511Articles/DT201511_A06.pdf,DB11158
L1962,ScienceDirect,https://www.sciencedirect.com/science/article/pii/S0921042396803005,DB11158
L2495,Prescribing Information: Tussionex Suspension and Tablets,http://products.sanofi.ca/en/tussionex.pdf,DB11160
L2499,"DailyMed: Dologesic( acetaminophen, phenyltoloxamine citrate, alcool liquid)",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=738e7767-42de-4076-acf2-9152484c2007,DB11160
L2508,SMPDB: Phenyltoloxamine H1-Antihistamine Action,http://smpdb.ca/view/SMP58916,DB11160
L2026,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e094cb1d-80fe-4277-b8f4-9817918f8c76,DB11164
L2029,FDA approved drugs,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=020256,DB11164
L2032,WHO,http://www.who.int/medicines/areas/quality_safety/quality_assurance/Technetium99mTc-bicisate-complex-injection-QAS17-736_21092017.pdf,DB11164
L2034,Dailymed,https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f9adbcd5-1ac1-42d8-b18a-a76c9204014c&type=pdf&name=f9adbcd5-1ac1-42d8-b18a-a76c9204014c,DB11164
L2069,Heart and stroke foundation,http://www.heartandstroke.ca/stroke/what-is-stroke,DB11164
L664,ATryn monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1,DB11166
L2463,European Food Safety Authority (EFSA): Opinion on Calcium L-threonate for use as a source of calcium in food supplements,https://efsa.onlinelibrary.wiley.com/doi/epdf/10.2903/j.efsa.2008.866,DB11168
L2003,FDA Code of Federal Regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1307,DB11171
L2001,Tetrofosmin monograph,https://www3.gehealthcare.com/~/media/documents/us-global/products/nuclear-imaging-agents_non-gatekeeper/clinical%20product%20info/myoview/gehealthcare_myoview-30ml-prescribing-information.pdf?Parent=%7B8676C68D-813E-43A2-BBB8-036FD061A97B%7D,DB11180
L12702,FDA Approved Drug Products: Myoview (Kit for the preparation of technetium Tc99m tetrofosmin injection) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020372s028lbl.pdf,DB11180
L2663,Sulsibenzone,https://pubchem.ncbi.nlm.nih.gov/compound/Sulisobenzone,DB11185
L2664,SULISOBENZONE,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7422,DB11185
L2665,SULISOBENZONE,https://www.ewg.org/skindeep/ingredient/706390/SULISOBENZONE/#.WuyKoi8ZP-Y,DB11185
L2666,"Sulisobezone, U.S. Pharmacopoeia Monograph",http://www.pharmacopeia.cn/v29240/usp29nf24s0_m80090.html,DB11185
L2153,FDA - CFR - Code of Federal Regulations Title 21: PART 352 -- SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY],https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=352.50,DB11185
L2667,ECHA Sulisobenzone toxicity study,https://echa.europa.eu/registration-dossier/-/registered-dossier/10063/7/3/4,DB11185
L2668,"Sulisobenzone, Daily Med Search",https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=SULISOBENZONE,DB11185
L2669,Benzophenone,https://pubchem.ncbi.nlm.nih.gov/compound/benzophenone,DB11185
L2670,"Benzophenone, science direct",https://www.sciencedirect.com/topics/neuroscience/benzophenone,DB11185
L2671,DermNet NZ: Benzophenone Allergy,https://www.dermnetnz.org/topics/allergy-to-benzophenone/,DB11185
L2047,Cobamamide Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/24892716,DB11191
L2048,Cobamamide Overview,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cobamamide,DB11191
L2050,Vitamin B12,https://www.whocc.no/atc_ddd_index/?code=B03BA04&showdescription=yes,DB11191
L2051,Cobamamide,http://www.ebi.ac.uk/chebi/fr/searchId.do;1E0D9C58D62CF2B18E447193C800A132?printerFriendlyView=true&locale=null&chebiId=18408&viewTermLineage=null&structureView=&,DB11191
L2052,Science Labs MSDS Cobamamide,http://www.sciencelab.com/msds.php?msdsId=9923527,DB11191
L2053,Neuroenhancement with Vitamin B12—Underestimated Neurological Significance,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875920/,DB11191
L2054,Treatment of vitamin B12 deficiency–Methylcobalamine? Cyancobalamine? Hydroxocobalamin?—clearing the confusion,https://www.nature.com/articles/ejcn2014165,DB11191
L2055,Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency,https://onlinelibrary.wiley.com/doi/pdf/10.1002/mnfr.201500019,DB11191
L2056,"Cobamamide, Drugs.com",https://www.drugs.com/international/cobamamide.html,DB11191
L2701,ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY,https://www.ewg.org/skindeep/ingredient/716585/ALUMINUM_ZIRCONIUM_OCTACHLOROHYDREX_GLY/#,DB11200
L2702,Aluminum zirconium pentachlorohydrex Gly,https://pubchem.ncbi.nlm.nih.gov/compound/72941670#section=Top,DB11200
L2703,Product Assessment Against Criteria: Antiperspirants,https://www.canada.ca/en/health-canada/services/consumer-product-safety/reports-publications/industry-professionals/product-assessment-against-criteria-antiperspirants.html,DB11200
L2705,LABEL: SECRET COOL WATERLILY CLEAR- aluminum zirconium octachlorohydrex gly gel,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40529ae4-72f0-1f97-e054-00144ff8d46c,DB11200
L2706,SECRET ACTIVE COOL INVISIBLE- aluminum zirconium tetrachlorohydrex gly stick,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51c9ade0-cb14-4d56-e054-00144ff8d46c,DB11200
L2707,"Household Product Database, NIH",https://hpd.nlm.nih.gov/cgi-bin/household/brands?tbl=brands&id=4002183,DB11200
L2012,"FDA CFR - Code of Federal Regulations Title 21, PART 350: ANTIPERSPIRANT DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE",https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=350&showFR=1,DB11200
L2708,Health Canada Document : Chemical Substance - Aluminum zirconium octachlorohydrex glycine,http://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq.do?id=13702&lang=eng,DB11200
L2709,"Breast Cancer Organization, UK",https://www.breastcanceruk.org.uk/science-and-research/background-briefings/aluminium-salts/,DB11200
L2808,"Menthyl Salicylate, EWG",https://www.ewg.org/skindeep/ingredient/720582/MENTHYL_SALICYLATE/#.Wv9EhC_Mz-Y,DB11201
L2810,Menthyl Salicylate,https://www.webmd.com/drugs/2/drug-18536/methyl-salicylate-menthol-topical/details,DB11201
L2811,Salicylate toxicity,https://www.uptodate.com/contents/salicylate-aspirin-poisoning-in-adults,DB11201
L2812,"Best Practice BMJ, Salicylate poisoning",http://bestpractice.bmj.com/topics/en-us/1129,DB11201
L2813,"Salicylate poisoning, patient info",https://patient.info/doctor/salicylate-poisoning,DB11201
L2814,Medicine.net: menthol and methylsalicylate,https://www.medicinenet.com/methyl_salicylate_and_menthol-topical/article.htm,DB11201
L2855,The Clorox Company: Ingredients Inside Clorox Disinfecting Wipes,https://www.thecloroxcompany.com/en-us/what-were-made-of/ingredients-inside/clorox/clorox-disinfecting-wipes1-citrus-blend-44600017273/,DB11202
L2757,IPCS INCHEM: Quaternary ammonium profile,http://www.inchem.org/documents/pims/chemical/pimg022.htm,DB11202
L2525,Pharmacokinetic and Toxicological Characterization of Repellent DEET and Sunscreen Oxybenzone (2011) - by DJ Fediuk,https://mspace.lib.umanitoba.ca/bitstream/handle/1993/8112/fediuk_daryl.pdf?sequence=1,DB11221
L2527,BENZOPHENONE - National Library of Medicine HSDB Database - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6809,DB11221
L2847,Hallstar: SolaStay S1 Product Profile,https://www.hallstar.com/product/solastay-s1/,DB11226
L500,HMDB,http://www.hmdb.ca/metabolites/HMDB29925,DB11228
L502,FDA,https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm260473.htm,DB11228
L503,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1198,DB11228
L504,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/9004-67-5,DB11228
L515,Webmd,http://www.webmd.com/drugs/2/drug-6391/methylcellulose-laxative-oral/details,DB11228
L999,FDA Packaging label: Shrimp-derived chitosan,https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm337459.pdf,DB11234
L2144,Aluminum sulfate PubChem,https://pubchem.ncbi.nlm.nih.gov/compound/3080712,DB11239
L2145,Aluminium sulphate exposure increases oxidative stress and suppresses brain development in Ross broiler chicks,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560745/,DB11239
L2146,Aluminum Sulfate,https://www.drugs.com/ingredient/aluminum-sulfate.html,DB11239
L2147,"Aluminum Sulfate, Brittanica online",https://www.britannica.com/science/aluminum-sulfate,DB11239
L2148,Aluminum Sulfate Excipient,https://www.drugs.com/inactive/aluminum-sulfate-596.html,DB11239
L2149,Aluminum in Drinking Water,http://apps.who.int/iris/bitstream/handle/10665/75362/WHO_SDE_WSH_03.04_53_eng.pdf;jsessionid=D408B68ACD76B131D7F51835F1F1DD38?sequence=1,DB11239
L2150,HIS STYPTIC PENCIL- aluminum sulfate stick ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50c679f9-b082-4a3b-9d26-661300e95271&audience=consumer#,DB11239
L2152,EMA document,http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500010018.pdf,DB11239
L2154,"ToxNet, Aluminum sulfate",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5067,DB11239
L2155,"InChem, Aluminum Sulfate",http://www.inchem.org/documents/ukpids/ukpids/ukpid34.htm,DB11239
L2156, PRIORITY SUBSTANCES LIST ASSESSMENT REPORT,https://www.ec.gc.ca/lcpe-cepa/documents/substances/sa-as/assessment_rpt-eng.pdf,DB11239
L2157,Aluminium Toxicokinetics: An Updated MiniReview,https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0773.2001.880401.x,DB11239
L2158,Aluminum Sulfate Overview,https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/aluminium-sulfate,DB11239
L2159,"Hazardous Materials Sheet, NJ",http://www.nj.gov/health/eoh/rtkweb/documents/fs/0068.pdf,DB11239
L2160,Formulation and evaluation of potash alum as deodorant lotion and after shaving astringent as cream and gel,https://www.banglajol.info/index.php/ICPJ/article/viewFile/17512/12288,DB11239
L2161,Use of Underarm Cosmetic Products in Relation to Risk of Breast Cancer: A Case-Control Study,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514401/,DB11239
L2164,ASSURED- aluminum sulfate powder ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad067b04-ff57-44ab-a6cb-f524f8294989&audience=consumer,DB11239
L2165,Antiperspirants/Deodorants and Breast Cancer,https://www.cancer.gov/about-cancer/causes-prevention/risk/myths/antiperspirants-fact-sheet,DB11239
L2167,Underarm antiperspirants/deodorants and breast cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797685/,DB11239
L2168,BREAST CANCER AND DEODORANTS/ ANTIPERSPIRANTS: A SYSTEMATIC REVIEW,https://pdfs.semanticscholar.org/2877/4ce8ef9459eac3d0fb8ef8db755aa75dc492.pdf,DB11239
L2169,Influence of Lifestyle Factors on Breast Cancer Risk,https://www.karger.com/Article/Abstract/369571,DB11239
L998,FDA GRAS Substances: Gelatin,https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/SCOGS/ucm261307.htm,DB11242
L2109,GELATIN—ITS USEFULNESS AND TOXICITY,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2135456/,DB11242
L2110,"Federal code of regulations, Gelatin",https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=189.5,DB11242
L2111,Gelatin-based hydrogels for biomedical applications,https://www.cambridge.org/core/journals/mrs-communications/article/gelatinbased-hydrogels-for-biomedical-applications/C1DA8426E188AEBDBC412B64B7D87BFD,DB11242
L2112,Daily consumption of the collagen supplement Pure Gold Collagen® reduces visible signs of aging,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206255/,DB11242
L2113,"Gelatin Supplements, Medline plus",https://medlineplus.gov/druginfo/natural/1051.html,DB11242
L2115,"MIMS, gelatin",http://www.mims.com/philippines/drug/info/gelatin?mtype=generic,DB11242
L2116,Volume expander,https://www.sciencedirect.com/topics/neuroscience/volume-expander,DB11242
L2117,Plasma Expanders in Practice,http://shoof.co.nz/docs/InFocus_May12.pdf,DB11242
L2118,Intravenous volume replacement: which fluid and why?,http://adc.bmj.com/content/archdischild/67/5/649.full.pdf,DB11242
L2119,Benefits and risks of using gelatin solution as a plasma expander for perioperative and critically ill patients: A meta-analysis,https://www.researchgate.net/publication/221813335_Benefits_and_risks_of_using_gelatin_solution_as_a_plasma_expander_for_perioperative_and_critically_ill_patients_A_meta-analysis,DB11242
L2121,Religious constraints on prescribing medication,https://onlinelibrary.wiley.com/doi/pdf/10.1002/psb.1524,DB11242
L2122,FUNCTIONAL AND BIOACTIVE PROPERTIES OF COLLAGEN AND GELATIN FROM ALTERNATIVE SOURCES: A REVIEW,https://pdfs.semanticscholar.org/f004/71261cc9f93aeda9d5049ec3c7351cd32754.pdf,DB11242
L2124,"Gelatin, Lab Grade",https://beta-static.fishersci.com/content/dam/fishersci/en_US/documents/programs/education/regulatory-documents/sds/chemicals/chemicals-g/S25335.pdf,DB11242
L2080,Zinc Gluconate,https://pubchem.ncbi.nlm.nih.gov/compound/452949,DB11248
L422,NCBI,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113371/,DB11248
L2081,Code of federal regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=182.8988,DB11248
L2082,Zinc Absorption by Young Adults from Supplemental Zinc Citrate Is Comparable with That from Zinc Gluconate and Higher than from Zinc Oxide,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901420/,DB11248
L2084,Zinc Gluconate Toxicity,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1054,DB11248
L2085,"Zinc Gluconate, Anhydrous",http://www.t3db.ca/system/msds/attachments/000/000/802/original/T3D0729.pdf?1413587577,DB11248
L2086,"Zinc gluconate, Drugs.com",https://www.drugs.com/ppa/zinc-gluconate.html,DB11248
L2087,Zinc Medline Plus,https://medlineplus.gov/druginfo/natural/982.html,DB11248
L2088,Drug Info SYS Zinc Gluconate,http://www.druginfosys.com/drug.aspx?drugcode=2238&type=1,DB11248
L2089,"Absorption and metabolism of oral zinc gluconate in humans in fasting state, during, and after a meal",https://link.springer.com/article/10.1007/BF02784604,DB11248
L2090,ReductioninDurationofCommon ColdsbyZincGluconate Lozengesina Double-BlindStudy,"https://www.colorado.edu/intphys/Class/IPHY3700_Greene/TIPS/zinc/Eby,_GA-Yes.pdf",DB11248
L2091,Zinc Toxicity in Humans,https://pdfs.semanticscholar.org/a9e2/8321ae506e646f32ce59d87b7589851aa7e4.pdf,DB11248
L2105,The pharmacokinetics of zinc from zinc gluconate: a comparison with zinc oxide in healthy men,https://www.researchgate.net/publication/7397767_The_pharmacokinetics_of_zinc_from_zinc_gluconate_a_comparison_with_zinc_oxide_in_healthy_men,DB11248
L2114,FDA Code of Federal Regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=182.3890,DB11251
L2120,National Institute for Health ,https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/#h5,DB11251
L2123,Researchgate,https://www.researchgate.net/publication/244357310_Antioxidant_activities_of_tocopherols,DB11251
L2734,DailyMed: S.T.37-hexylresorcinol solution monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d7acca2-aa8a-5272-e813-faab039cc798,DB11254
L2735,Electronic Medicines Compendium: Strepsils (hexylresorcinol) Extra Triple Action Blackcurrant Lozenges Monograph,https://www.medicines.org.uk/emc/product/5601/smpc,DB11254
L2736,Hexylresorcinol: Providing Skin Benefits by Modulating Multiple Molecular Targets,https://www.researchgate.net/publication/283776287_Hexylresorcinol_Providing_Skin_Benefits_by_Modulating_Multiple_Molecular_Targets,DB11254
L2739,NIH Toxnet: Hexylresorcinol Profile,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+566,DB11254
L2740,IPCS INCHEM 4-Hexylresorcinol Profile,http://www.inchem.org/documents/jecfa/jecmono/v35je04.htm,DB11254
L563,Dailymed,https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=174005,DB11256
L773,FDA Center for Drug Evaluation and Research: Summary Review,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022532Orig1s000SumR.pdf,DB11256
L774,Cayman Chemicals Safety Data Sheet,https://www.caymanchem.com/msdss/21616m.pdf,DB11256
L775,Dailymed L-Methyl-MC-NAC Tablets,https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=177531,DB11256
L2796,DSM Presents Latest Data on Parsol,https://www.happi.com/contents/view_breaking-news/2010-11-01/dsm-presents-latest-data-on-parsol-slx/,DB11271
L2797,"IJPDerma: International Journal of Parenteral and Dermatology - Sunscreen Actives, An Overview",http://www.ijpderma.com/assets/resources/documents/20170817T0823516353.pdf,DB11271
L2799,Cosmetics Info: Polysilicone-15,http://www.cosmeticsinfo.org/ingredient/polysilicone-15,DB11271
L2802,Ross Organic: Sunscreen Photostability 101,http://www.rossorg.com/sunscreen-photostability-101,DB11271
L2791,Health Canada Approved ingredients list,https://www.canada.ca/en/public-health/services/antibiotic-antimicrobial-resistance/animals/veterinary-antimicrobial-sales-reporting/list-a.html,DB11271
L2833,DL-Methylphedrine Hydrochloride,https://pubchem.ncbi.nlm.nih.gov/compound/13666,DB11278
L2834,"Methylphedrine, DL, Drugs.com",https://www.drugs.com/international/methylephedrine-dl.html,DB11278
L2835,"NIH Toxnet, DL Methylphedrine",https://chem.nlm.nih.gov/chemidplus/rn/18760-80-0,DB11278
L2836,Methylphedrine concentrations in drug ad urine specimens,https://watermark.silverchair.com/22-4-310.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAZ8wggGbBgkqhkiG9w0BBwagggGMMIIBiAIBADCCAYEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMHvBl58PCAh5IVtqRAgEQgIIBUsAFre-k9JzoXFCVGmsHsnRKuW46Ad4sCK1dN9GGaobEaRK1DdpCEw3ZyiJ6Dm0dKrzcPU4c_Y6DnDZD-q7xudRPzrz6NlHoCsflEneNYFg25Lu-tHZ81seowX9n9P66nzU-K_aayGvYnod7uC2_PscJmSNh5YyxY34u6tW1PMTXbUTR9pqstD7gAmJPvD5nO5Uk8D1Q0VGAxzbz7jmqutL8rwpIek2RfhAjRXI-NF_Ru1nE8d-4kGBxfVh5ucWeop_SnbR3NSYWZHRwzDacJPE-MyqMLKkimR1zWPvr_1EJ2iHy2XlAEmhYy04mUr2QGRg-bXBzgw4zA3snuEsgfU03frQAsZgQ-l_EkotnzYf-IpbZy_KdQBTbhIT7AgYRuN8JN3KFWpR9sneEdSeAase_zhUf11bz9NwJlh0hQ3gyE1JspVje0vndhPPL1cqR6RI_,DB11278
L2837,Genome. JP DL-methylphedrine,http://www.genome.jp/dbget-bin/www_bget?dr:D02109,DB11278
L2838,"Daily Med, Pancold S",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52726d93-b3ba-432f-96f6-d03bf9f7b840,DB11278
L2839,Chlorphenamine/Dihydrocodeine/Guaifenesin/Methylephedrine/dl Uses More: https://www.ndrugs.com/?s=chlorphenamine/dihydrocodeine/guaifenesin/methylephedrine/dl More: https://www.ndrugs.com/?s=chlorphenamine/dihydrocodeine/guaifenesin/methylephedrine/dl,https://www.ndrugs.com/?s=chlorphenamine/dihydrocodeine/guaifenesin/methylephedrine/dl,DB11278
L2840,Tossamin Plus,https://www.sdrugs.com/?c=drug&s=tossamin%20plus&ingredient=codeine%20phosphate%20hemihydrate/diphenhydramine%20hydrochloride/methylephedrine%20hydrochloride/noscapine,DB11278
L2844,"Methylphedrine, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/N-Methylephedrine#section=Pharmacology-and-Biochemistry,DB11278
L2848,Family Practice Notebook: Sympathomimetics,https://fpnotebook.com/Pharm/Alternative/Ephdrn.htm,DB11278
L2774,United States Environmental Protection Agency: DEET Profile,https://www.epa.gov/insect-repellents/deet,DB11282
L2775,IPCS INCHEM: DEET Profile,http://www.inchem.org/documents/pims/chemical/deet.htm#SectionTitle:5.1%20Oral,DB11282
L2776,"In Vitro Human Metabolism and Interactions of Repellent N,N-Diethyl-m-Toluamide",https://www.researchgate.net/figure/Primary-in-vitro-metabolites-of-DEET_fig1_11507717,DB11282
L2777,National Pesticide Information Centre: DEET Technical Fact Sheet,http://npic.orst.edu/factsheets/archive/DEETtech.html,DB11282
L2778,"""Mosquito odorant receptor for DEET and methyl jasmonate."" Proceedings of the National Academy of Sciences.",http://www.pnas.org/content/111/46/16592,DB11282
L2779,NIH Toxnet: Diethyltoluamide Profile,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1582,DB11282
L665,Spherusol Monograph,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77108624-4771-4886-a3e2-b2625c444d1b,DB11294
L2079,EMEA European Medicines Agency Withdrawal Assessment Report for Recothrom (thrombin alpha),http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/human/001063/WC500076372.pdf,DB11300
L2618,Phenoxyethanol,https://pubchem.ncbi.nlm.nih.gov/compound/2-phenoxyethanol,DB11304
L2619,Phenoxyethanol - Brumer,https://brumer.com/products/phenoxyethanol,DB11304
L2621,Phenoxyethanol: A Globally-Approved Preservative,https://knowledge.ulprospector.com/2532/pcc-phenoxyethanol-globally-approved-preservative/,DB11304
L2623,Health Canada: Phenoxyethanol,http://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq.do?id=4720&lang=eng,DB11304
L2625,Opinion on Phenoxyethanol - EU Law and Publications,https://publications.europa.eu/en/publication-detail/-/publication/1c728aea-ffde-11e6-8a35-01aa75ed71a1/language-en,DB11304
L2628,pharmacokinetic model of 2-phenoxyethanol and its metabolite phenoxyacetic acid in rats and humans to address toxicokinetic uncertainty in risk assessment,https://www.semanticscholar.org/paper/Development-of-a-physiologically-based-model-of-and-Troutman-Rick/f89ee428f803f27ec66490cc1c4cc3e2a42a01bf,DB11304
L2629,"Simultaneous determination of phenoxyethanol and its major metabolite, phenoxyacetic acid, in rat biological matrices by LC–MS/MS with polarity switching: Application to ADME studies",https://www.sciencedirect.com/science/article/pii/S003991401530031X,DB11304
L2854,"Final Report on the Safety Assessment of Quaternium-18, Quaternium-18 Hectorite, and Quaternium-18 Bentonite",http://journals.sagepub.com/doi/pdf/10.3109/10915818209013148,DB11305
L12831,FDA Approved Drug Products: Ceprotin (protein C concentration [human]) powder for solution,https://www.fda.gov/media/75033/download,DB11312
L12834,FDA Approved Drug Products: Kcentra (prothrombin complex concentrate [human]) powder for reconsitution,https://www.fda.gov/media/85512/download,DB11312
L2871,"USDA: Full Report (All Nutrients): 04589, Fish oil, cod liver",https://ndb.nal.usda.gov/ndb/foods/show?n1=%7BQv%3D1%7D&fg=&fgcd=&man=&lfacet=&count=&max=25&sort=c&qlookup=&offset=0&format=Full&new=&rptfrm=nl&ndbno=04589&nutrient1=621&nutrient2=629&nutrient3=851&subset=0&totCount=5674&measureby=g,DB11321
L2872,NIH NCCIH Clinical Digest for Health Professionals: Omega-3 Fatty Acids - What the Science Says,https://nccih.nih.gov/health/providers/digest/omega3s-science,DB11321
L2686,"Glycol Salicylate, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/2-Hydroxyethyl_salicylate,DB11323
L2687,Skin Irritation and Pharmacokinetics of Glycol Salicylate Transdermal Patches in Sprague–Dawley Rats,http://abstracts.aaps.org/Verify/AAPS2016/PosterSubmissions/10T1000.pdf,DB11323
L2688,Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies,https://pdfs.semanticscholar.org/c16b/e26a1373f9560453c96473e178b105297c6d.pdf,DB11323
L2689,FAMILY CARE THERA FLEX- menthol glycol salicylate nonivamide tocopherol acetate patch,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9753542-1b08-4dcc-a0f5-299384b44227,DB11323
L2690,SALONPAS,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=724bc4d3-0bc1-4275-a23b-4bbc62fbc0d2,DB11323
L2691,"Salicylates, PubMED",https://emedicine.medscape.com/article/1009987-overview,DB11323
L2692,Aspirin and Other Salicylate Poisoning,https://www.merckmanuals.com/en-ca/professional/injuries-poisoning/poisoning/aspirin-and-other-salicylate-poisoning,DB11323
L2694,Glycol Salicylate,https://www.tabletwise.com/medicine/glycol-salicylate,DB11323
L2696,Glycol Salicylate,http://www.worldofchemicals.com/chemicals/chemical-properties/glycol-salicylate.html,DB11323
L2697,Counter-Irritant,https://www.sciencedirect.com/topics/neuroscience/counterirritant,DB11323
L2698,Counterirritants,http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=counter,DB11323
L2700,Clinical Pharmacokinetics of the Salicylates,https://link.springer.com/article/10.2165/00003088-198510020-00004,DB11323
L2641,Nonivamine,https://pubchem.ncbi.nlm.nih.gov/compound/N-Vanillylnonanamide,DB11324
L2642,Nonivamide/Nicoboxil Ointment in Acute Low Back Pain,https://clinicaltrials.gov/ct2/show/NCT01708915,DB11324
L2643,Capsaicin and nonivamide similarly modulate outcome measures of mitochondrial energy metabolism in HepG2 and 3T3-L1 cells,http://pubs.rsc.org/en/content/articlelanding/2018/fo/c7fo01626c/unauth#!divAbstract,DB11324
L2645,"Nonivamide, a capsaicin analog, increases dopamine and serotonin release in SH‐SY5Y cells via a TRPV1‐independent pathway",https://onlinelibrary.wiley.com/doi/pdf/10.1002/mnfr.201200846,DB11324
L2140,BORIC ACID - National Library of Medicine HSDB Database- Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1432,DB11326
L2141,Boric Acid - National Toxicology Program - NIH,https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr324.pdf,DB11326
L2610,Dipyrithione,https://www.drugs.com/international/dipyrithione.html,DB11327
L2611,Dipyrithione,https://drugs.ncats.io/ginas/app/substance/9L87N86R9A,DB11327
L2612,PPBD: dipyrithione (Ref: OSY-20),https://sitem.herts.ac.uk/aeru/ppdb/en/Reports/2764.htm,DB11327
L2613,Dipyrithione inhibits lipopolysaccharide-induced iNOS and COX-2 up-regulation in macrophages and protects against endotoxic shock in mice,https://www.sciencedirect.com/science/article/pii/S0014579308003347,DB11327
L2615,Feix-Sulfur Liquid,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a00ab0c-eb56-4463-9897-90e521b80db5,DB11327
L2616,Dandruff,https://www.mayoclinic.org/diseases-conditions/dandruff/diagnosis-treatment/drc-20353854,DB11327
L2617,Fungicide,https://www.britannica.com/science/fungicide,DB11327
L2030," SOTRADECOL- tetradecyl hydrogen sulfate (ester) injection, solution ",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1756c28-dcd2-4b49-be62-07ca20682018,DB11328
L2031,"Sotradecol, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/23665772,DB11328
L2035,Sodium tetradecyl sulfate,https://www.sciencedirect.com/topics/neuroscience/sodium-tetradecyl-sulfate,DB11328
L2036,Sodium Tetradecyl Sulfate,https://www.drugs.com/monograph/sodium-tetradecyl-sulfate.html,DB11328
L2037,PDR Sotradecol ,http://www.pdr.net/drug-summary/Sotradecol-sodium-tetradecyl-sulfate-878,DB11328
L2039,Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation,http://journals.sagepub.com/doi/abs/10.1177/0268355516673768,DB11328
L2040,Anaphylactoid Reaction After the Use of Sodium Tetradecyl Sulfate: A Case Report,http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.848.8389&rep=rep1&type=pdf,DB11328
L2041,Drug Approval Package,https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/005970-S22_Sotradecol_toc.cfm,DB11328
L2042,NZ Drug Safe Fibrovein,http://www.medsafe.govt.nz/profs/Datasheet/f/Fibroveininj.pdf,DB11328
L2043,Intralesional 3% Sodium Tetradecyl Sulfate for Treatment of Cutaneous Kaposi's Sarcoma,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276773/,DB11328
L2044,Sodium tetradecyl sulfate actions,https://www.ndrugs.com/?s=sodium%20tetradecyl%20sulfate&t=actions,DB11328
L2046,Sotradecol,http://www.angiodynamics.com/uploads/pdf/120711-044819_Sotradecol%20Dilution%20Chart.pdf,DB11328
L2501,"Sinapultide, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/Sinapultide,DB11332
L2502,"Sinapultide, Pharmacodia",http://en.pharmacodia.com/web/drug/1_14364.html,DB11332
L2503,Sinapultide,http://www.drugfuture.com/chemdata/sinapultide.html,DB11332
L2504,Surfactant respiratory therapy using Surfaxin/sinapultide,http://journals.sagepub.com/doi/pdf/10.1177/1753465808097113,DB11332
L2505,Sinapultide - Windtree Therapeutics,https://adisinsight.springer.com/drugs/800008549,DB11332
L2506, EMA Withdrawal Public Assessment Report,http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2010/01/WC500069610.pdf,DB11332
L2507,FDA label for Surfaxin,https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021746s000lbl.pdf,DB11332
L2511,"KL4 Surfactant, WindTree",http://www.windtreetx.com/kl4-surfactant-technology2/,DB11332
L2849,Drug Infosys: Clove Oil,http://www.druginfosys.com/drug.aspx?drugcode=1272&type=1,DB11338
L2850,"Medicines UK Document, Clove Oil",https://www.medicines.org.uk/emc/product/4817/smpc,DB11338
L2852,Eugenol Overview,https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/eugenol,DB11338
L997,Ichthyol official website,http://www.ichthyol.com/ichthammol_1.html,DB11341
L2805,CAMPHOR - National Library of Medicine HSDB Database,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+37,DB11345
L851,HSDB: Calcium Phosphate,http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+879,DB11348
L2845,FDA new dietary ingredients,https://www.fda.gov/Food/DietarySupplements/NewDietaryIngredientsNotificationProcess/ucm109764.htm,DB11358
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB11358
L2851,EMA,http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2012/04/WC500124922.pdf,DB11358
L349,Monograph,https://pubchem.ncbi.nlm.nih.gov/compound/guaiacol#section=Pharmacology-and-Biochemistry,DB11359
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB11361
L2862,FDA EAFUS,https://www.accessdata.fda.gov/scripts/fcn/fcndetailnavigation.cfm?rpt=eafuslisting&id=212,DB11361
L2863,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a001d2e-f076-4bfc-a61c-c8f8d8044fea,DB11361
L2865,EMA Records,http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/herbal/medicines/herbal_med_000030.jsp&mid=WC0b01ac058001fa1d,DB11361
L2866,Vishpha,http://www.vishpha.ua/en/drugs/catalogue/vishpha/ointments/balsamic-liniment-wishnevsky/,DB11361
L2869,EMA Public Assessment,http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_HMPC_assessment_report/2010/01/WC500069013.pdf,DB11361
L2870,Liniment balsamic,https://vision1cycling.com/zdorove/116563-liniment-balzamicheskiy-po-vishnevskomu-za-i-protiv.html,DB11361
L929,AIFA: Pidotimod Summary of Product Characteristics,https://drive.google.com/open?id=0B2K5buBGjy5rSHQ2dTFlVk5LazQ,DB11364
L771,Senokot Tablet Product Information,https://www.medicines.org.uk/emc/medicine/6883,DB11365
L2970,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210867,DB11431
L2971,Pnswire,https://www.prnewswire.com/news-releases/us-fda-approves-moxidectin-for-the-treatment-of-river-blindness-300666114.html,DB11431
L2986,Luxembourg Institute of Health,https://www.lih.lu/blog/our-news-1/post/a-new-treatment-against-river-blindness-lih-contributed-to-clinical-trials-for-moxidectin-194,DB11431
L12708,FDA Approved Drug Products: Moxidectin for oral use,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210867s001lbl.pdf,DB11431
L2876,FDA Poisonous Plant Database,https://www.accessdata.fda.gov/scripts/plantox/detail.cfm?id=26974,DB11482
L2878,FDA Inactive ingredient search,https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browsebyletter.page&letter=b,DB11482
L2879,Food Additives & Ingredients,https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htm,DB11482
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB11482
L218,Sebelipase alfa FDA Approval,http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm476013.htm,DB11563
L2151,PADIMATE O - National Library of Medicine HSDB Database,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7169,DB11570
L2153,FDA - CFR - Code of Federal Regulations Title 21: PART 352 -- SUNSCREEN DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE [STAYED INDEFINITELY],https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=352.50,DB11570
L2079,EMEA European Medicines Agency Withdrawal Assessment Report for Recothrom (thrombin alpha),http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/human/001063/WC500076372.pdf,DB11571
L12936,"DailyMed Label: VISTASEAL (human fibrinogen, human thrombin) kit, for topical use",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a8708417-2f74-4dfa-b6f9-ef88f902e0fc,DB11571
L12939,"FDA Approved Drug Products: EVITHROM (Human Thrombin), for topical use",https://www.fda.gov/media/71754/download,DB11571
L2079,EMEA European Medicines Agency Withdrawal Assessment Report for Recothrom (thrombin alpha),http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/human/001063/WC500076372.pdf,DB11572
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB11574
L10253,Zepatier FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208261s002lbl.pdf,DB11574
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB11575
L2215,"Indigo Carmine® (indigotindisulfonate sodium injection, USP)",http://www.akorndirect.com/documents/catalog/sell_sheets/17478-508-01.pdf,DB11577
L2216,"Pub Chef, Indigo Carmine",https://pubchem.ncbi.nlm.nih.gov/compound/Indigotindisulfonate,DB11577
L2217,Toward an easier indigocarmine chromoendoscopy,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501975/,DB11577
L2218,Indigo Carmine Drugs.com,https://www.drugs.com/pro/indigo-carmine.html,DB11577
L2219,MIMS Indigo Carmine,http://www.mims.com/india/drug/info/indigo%20carmine?mtype=generic,DB11577
L2220,Indigo Carmine Daily Med,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6f0dfc8-63b1-4bc1-96eb-3cd0c3d5d4c2,DB11577
L2222,Scientific Opinion on the re-evaluation of Indigo Carmine (E 132) as a food additive1,http://www.cibr.es/ka/apps/cibr/docs/indigo-julio-2014.pdf,DB11577
L2223,Hypotension in patients administered indigo carmine containing impurities -A case report-,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229025/,DB11577
L2224,Indigo carmine,https://www.sigmaaldrich.com/catalog/product/sigma/57000?lang=en&region=CA,DB11577
L4900,Alexion Receives Early FDA Approval for ULTOMIRIS™ (Ravulizumab-cwvz) in Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH),https://www.businesswire.com/news/home/20181221005364/en/Alexion-Receives-Early-FDA-Approval-ULTOMIRIS-Ravulizumab-cwvz,DB11580
L4915,"First in Human Single-Ascending Dose Study: Safety, Biomarker, Pharmacokinetics and Exposure-Response Relationships of ALXN1210, a Humanized Monoclonal Antibody to C5, with Marked Half-Life Extension and Potential for Significantly Longer Dosing Intervals / Blood 2015 125:4777",http://www.bloodjournal.org/content/126/23/4777,DB11580
L4816,"Venetoclax, Safety Sheet",https://lclabs.com/products/v-3579-venetoclax-free-base/sds,DB11581
L1656,European Medicines Agency recommends restricting use of thiocolchicoside by mouth or injection,http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/11/news_detail_001967.jsp&mid=WC0b01ac058004d5c1,DB11582
L1658,Thiocolchicine EMA label,http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Thiocolchicoside-containing_medicines/WC500155449.pdf,DB11582
L1659,Thiocolchicine Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/Thiocolchicine,DB11582
L1660,Thiocolchicine,http://www.abcam.com/thiocolchicine-ab144374.html,DB11582
L1661,THIOCOLCHICOSIDE AS MUSCLE RELAXANT: A REVIEW,https://www.ijpbs.com/ijpbsadmin/upload/ijpbs_50c8471a463c9.pdf,DB11582
L1663,"To compare the efficacy and safety of fixed dose combination of thiocolchicoside and aceclofenac versus chlorzoxazone, aceclofenac and paracetamol in patients with acute lower backache associated with muscle spasm",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137632/,DB11582
L1664,"The effect of topical thiocolchicoside in preventing and reducing the increase of muscle tone, stiffness, and soreness: A real-life study on top-level road cyclists during stage competition",https://journals.lww.com/md-journal/Fulltext/2017/07280/The_effect_of_topical_thiocolchicoside_in.63.aspx,DB11582
L1665,Neurotransmitters as food supplements: the effects of GABA on brain and behavior,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594160/,DB11582
L1666,GABA AND GLYCINE receptor modulators,https://www.sigmaaldrich.com/life-science/cell-biology/cell-biology-products.html?TablePage=18433831,DB11582
L1669,"hiocolchicoside, 99% (HPLC)",https://aksci.com/item_detail.php?cat=W0078,DB11582
L1670,"Review of the toxicology, pharmacodynamics and pharmacokinetics of thiocolchicoside, a GABA-agonist muscle relaxant with anti-inflammatory and analgesic actions",https://www.researchgate.net/publication/291818675_Review_of_the_toxicology_pharmacodynamics_and_pharmacokinetics_of_thiocolchicoside_a_GABA-agonist_muscle_relaxant_with_anti-inflammatory_and_analgesic_actions,DB11582
L2737,FDA history,https://www.fda.gov/downloads/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm207938.xls,DB11583
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB11583
L2137,Bonjela: treatment for mouth ulcers,http://www.netdoctor.co.uk/medicines/mouth-and-teeth/a7835/bonjela/,DB11583
L2809,Current issues in Pharmacy and medical sciences,https://content.sciendo.com/view/journals/cipms/28/2/article-p77.xml,DB11583
L2815,Quaternary ammonium compounds,http://www.inchem.org/documents/pims/chemical/pimg022.htm#PartTitle:6.%20%20KINETICS,DB11583
L2515,Pripradrol PubChem,https://pubchem.ncbi.nlm.nih.gov/compound/Pipradrol_hydrochloride,DB11584
L2516,Use of Pripradrol in Obstetrics and Gynecology,http://www.nejm.org/doi/full/10.1056/NEJM195603152541103,DB11584
L2517,"ToxNet, Pripradrol",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+8016,DB11584
L2518,Norepinephrine-dopamine reuptake inhibitor,https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/norepinephrine-dopamine-reuptake-inhibitor,DB11584
L2519,Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP),https://www.tandfonline.com/doi/abs/10.3109/15563650.2012.716158?src=recsys&journalCode=ictx20,DB11584
L2522,NIH Inxight Drugs: Pipradrol,https://drugs.ncats.io/ginas/app/substance/S6I030E0DA,DB11584
L2523,Psychiatric uses of Meratran,https://www.cambridge.org/core/journals/journal-of-mental-science/article/psychiatric-uses-of-meratran/3E82BB0C7B9BAF79D98065ECD971ECCB,DB11584
L2524,Pipradrol and derivatives,https://www.researchgate.net/publication/279946278_Pipradrol_and_Pipradrol_Derivatives,DB11584
L2526,Conditioned Place Preference,https://www.ncbi.nlm.nih.gov/books/NBK5229/,DB11584
L2780,Dermascope: The State of Sunscreen Innovation in 2015,https://www.dermascope.com/scope-this/the-state-of-sunscreen-innovation-in-2015,DB11585
L2781,Skin Therapy Letter: Update on Sunscreens,http://www.skintherapyletter.com/sunscreen/advances-update/,DB11585
L2782,Current Trends in Photoprotection - A New Generation of Oral Photoprotectors,https://www.researchgate.net/profile/Angeles_Juarranz/publication/228352216_Current_Trends_in_Photoprotection-A_New_Generation_of_Oral_Photoprotectors/links/542be3990cf277d58e8a4f3f/Current-Trends-in-Photoprotection-A-New-Generation-of-Oral-Photoprotectors.pdf,DB11585
L2783,PhaMix: Mexoryl SX/XL Sunscreens,https://phamix.com/2016/02/mexoryl-sxxl-sunscreens/,DB11585
L2789,Government of Canada: What is ultraviolet radiation?,https://www.canada.ca/en/health-canada/services/sun-safety/what-is-ultraviolet-radiation.html?wbdisable=true,DB11585
L2795,"Chemical & Engineering News: After More Than A Decade, FDA Still Won't Allow New Sunscreens",https://cen.acs.org/articles/93/i20/Decade-FDA-Still-Wont-Allow.html,DB11585
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB11586
L2278,Health Canada Approved Drug Products: Sunvepra (asunaprevir) capsule,https://pdf.hres.ca/dpd_pm/00037935.PDF,DB11586
L2281,WHO,http://www.who.int/mediacentre/factsheets/fs164/en/,DB11586
L2282,HepatitisCentral,http://www.hepatitiscentral.com/hepatitis-c/,DB11586
L2287,Australian Product Information: Sunvepra (Asunaprevir) Capsules,http://www.medicines.org.au/files/bqpsunve.pdf,DB11586
L2293,Australian Public Assessment Report: Asunaprevir,https://www.tga.gov.au/sites/default/files/auspar-asunaprevir-151214.pdf,DB11586
L2555,https://pubchem.ncbi.nlm.nih.gov/compound/etafedrine,https://pubchem.ncbi.nlm.nih.gov/compound/etafedrine,DB11587
L2556,"SA Drug label, Nethaprin",http://home.intekom.com/pharm/adcock/neth-exp.html,DB11587
L2563,Etafedrine,https://www.revolvy.com/main/index.php?s=Etafedrine&item_type=topic,DB11587
L2565,Ephedrine,https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0000654/,DB11587
L2566,Ephedrine,http://www.inchem.org/documents/pims/pharm/pim209.htm,DB11587
L2568,Dalmacol,http://sante.canoe.ca/drug/getdrug/dalmacol,DB11587
L2529,CARBON MONOXIDE,https://www.rcsb.org/ligand/CMO,DB11588
L2530,Therapeutic Applications of Carbon Monoxide,https://www.hindawi.com/journals/omcl/2013/360815/,DB11588
L2531,FDA Federal Code of Regulation Document,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=173.350,DB11588
L2535,Diverse Pharmacological Effects of Carbon Monoxide-Releasing Molecules,https://www.cell.com/biophysj/pdf/S0006-3495(17)33911-5.pdf,DB11588
L2536,"Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications",http://pharmrev.aspetjournals.org/content/57/4/585,DB11588
L2537,Regulatory Status of Carbon Monoxide for Meat Packaging,http://www.meatscience.org/docs/default-source/publications-resources/rmc/2006/regulatory-status-of-carbon-monoxide-for-meat-packaging(4).pdf?sfvrsn=27cbbb3_2,DB11588
L2538,FDA Is Urged to Ban Carbon-Monoxide-Treated Meat,http://www.washingtonpost.com/wp-dyn/content/article/2006/02/19/AR2006021901101.html,DB11588
L2539,"NZ document, carbon monoxide in fish",https://www.mpi.govt.nz/dmsdocument/3357-carbon-monoxide-in-fish,DB11588
L2540, Subscribe to our FREE newsletter Subscribe FDA asked to rescind use of carbon monoxide for meats,https://www.foodnavigator-usa.com/Article/2005/11/17/FDA-asked-to-rescind-use-of-carbon-monoxide-for-meats,DB11588
L2541,Modified Atmosphere Packaging (MAP): Microbial Control and Quality,http://articles.extension.org/pages/27345/modified-atmosphere-packaging-map:-microbial-control-and-quality,DB11588
L2542,Afrox Carbon Monoxide MSDS,http://www.afrox.co.za/internet.global.corp.zaf/en/images/Carbon%20Monoxide.doc266_27628.pdf?v=3.0,DB11588
L2544,Myoglobin Chemistry and Meat Color,https://edisciplinas.usp.br/pluginfile.php/3363743/mod_resource/content/1/Paper%20de%20Cor%281%29.pdf,DB11588
L2545,"WHO document, toxokinetics of CO",http://www.who.int/ipcs/publications/ehc/ehc_213_part_3.pdf,DB11588
L2546,Pharmacokinetics and Mechanisms of Action of Carbon Monoxide,https://pdfs.semanticscholar.org/3899/ed954407ca7e2026269f5835634a5c850983.pdf,DB11588
L2548,"METMYOGLOBIN REDUCTION IN BEEF SYSTEMS AS AFFECTED BY AEROBIC, ANAEROBIC AND CARBON MONOXIDE‐CONTAINING ENVIRONMENTS",https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365-2621.1978.tb07415.x,DB11588
L2549, The binding of carbon monoxide to hemoglobin,http://www.jbc.org/content/243/11/2918.full.pdf,DB11588
L2550,CDC toxicological Profile for Carbon Monoxide,https://www.atsdr.cdc.gov/ToxProfiles/tp201-c2.pdf,DB11588
L2552,Carbon Monoxide Toxicity,https://emedicine.medscape.com/article/819987-overview?pa=Al6yOkIWUQx%2F9ocd8skTnBHDLsu9%2BeTnm4RWozCic5hzkZduVENL%2Bq3t4qQdyBJITux0glhnKYlQwHrKqLk34k3B6KLODm2MpyHuPkYf%2Bs0%3D,DB11588
L2557,Diffusing capacity for carbon monoxide,https://www.uptodate.com/contents/diffusing-capacity-for-carbon-monoxide,DB11588
L2558,"Merck Manuals, Diffusing Lung Capacity",https://www.merckmanuals.com/en-ca/professional/pulmonary-disorders/tests-of-pulmonary-function-pft/measurement-of-gas-exchange,DB11588
L2559,Praxair website,http://www.praxair.com/gases/buy-carbon-monoxide-gas,DB11588
L2562,"Neon, Elemental - National Library of Medicine HSDB Database - Toxnet",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7916,DB11589
L2564,FDA Code of Federal Regulations (CFR) Title 21 Sec. 868.1670 Neon gas analyzer,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=868.1670,DB11589
L1671,Thimerosal and Vaccines,https://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/UCM096228,DB11590
L1672,"Thimerosal, Pubchem",https://pubchem.ncbi.nlm.nih.gov/compound/thimerosal,DB11590
L1673,Questions about Vaccines,https://www.fda.gov/BiologicsBloodVaccines/Vaccines/QuestionsaboutVaccines/ucm070430.htm,DB11590
L1674,54-64-8(Thimerosal) Product Description,https://www.chemicalbook.com/ChemicalProductProperty_US_CB4227430.aspx,DB11590
L1675,Thimerosal-Containing Vaccines and Autism: A Review of Recent Epidemiologic Studies,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018252/,DB11590
L1676,Toxic Effects of Mercury on the Cardiovascular and Central Nervous Systems,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395437/,DB11590
L1677,Thimerosal [54-64-8],https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/thimerosal_508.pdf,DB11590
L1678,Toxicokinetics of Mercury after Long-Term Repeated Exposure to Thimerosal-Containing Vaccine,https://watermark.silverchair.com/kfr009.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAakwggGlBgkqhkiG9w0BBwagggGWMIIBkgIBADCCAYsGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMW0bWnQIT2cgCI9grAgEQgIIBXConbxAIybSm8nt9sq3XLD6FXwk5iR6JvWmt0TZ_eNo1i23x9WAeA27ZgFUJjbtsNrf_SPnPqljOSDTHviFNpDedT1VXht8CrynwJnGIxKgYSgTlvvLMTp529pd4W1rfpurel-Dtb0SEV2z7S5DC8sgbttUwVZldRaQX-BnhUB80qyNopJumFasQtCI2fv1mVs8_jcnECqFbIHY-QMKCcsSB9VYf1hNwnF0sNqPWBVjl-bP8Za1Wjq01NGA9qQUhdZ92c5jGmyFRBhZdbxmOC-9VzwcefYnWxb3C-5DbmOgg7dy3E9o-7JKuOqJWR4Earir-bepLCUqER5TQwzJ-P3XMEWqkuZeVDC7E5mfneV-uVSk7pFVKxLYfkDxma_e-s0xwm2G0DKCPUG2gAMaOcxTaRM2ybi3dOf-X_Hks3ZhQbocEy3ngvPbkmNmnDGzHK67asKvJr9LN27wFdQ,DB11590
L1679,https://www.researchgate.net/publication/51732698_Administration_of_Thimerosal_to_Infant_Rats_Increases_Overflow_of_Glutamate_and_Aspartate_in_the_Prefrontal_Cortex_Protective_Role_of_Dehydroepiandrosterone_Sulfate,https://www.researchgate.net/publication/51732698_Administration_of_Thimerosal_to_Infant_Rats_Increases_Overflow_of_Glutamate_and_Aspartate_in_the_Prefrontal_Cortex_Protective_Role_of_Dehydroepiandrosterone_Sulfate,DB11590
L1680,"Thimerosal, an overview",https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/thiomersal,DB11590
L1681,Thimerosal in Flu Vaccine,https://www.cdc.gov/flu/protect/vaccine/thimerosal.htm,DB11590
L1682,Thimerosal and Animal Brains: New Data for Assessing Human Ethylmercury Risk,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1280369/,DB11590
L1683,"Thimerosal: Clinical, epidemiologic and biochemical studies",https://www.sciencedirect.com/science/article/pii/S0009898115001023,DB11590
L1684,The Thimerosal Controversy,https://vtechworks.lib.vt.edu/bitstream/handle/10919/80308/media_aimee-2.pdf?sequence=1&isAllowed=y,DB11590
L1685,A systematic study of the disposition and metabolism of mercury species in mice after exposure to low levels of thimerosal (ethylmercury),https://www.sciencedirect.com/science/article/pii/S0013935114002400,DB11590
L1686,Toxicity of ethylmercury (and Thimerosal): a comparison with methylmercury,https://www.ncbi.nlm.nih.gov/pubmed/23401210,DB11590
L1687,Mercury,http://enhs.umn.edu/current/5103_spring2003/mercury/mercdose.html,DB11590
L1688,The toxicology of Mercury,https://watermark.silverchair.com/labmed33-0614.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAbQwggGwBgkqhkiG9w0BBwagggGhMIIBnQIBADCCAZYGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMsxyoo6ayNnavpRMYAgEQgIIBZwQ2AC4ARl-zeCYCa2MQcJAd1AkmoMK8ptLgKM9mBUBwirzWPTlFbE5wj9NMdzL8CS0Op19jzNhFCesfDlJPBce-OLrUnmUvT42HIhVtRptl68FzRpK7wHWZXsLO70kIvFnxhtV5GVf_O-S0OcIjX3BNjBOoPj7o5F-QuMhIILw5_Om7TXxyCLkS3IRTug9kahcrc6g3Hwo4pprHSocAK5z8-gGhBVbzJGtMtuGpbfuJ0j-5p2FmSA36w1E5vv1hEhdLB6OMvCBS_9YbHU2STapL0l4x2lZSzvGY3OfNu7JiM_5vFiIHaUa1MaHRGy2ymEe2ibQ1NCi31tGvnqPix2tumsBqVIMcaHyERB1fhZC4pQ-KXqj8ZGo_atoMGlHQKYJRvJMAXWTEjaPpUTaEm8vBJHKp2hSazSTt_mUSsSQisOKZKw2x88VbK6Bzy4GRcZiLOuiAEIuXQ0JigH9gE0m3hcdl4tcU,DB11590
L1689,The Toxicology of Mercury,https://www.hindawi.com/journals/jt/2012/373678/,DB11590
L1690,Sigma Aldrich Thimerosal,https://www.sigmaaldrich.com/catalog/product/aldrich/e35257?lang=en&region=CA,DB11590
L1692,Identification and distribution of mercury species in rat tissues following administration of Thimerosal or methylmercury,https://www.researchgate.net/publication/43131971_Identification_and_distribution_of_mercury_species_in_rat_tissues_following_administration_of_Thimerosal_or_methylmercury,DB11590
L1693,Molecular Interactions with Mercury in the Kidney,http://pharmrev.aspetjournals.org/content/52/1/113,DB11590
L1694,Material Safety Data Sheet Thimerosal MSDS,http://www.sciencelab.com/msds.php?msdsId=9925236,DB11590
L7489,FDA Approved Drug Products: Atezolizumab Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761034s014lbl.pdf,DB11595
L306,product info,http://www.rxlist.com/levoleucovorin-drug/clinical-pharmacology.htm,DB11596
L307,product info,http://davisplus.fadavis.com/3976/meddeck/pdf/levoleucovorincalcium.pdf,DB11596
L803,Rhophylac Summary of Basis for Approval,https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM119475.pdf,DB11597
L804,WinRho Product information,https://www.fda.gov/downloads/ApprovedProducts/UCM198717.pdf,DB11597
L805,RhoGam (Rho(D) Immune Globulin intramuscular injection) product information,http://www.ctint.org/inserts/RhoGam_insert.pdf,DB11597
L609,FDA label,https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM134045.pdf,DB11598
L806,Tubersol (Tuberculin Purified Protein Derivative) product information,https://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm114924.pdf,DB11601
L778,World Health Organization Model List of Essential Medicines (19th List),http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1,DB11601
L756,Cellosize product information,http://www.dow.com/assets/attachments/industry/building_construction/Cellosize_brochure.pdf,DB11602
L544,Myrrh Monograph Natural Medicines Database,"https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=570",DB11605
L1129,"FDA Approves Baxter's OBIZUR [Antihemophilic Factor (Recombinant), Porcine Sequence], for Acquired Hemophilia A",https://www.baxter.com/news-media/newsroom/press-releases/2014/10_24_14_obizur.page,DB11606
L1130,Obizur Product Information,http://www.guildlink.com.au/gc/ws/zi/pi.cfm?product=zipobizu10317,DB11606
L13700,"FDA Approved Drug Products: Eloctate (Antihemophilic Factor (Recombinant), Fc Fusion Protein) powder for intravenous injection",https://www.fda.gov/media/88746/download,DB11607
L888,KEGG: Oxilofrine,http://www.genome.jp/dbget-bin/www_bget?dr:D08314,DB11610
L769,FDA Clinical Pharmacology and Biopharmaceutics Review,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208073Orig1s000ClinPharmR.pdf,DB11611
L14156,FDA Approved Drug Products: Xiidra (lifitegrast) ophthalmic solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208073s002lbl.pdf,DB11611
L758,Epclusa FDA Approval Announcement,http://www.gilead.com/news/press-releases/2016/6/us-food-and-drug-administration-approves-gileads-epclusa-sofosbuvirvelpatasvir-for-the-treatment-of-all-genotypes-of-chronic-hepatitis-c,DB11613
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB11613
L1695,Gestrinone,http://www.druginfosys.com/drug.aspx?drugcode=1462&type=1,DB11619
L1696,Gestrinone Pub Chef,https://pubchem.ncbi.nlm.nih.gov/compound/Gestrinone,DB11619
L1697,Therapeutic effects of mifepristone combined with Gestrinone on patients with endometriosis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103146/,DB11619
L1698,Australian Gestrinone Prescriber Article ,https://www.nps.org.au/australian-prescriber/articles/gestrinone,DB11619
L1699,Gestrinone MIMS label,http://www.mims.com/india/drug/info/gestrinone?type=full&mtype=generic,DB11619
L1700,"Approved Product Information, Dimetriose",https://gp2u.com.au/static/pdf/D/DIMETRIOSE-PI.pdf,DB11619
L1701,Evolution of medical treatment for endometriosis: back to the roots?,https://watermark.silverchair.com/dmm015.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAaYwggGiBgkqhkiG9w0BBwagggGTMIIBjwIBADCCAYgGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMmPqRMgd4-VnwfGbaAgEQgIIBWX72sDg7T9ge-XkZKPa1N7eDeq6yvLyeWRH625GyAVqNequbpH8nYdPB4DLzZlXv0VQqGkoPC0x7h1ly1RxX3lU-vexntnel51tijAuPa55BX4yqYKMFMQabKNlH0ytKlk1DH_A0XMtpnoKjWgIyBRD5V0GRSxZZ6FfwxkCUYUt1h2QrStHmXb9UP2onsSAYlNcb6Yxak0UR-lxTx86JuVssRYShkoCyFAyi_isHS2Zg_vIwlKSMuDEvONVs511cV2yucUhl4KrFeQmeF4FmpEPXt1PAaWJcqgjgEGIKnoYgYF8CjxuL-ueLPirVjHjVqg2WxhiaiqPVQkuOESyzLsx8srBBYfeurKC0iL3hGLoBzoozzJRRnX3rfeQcoYK7LzGt2g1Ugyf4RZ9ziBgW8OoWn21MzobRr5chXOi48fUI-D00WmkZMEnvufxPqmFeBCG3YvTvX0QUhQ,DB11619
L1706,Gestrinone,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1868702,DB11619
L652,DRUGS.COM,https://www.drugs.com/monograph/varicella-zoster-immune-globulin.html,DB11621
L653,Virizig,http://varizig.com/capage/_uploads/documents/VariZIG_approved_PM_Jan_2008_English.pdf,DB11621
L1339,EMA: Tasonermin Scientific Discussion,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000206/WC500052375.pdf,DB11626
L337,Engerix-B Monograph ,http://ca.gsk.com/media/590068/engerix-b.pdf,DB11627
L12777,FDA Approved Products: Recombivax HB (hepatitis B) vaccine,https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/package-insert-recombivax-hb.pdf,DB11627
L1128,EMA: Temoporfin Scientific Discussion,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000318/WC500024394.pdf,DB11630
L2336,Opicapone:once-daily adjunctive therapy for Parkinson’s disease,https://onlinelibrary.wiley.com/doi/pdf/10.1002/psb.1543,DB11632
L2339,Clinical pharmacology review of opicapone for the treatment of Parkinson's disease,https://www.futuremedicine.com/doi/10.2217/nmt-2016-0022,DB11632
L2341,EMA assessment report,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002790/WC500209538.pdf,DB11632
L2342,Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853535/,DB11632
L2343,European Medicines Agency: Ongentys (opicapone) Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002790/WC500209536.pdf,DB11632
L2344,"Pharmacological Profile of Opicapone, a Third Generation Nitrocatechol COMT Inhibitor, in the Rat",https://www.fasebj.org/doi/abs/10.1096/fasebj.29.1_supplement.771.15,DB11632
L2431,Wikigenes,https://www.wikigenes.org/e/chem/e/66377.html,DB11632
L13772,"FDA Approved Drug Products: ONGENTYS (opicapone) capsules, for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212489s000lbl.pdf,DB11632
L1482,"EMA Label: Cresemba, Isavuconazole - European Medicines Agency - Europa EU",http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002734/WC500196128.pdf,DB11633
L2371,EMA Summary Assessment Report,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000920/WC500047919.pdf,DB11635
L2374,Cholestasis,https://www.merckmanuals.com/en-ca/home/liver-and-gallbladder-disorders/manifestations-of-liver-disease/cholestasis,DB11635
L2375,"Emedicine, Cholestasis",https://emedicine.medscape.com/article/927624-overview,DB11635
L2376,"Tocophersolan, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/Tocophersolan,DB11635
L2378,Parmentier document,http://www.parmentier.de/gpfneu/english/tpgs.php,DB11635
L2379,Dosage and formulation issues: oral vitamin E therapy in children,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805799/,DB11635
L2380,"Scottish Medicines Document, Tocofersolan",https://www.scottishmedicines.org.uk/files/advice/tocofersolan_Vedrop_FINAL_APRIL_2011_for_website.pdf,DB11635
L2382,"MSDS, Santa Cruz",http://datasheets.scbt.com/sds/aghs/en/sc-474339.pdf,DB11635
L2384,Vitamin E Regulatory Mechanisms,https://www.annualreviews.org/doi/abs/10.1146/annurev.nutr.27.061406.093819,DB11635
L2385,α-TOCOPHEROL β-OXIDATION LOCALIZED TO RAT LIVER MITOCHONDRIA,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818260/,DB11635
L1407,"Deltyba, INN-Delamanid - European Medicines Agency - Europa EU",http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002552/WC500166232.pdf,DB11637
L1149,EMA: Eurartesim Assessment Report,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001199/WC500118116.pdf,DB11638
L1156,WHO: Guidelines for the Treatment of Malaria 3rd Edition,http://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdf?ua=1&ua=1,DB11638
L1391,EMA Label: InductOs Summary of Product Characteristics,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000408/WC500032317.pdf,DB11639
L3171,Harvard Law Blog: Jacobus and Catalyst Continue to Race for Approval of LEMS Drug,http://blogs.harvard.edu/billofhealth/2016/02/22/jacobus-and-catalyst-approval/,DB11640
L4819,US FDA,https://www.drugs.com/newdrugs/fda-approves-firdapse-amifampridine-lambert-eaton-myasthenic-syndrome-4875.html,DB11640
L6250,"FDA NEWS RELEASE: FDA approves first treatment for children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder",https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-children-lambert-eaton-myasthenic-syndrome-rare-autoimmune-disorder,DB11640
L1396,EMA: Vinflunine Public Assessment Report,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/000983/WC500039919.pdf,DB11641
L2381,EMA Label (SUMMARY OF PRODUCT CHARACTERISTICS): Javlor,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000983/WC500039604.pdf,DB11641
L1471,"Wakix, INN-Pitolisant - European Medicines Agency - Europa EU",http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002616/WC500204746.pdf,DB11642
L1476,"Wakix, INN-pitolisant - European Medicines Agency - Europa EU: Assessment report",http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002616/WC500204749.pdf,DB11642
L8063,"WAKIX® (pitolisant) tablets, for oral use - FDA Label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/0211150s000lbl.pdf,DB11642
L11914,Harmony Biosciences: Wakix (pitolisant) Safety data sheet,https://www.harmonybiosciences.com/static/Safety-Data-Sheet.808d8a4b.pdf,DB11642
L12405,FDA Center for Drug Evaluation and Research: Pitolisant Non-clinical Review(s),https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211150Orig1s000PharmR.pdf,DB11642
L6247,Tafamadis SmPC EMA,https://www.ema.europa.eu/en/documents/product-information/vyndaqel-epar-product-information_en.pdf,DB11644
L11280,FDA Approved Drug Products: Vyndaqel Tafamidis Meglumine Oral Capsules,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211996s000,212161s000lbl.pdf",DB11644
L12945,FDA approved products: Tukysa (tucatinib) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213411s000lbl.pdf,DB11652
L12951,"FDA News Release: FDA Approves First New Drug Under International Collaboration, A Treatment Option for Patients with HER2-Positive Metastatic Breast Cancer",https://www.fda.gov/news-events/press-announcements/fda-approves-first-new-drug-under-international-collaboration-treatment-option-patients-her2,DB11652
L9635,FDA Approved Drug Products: Bremelanotide Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf,DB11653
L12039,Coronavirus treatment: Vaccines/drugs in the pipeline for Covid-19,https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/,DB11676
L12042,BioCryst Initiates Phase 1 Clinical Trial of Galidesivir,http://ir.biocryst.com/news-releases/news-release-details/biocryst-initiates-phase-1-clinical-trial-galidesivir,DB11676
L12084,Galidesivir - BioCryst,https://www.biocryst.com/our-program/galidesivir/,DB11676
L12852,FDA Approved Drug Products: Koselugo (selumetinib) capsules for oral use,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213756s000lbl.pdf,DB11689
L12969,NIH National Cancer Institute: Clinical Trials Using Selumetinib,https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/selumetinib,DB11689
L365,product info,https://pubchem.ncbi.nlm.nih.gov/compound/TROPISETRON_HCl#section=Pharmacology-and-Biochemistry,DB11699
L366,Monograph,http://www.medsafe.govt.nz/profs/Datasheet/t/tropisetronaftinj.pdf,DB11699
L368,MSDS,http://www.abcam.com/ps/Products/120/ab120156/Msds/ab120156_CLP1_EN.pdf,DB11699
L370,Article,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2014558/,DB11699
L1008,Lymphoma Research Foundation's Getting the Facts: Mantle Cell Lymphoma - Relapsed/Refractory,http://www.lymphoma.org/atf/cf/%7BAAF3B4E5-2C43-404C-AFE5-FD903C87B254%7D/LRF_FACTSHEET_MCL_RR_2013.PDF?auid=12730367,DB11703
L1009,Astra Zeneca Press Release: US FDA Approves Astrazeneca's Calquence for Adult Patients with Previously-Treated Mantle Cell Lymphoma,https://www.astrazeneca.com/content/astraz/media-centre/press-releases/2017/us-fda-approves-astrazenecas-calquence-acalabrutinib-for-adult-patients-with-previously-treated-mantle-cell-lymphoma-24102017.html#!,DB11703
L10241,FDA Approved Drug Products: Calquence Acalabrutinib Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210259s006s007lbl.pdf,DB11703
L1595,Cystic fibrosis news,https://cysticfibrosisnewstoday.com/tezacaftor-vx-661-for-cystic-fibrosis,DB11712
L1596,Vertex news,http://investors.vrtx.com/releasedetail.cfm?releaseid=1047092,DB11712
L1598,Vertex news,https://www.vrtx.com/story/fda-approves-symdeko,DB11712
L1599,Vertex news,http://investors.vrtx.com/releasedetail.cfm?releaseid=1038173,DB11712
L6814,Symdeko FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210491lbl.pdf,DB11712
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB11712
L6820,NIH Medline Tezacaftor/Ivacaftor,https://medlineplus.gov/druginfo/meds/a618022.html,DB11712
L6826,"Pharmacology review, FDA",https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/210491Orig1s000PharmR.pdf,DB11712
L6829,"Monograph, Tezacaftor/Ivacaftor",https://pdf.hres.ca/dpd_pm/00046145.PDF,DB11712
L9395,"FDA Approved Drug Products: Trikafta (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets)",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212273s000lbl.pdf,DB11712
L12621,"FDA Approved Drug Products: IMFINZI (durvalumab) injection, for intravenous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761069s002lbl.pdf,DB11714
L12624,FDA.gov Resources for Information: FDA approves durvalumab for extensive-stage small cell lung cancer,https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-durvalumab-extensive-stage-small-cell-lung-cancer,DB11714
L12627,European Medicines Agency: IMFINZI (durvalumab) Summary of Product Characteristics,https://www.ema.europa.eu/en/documents/product-information/imfizi-epar-product-information_en.pdf,DB11714
L3335,FDA approves encorafenib and binimetinib in combination for unresectable or metastatic melanoma with BRAF mutations,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm611981.htm,DB11718
L3344,"BRAF B-Raf proto-oncogene, serine/threonine kinase [ Homo sapiens (human) ]",https://www.ncbi.nlm.nih.gov/gene/673,DB11718
L3347,Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF-Mutant Melanoma,http://clincancerres.aacrjournals.org/content/early/2017/08/21/1078-0432.CCR-16-2923,DB11718
L496,"PDF Article- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer",http://www.nejm.org/doi/pdf/10.1056/NEJMoa1609709,DB11730
L497,FDA approval,https://novartis.gcs-web.com/LEE011-US-FDA-Approval,DB11730
L9338,FDA Approved Drugs: Reyvow,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211280s000lbl.pdf,DB11732
L9344,AChemBlock: Lasmiditan hemisuccinate MSDS,https://www.achemblock.com/AC_SDS.php?Catalog=S72361,DB11732
L9356,FDA News Release: Lasmiditan Approval,https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-patients-migraine,DB11732
L2632,Electronic Medicines Compendium: Duphalac (lactulose) monograph,https://www.medicines.org.uk/emc/product/5525/smpc,DB11735
L2633,ScienceDirect: Galactose Profile,https://www.sciencedirect.com/topics/medicine-and-dentistry/galactose,DB11735
L323,Icotonib approval,https://newdrugapprovals.org/2014/12/09/icotinib/,DB11737
L356,Efficacy and safety of icotinib as first-line therapy in patients with advanced non-small-cell lung cancer,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771396/,DB11737
L4800,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/indeX.cfm?event=overview.process&ApplNo=210910,DB11753
L4801,EMA approvals,https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001754-pip01-15,DB11753
L4802,FDA news,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626121.htm,DB11753
L4804,Bentham Science,http://www.eurekaselect.com/110777/article,DB11753
L8213,FDA News Release: Istradefylline Approval,https://www.fda.gov/news-events/press-announcements/fda-approves-new-add-drug-treat-episodes-adults-parkinsons-disease,DB11757
L8216,Cayman Chemicals: Istradefylline MSDS,https://www.caymanchem.com/msdss/22958m.pdf,DB11757
L8225,Pharmaceuticals and Medical Devices Agency Japan: Report on Istradefylline,https://www.pmda.go.jp/files/000153870.pdf,DB11757
L8237,FDA Approved Drug Products: Istradefylline Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022075s000lbl.pdf,DB11757
L4661,Talazoparib FDA Approval,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm623540.htm,DB11760
L8558,FDA Approved Drugs: Tenapanor,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211801s000lbl.pdf,DB11761
L1000,ema.europa,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004254/WC500230070.pdf,DB11767
L1001,Kevzara product monograph,https://pdf.hres.ca/dpd_pm/00037766.PDF,DB11767
L313,article,https://www.ncbi.nlm.nih.gov/pubmed/27577550,DB11776
L325,article,https://www.ncbi.nlm.nih.gov/pubmed/24846347,DB11776
L13347,FDA Approved Drug Products: Tabrecta (capmatinib) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213591s000lbl.pdf,DB11791
L13380,FDA Approvals and Databases: FDA grants accelerated approval to capmatinib for metastatic non-small cell lung cancer,https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-capmatinib-metastatic-non-small-cell-lung-cancer,DB11791
L13401,CaymanChem: Capmatinib MSDS,https://www.caymanchem.com/msdss/20056m.pdf,DB11791
L637,FDA approval,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm548487.htm,DB11793
L639,Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors,http://www.academia.edu/2570464/Trapping_of_PARP1_and_PARP2_by_Clinical_PARP_Inhibitors,DB11793
L640,FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208447lbl.pdf,DB11793
L1218,"Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1–Infected Adults",https://www.researchgate.net/publication/313581562_Antiviral_Activity_Safety_and_Pharmacokinetics_of_Bictegravir_as_10-Day_Monotherapy_in_HIV-1-Infected_Adults,DB11799
L1219,BICTEGRAVIR,https://aidsinfo.nih.gov/drugs/print/570/bictegravir/0/1/professional,DB11799
L1220,FDA APPROVES BIKTARVY,https://www.drugs.com/newdrugs/fda-approves-biktarvy-bictegravir-emtricitabine-tenofovir-alafenamide-hiv-1-infection-4691.html,DB11799
L1221,BICTEGRAVIR SODIUM,https://pubchem.ncbi.nlm.nih.gov/compound/122197537,DB11799
L5593,FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632761.htm,DB11823
L5596,WHO International fact sheet,https://www.who.int/en/news-room/fact-sheets/detail/depression,DB11823
L1132,Pfizer News,https://www.pfizer.com/news/press-release/press-release-detail/fda_approves_sglt2_inhibitor_steglatro_ertugliflozin_and_fixed_dose_combination_steglujan_ertugliflozin_and_sitagliptin_for_adults_with_type_2_diabetes,DB11827
L1134,Segluromet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209806s000lbl.pdf,DB11827
L1135,Steglujan,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209805s000lbl.pdf,DB11827
L1136,Clinical trials,https://clinicaltrials.gov/ct2/show/results/NCT02411929?sect=Xgf0156#outcome10,DB11827
L12123,FDA Approved Drug Products: Isturisa (osilodrostat) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212801s000lbl.pdf,DB11837
L12132,EMA Summary of Product Characteristics: Isturisa (osilodrostat) oral tablets,https://www.ema.europa.eu/en/documents/product-information/isturisa-epar-product-information_en.pdf,DB11837
L12159,EMA Assessment Report: Isturisa (osilodrostat) oral tablets,https://www.ema.europa.eu/en/documents/assessment-report/isturisa-epar-public-assessment-report_en.pdf,DB11837
L12162,FDA News Release: Osilodrostat Approval,https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-adults-cushings-disease,DB11837
L4818,FDA approvals,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210598,DB11855
L4820,FDA news,https://www.drugs.com/newdrugs/fda-approves-yupelri-revefenacin-chronic-obstructive-pulmonary-copd-4861.html,DB11855
L4821,Respirology paper,https://onlinelibrary.wiley.com/doi/full/10.1111/resp.12660,DB11855
L4822,Theravance Biopharma Report Filing,http://files.shareholder.com/downloads/AMDA-2C8P6P/0x0xS1104659-14-65070/1583107/filing.pdf,DB11855
L4823,ATS Journals paper,https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A3033,DB11855
L5750,Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus: Press Release,https://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-reports-top-line-results-phase-3-status-trial,DB11859
L5921,Romosozumab FDA Approval Announcement,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm635653.htm,DB11866
L5924,"FDA Meeting Of The Bone, Reproductive and Urologic Drugs Advisory Committee For Rosozumab",https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ReproductiveHealthDrugsAdvisoryCommittee/UCM629776.pdf,DB11866
L9554,FDA Approved Drug Products: Romosozumab Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761062s000lbl.pdf,DB11866
L1295,FDA Press Announcements: FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm596768.htm,DB11901
L14165,FDA Approved Drug Products: Ingrezza (valbenazine) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209241s016lbl.pdf,DB11915
L6694,FDA approval information,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208684,DB11921
L6697,Duchenne Muscular Dystrophy organization page,https://www.mda.org/disease/duchenne-muscular-dystrophy,DB11921
L6703,"Calcort 6mg tablets, Medicines UK",https://www.medicines.org.uk/emc/product/6287/smpc,DB11921
L6706,FDA Approved Drug Products: Emflaza (deflazacort) tablets,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208684s000,208685s000lbl.pdf",DB11921
L12144,FDA Approved Products: Nexletol (bempedoic acid) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211616s000lbl.pdf,DB11936
L12147,Bempedoic acid: A novel agent (Esperion),https://www.esperion.com/science/bempedoic-acid/,DB11936
L12150,FDA Approved Products: Nexlizet (bempedoic acid and ezetimibe) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211617s000lbl.pdf,DB11936
L12153,NIH StatPearls: Cholesterol levels,https://www.ncbi.nlm.nih.gov/books/NBK542294/,DB11936
L12156,Biovision: Bempedoic acid MSDS,https://www.biovision.com/documentation/sds/B1913_SDS.pdf,DB11936
L12168,The Role of Lipids and Lipoproteins in Atherosclerosis,https://www.ncbi.nlm.nih.gov/books/NBK343489/,DB11936
L12180,Global News Wire: Esperion-Announces FDA Approval of NEXLETOL bempedoic acid Tablet an Oral Once Daily Non Statin LDL Cholesterol Lowering Medicine,https://www.globenewswire.com/news-release/2020/02/21/1988825/0/en/Esperion-Announces-FDA-Approval-of-NEXLETOL-bempedoic-acid-Tablet-an-Oral-Once-Daily-Non-Statin-LDL-Cholesterol-Lowering-Medicine.html,DB11936
L7117,Xpovio FDA Announcement,https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-refractory-multiple-myeloma,DB11942
L7120,Cancer.ca: Multiple Myeloma,http://www.cancer.ca/en/cancer-information/cancer-type/multiple-myeloma/multiple-myeloma/?region=bc,DB11942
L7123,BC Cancer Agency: Treatment of Multiple Myeloma,http://www.bccancer.bc.ca/health-professionals/clinical-resources/cancer-management-guidelines/lymphoma-chronic-leukemia-myeloma/multiple-myeloma#Treatment-of-Myeloma,DB11942
L7126,Clinical Trials: BOSTON Trial,https://clinicaltrials.gov/ct2/show/NCT03110562,DB11942
L7129,ChemSpider: Selinexor,http://www.chemspider.com/Chemical-Structure.32701989.html,DB11942
L10145,FDA Approved Drug Products: Xpovio oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212306s000lbl.pdf,DB11942
L860,Merck-Pfizer Alliance: Avelumab Fact Sheet,https://www.pfizer.com/files/news/asco/Merck-PfizerAlliance_AvelumabFactSheet_19May2015US.pdf,DB11945
L861,IMGT/mAb-DB card: Avelumab ,http://imgt.org/mAb-DB/mAbcard?AbId=512,DB11945
L10863,FDA Approved Drug Products: Dayvigo (lemborexant) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212028s000lbl.pdf,DB11951
L10869,Carbosynth: Lemborexant MSDS,https://www.carbosynth.com/80257AD2003D1CDB/0/2DE532CE6709B35280258260002ED773/$file/MSDS+-+FL103847+-+SDS117181.pdf,DB11951
L4585,FDA news,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621503.htm,DB11952
L4586,MarketWatch,https://www.marketwatch.com/press-release/verastem-oncology-receives-fda-approval-of-copiktratm-duvelisib-capsules-2018-09-24,DB11952
L4587,Canadian Cancer Society,http://www.cancer.ca/en/cancer-information/cancer-type/leukemia-chronic-lymphocytic-cll/chronic-lymphocytic-leukemia/?region=on,DB11952
L4588,Cancer.gov,https://www.cancer.gov/publications/dictionaries/cancer-terms/def/chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma,DB11952
L4589,Canadian Cancer Society,http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/follicular-lymphoma/?region=on,DB11952
L4810,FDA approval,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=211288,DB11963
L4812,FDA news,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm621967.htm,DB11963
L3334,Cancer.gov link,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/binimetinib,DB11967
L3335,FDA approves encorafenib and binimetinib in combination for unresectable or metastatic melanoma with BRAF mutations,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm611981.htm,DB11967
L3340,"A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor",https://www.nature.com/articles/bjc201710,DB11967
L3341,Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression,https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2199-z,DB11967
L5080,FDA news,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm626494.htm,DB11978
L4832,NIH,https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq,DB11978
L11935,FDA Approved Drug Products: Daurismo (glasdegib) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210656s000lbl.pdf,DB11978
L8081,FDA Label: Rozlytrek,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,DB11986
L8186,Cayman Chemical: Entrectinib MSDS,https://www.caymanchem.com/msdss/19476m.pdf,DB11986
L8207,FDA Announcement: Entrectinib Approval,https://www.fda.gov/news-events/press-announcements/fda-approves-third-oncology-drug-targets-key-genetic-driver-cancer-rather-specific-type-tumor,DB11986
L1199,FDA Press Announcements: FDA approves new drug to treat multiple sclerosis,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm549325.htm,DB11988
L939,FDA: Benznidazole Announcement,https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm573942.htm,DB11989
L780,WHO Diacerein: Restricted Use,http://www.who.int/medicines/publications/druginformation/DI_28-2_SafetyEfficacy.pdf,DB11994
L2819,Avotrombopag,http://www.bloodjournal.org/content/123/25/3887?sso-checked=true,DB11995
L2820,FDA Ok's avatrombopag,https://seekingalpha.com/news/3358283-fda-oks-dova-pharmas-avatrombopag,DB11995
L2821,Avatrombopag,https://pubchem.ncbi.nlm.nih.gov/compound/avatrombopag,DB11995
L2822,FDA approves avatrombopag for thrombocytopenia in adults with chronic liver disease,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm608323.htm,DB11995
L2824,"Avatrombopag, a Novel Thrombopoietin Receptor Agonist, Increases Platelet Counts without Increasing Platelet Activation in Patients with Thrombocytopenia Due to Chronic Liver Disease",http://www.bloodjournal.org/content/130/Suppl_1/290,DB11995
L2927,"Avotrombopag maleate approval, FDA",https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210238,DB11995
L2928,NCI Drug Dictionary: Avotrombopag maleate,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/793425,DB11995
L2929,Drugs.com: Avotrombopag,https://www.drugs.com/history/doptelet.html,DB11995
L2931,NEJM Journal Watch: FDA Approval of Avatrombopag,https://www.jwatch.org/na46878/2018/06/01/fda-approval-avatrombopag,DB11995
L2932,Avatrombopag Gains FDA Approval for Patients with Chronic Liver Disease,https://www.specialtypharmacytimes.com/news/avatrombopag-gains-fda-approval-for-patients-with-chronic-liver-disease,DB11995
L1003,FDA approves new treatment for certain advanced or metastatic breast cancers,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm578071.htm,DB12001
L2644,Fostamatinib FDA Approval,https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm604956.htm,DB12010
L6652,FDA Approved Drug Products: Piqray (alpelisib) tablet,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212526s000lbl.pdf,DB12015
L3614,FDA approves the first drug with an indication for treatment of smallpox,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm613496.htm,DB12020
L3626,FDA approves first smallpox indicated treatment,https://www.genengnews.com/gen-news-highlights/fda-approves-first-smallpox-indicated-treatment-sigas-tpoxx/81256026,DB12020
L1019,Newswire,https://www.prnewswire.com/news-releases/fasenra-benralizumab-receives-us-fda-approval-for-severe-eosinophilic-asthma-300556129.html,DB12023
L1020,Astra Zeneca news,https://www.astrazeneca.com/media-centre/press-releases/2017/fasenra-benralizumab-receives-us-fda-approval-for-severe-uncontrolled-eosinophilic-asthma-14112017.html,DB12023
L852,"American Association for the Study of Liver Diseases; Infectious Diseases Society of America. HCV guidance. http://hcvguidelines.org. Accessed June 12, 2017.",http://hcvguidelines.org/full-report-view,DB12026
L935,FDA News Release: FDA approves Vosevi for Hepatitis C,https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm567467.htm,DB12026
L4814,FDA Approval of Seysara (sarecycline) by Almirall Press Release,https://www.drugs.com/newdrugs/fda-approves-seysara-sarecycline-moderate-severe-acne-4835.html,DB12035
L4815,"Acquisition of Allergan US Medical Dermatology Department by Almirall, S.A. Press Release",https://www.almirall.com/en/media/press-releases/media-detail-new?title=transformational-transaction-almirall-to-acquire-us-medical-dermatology-portfolio-from-allergan&articleId=3261397,DB12035
L1021,FDA Approved Drugs: Letermovir,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&applno=209939,DB12070
L374,FDA Review- Telotristat ,http://www.lexpharma.com/media-center/news/525-fda-extends-pdufa-date-for-telotristat-etiprate-for-the-treatment-of-carcinoid-syndrome,DB12095
L4848,FDA Approval of,https://www.drugs.com/newdrugs/fda-approves-lorbrena-lorlatinib-previously-treated-alk-positive-metastatic-non-small-cell-lung-4856.html,DB12130
L4830,FDA news,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm627072.htm,DB12141
L4832,NIH,https://www.cancer.gov/types/leukemia/patient/adult-aml-treatment-pdq,DB12141
L4833,American Society of Clinical Oncology,http://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.7026,DB12141
L4834,Clinical trials,https://clinicaltrials.gov/ct2/show/NCT02181660,DB12141
L4835,Clinical trials,https://clinicaltrials.gov/ct2/show/NCT02456883,DB12141
L5956,FDA grants accelerated approval to erdafitinib for metastatic urothelial carcinoma: Press Release,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm635910.htm,DB12147
L5959,First Targeted Therapy for Metastatic Bladder Cancer Receives FDA Approval,https://www.pharmacytimes.com/news/first-targeted-therapy-for-metastatic-bladder-cancer-receives-fda-approval,DB12147
L7186,"DUPIXENT® (dupilumab) injection, for subcutaneous use - FDA Label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761055s012lbl.pdf,DB12159
L7192,"Dupixent, INN-dupilumab - European Medicines Agency - Europa EU",https://www.ema.europa.eu/en/documents/product-information/dupixent-epar-product-information_en.pdf,DB12159
L7225,Dupixent® (dupilumab) Approved for Severe Asthma by European Commission - Regeneron,https://newsroom.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-severe-asthma-european-commission,DB12159
L7258,FDA approves first treatment for chronic rhinosinusitis with nasal polyps,https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-chronic-rhinosinusitis-nasal-polyps,DB12159
L7369,"Dupixent, INN - dupilumab -Public Assessment Report - European Medicines Agency - Europa EU",https://www.ema.europa.eu/en/documents/assessment-report/dupixent-epar-public-assessment-report_en.pdf,DB12159
L7372,Australian Public Assessment Report for Dupilumab - TGA,https://www.tga.gov.au/sites/default/files/auspar-dupilumab-180612.pdf,DB12159
L10770,"DUPIXENT® (dupilumab) injection, for subcutaneous use - FDA Label (Revised: 06/2019)",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761055s014lbl.pdf,DB12159
L6658,FDA Approved Drug Products: Polivy,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=761121,DB12240
L754,Mitsubishi Tanabe Pharma Corporation Radicut Label,http://www.e-search.ne.jp/~jpr/PDF/MT18.PDF,DB12243
L5449,FDA Approves EGATEN (Triclabendazole) for Fascioliasis in Patients 6 Years of Age or Older,http://app.info.fda.gov/e/es?s=2027422842&e=186249&elqTrackId=78D8A052C380BCBFF284D754BEBE9730&elq=696bbb7220e749c480a24a2944222376&elqaid=6800&elqat=1,DB12245
L5452,"Novartis receives FDA approval for Egaten® for the treatment of fascioliasis, a neglected tropical disease",https://www.novartis.com/news/media-releases/novartis-receives-fda-approval-egaten-treatment-fascioliasis-neglected-tropical-disease,DB12245
L1026,FDA News and Events,https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm555841.htm,DB12267
L1028,FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/208772Orig1s000MultidisciplineR.pdf,DB12267
L2315,Mictoryl monograph,https://www.duchesnay.com/files/pdf/mictoryl-monograph.pdf,DB12278
L2317,CDR CLINICAL REVIEW REPORT FOR MICTORYL,https://www.cadth.ca/sites/default/files/cdr/clinical/SR0504_Mictoryl_CL%20Report.pdf,DB12278
L2319,The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130959/,DB12278
L2320,Propiverine hydrochloride,https://www.sigmaaldrich.com/catalog/product/sigma/sml0602?lang=en&region=CA,DB12278
L2321,Propiverine Hydrochloride PubChem,https://pubchem.ncbi.nlm.nih.gov/compound/propiverine_hydrochloride,DB12278
L2322,Public assessment report,http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con143796.pdf,DB12278
L2323,Pharmacokinetic Studies on Propiverine Hydrochloride,https://www.jstage.jst.go.jp/article/dmpk1986/10/2/10_2_205/_article,DB12278
L2324,Mictonorm,https://www.ioni.pom.go.id/sites/default/files/obat_baru/Mictonorm.pdf,DB12278
L2325,The muscarinic receptor antagonist propiverine exhibits α1-adrenoceptor antagonism in human prostate and porcine trigonum,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062771/,DB12278
L2327,"Mayo Clinic, Overactive Bladder",https://www.mayoclinic.org/diseases-conditions/overactive-bladder/symptoms-causes/syc-20355715,DB12278
L2328,Maximizing the Treatment of Overactive Bladder in the Elderly,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2312344/,DB12278
L2332,Muscarinic receptor antagonists for overactive bladder,https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1464-410X.2007.07205.x,DB12278
L2333,Propiverine overview,https://www.sciencedirect.com/topics/neuroscience/propiverine,DB12278
L2334,The N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and Pharmacokinetics,http://dmd.aspetjournals.org/content/38/8/1314,DB12278
L9980,FDA Approved Drug Products: Reblozyl® subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761136lbl.pdf,DB12281
L4562,Merck Pifeltro FDA Approval Press Release,https://www.drugs.com/newdrugs/fda-approves-merck-s-pifeltro-doravirine-hiv-1-appropriate-patients-4815.html,DB12301
L12729,FDA Approved Drug Products: Pifeltro (doravirine) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210806s003lbl.pdf,DB12301
L2647,"NIH ClinicalTrials.gov: First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699",https://clinicaltrials.gov/ct2/show/NCT03426995,DB12328
L2648,NLM Toxnet: Catharidine,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2181,DB12328
L4540,Xerava Approval History,https://www.drugs.com/history/xerava.html,DB12329
L315,CENTER FOR DRUG EVALUATION AND RESEARCH ,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/209115Orig1s000MultiDisciplineR.pdf,DB12332
L344,Daily med.,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6d46c03-bb1d-417b-b8e5-3bffe352fe29,DB12332
L345,FDA Label,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/209115s000lbl.pdf,DB12332
L1047,FDA List of Cleared or Approved Companion Diagnostic Devices (In Vitro and Imaging Tools),https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm,DB12332
L5792,FDA approves new oral drug to treat multiple sclerosis,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm634469.htm,DB12371
L5801,"MS Society Document, Canada",https://mssociety.ca/about-ms/symptoms,DB12371
L12171,Health Canada Product Monograph: Mayzent (siponimod) oral tablets,https://pdf.hres.ca/dpd_pm/00055111.PDF,DB12371
L7568,FDA: Recarbrio Label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212819s000lbl.pdf,DB12377
L11028,BiopharmaDive: 5 FDA Approval Decisions to Watch in the 1st Quarter,https://www.biopharmadive.com/news/5-fda-approval-decisions-to-watch-first-quarter/569687/,DB12457
L11971,FDA Approved Drug Products: Nurtec ODT (rimegepant) orally disintegrating tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212728s000lbl.pdf,DB12457
L11974,Biohaven Pharmaceuticals Press Release: Nurtec ODT FDA Approval,https://www.biohavenpharma.com/investors/news-events/press-releases/02-27-2020,DB12457
L11977,CaymanChem: Rimegepant MSDS,https://www.caymanchem.com/msdss/26338m.pdf,DB12457
L12012,Nature Biotechnology: Coronavirus puts drug repurposing on the fast track,https://www.nature.com/articles/d41587-020-00003-1,DB12466
L12075,Pharmaceuticals and Medical Devices Agency: Avigan (favipiravir) Review Report,https://www.pmda.go.jp/files/000210319.pdf,DB12466
L12090,World Health Organization: Influenza (Avian and other zoonotic),https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic),DB12466
L994,FDA Press Announcements: FDA approves new treatment for adults with relapsed follicular lymphoma,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm576129.htm,DB12483
L4168,FDA approves treatment for two rare types of non-Hodgkin lymphoma,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm616176.htm,DB12498
L4170,Sezary Syndrome,https://ghr.nlm.nih.gov/condition/sezary-syndrome,DB12498
L4171,POTELIGEO,https://www.drugs.com/history/poteligeo.html,DB12498
L4175,Mogamulizumab NCI,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mogamulizumab,DB12498
L11770,"FDA Approved Drug Products: POTELIGEO (mogamulizumab-kpkc) injection, for intravenous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761051s000lbl.pdf,DB12498
L8090,FDA Approved Drug Products: Fedratinib Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212327s000lbl.pdf,DB12500
L14315,FDA Approved Drug Products: Uplizna (inebilizumab-cdon) injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761142s000lbl.pdf,DB12530
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB12532
L2816,EMA Herbal substances,http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500163679,DB12532
L770,FDA Executive Summary,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM543963.pdf,DB12598
L11025,Celgene: Press releases archive,https://ir.celgene.com/press-releases-archive/default.aspx,DB12612
L12573,AJMC: FDA approves Zeposia (Ozanimod) for patients with RMS,https://www.ajmc.com/newsroom/fda-approves-zeposia-ozanimod-for-patients-with-rms,DB12612
L12582,FDA Approved Products: Zeposia (Ozanimod) oral capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209899s000lbl.pdf,DB12612
L13874,NIH: Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection (NCT04374032),https://clinicaltrials.gov/ct2/show/NCT04374032,DB12668
L13877,Bosna Lijek: Enkorten Metenkefalin and Tridecactide Injection,http://www.bosnalijek.com/products-L2e?c=ign&ign=metenkefalin%20%2B%20tridecactide,DB12668
L13889,Bosna Lijek: Enkorten Summary of Product Characteristics,http://bosnalijek.ba/enkorten-liofilizat-za-otopinu-za-injekciju-6-bocica-liofilizata---6-ampula-otopine-za-rastvaranje-5-mg---1-mg-,DB12668
L14327,FDA Approved Drug Products: Zepzelca (lurbinectedin) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213702s000lbl.pdf,DB12674
L14336,FDA Drug Approvals and Databases: FDA grants accelerated approval to lurbinectedin for metastatic small cell lung cancer,https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-lurbinectedin-metastatic-small-cell-lung-cancer,DB12674
L4568,FDA news,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620448.htm,DB12688
L4569,Patent WO20141002243A2,https://patents.google.com/patent/WO2014100443A2/en,DB12688
L4572,AstraZeneca news,https://www.astrazeneca.com/media-centre/press-releases/2018/us-fda-accepts-biologics-license-application-for-moxetumomab-pasudotox-in-hairy-cell-leukaemia-03042018.html,DB12688
L1553,FDA label Trogarzo,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761065lbl.pdf,DB12698
L1554,Trogarzo Approved to Treat Multidrug Resistant HIV-1 Infection,https://www.empr.com/news/trogarzo-ibalizumab-antiretroviral-multi-drug-resistant-hiv-1-infection/article/749090/,DB12698
L1555,Ibalizumab,https://aidsinfo.nih.gov/drugs/511/ibalizumab/0/professional,DB12698
L1556,"Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2630626/,DB12698
L1558,Ibalizumab,https://aidsinfo.nih.gov/drugs/511/ibalizumab/0/patient,DB12698
L1559,"Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711820/,DB12698
L1560,Monotherapy With Anti-CD4 Monoclonal Antibody  Cuts Viral Load 10-Fold in 7 Days ,http://www.natap.org/2016/IDSA/IDSA_10.htm,DB12698
L21,Product Announcement,http://www.emaxhealth.com/95/13668.html,DB12742
L2553,Electronic Medicines Compendium: Madopar (levodopa/benserazide hydrochloride) 200mg/50mg Hard Capsules Monograph,https://www.medicines.org.uk/emc/product/6926/smpc,DB12783
L9013,FDA Approved Drugs: Aklief®,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211527s000lbl.pdf,DB12808
L8093,Xenleta FDA label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211672s000,211673s000lbl.pdf",DB12825
L4766,WHO,https://www.who.int/medicines/services/inn/stembook/en/,DB12836
L2925,"FDA Press Announcements: FDA approves a new treatment for PKU, a rare and serious genetic disease",https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm608835.htm,DB12839
L663,FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208325Orig1s000Lbledt.pdf,DB12865
L1849,Boston Children's Hospital,https://vector.childrenshospital.org/2016/02/von-willebrand-factor-drug-vonvendi/,DB12872
L1862,EMA,http://www.ema.europa.eu/docs/en_GB/document_library/PIP_decision/WC500196963.pdf,DB12872
L1866,FDA application,https://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/UCM478968.pdf,DB12872
L1867,National Institute for Health Research,http://www.io.nihr.ac.uk/wp-content/uploads/migrated/Vonicog-alfa-Feb16.pdf,DB12872
L1871,Hemophilia,https://www.hemophilia.org/Newsroom/Medical-News/FDA-Approves-First-Recombinant-von-Willebrand-Factor-Therapy,DB12872
L11476,FDA Approved Drug Products: Tazverik Tazemetostat Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211723s000lbl.pdf,DB12887
L13002,FDA Approved Drug Products: Trodelvy (sacituzumab govitecan-hziy) injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761115s000lbl.pdf,DB12893
L10872,"FDA Approved Drug Products: NUBEQA (darolutamide) tablets, for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212099Orig1s000lbl.pdf,DB12941
L10881,Darolutamide MSDS,https://www.selleckchem.com/msds/MSDS_S7559.pdf,DB12941
L10887,FDA approves darolutamide,https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-darolutamide-non-metastatic-castration-resistant-prostate-cancer,DB12941
L10890,Darolutamide patent,https://patents.google.com/patent/WO2019032840A1/en,DB12941
L11803,FDA Approved Drug Products: Pizensy (lactitol) oral solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211281s000lbl.pdf,DB12942
L11806,MOLBASE: Lactitol monohydrate MSDS,http://www.molbase.com/en/msds_81025-04-9-moldata-1532600.html,DB12942
L2853,"SILVER, ELEMENTAL - National Library of Medicine HSDB Database - Toxnet",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5034,DB12965
L7883,FDA Approved Drug Products: Turaliotm (pexidartinib) capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf,DB12978
L7895,"TURALIO (PEXIDARTINIB) CAPSULES - Daiichi Sankyo, Inc. - FDA Oncologic Drugs Advisory Committee Briefing Document",https://www.fda.gov/media/124893/download,DB12978
L7901,FDA approves first therapy for rare joint tumor - FDA News Release,https://www.fda.gov/news-events/press-announcements/fda-approves-first-therapy-rare-joint-tumor,DB12978
L10836,FDA Approved Drug Products: Padcev (enfortumab vedotin-ejfv) for IV injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761137s000lbl.pdf,DB13007
L797,Meclocycline Phase II Trial: Oral Mucositis,https://clinicaltrials.gov/ct2/show/NCT00385515,DB13092
L4166,FDA approves lusutrombopag for thrombocytopenia in adults with chronic liver disease,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm615348.htm,DB13125
L1878,FDA Records,https://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm193123.htm,DB13133
L1880,Octapharma ,http://www.wilateusa.com/index.php?option=com_content&view=article&id=130:octapharma-usa-fda-approves-wilate-license-supplement&catid=2&Itemid=22,DB13133
L1867,National Institute for Health Research,http://www.io.nihr.ac.uk/wp-content/uploads/migrated/Vonicog-alfa-Feb16.pdf,DB13133
L568,Sciencedirect,http://www.sciencedirect.com/science/article/pii/B978032301840150013X,DB13139
L360,FDA Monograph for Zinplava,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf,DB13140
L669,Drug Information,http://davisplus.fadavis.com/3976/meddeck/pdf/calciumglubionate.pdf,DB13142
L529,Medsafe,http://www.medsafe.govt.nz/profs/Datasheet/g/Granocyteinj.htm,DB13144
L531,ChemIDPlus,https://chem.nlm.nih.gov/chemidplus/rn/135968-09-1,DB13144
L1049,FDA News and Events,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm503920.htm,DB13146
L1050,Axumin,http://www.axumin.com/pdf/formulary_information/Dosing_Admin_03%20FINAL.pdf,DB13146
L1051,Axumin,http://www.axumin.com/pdf/formulary_information/Clinical_Summary_FINAL.pdf,DB13146
L1052,FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/208054Orig1s000PharmR.pdf,DB13146
L2509,Creon monograph,http://www.rxabbvie.com/pdf/creon_PI.pdf,DB13147
L2510,FDA approval,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2010/022523_pancreaze_toc.cfm,DB13147
L413,KCENTRA monograph ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eee1afb8-324c-42e4-8bf0-f0c9da5e6d42,DB13150
L642,NCBI,https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Term=2158,DB13152
L580,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/_-_-alpha-Bisabolol,DB13153
L585,NCBI,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958188/,DB13153
L394,Sciencelab,http://www.sciencelab.com/msds.php?msdsId=9923432,DB13154
L395,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/4684#section=Absorption-Distribution-and-Excretion,DB13154
L396,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/2-chlorophenol#section=Mechanism-of-Action,DB13154
L397,TOXNET,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1414,DB13154
L538,ChemSpider,http://www.chemspider.com/Chemical-Structure.13875219.html,DB13154
L398,HMDB,http://www.hmdb.ca/metabolites/HMDB30820,DB13155
L400,Indena,http://cn.indena.com/pdf/cn/esculoside.pdf,DB13155
L401,Toxnet,https://chem.nlm.nih.gov/chemidplus/rn/531-75-9,DB13155
L648,ChemIDplus,https://chem.nlm.nih.gov/chemidplus/rn/36703-88-5,DB13156
L649,Pubchem,https://pubchem.ncbi.nlm.nih.gov/compound/inosine,DB13156
L2513,US Patent 3211614,https://patentimages.storage.googleapis.com/ac/fe/8b/4510bbea246636/US3211614.pdf,DB13157
L403,Medsafe,http://www.medsafe.govt.nz/profs/Datasheet/e/Eumovatecrm.pdf,DB13158
L404,ChemIdplus,https://chem.nlm.nih.gov/chemidplus/rn/25122-57-0,DB13158
L322,CENTER FOR DRUG EVALUATION AND RESEARCH ,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/209531Orig1s000ClinPharmR.pdf,DB13161
L13691,FDA Approved Drug Products: Spinraza (nusinersen) for intrathecal injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209531s007s008lbl.pdf,DB13161
L766,Hanmi Pharmaceutical Olmutinib Phase I Poster,http://www.hanmi.co.kr/hanmi/img/rnd/2013_WCLC_(HM61713).pdf,DB13164
L376,Drug Information,https://www.drugs.com/history/trulance.html,DB13170
L377,Medscape,http://reference.medscape.com/drug/trulance-pecanatide-1000108#10,DB13170
L378,FDA label,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208745lbl.pdf,DB13170
L755,"Intracerebroventricular Cerliponase Alfa (BMN 190) in Children with CLN2 Disease: Interim Results from a Phase 1/2, Open-Label, Dose-Escalation Study",https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0036-1583718,DB13173
L772,Human Metabolome Database: Rheinanthrone,http://www.hmdb.ca/metabolites/HMDB39449,DB13175
L2560,Examine,https://examine.com/supplements/inositol/,DB13178
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13178
L2561,FDA code of federal regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1370,DB13178
L1053,CSL Behring,http://labeling.cslbehring.com/PI/US/Monoclate-P/EN/Monoclate-P-Prescribing-Information.pdf,DB13192
L1055,Hemofil M,http://www.baxaltahematology.com/hcp/assets/files/Hemofil-M-EU-PI.pdf,DB13192
L1056,Dailymed,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d9c17023-cbff-4d95-8f44-ef842d59d938#CP,DB13192
L1057,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f77d685-e382-b2e7-2414-0d3a3448688a,DB13192
L2352,"Nutritional Interventions for Gastroesophageal Reflux, Irritable Bowel Syndrome, and Hypochlorhydria: A Case Report",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991651/,DB13198
L2353,"Pepsin, Sigma Aaldrich",https://www.sigmaaldrich.com/catalog/product/roche/10108057001?lang=en&region=CA&gclid=EAIaIQobChMIt7vDocfE2gIVBqvsCh2qXQ-hEAMYASAAEgJSkPD_BwE,DB13198
L2354,Effect of Pepsin on the Absorption of Food Vitamin B12 and Iron,https://academic.oup.com/ajcn/article-abstract/20/6/636/4787901?redirectedFrom=PDF,DB13198
L2355,Pepsin,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/pepsin,DB13198
L2356,Pepsin: science.gov topics,https://www.science.gov/topicpages/p/pepsin+a,DB13198
L2357,Pancreatic Enzyme Replacement Therapy During Pancreatic Insufficiency,http://journals.sagepub.com/doi/abs/10.1177/0884533614527773,DB13198
L2358,Pepsin,https://www.britannica.com/science/pepsin,DB13198
L2359,Gastritis,https://www.niddk.nih.gov/health-information/digestive-diseases/gastritis,DB13198
L2360,Zypan,https://cdn.vortala.com/childsites/uploads/1819/files/zypan8475.pdf,DB13198
L2361,PDB-pepsin,http://pdb101.rcsb.org/motm/12,DB13198
L2362,NIH Dictionary- Pepsin,https://www.cancer.gov/publications/dictionaries/cancer-terms/def/pepsin,DB13198
L2363,"Code of Federal Regulations, Pepsin",https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1595,DB13198
L2366,Pepsin Drug Monograph,http://www.druginfosys.com/drug.aspx?drugcode=1341&type=1,DB13198
L2367,"Pepsin, Drugs.com",https://www.drugs.com/international/pepsin.html,DB13198
L2369, Determining the Safety of Enzymes Used in Food Processing,http://jfoodprotection.org/doi/pdf/10.4315/0362-028X-46.5.453?code=fopr-site,DB13198
L2389,"PEPSIN, SIGMA AALDRICH",https://www.sigmaaldrich.com/life-science/metabolomics/enzyme-explorer/analytical-enzymes/pepsin.html,DB13198
L2391,Digestion of Nucleic Acids Starts in the Stomach,https://www.nature.com/articles/srep11936,DB13198
L2441,European Medicines Agency (EMA) Summary of Product Characteristics: Lonquex (lipegfilgrastim),http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002556/WC500148380.pdf,DB13200
L2449,Australian Public Assessment Report for Lipefilgrastim (rbe),https://www.tga.gov.au/sites/default/files/auspar-lipegfilgrastimrbe-160223.pdf,DB13200
L2455,Therapeutic Goods Administration (TGA) product Information: Lonquex,https://www.tga.gov.au/sites/default/files/auspar-lipegfilgrastim-rbe-160223-pi.pdf,DB13200
L2733,BISMUTH SUBNITRATE - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1608,DB13209
L5413,FDA - CFR - Code of Federal Regulations Title 21,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=173.325,DB13210
L5143,NIH - Inxight Drugs - Butaperazine Maleate,https://drugs.ncats.io/drug/22VUW43J2H#general,DB13213
L5416,NIH - Inxight: Drugs,https://drugs.ncats.io/drug/K5X4XBR694,DB13216
L5419,New Zealand - Medicines Amendment Regulations 2009,http://www.legislation.govt.nz/regulation/public/2009/0212/latest/whole.html,DB13216
L5422,Taiwan FDA - News,https://www.fda.gov.tw/EN/newsContent.aspx?id=7705,DB13216
L5458,FDA - Alpha Hydroxy Acids,https://www.fda.gov/cosmetics/productsingredients/ingredients/ucm107940.htm,DB13218
L5461,"WHO Pharmaceuticals Newsletter 1999, No. 09&12 (1999; 30 pages)",http://apps.who.int/medicinedocs/en/d/Js2266e/1.6.html#Js2266e.1.6,DB13219
L5464,Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia (ACCESS),https://clinicaltrials.gov/ct2/show/NCT03524651?intr=FERROUS+ASPARTATE&rank=1,DB13220
L5467,Pharmaceuticals: Restrictions in Use and Availability -2001,http://apps.who.int/medicinedocs/en/d/Js2203e/2.58.html#Js2203e.2.58,DB13222
L2741,FDA CFR - Code of Federal Regulations Title 21: Sec. 184.1207 Calcium lactate,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1207&SearchTerm=calcium%20lactate,DB13231
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13235
L2764,FDA Poisonous Plant Database,https://www.accessdata.fda.gov/scripts/plantox/detail.cfm?id=24999,DB13235
L2768,Manufacturer,https://www.belinka-perkemija.com/sodium-perborate/,DB13235
L2770,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be57ca56-834f-4170-a407-f193484d8b0a,DB13235
L2772,EPA,https://www.epa.gov/pesticides,DB13235
L5425,"Re-evaluation Decision RVD2018-38, Thiram and Its Associated End-use Products",https://www.canada.ca/en/health-canada/services/consumer-product-safety/reports-publications/pesticides-pest-management/decisions-updates/reevaluation-decision/2018/thiram.html,DB13245
L1469,FDA orphan list,https://www.fda.gov/downloads/forindustry/developingproductsforrarediseasesconditions/howtoapplyfororphanproductdesignation/ucm162066.xls,DB13247
L5470,Inxight: Drugs - PRAMIRACETAM,https://drugs.ncats.io/substances?q=root_relationships_relatedSubstance_refPname:%22%5Epramiracetam$%22,DB13247
L2603,FDA Ingredients,https://www.fda.gov/Cosmetics/ProductsIngredients/Ingredients/ucm293184.htm,DB13249
L2605,FDA code of federal regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=182.2437,DB13249
L2614,Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+5823,DB13249
L5476,WHO Pharmaceuticals: Restrictions in Use and Availability (2001; 40 pages) View the PDF document,http://apps.who.int/medicinedocs/en/d/Js2203e/2.50.html,DB13253
L2175,FERROUS SULFATE - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+465,DB13257
L2233,Iron poisoning,https://www.merckmanuals.com/en-ca/professional/injuries-poisoning/poisoning/iron-poisoning,DB13257
L2234,Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336293/,DB13257
L2238,"Ferrous sulfate, Daily Med",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c0fb0c2-8c64-4dd6-adfe-74b1bf8f39c3,DB13257
L2239,"Ferrous sulfate, epocrates",https://online.epocrates.com/u/107327/ferrous+sulfate/Pharmacology,DB13257
L2240,Ferrous sulfate DavisPlus,https://davisplus.fadavis.com/3976/meddeck/pdf/ferroussulfate.pdf,DB13257
L2246,"Ferrous Sulfate Tablet, Delayed Release (Enteric Coated)",https://www.webmd.com/drugs/2/drug-4127/ferrous-sulfate-oral/details,DB13257
L2263,Antianemia Drugs,http://tmedweb.tulane.edu/pharmwiki/doku.php/antianemia_drugs,DB13257
L11767,Dailymed: Ferrous sulfate tablets,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=38104333-f334-4d97-8657-94a00942faf2,DB13257
L11773,The Science Company: Ferrous sulfate MSDS,https://www.sciencecompany.com/msds/Ferrous_Sulfate_MSDS.pdf,DB13257
L11800,ODS Health Professional Fact Sheet: Iron,https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/,DB13257
L11836,Medicines UK: Ferrous sulfate 200mg oral tablets,https://www.medicines.org.uk/emc/product/3130/smpc,DB13257
L11794,"NIH Statpearls: Biochemistry, Iron Absorption",https://www.ncbi.nlm.nih.gov/books/NBK448204/,DB13257
L5617,Pfizer Brazil Kitnos,https://www.pfizer.com.br/noticias/Comunicado-Kitnos,DB13258
L2791,Health Canada Approved ingredients list,https://www.canada.ca/en/public-health/services/antibiotic-antimicrobial-resistance/animals/veterinary-antimicrobial-sales-reporting/list-a.html,DB13264
L5620,Categorizing Antimicrobials on List A Government of Canada,https://www.canada.ca/en/health-canada/services/drugs-health-products/veterinary-drugs/antimicrobial-resistance/categorization-antimicrobial-drugs-based-importance-human-medicine.html,DB13264
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13268
L2622,National Cancer Institute,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C61621,DB13268
L2624,NIH,https://drugs.ncats.io/ginas/app/substance/e7e0485f,DB13268
L2626,NHS,https://www.sps.nhs.uk/wp-content/uploads/2015/06/QA17.7_Can_actarsol_be_used_to_treat_proctitis-Final.docx,DB13268
L2627,NIH,https://meshb.nlm.nih.gov/record/ui?name=Protozoan%20Infections,DB13268
L2773,FDA Inactive ingredient search,https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browsebyletter.page&letter=d,DB13269
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13269
L5623,Institute of Microbial Chemistry - Japan - History,http://www.bikaken.or.jp/english/aboutus/history.html,DB13270
L5626,Inxight: Drugs - Sultopride,https://drugs.ncats.io/drug/AA0G3TW31W,DB13273
L5635,Springer AdisInsight Drug Profile Carbocromen,https://adisinsight.springer.com/drugs/800000219,DB13279
L5647,Kegg Drug - Meticrane,https://www.genome.jp/dbget-bin/www_bget?D01605,DB13284
L5650,WHO - Consolidated list of products whoes consumption has been banned or withdrawn,http://apps.who.int/medicinedocs/documents/s16780e/s16780e.pdf,DB13286
L5737,Kegg Japanese Pharmacopoeia,https://www.genome.jp/kegg-bin/get_htext?br08311+D01636,DB13287
L5740,Viru-Merz Information,http://www.sukl.eu/modules/medication/detail.php?code=0070445&tab=info,DB13288
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13293
L2752,FDA code of federal regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=201.308,DB13293
L2753,FDA federal register,http://cdn.loc.gov/service/ll/fedreg/fr040/fr040056/fr040056.pdf#page=115,DB13293
L2759,FDA Poisonous Plant Database,https://www.accessdata.fda.gov/scripts/plantox/detail.cfm?id=10095,DB13293
L2637,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf973160-d467-4192-a432-04c8c2140369,DB13345
L2649,ANVISA,https://www.smerp.com.br/anvisa/?ac=prodDetail&anvisaId=108970015,DB13345
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13421
L2407,National Cancer Institute,https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C87662,DB13421
L2411,WHO,http://www.who.int/mediacentre/factsheets/fs400/en/,DB13421
L2431,Wikigenes,https://www.wikigenes.org/e/chem/e/66377.html,DB13421
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13444
L2791,Health Canada Approved ingredients list,https://www.canada.ca/en/public-health/services/antibiotic-antimicrobial-resistance/animals/veterinary-antimicrobial-sales-reporting/list-a.html,DB13456
L4778,Pre-Clinical Assessment of the Potential Intrinsic Hepatotoxicity of Candidate Drugs,https://www.intechopen.com/books/new-insights-into-toxicity-and-drug-testing/pre-clinical-assessment-of-the-potential-intrinsic-hepatotoxicity-of-candidate-drugs,DB13501
L4780,eFarma.com: Bendazac Cream Product Page,https://www.efarma.com/versus-crema-50-gr-3.html,DB13501
L4781,Iwaki Seiyaku Co.Ltd.: Bendazac Ointment 3% Discontinued Product Page,https://www.iwakiseiyaku.co.jp/en_medical/index.php/item?id=124,DB13501
L4782,Pharmacompass: Bendazac Profile,https://www.pharmacompass.com/chemistry-chemical-name/bendazac,DB13501
L4019,"Arnold Vosloo, J., Beims, H., Allsopp, M.H. et al. Tolerance of honey bee adults and larvae toward tyrothricin peptides derived from Brevibacillus parabrevis Apidologie (2017) 48: 833. https://doi.org/10.1007/s13592-017-0528-0",https://link.springer.com/article/10.1007/s13592-017-0528-0,DB13503
L4021,National Research Foundation Institutional Repository: Characterization of natural antimicrobial peptides adsorbed to different matrices,http://ir.nrf.ac.za/handle/10907/406,DB13503
L4022,Production and characterisation of analogues of the antimicrobial tyrocidine peptides with modified aromatic amino acid residues.,https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=2ahUKEwii6LGp4czcAhWJJDQIHe6GCgoQFjAAegQIABAC&url=https%3A%2F%2Fscholar.sun.ac.za%2Fbitstream%2Fhandle%2F10019.1%2F103710%2Fberge_production_2018.pdf%3Fsequence%3D1%26isAllowed%3Dy&usg=AOvVaw00U0OObBdDGaJuIhtV_CRJ,DB13503
L4028,Electronic Medicines Compendium: Tyrozets (benzocaine and tyrothricin) lozenges Monograph,https://www.medicines.org.uk/emc/product/372/smpc,DB13503
L2693,FDA CFR - Code of Federal Regulations Title 21 Sec. 184.1011 Alginic acid,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=184.1011,DB13518
L2695,ALGINIC ACID - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+2967,DB13518
L2620,ScienceDirect: Aluminosilicate Profile,https://www.sciencedirect.com/topics/earth-and-planetary-sciences/aluminosilicate,DB13595
L12012,Nature Biotechnology: Coronavirus puts drug repurposing on the fast track,https://www.nature.com/articles/d41587-020-00003-1,DB13609
L1203,"EMA Summary of product characteristics: Mepact, INN-mifamurtide",http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000802/WC500026565.pdf,DB13615
L2650,"Potassium Gluconate, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/potassium_gluconate,DB13620
L2651,POTASSIPOWDER- potassium gluconate powder,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66853766-f3a2-42ef-91e2-033a31caf0e7,DB13620
L2652,NIH Potassium Fact Sheet for Health Professionals,https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/,DB13620
L2653,"NIH Toxnet, Potassium",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3165,DB13620
L2654,Everything Added to Food in the United States (EAFUS) Print Share E-mail,https://www.accessdata.fda.gov/scripts/fcn/fcnNavigation.cfm?filter=&sortColumn=36%28%25%3AH%2152ED0%21AP%2C%2C1M%2F5Q9Q%2CF%40++%0D%0A&rpt=eafuslisting&displayAll=false&page=40,DB13620
L2655,Potassium Supplements (Systemic),https://www.drugs.com/mmx/potassium-gluconate-and-potassium-chloride.html,DB13620
L2656,POTASSIUM GLUCONATE,http://chemicalland21.com/lifescience/foco/POTASSIUM%20GLUCONATE.htm,DB13620
L2657,DRUG: Potassium gluconate,http://www.genome.jp/dbget-bin/www_bget?D01298,DB13620
L2658,Overview: Potassium Gluconate,https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/potassium-gluconate,DB13620
L2659,"Potassium Supplement, Oral Route, Mayo Clinic",https://www.mayoclinic.org/drugs-supplements/potassium-supplement-oral-route-parenteral-route/proper-use/drg-20070753,DB13620
L2660,Regulation of Potassium Homeostasis,http://cjasn.asnjournals.org/content/early/2014/04/30/CJN.08580813.full.html,DB13620
L2590,"Sodium Tartrate, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/Sodium_tartrate,DB13707
L2591,Sodium Tartrate Monograph,http://www.druginfosys.com/drug.aspx?drugcode=1355&type=1,DB13707
L2592,"Sodium tartrate, chemspider",http://www.chemspider.com/Chemical-Structure.12786.html,DB13707
L2593,"Sodium Tartrate Overiew, Science Direct",https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/sodium-tartrate,DB13707
L2594,"List of Permitted Emulsifying, Gelling, Stabilizing or Thickening Agents (Lists of Permitted Food Additives)",https://www.canada.ca/en/health-canada/services/food-nutrition/food-safety/food-additives/lists-permitted/4-emulsifying-gelling-stabilizing-thickening-agents.html,DB13707
L2595,The pharmacology of sodium tartrate,https://jamanetwork.com/journals/jama/article-abstract/436979?redirect=true,DB13707
L2596,Sodium tartrate,https://www.revolvy.com/main/index.php?s=Sodium%20tartrate,DB13707
L2597,"Sodium Tartrate, FCC",https://www.ulprospector.com/en/na/Food/Detail/12002/392295/Sodium-Tartrate--FCC,DB13707
L2598,Tartrates,http://www.harke.com/index.php?tx_hkcatalog_pi1%5Bproductid%5D=872&tx_hkcatalog_pi1%5Bcountry%5D=9999&tx_hkcatalog_pi1%5Blegal%5D=294,DB13707
L13197,Ono Pharmaceutical: Foipan Camostat Mesilate Oral Tablets,http://www.shijiebiaopin.net/upload/product/201272318373223.PDF,DB13729
L991,WHO SPECIFICATIONS AND EVALUATIONS FOR PUBLIC HEALTH PESTICIDES: Bioallethrin,http://www.who.int/whopes/quality/Bioallethrin_%20spec_eval_May2005.pdf?ua=1,DB13746
L2609,HSDB: Allethrins,http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+1511,DB13746
L2599,"PubChem, Sodium Gluconate",https://pubchem.ncbi.nlm.nih.gov/compound/Magnesium_gluconate,DB13749
L2600,Magnesium Gluconate,https://www.webmd.com/drugs/2/drug-7946/magnesium-gluconate-oral/details,DB13749
L2601,"NIH document, Magnesium",https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/,DB13749
L2602,"NIH Medlie, Magnesium Gluconate",https://medlineplus.gov/druginfo/meds/a601072.html,DB13749
L2604,Mg products,http://www.globalrph.com/magnesium_supplements.htm,DB13749
L2606,MIMS: Magnesium gluconate,http://www.mims.com/malaysia/drug/info/magnesium%20gluconate?mtype=generic,DB13749
L2607,Mg Gluconate,https://www.drugs.com/ppa/magnesium-gluconate.html,DB13749
L2608,Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach,http://www.jle.com/download/mrh-267774-study_of_magnesium_bioavailability_from_ten_organic_and_inorganic_mg_salts_in_mg_depleted_rats_using_a_stable_isotope_approach--WuiPHn8AAQEAADOFX1sAAAAH-a.pdf,DB13749
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13751
L2338,WHO,http://apps.who.int/medicinedocs/index/assoc/h5775e/h5775e.pdf,DB13761
L2340,Australian Complementary Medicines Evaluation,https://www.tga.gov.au/sites/default/files/cmec-minutes-47.pdf,DB13761
L2345,Lacdigest monograph,https://compendium.ch/mpro/mnr/23598/html/fr?Platform=Desktop,DB13761
L1044,Rantudil label,http://www.meppo.com/pdf/drugs/2943-RANTUDIL-RETARD-1440583577.pdf,DB13783
L1045,Emflex label,https://www.medicines.org.uk/emcmobile/PIL.26398.latest.pdf,DB13783
L1046,Vademecum,http://mx.prvademecum.com/producto.php?producto=4873,DB13783
L2765,Preparing process and application of calcium lévulinate,https://patents.google.com/patent/CN1304923A/en?oq=B.+Q.+Xue%2c+S.+Q.+Wang%2c+China+Patent+1304923%2c+2001.,DB13800
L2766,Energy densification of levulinic acid by thermal deoxygenation,http://pubs.rsc.org/en/content/articlepdf/2010/gc/c005067a,DB13800
L2767,Advances in the Catalytic Production of Valuable Levulinic Acid Derivatives,https://www.researchgate.net/profile/Shubin_Wu/publication/259293799_1230_ftp/links/0deec52ad14e084236000000.pdf,DB13800
L2769,National Institutes of Health: Calcium Fact Sheet,https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/#h3,DB13800
L2771,Dietary Reference Intakes for Calcium and Vitamin D,https://www.ncbi.nlm.nih.gov/books/NBK56060/,DB13800
L2646,IODOFORM - National Library of Medicine HSDB Database - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb%3A%40term+%40DOCNO+4099,DB13813
L12849,FDA Approved Drug Products: Fluorodopa F18 injection for intravenous use,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/200655s000lbl.pdf,DB13848
L2373,NIH National Cancer Institute Dictionary of Cancer Terms: Anetholtrithione,https://www.cancer.gov/publications/dictionaries/cancer-terms/def/anetholtrithione,DB13853
L2377,"The Medicine Shoppe Pharmacy: Sialor, 25MG, Tablet (anethole trithione) Monograph",https://www.medicineshoppe.ca/en/article/sialor,DB13853
L2388,Anethole trithione liposome and its prepn,https://patents.google.com/patent/CN1771938A/en,DB13853
L5962,FDA Approved Drug Products December 1990,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process&rptName=2&reportSelectMonth=12&reportSelectYear=1990&nav,DB13867
L5965,FDA Fluticasone Furoate Approval 2007,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022051_veramyst_toc.cfm,DB13867
L927,MRHA: Lormetazepam Summary of Product Characteristics,https://drive.google.com/open?id=0B2K5buBGjy5rLTZfTUhIR1RsTms,DB13872
L928,ChemIDPlus: Lormetazepam,https://chem.nlm.nih.gov/chemidplus/rn/848-75-9,DB13872
L1526,DailyMed Trilipix (fenofibric acid) delayed release capsule monogram,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bbf3e782-d163-49c8-0e81-4eeabef48190,DB13873
L12855,"FDA Approved Drug Products: FIBRICOR (fenofibric acid) Tablets, for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022418s010lbl.pdf,DB13873
L940,FDA Press Announcements: FDA approves Mavyret for Hepatitis C,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm570038.htm,DB13878
L940,FDA Press Announcements: FDA approves Mavyret for Hepatitis C,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm570038.htm,DB13879
L942,FDA Press Announcements: FDA approval brings first gene therapy to the United States,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574058.htm,DB13881
L2176,"Dailymed: North American Coral Snake Antivenin (Equine) - coral snake (microbus fulvous) immune globulin antivenin (equine) injection, powder, for solution  Label",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d,DB13883
L2305,Health Canada monograph,https://pdf.hres.ca/dpd_pm/00039026.PDF,DB13884
L2306,EMA Product report,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003955/WC500207380.pdf,DB13884
L2313,PMDA report on the deliberation ,https://www.pmda.go.jp/files/000221483.pdf,DB13884
L2225,Cytomegalovirus Immune Globulin (Intravenous-Human),https://www.drugs.com/cdi/cytomegalovirus-immune-globulin-intravenous-human.html,DB13886
L2227,Cytomegalovirus Immune globulin,http://m.pdr.net/drug-summary/Cytogam-cytomegalovirus-immune-globulin-intravenous--human--836,DB13886
L2228,Roche Document,http://www.rochecanada.com/content/dam/roche_canada/en_CA/documents/package_inserts/CMV%20IgG-04784596190-EN-CAN.pdf,DB13886
L2229,Cytomegalovirus infection in immunosuppressed patients after kidney transplantation,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990428/,DB13886
L2230,"Up to date, cytomegalovirus",https://www.uptodate.com/contents/epidemiology-clinical-manifestations-and-treatment-of-cytomegalovirus-infection-in-immunocompetent-adults,DB13886
L2231,Monograph for Cytogam,https://www.drugs.com/monograph/cytogam.html,DB13886
L2856,Mojave Rattlesnake Envenomation,https://emedicine.medscape.com/article/771586-overview,DB13891
L2857,Crotalidae Polyvalent Immune Fab,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+8114,DB13891
L2858,Crofab.com,https://www.crofab.com,DB13891
L2859,Drugs.com Crotalidae polyvalent immune fab,https://www.drugs.com/monograph/crotalidae-polyvalent-immune-fab-ovine.html,DB13891
L2860,Mayo clinic: Antivenin (crotalidae),https://www.mayoclinic.org/drugs-supplements/antivenin-crotalidae-polyvalent-immune-fab-intravenous-route/description/drg-20061997,DB13891
L2861,Safety and Efficacy of Crotalidae Polyvalent Immune Fab in Pediatric Crotaline Envenomations,https://onlinelibrary.wiley.com/doi/pdf/10.1197/j.aem.2006.10.095,DB13891
L2889,Review of Agkistrodon-Piscivorus,https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/agkistrodon-piscivorus,DB13891
L2864,Delayed antivenom treatment for a patient after envenomation by Crotalus atrox,https://www.sciencedirect.com/science/article/pii/S0196064400701119,DB13892
L2868,CROFAB.COM,https://www.crofab.com/Treatment-With-CroFab/What-is-CroFab,DB13892
L2873,"Epocrates online, Crofab",https://online.epocrates.com/u/1073686/CroFab/Pharmacology,DB13892
L2874,"Drugs.com, Crofab",https://www.drugs.com/monograph/crofab.html,DB13892
L2875,"Crotalidae Antivenin, Drugs.com",https://www.drugs.com/drp/antivenin-crotalidae-polyvalent.html,DB13893
L2874,"Drugs.com, Crofab",https://www.drugs.com/monograph/crofab.html,DB13893
L2877,Eastern Diamondback Rattlesnake (Crotalus adamanteus) - Venomous,https://srelherp.uga.edu/snakes/croada.htm,DB13893
L2880,"PDR, Crofab",http://m.pdr.net/drug-summary/CroFab-crotalidae-polyvalent-immune-fab--ovine--2650,DB13893
L2881,Crotalus adamanteus,https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/crotalus-adamanteus,DB13893
L2883,Uniprot PDE3,http://www.uniprot.org/uniprot/J3SEZ3,DB13893
L2885,Amino Acid Sequence of Phospholipase AZ-a! from the Venom of Crotalus adamanteus,http://www.jbc.org/content/252/14/4913.full.pdf,DB13893
L2889,Review of Agkistrodon-Piscivorus,https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/agkistrodon-piscivorus,DB13893
L2888,Agkistrodon piscivorus &mdash; Details Cottonmouth,http://eol.org/pages/452959/hierarchy_entries/41232140/details,DB13894
L2889,Review of Agkistrodon-Piscivorus,https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/agkistrodon-piscivorus,DB13894
L2890,Crofab website,https://www.crofab.com/Envenomation/Venom-effects,DB13894
L2891,Agkistrodon,https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/agkistrodon,DB13894
L2893,Agkistrodon piscivorus,http://www.iucnredlist.org/details/64298/0,DB13894
L2209,EMA: Imylgic (talimogene laherparepvec) prescribing information,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002771/WC500201079.pdf,DB13896
L2212,Electronic Medicines Compendium: Imlygic (talimogene laherparepvec) monograph,https://www.medicines.org.uk/emc/product/5117,DB13896
L2221,European Medicines Agency: Imlygic (talimogene laherparepvec),http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002771/human_med_001941.jsp&mid=WC0b01ac058001d124,DB13896
L2195,Antidote Relieves Scorpion Stings,https://www.fda.gov/ForConsumers/ConsumerUpdates/ucm266515.htm,DB13905
L2196,Anascorp,https://www.drugs.com/history/anascorp.html,DB13905
L2197,Scorpion antivenin approved,http://www.ajhp.org/content/68/18/1668.1?sso-checked=true,DB13905
L2198,FDA Approves First-Ever Antivenom for Scorpion Stings,https://www.medscape.com/viewarticle/747536,DB13905
L2199,Efficacy and safety of scorpion antivenom plus prazosin compared with prazosin alone for venomous scorpion (Mesobuthus tamulus) sting: randomised open label clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016167/,DB13905
L2200,Management of scorpion envenoming: a systematic review and meta-analysis of controlled clinical trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385045/,DB13905
L2201,Emerging options for the management of scorpion stings,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401053/,DB13905
L2203,Hypersensitivity reaction to scorpion antivenom,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252954/,DB13905
L2204,"Adverse reactions to snake antivenom, and their prevention and treatment",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767202/,DB13905
L2205,Centruroides (Scorpion) Immune F(ab′)2 (Equine),https://www.drugs.com/monograph/centruroides-scorpion-immune-f-ab-8242-2-equine.html,DB13905
L2206,PDR drug reference,http://www.pdr.net/drug-summary/Anascorp-centruroides--scorpion--immune-F-ab--39--2--equine--1483,DB13905
L2207,Utah poison control,https://poisoncontrol.utah.edu/newsletters/pdfs/toxicology-today-archive/Vol14_Iss3.pdf,DB13905
L2569,Amylmetacresol,https://pubchem.ncbi.nlm.nih.gov/compound/Amylmetacresol,DB13908
L2570,"Amylmetacresol, MIMS",https://www.mims.com/malaysia/drug/info/amylmetacresol?mtype=generic,DB13908
L2571,"Bioxer Pharma, Amylmetacresol",http://www.bioxerapharma.com/product-details/amylmetacresol.php,DB13908
L2572,"Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat",https://www.dovepress.com/amylmetacresol24-dichlorobenzyl-alcohol-hexylresorcinol-or-carrageenan-peer-reviewed-article-IJGM,DB13908
L2573,Neo agin,https://www.neoangin.eu/neo-angin.html,DB13908
L2574,A Note on the Toxicity of Amyl-meta-cresol,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048249/?page=5,DB13908
L2575,Review Article: Sprays and lozenges for sore throats,http://safpj.co.za/index.php/safpj/article/viewFile/2632/4120,DB13908
L2309,Devrom Internal Deodorant (200 mg bismuth sabgallate),https://devrom.com,DB13909
L2312,Drugs.com: Bismuth Subgallate Monograph,https://www.drugs.com/ppa/bismuth-subgallate.html,DB13909
L2314,"COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS: BISMUTH SUBNITRATE, BISMUTH SUBCARBONATE, BISMUTH SUBGALLATE,  BISMUTH SUBSALICYLATE",http://www.ema.europa.eu/docs/en_GB/document_library/Maximum_Residue_Limits_-_Report/2009/11/WC500010981.pdf,DB13909
L2316,Pepto-Bismol: Why does Pepto-Bismol sometimes darken the tongue/stool and how long does it last?,https://www.pepto-bismol.com/en-us/faq/black-stool-black-tongue,DB13909
L2330,ScienceDirect: Bismuth subgallate ,https://www.sciencedirect.com/topics/neuroscience/bismuth-subgallate,DB13909
L1662,Shire Pharmaceuticals - Newsroom Announcement,https://www.shire.com/newsroom/2016/july/7zve23,DB13914
L1015,Roche news,https://www.roche.com/dam/jcr:cab28a4e-d5ba-4e19-a4b3-52eaa123147b/en/inv-update-2017-08-24-e.pdf,DB13923
L1016,Bussiness wire ,http://www.businesswire.com/news/home/20171116006052/en/FDA-Approves-Genentech%E2%80%99s-HEMLIBRA-emicizumab-kxwh-Hemophilia-Inhibitors,DB13923
L1017,Roche study,https://www.roche.com/dam/jcr:ac88b7d7-1f5e-4c0d-be31-e293740f9469/en/haven-1-haven-2-presentation.pdf,DB13923
L1018,Genentech professionals information,https://www.gene.com/medical-professionals/medicines/hemlibra,DB13923
L4657,FDA news,https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm622564.htm,DB13923
L4660,FDA news,https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm585650.htm,DB13923
L1036,New phase 3 data on shingles vaccine Shingrix presented at CDC Advisory Meeting.,https://www.ptcommunity.com/news/20170622/new-phase-3-data-shingles-vaccine-shingrix-presented-cdc-advisory-meeting,DB13924
L1037,CDC - Clinical Overview of Shingles (Herpes Zoster),https://www.cdc.gov/shingles/hcp/clinical-overview.html,DB13924
L1038,CDC - What Everyone Should Know about Shingles Vaccine,https://www.cdc.gov/vaccines/vpd/shingles/public/index.html,DB13924
L1048,FDA News and Events,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm504524.htm,DB13925
L4563,Dompe Farmaceutici SpA Cenegermin FDA Approval Press Release,https://www.drugs.com/newdrugs/fda-approves-oxervate-cenegermin-neurotrophic-keratitis-4807.html,DB13926
L1067,FDA Reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM580461.pdf,DB13928
L1068,Novo Nordisk News,https://www.novonordisk.com/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2154210.html,DB13928
L1069,FDA Reports,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM580460.pdf,DB13928
L8678,Rybelsus tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213051s000lbl.pdf,DB13928
L8681,Ozempic injection FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209637s001lbl.pdf,DB13928
L8690,Semaglutide MSDS,https://www.novonordiskmedical.com/content/dam/medical/novonordiskmedical/safety-data-sheets/Ozempic%C2%AE%20SDS%20August%202018.pdf,DB13928
L8693,"Ozempic, Medicines UK document",https://www.medicines.org.uk/emc/product/9728/smpc,DB13928
L12846,DailyMed: Rybelsus (semaglutide) oral tablet,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98,DB13928
L1093,FDA Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Briefing Document on Rhopressa (netarsudil ophthalmic solution) 0.02%,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DermatologicandOphthalmicDrugsAdvisoryCommittee/UCM579731.pdf,DB13931
L1094,"FDA Vaccines, Blood and Biologics",https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm589507.htm,DB13932
L1095,FDA News and Events,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm589467.htm,DB13932
L1098,Globe Newswire,https://globenewswire.com/news-release/2017/05/31/1004785/0/en/Novo-Nordisk-receives-US-FDA-approval-of-REBINYN-nonacog-beta-pegol-N9-GP.html,DB13933
L1099,Novo Nordisk News,https://www.novonordisk.com/bin/getPDF.2110891.pdf,DB13933
L1100,FDA Advisory committees,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM549858.pdf,DB13933
L1101,FDA Advisory committees,https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommittee/UCM549857.pdf,DB13933
L1103,EMA Reports,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/004178/WC500232819.pdf,DB13933
L1149,EMA: Eurartesim Assessment Report,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001199/WC500118116.pdf,DB13941
L1151,Dailymed,https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=3996,DB13943
L1152,Steroidal,https://www.steroidal.com/steroid-profiles/testosterone-cypionate/,DB13943
L1153,Pfizer monograph,https://www.pfizer.ca/sites/g/files/g10028126/f/201601/DepoTestosterone_PM_189981_15Jan2016_E.pdf,DB13943
L1155,Pfizer monograph,http://www.bayerresources.com.au/resources/uploads/pi/file9425.pdf,DB13943
L1158,Steroidal,https://www.steroidal.com/steroid-profiles/testosterone-enanthate/,DB13944
L1152,Steroidal,https://www.steroidal.com/steroid-profiles/testosterone-cypionate/,DB13944
L1153,Pfizer monograph,https://www.pfizer.ca/sites/g/files/g10028126/f/201601/DepoTestosterone_PM_189981_15Jan2016_E.pdf,DB13944
L1155,Pfizer monograph,http://www.bayerresources.com.au/resources/uploads/pi/file9425.pdf,DB13944
L4659,Drugs.com: FDA Approves Xyosted (testosterone enanthate) Press Release,https://www.drugs.com/newdrugs/fda-approves-xyosted-testosterone-enanthate-testosterone-replacement-therapy-adult-males-4834.html,DB13944
L8941,FDA Approved Drug Products: Delatestryl Testosterone Enanthate Injection (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009165,DB13944
L1164,Steroidal,https://www.steroidal.com/steroid-profiles/andriol/,DB13946
L1152,Steroidal,https://www.steroidal.com/steroid-profiles/testosterone-cypionate/,DB13946
L1165,FDA pharmacology reviews,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/022219Orig1s000PharmR.pdf,DB13946
L1155,Pfizer monograph,http://www.bayerresources.com.au/resources/uploads/pi/file9425.pdf,DB13946
L1148,Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice,https://www.frontiersin.org/articles/10.3389/fphar.2018.00017/abstract,DB13948
L2257,Iron,http://lpi.oregonstate.edu/mic/minerals/iron,DB13949
L2258,InChem: Iron,http://www.inchem.org/documents/jecfa/jecmono/v18je18.htm,DB13949
L2894,Fat Absorption and Lipid Metabolism in Cholestasis,https://www.ncbi.nlm.nih.gov/books/NBK6420/,DB13959
L2895,ScienceDirect: Medium Chain Triglycerides Profile,https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/medium-chain-triglyceride,DB13959
L784,National Institutes of Health (NIH) Office of Dietary Supplements: Omega-3 Fatty Acids Fact Sheet for Health Professionals,https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/,DB13959
L2578,BRONOPOL - National Library of Medicine HSDB Database,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7195,DB13960
L4873,Health Canada Cosmetic Ingredient Hotlist of Prohibited and/or Restricted Ingredients,https://www.canada.ca/en/health-canada/services/consumer-product-safety/cosmetics/cosmetic-ingredient-hotlist-prohibited-restricted-ingredients/hotlist.html#b1,DB13960
L4874,Health Canada Drug and Health Products Chemical Substance: Bronopol Profile,http://webprod.hc-sc.gc.ca/nhpid-bdipsn/ingredReq.do?id=846&lang=eng,DB13960
L784,National Institutes of Health (NIH) Office of Dietary Supplements: Omega-3 Fatty Acids Fact Sheet for Health Professionals,https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/,DB13961
L2661,Electronic Medicines Compendium: Omacor (omega-3-acid ethyl esters 90) Monograph,https://www.medicines.org.uk/emc/product/1706/smpc,DB13961
L2662,NIH National Centre for Complementary and Integrative Health: Omega-3 Supplements - In Depth,https://nccih.nih.gov/health/omega3/introduction.htm#hed6,DB13961
L2242,FDA Inactive ingredient search,https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browsebyletter.page&letter=p,DB13964
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13964
L2892,Oilatum,https://www.amazon.com/Oilatum-Cleansing-Bar-Unscented-3-5-Ounce/dp/B002QV6P7S,DB13964
L2896,OLEIC ACID - National Library of Medicine HSDB Database - Toxnet,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1240,DB13964
L2897,Natural Medicines,http://naturaldatabase.therapeuticresearch.com/nd/PrintVersion.aspx?id=483,DB13964
L1963,Cosmetic Ingredient Review: Amended Safety Assessment of Alkyl Esters as Used in Cosmetics,https://www.cir-safety.org/sites/default/files/alkyle122012tent_faa_final%20for%20posting.pdf,DB13966
L1964,Canadian Paediatric Society: Head Lice Infestations - A clinical update,https://www.cps.ca/en/documents/position/head-lice,DB13966
L1966,Resultz: Why Resultz is the Best Choice For Your Patients,https://resultz.ca/why-resultz-is-the-best-choice-for-your-patients/,DB13966
L1969,ECHA Registration Dossier: Isopropyl Myristate,https://echa.europa.eu/registration-dossier/-/registered-dossier/16077/7/2/3,DB13966
L1973,NIH Toxnet: Isopropyl Myristate,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+626,DB13966
L1978,Journal of the American College of Toxicology: Final Report on the Safety Assessment of Myristyl Myristate and Isopropyl Myristate,http://www.beauty-review.nl/wp-content/uploads/2014/05/Final-report-on-the-safety-assessment-of-myristyl-myristate-and-isopropyl-myristate.pdf,DB13966
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB13967
L2318,Canadian Cancer Society,http://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/tests-and-procedures/sentinel-lymph-node-biopsy-slnb/?region=on,DB13967
L2326,Patent blue V monograph,http://www.pharmaline.co.il/images/newsletterregistration/neopharm/promedico/16112012/patentbluedr.pdf,DB13967
L2331,European Food Safety Authority,https://efsa.onlinelibrary.wiley.com/doi/pdf/10.2903/j.efsa.2013.2818,DB13967
L2260,FDA code of federal regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=640&showFR=1&subpartNode=21:7.0.1.1.7.9,DB13968
L2261,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=679bbaf2-b082-5948-8400-ece5340eabc1,DB13968
L2262,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=998415d8-9bbe-e5b8-c3b0-3ba0344faacb,DB13968
L2264,Octapharma,http://www.octapharma.co.uk/fileadmin/user_upload/Octapharma_UK_New/OPL1402E.pdf,DB13968
L2266,Octapharma monograph,http://www.octapharma.ca/fileadmin/user_upload/octapharma.ca/20120502_PM_950_Octaplasma.pdf,DB13968
L11022,Health Canada Product Monograph: Remestemcel-L adult mesenchymal stem cells,https://pdf.hres.ca/dpd_pm/00024994.PDF,DB13973
L2301,Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029542/,DB13975
L2302,Black Cohosh: Insights into its Mechanism(s) of Action,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046019/,DB13975
L2303,Black Cohosh,https://ods.od.nih.gov/factsheets/BlackCohosh-HealthProfessional/,DB13975
L2304,"Treatment of Vasomotor Symptoms of Menopause with Black Cohosh, Multibotanicals, Soy, Hormone Therapy, or Placebo",https://pdfs.semanticscholar.org/6d21/97a9078c86882f35caf132eacd893849077b.pdf,DB13975
L2307,Black Cohosh,https://www.aafp.org/afp/2003/0701/p114.html,DB13975
L2308,Triterpene Biosynthesis in Plants,https://www.annualreviews.org/doi/abs/10.1146/annurev-arplant-050312-120229,DB13975
L2310,Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1142198/,DB13975
L2311,Cytochrome P450 enzyme mediated herbal drug interactions (Part 2),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464477/,DB13975
L1564,European Medicines Agency: Scintimun (besilesomab) Product Information,http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001045/human_med_001232.jsp&mid=WC0b01ac058001d124,DB13979
L1623,EMA Assessment Report For Scintimun (International Nonproprietary Name: besilesomab),http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/001045/WC500075575.pdf,DB13979
L1711,Making bone inflammation/infection simpler to detect: Scintimun 1mg Monograph,http://www.isotopia.co.il/wp-content/uploads/2013/06/Scintimun_monograph_GB_march-2011.pdf,DB13979
L1712,"Granulocyte-binding antibody constructs, their preparation and use: US Grant US5645817A (Monoclonal antibody amino acid sequence)",https://patents.google.com/patent/US5645817A/en,DB13979
L1191,FDA Press Announcements: FDA approves new treatment for certain digestive tract cancers,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm594043.htm,DB13985
L2882,Natural Medicines Comprehensive Database: Strontium Monograph,http://naturaldatabase.therapeuticresearch.com/nd/PrintVersion.aspx?id=1077,DB13987
L2884,Colgate: How Long Should You Brush Your Teeth For?,https://www.colgate.com/en-us/oral-health/basics/brushing-and-flossing/how-long-should-you-brush-your-teeth-for-0113,DB13987
L2886,Pennsylvania Department of Health: Strontium,http://www.health.pa.gov/My%20Health/Environmental%20Health/Environmental%20Fact%20Sheets/Pages/Strontium.aspx#.Wwh-ULYZPOQ,DB13987
L2887,PubChem: Strontium Chloride,https://pubchem.ncbi.nlm.nih.gov/compound/strontium_chloride#section=Metabolism-Metabolites,DB13987
L2936,AstraZeneca: AZD7325 Profile,https://openinnovation.astrazeneca.com/azd7325.html,DB13994
L1420,KEGG,http://www.genome.jp/dbget-bin/www_bget?D04946,DB13995
L1419,Nippon,https://www.nippon.com/en/currents/d00106/,DB13995
L1423,FDA Reports,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206317orig1s000medr.pdf,DB13995
L1473,NME submissions and their additional indications Projects currently in phase II and III  ,https://www.roche.com/dam/jcr:77aa35dc-feef-427b-b9e3-befd9e735d2e/en/irp180201-annex.pdf,DB13997
L1475,"Cap-dependent Endonuclease Inhibitor S-033188 for the Treatment of Influenza: Results from a Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study in Otherwise Healthy Adolescents and Adults with Seasonal Influenza",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631501/,DB13997
L1477,Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor,http://www.pnas.org/content/113/13/3669,DB13997
L1478,A novel small-molecule inhibitor of influenza A virus acts by suppressing PA endonuclease activity of the viral polymerase,https://www.nature.com/articles/srep22880,DB13997
L1479,Pharmacokinetics/pharmacodynamics of S-033188,https://www.escmid.org/escmid_publications/escmid_elibrary/material/?mid=52614,DB13997
L1480,"Synergistic Antiviral Activity of S-033188/S-033447, a Novel Inhibitor of Influenza Virus Cap-Dependent Endonuclease, in Combination with Neuraminidase Inhibitors In Vitro",https://academic.oup.com/ofid/article/4/suppl_1/S371/4294857,DB13997
L4779,FDA Approves New Drug to Treat Influenza,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624226.htm,DB13997
L2177,Have we forgotten the lessons of the tainted blood scandal? - The Globe and Mail,https://www.theglobeandmail.com/opinion/have-we-forgotten-the-lessons-of-the-tainted-blood-scandal/article37097051/,DB13999
L85,Link,http://lpi.oregonstate.edu/infocenter/vitamins/vitaminE/,DB14001
L2699,Natural Medicine Journal: Alpha Tocopherol Succinate in Cancer Care,https://www.naturalmedicinejournal.com/journal/2011-06/alpha-tocopheryl-succinate-cancer-care,DB14001
L2120,National Institute for Health ,https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/#h5,DB14001
L2250,Cosmetic Ingredient Review: Safety Assessment of Tocopherols and Tocotrienols as Used in Cosmetics,http://www.cir-safety.org/sites/default/files/tocopherols.pdf,DB14001
L2268,Journal of Clinical & Experimental Cardiology: Pharmacokinetics and Bioavailability of Annatto δ-tocotrienol in Healthy Fed Subjects,https://www.omicsonline.org/open-access/pharmacokinetics-and-bioavailability-of-annatto-tocotrienol-in-healthy-fed-subjects-2155-9880-1000411.php?aid=64658,DB14001
L85,Link,http://lpi.oregonstate.edu/infocenter/vitamins/vitaminE/,DB14002
L2120,National Institute for Health ,https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/#h5,DB14002
L2250,Cosmetic Ingredient Review: Safety Assessment of Tocopherols and Tocotrienols as Used in Cosmetics,http://www.cir-safety.org/sites/default/files/tocopherols.pdf,DB14002
L2268,Journal of Clinical & Experimental Cardiology: Pharmacokinetics and Bioavailability of Annatto δ-tocotrienol in Healthy Fed Subjects,https://www.omicsonline.org/open-access/pharmacokinetics-and-bioavailability-of-annatto-tocotrienol-in-healthy-fed-subjects-2155-9880-1000411.php?aid=64658,DB14002
L2120,National Institute for Health ,https://ods.od.nih.gov/factsheets/VitaminE-HealthProfessional/#h5,DB14003
L2250,Cosmetic Ingredient Review: Safety Assessment of Tocopherols and Tocotrienols as Used in Cosmetics,http://www.cir-safety.org/sites/default/files/tocopherols.pdf,DB14003
L2268,Journal of Clinical & Experimental Cardiology: Pharmacokinetics and Bioavailability of Annatto δ-tocotrienol in Healthy Fed Subjects,https://www.omicsonline.org/open-access/pharmacokinetics-and-bioavailability-of-annatto-tocotrienol-in-healthy-fed-subjects-2155-9880-1000411.php?aid=64658,DB14003
L1858,FDA Approves ILUMYA (tildrakizumab-asmn) for the Treatment of Adults with Moderate-To-Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy or Phototherapy,http://s2027422842.t.en25.com/e/es?s=2027422842&e=66767&elqTrackId=78D8A052C380BCBFF284D754BEBE9730&elq=096ab38d576c4c76b4f65be4cded361f&elqaid=2935&elqat=1,DB14004
L1859,Ilumya,https://www.psoriasis.org/content/ilumya-tildrakizumab-asmn,DB14004
L1861,The safety and side effects of monoclonal antibodies,http://theory.bio.uu.nl/immbio/pdf/TherapeuticReview2010.pdf,DB14004
L1864,"The effect of tildrakizumab, a high-affinity, selective anti-IL23p19 monoclonal antibody (mAb), on cytochrome P450 (CYP) metabolism",http://www.jaad.org/article/S0190-9622(17)31465-2/fulltext,DB14004
L1868,Tildrakizumab for treating psoriasis,https://www.tandfonline.com/doi/abs/10.1080/14712598.2017.1304537?scroll=top&needAccess=true&journalCode=iebt20,DB14004
L1869,Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value ,https://icer-review.org/wp-content/uploads/2017/11/ICER_Draft_Psoriasis_CU_Scope_120417.pdf,DB14004
L11731,FDA approved products: Tildrakizumab injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761067s000lbl.pdf,DB14004
L2162,FDA Code of Federal Regulations,https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=347.10&SearchTerm=dimethicone,DB14005
L2163,FDA Reports,https://www.fda.gov/downloads/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/abbreviatednewdrugapplicationandagenerics/ucm291010.pdf,DB14005
L2166,Dow corning monograph,http://www.healthcare-plus.com.tw/big5/pdf/05-01.pdf,DB14005
L2170,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d91c8fa1-9036-4c80-9b15-65100a3a7be3,DB14005
L2171,Dailymed,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=ae82d2b7-eb86-4bbe-825c-f7d7cd7610ad&type=display,DB14005
L1769,"Public Assessment Report, Dimethicone",http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2023415.pdf,DB14005
L2180,"Public Assesment report, Silicone",http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con2033274.pdf,DB14005
L2125,Choline Salicylate,https://pubchem.ncbi.nlm.nih.gov/compound/Arthropan#section=Top,DB14006
L2126,Topical choline salicylates implicated in Reye’s syndrome,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427076/,DB14006
L2127,Characterization of new eye drops with choline salicylate and assessment of their irritancy by in vitro short time exposure tests.,https://www.ncbi.nlm.nih.gov/pubmed/27134543,DB14006
L2128,Choline Salicylate,https://www.drugs.com/international/choline-salicylate.html,DB14006
L2129,Choline Salicylate; Magnesium Salicylate oral tablet,https://www.pillpack.com/medication/choline-salicylate-magnesium-salicylate-oral-tablet,DB14006
L2130,"Salicylates, Mayo Clinic",https://www.mayoclinic.org/drugs-supplements/salicylate-oral-route-rectal-route/precautions/drg-20070551,DB14006
L2131,"Choline Salicylate drug info, UC Irvine",http://www.ucirvinehealth.org/health-library/content?contentTypeID=121&contentID=104,DB14006
L2132,Choline Salicylate,http://www.mims.com/malaysia/drug/info/choline%20salicylate?mtype=generic,DB14006
L2133,Choline Salicylate,http://www.drugsupdate.com/generic/view/880/Choline-Salicylate,DB14006
L2134,Oral salicylate gels: not for use in those younger than age 16 years,https://www.gov.uk/drug-safety-update/oral-salicylate-gels-not-for-use-in-those-younger-than-age-16-years,DB14006
L2135,Bonjela oral mucosal gel,http://www.medicines.ie/medicine/580/SPC/Bonjela+Oromucosal+Gel/,DB14006
L2136,"Drug Monograph, Choline Salicylate",http://www.druginfosys.com/drug.aspx?drugcode=853&type=1,DB14006
L2137,Bonjela: treatment for mouth ulcers,http://www.netdoctor.co.uk/medicines/mouth-and-teeth/a7835/bonjela/,DB14006
L2138,"Efficacy, Disposition and Pharmacodynamics of Aspirin, Acetaminophen and Choline Salicylate in Young Febrile Children","https://journals.lww.com/drug-monitoring/Abstract/1982/06000/Efficacy,_Disposition_and_Pharmacodynamics_of.3.aspx",DB14006
L2139,Bonjela,https://www.medicines.org.uk/emc/product/624,DB14006
L2142,Choline and magnesium salicylates,https://davisplus.fadavis.com/3976/meddeck/pdf/cholinemagnesiumsalicylates.pdf,DB14006
L2143,Salicyluric acid,https://www.sciencedirect.com/topics/neuroscience/salicyluric-acid,DB14006
L2242,FDA Inactive ingredient search,https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browsebyletter.page&letter=p,DB14007
L2243,FDA guidelines,https://www.fda.gov/downloads/Drugs/.../Guidances/ucm071320.pdf,DB14007
L1469,FDA orphan list,https://www.fda.gov/downloads/forindustry/developingproductsforrarediseasesconditions/howtoapplyfororphanproductdesignation/ucm162066.xls,DB14007
L2346,"FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia",https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm604810.htm,DB14012
L2347,Crysvita Drug Label,http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/004275/WC500245537.pdf,DB14012
L2348,Burosumab for a rare bone disease,http://www.who.int/medicines/publications/druginformation/issues/WHO_DI_32-1.pdf,DB14012
L2349,DRUG: Burosumab,http://www.genome.jp/dbget-bin/www_bget?dr:D10913,DB14012
L2350,NHS document,https://www.sps.nhs.uk/medicines/burosumab/,DB14012
L2351,Burosumab for XLH,http://www.ultragenyx.com/pipeline/krn23-xlh/,DB14012
L2551,H3 Biomedicine Granted Orphan Drug Designation of H3B-8800 for Treatment of Acute Myelogenous Leukemia and Chronic Myelomonocytic Leukemia,https://www.h3biomedicine.com/2017/08/14/h3-biomedicine-granted-orphan-drug-designation-of-h3b-8800-for-treatment-of-acute-myelogenous-leukemia-and-chronic-myelomonocytic-leukemia/,DB14017
L1082,FDA Submission,https://www.fda.gov/downloads/drugs/developmentapprovalprocess/formssubmissionrequirements/drugmasterfilesdmfs/ucm370723.txt,DB14018
L1113,Health Canada,https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do,DB14018
L2737,FDA history,https://www.fda.gov/downloads/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm207938.xls,DB14018
L2738,Dailymed,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=37dfece3-d570-4ab2-ba95-af6eb1f3acd4,DB14018
L2742,CNKI,http://en.cnki.com.cn/Article_en/CJFDTotal-ZGYZ201004009.htm,DB14018
L2743,Annexpublishers,http://www.annexpublishers.co/articles/JBS/3101-Bioanalytical-Method-for-Pamabrom-Determined-As-8-Bromotheophylline-and-its-Application-to-a-Pharmacokinetic-Study.pdf,DB14018
L2631,Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States,https://www.helsinn.com/news-and-events/helsinn-group-announces-the-fda-approval-of-the-iv-formulation-of-akynzeo-fosnetupitant-palonosetron-in-the-united-states/,DB14019
L2634,"Safety Data Sheet, Netupitant",http://www.dcchemicals.com/product_show-Netupitant.html,DB14019
L2635,Akynzeo.com,https://www.akynzeo.com/hcp/moa,DB14019
L2636,"Antiemetic, Neurokinin-1 Receptor Blockers",https://www.ncbi.nlm.nih.gov/books/NBK470394/,DB14019
L2638,"Netupitant, PubChem",https://pubchem.ncbi.nlm.nih.gov/compound/Netupitant#section=Top,DB14019
L2788,Acetyl Sulfisoxazole,https://pubchem.ncbi.nlm.nih.gov/compound/Sulfisoxazole_acetyl,DB14033
L2790,ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb6ea746-3228-4969-8a26-653288662fd7,DB14033
L2792,Sulfisoxazole,http://www.druginfosys.com/drug.aspx?drugcode=1506&type=1,DB14033
L2793,Sulfadiazine or Sulfisoxazole,http://apps.who.int/medicinedocs/en/d/Js2252e/6.4.html,DB14033
L2798,Sulfisoxazole,http://www.nextbio.com/b/search/details/Sulfisoxazole?type=compound,DB14033
L2800,Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing,https://www.researchgate.net/publication/16079120_Comparison_of_the_disposition_of_total_and_unbound_sulfisoxazole_after_single_and_multiple_dosing,DB14033
L2803,Gantrisin,http://www.druglib.com/druginfo/gantrisin/indications_dosage/,DB14033
L2804,Gantrisin Description,https://www.drugs.com/pro/gantrisin.html,DB14033
L2806,"Sulfisoxazole, ToxNET",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+797,DB14033
L2807,Sulfisoxazole,https://drugs.ncats.io/ginas/app/substance/7c27a988,DB14033
L2823,"Press Release: Novartis and Amgen announce FDA approval of Aimovig(TM) (erenumab), a novel treatment developed specifically for migraine prevention",https://www.novartis.com/news/media-releases/novartis-and-amgen-announce-fda-approval-aimovigtm-erenumab-novel-treatment-developed-specifically-migraine-prevention,DB14039
L11764,"FDA Approved Drug Products: AIMOVIG (erenumab-aooe) injection, for subcutaneous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761077s001lbl.pdf,DB14039
L2825,EconoTimes Business Article: Alder BioPharmaceuticals® New Data Demonstrated Eptinezumab Increased Migraine-Free Intervals (Up to 32.5 days) and Improved Quality-of-Life Outcomes in Patients with Episodic Migraine,https://www.econotimes.com/Alder-BioPharmaceuticals-New-Data-Demonstrated-Eptinezumab-Increased-Migraine-Free-Intervals-Up-to-325-days-and-Improved-Quality-of-Life-Outcomes-in-Patients-with-Episodic-Migraine-1273647,DB14040
L12318,FDA Approved Drug Products: Vyepti (eptinezumab-jjmr) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761119s000lbl.pdf,DB14040
L2843,JAMA Network: Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine,https://jamanetwork.com/journals/jama/article-abstract/2681193?redirect=true,DB14041
L11749,FDA Approved Drug Products: Ajovy (fremanezumab-vfrm) subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761089s002lbl.pdf,DB14041
L11779,FDA Drug Approval Package: Ajovy (fremanezumab-vfrm),https://www.accessdata.fda.gov/drugsatfda_docs/nda/2018/761089Orig1s000TOC.cfm,DB14041
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB14042
L2930,AstraZeneca: ZS-9 (sodium zirconium cyclosilicate) Phase III long-term safety and efficacy data presented at ASN Kidney Week 2017,https://www.astrazeneca.com/media-centre/medical-releases/zs-9-sodium-zirconium-cyclosilicate-phase-iii-long-term-safety-and-efficacy-data-presented-at-asn-kidney-week-201702112017.html,DB14048
L2933,AstraZeneca: Lokelma approved in the US for the treatment of adults with hyperkalaemia,https://www.astrazeneca.com/media-centre/press-releases/2018/lokelma-approved-in-the-us-for-the-treatment-of-adults-with-hyperkalaemia-21052018.html,DB14048
L12822,FDA Approved Drug Products: Lokelma (sodium zirconium cyclosilicate) for oral suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/207078s000lbl.pdf,DB14048
L2949,GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006,https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-announces-preliminary-results-phase-2a-study-its-pipeline-compound,DB14050
L2950,GW Pharmaceuticals Commences Phase 1 Clinical Trial of GWP42006 as a Potential Treatment for Epilepsy,https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-commences-phase-1-clinical-trial-gwp42006-potential-treatment,DB14050
L2951,Public summary of opinion on orphan designation: Cannabidivarin for treatment of fragile X syndrome,http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2018/04/WC500247223.pdf,DB14050
L2952,Public summary of opinion on orphan designation: Cannabidivarin for the treatment of Rett syndrome,http://www.ema.europa.eu/docs/en_GB/document_library/Orphan_designation/2018/01/WC500241010.pdf,DB14050
L2959,Basifungin,https://adisinsight.springer.com/drugs/800004447,DB14058
L2960,AUR1- Uniprot,http://www.uniprot.org/uniprot/O13332,DB14058
L2962,Comparative Protection against Liver Inflammation and Fibrosis by a Selective Cyclooxygenase-2 Inhibitor and a Nonredox-Type 5-Lipoxygenase Inhibitor,http://jpet.aspetjournals.org/content/323/3/778,DB14059
L2964,SC-236,https://www.caymanchem.com/product/10004219,DB14059
L2965,Enhancement of Tumor Response to -Radiation by an Inhibitor of Cyclooxygenase-2 Enzyme,https://www.researchgate.net/publication/31132809_Enhancement_of_Tumor_Response_to_-Radiation_by_an_Inhibitor_of_Cyclooxygenase-2_Enzyme,DB14059
L2966,Overview of selective COX-2 inhibitors,https://www.uptodate.com/contents/overview-of-selective-cox-2-inhibitors,DB14059
L4595,"Gervais, J. A.; Wegner, P.; Luukinen, B.; Buhl, K.; Stone, D. 2009. Picaridin Technical Fact Sheet; National Pesticide Information Center, Oregon State University Extension Services.",http://npic.orst.edu/factsheets/archive/Picaridintech.html,DB14074
L4617,DailyMed - SG PLUS REPELLENT AROMA MIST- icaridin liquid,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=495548e6-1734-44eb-8d40-23283d7377d2,DB14074
L6103,PICARIDIN - National Library of Medicine HSDB Database - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+7374,DB14074
L13026,DailyMed: Kit for the Preparation of Technetium Tc 99m Medronate for Injection,https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=703d347c-e240-408a-b69d-9713e958a201&type=display,DB14078
L13035,FDA Approved Products: DRAXIMAGE® MDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate Injection),https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018035s032lbl.pdf,DB14078
L12954,DailyMed Label: KIT FOR THE PREPARATION OF TECHNETIUM TC99M MERTIATIDE,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ad62039-f848-4f3d-b489-2524e6b6b86e,DB14082
L12744,FDA Approved Drug Products: Cardiolite (Kit for the Preparation of Technetium Tc99m Sestamibi) for injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/019785s022lbl.pdf,DB14106
L12792,DailyMed: Antivenin (latrodectus mactans) kit,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=600e54ad-af13-462f-8a2d-2c3f7d91a8cd,DB14113
L6241,Pubmed books,https://www.ncbi.nlm.nih.gov/books/NBK533928/,DB14126
L6277,"FDA Approved Drug Products: Bictegravir, Emtricitabine, and Tenofovir Alafenamide Oral Tablets",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210251s000lbl.pdf,DB14126
L6346,"FDA Approved Drug Products: VIREAD (tenofovir disoproxil fumarate), for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022577lbl.pdf,DB14126
L3263,Nektar Therapeutics: Loxicodegol FDA Application Press Release,http://ir.nektar.com/news-releases/news-release-details/nektar-therapeutics-announces-submission-new-drug-application-us,DB14146
L12960,"FDA Approved Drug Products: Technescan HDP (Kit for the Preparation of Technetium Tc 99m Oxidronate), for intravenous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018321s022lbl.pdf,DB14159
L3333,"Geraniol — A review of a commercially important fragrance material; Chen and Viljoen, 2010.",https://www.sciencedirect.com/science/article/pii/S0254629910001559,DB14183
L12816,DailyMed: Draximage (technetium tc99m albumin aggregated injection) contrast kit,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bbefaa05-1dc0-3ae7-7264-ce1eddf0da2b,DB14230
L12801,"FDA Approved Drug Products: Vaxchora (cholera vaccine, live, oral) oral suspension",https://www.fda.gov/media/128415/download,DB14443
L11752,FDA Approved Drug Products: Alphanate (antihemophilic factor/von Willebrand factor complex) powder for intravenous injection,https://www.fda.gov/media/71753/download,DB14473
L851,HSDB: Calcium Phosphate,http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@DOCNO+879,DB14481
L2092,Zinc and its importance for human health: An integrative review,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724376/,DB14487
L2093,The Essential Toxin: Impact of Zinc on Human Health,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872358/,DB14487
L2094,Dietary factors affecting Zinc bioavailability,http://journals.sagepub.com/doi/pdf/10.1177/156482650102200204,DB14487
L2095,Zinc,https://www.mayoclinic.org/drugs-supplements-zinc/art-20366112,DB14487
L2096,"Zinc Transporters, Mechanisms of Action and Therapeutic Utility: Implications for Type 2 Diabetes Mellitus",https://www.hindawi.com/journals/jnme/2012/173712/,DB14487
L2097,"Zinc, future mono/adjunctive therapy for depression: Mechanisms of antidepressant action",https://www.sciencedirect.com/science/article/abs/pii/S1734114015000274,DB14487
L2098,MeSH Zinc,https://www.ncbi.nlm.nih.gov/mesh?Db=mesh&Cmd=DetailsSearch&Term=%22Zinc%22%5BMeSH+Terms%5D,DB14487
L2099,Agency for Toxic Substances and Disease Registry: Toxicological Profile for Zinc,https://www.atsdr.cdc.gov/toxprofiles/tp60-c3.pdf,DB14487
L1887,ZINC COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6912,DB14487
L2100,"Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394467/,DB14487
L2101,Net renal tubular reabsorption of zinc in healthy man and impaired handling in sickle cell anemia,https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.2830310203,DB14487
L2102,Zinc Therapy in Dermatology: A review ,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120804/,DB14487
L2103,Treatment of Wilson’s Disease with Zinc. I. Oral Zinc Therapy Regimens,https://pdfs.semanticscholar.org/896f/03dae9396d9463c552aff6e9ab78dcd44f06.pdf,DB14487
L2104,Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394849/,DB14487
L2106,Zinc Supplementation in treating diarrhea in children,http://www.cochrane.org/CD005436/INFECTN_oral-zinc-supplementation-treating-diarrhoea-children,DB14487
L2107,Zinc homeostasis in humans,https://academic.oup.com/jn/article/130/5/1360S/4686372,DB14487
L2172,"ZINC: Uses, Side Effects, Interactions and Warnings - WebMD",https://www.webmd.com/vitamins.../ingredientmono-982-zinc.aspx?...982...zinc,DB14487
L2091,Zinc Toxicity in Humans,https://pdfs.semanticscholar.org/a9e2/8321ae506e646f32ce59d87b7589851aa7e4.pdf,DB14487
L2208,Chapter 16. Zinc,http://www.fao.org/docrep/004/y2809e/y2809e0m.htm,DB14487
L2210,Zinc metabolism,http://flipper.diff.org/app/pathways/3503,DB14487
L2211,"Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance",https://www.omicsonline.org/copper-and-zinc-biological-role-and-significance-of-copper-zincimbalance-2161-0495.S3-001.php?aid=3055,DB14487
L2213,The emerging role of zinc transporters,https://www.nature.com/articles/sigtrans201729,DB14487
L2652,NIH Potassium Fact Sheet for Health Professionals,https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/,DB14500
L8744,Potassium chloride FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206814lbl.pdf,DB14500
L8747,Potassium chloride in dextrose and sodium chloride FDA label,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/18008s073,18037s073,18629s046,19308s030lbl.pdf",DB14500
L8753,Potassium citrate PDR,https://www.pdr.net/drug-summary/Urocit-K-potassium-citrate-414.583,DB14500
L8759,Potassium acetate drug summary,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8123cce8-42e3-49e4-a488-3bb836ecccd0,DB14500
L8768,"Highly concentrated potassium preparation, FDA label",https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019904s014lbl.pdf,DB14500
L8771,K-tab extended release FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018279s034lbl.pdf,DB14500
L798,FDA Guide: Sodium Phosphate Tablet,https://www.fda.gov/downloads/drugs/drugsafety/ucm134684.pdf,DB14502
L799,ChemIDPlus: Sodium Phosphate,https://chem.nlm.nih.gov/chemidplus/rn/7558-80-7,DB14502
L798,FDA Guide: Sodium Phosphate Tablet,https://www.fda.gov/downloads/drugs/drugsafety/ucm134684.pdf,DB14503
L799,ChemIDPlus: Sodium Phosphate,https://chem.nlm.nih.gov/chemidplus/rn/7558-80-7,DB14503
L2140,BORIC ACID - National Library of Medicine HSDB Database- Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+1432,DB14505
L2141,Boric Acid - National Toxicology Program - NIH,https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr324.pdf,DB14505
L14450,Fisher Scientific: Sodium Borate MSDS,https://beta-static.fishersci.ca/content/dam/fishersci/en_US/documents/programs/education/regulatory-documents/sds/chemicals/chemicals-s/S25537.pdf,DB14505
L894,ILO: Lithium,http://www.ilo.org/dyn/icsc/showcard.display?p_card_id=0710,DB14507
L894,ILO: Lithium,http://www.ilo.org/dyn/icsc/showcard.display?p_card_id=0710,DB14509
L5843,"Bipolar Disorders and Lithium: Pharmacokinetics, Pharmacodynamics, Therapeutic Effects and Indications of Lithium: Review of Articles",http://austinpublishinggroup.com/psychiatry-behavioral-sciences/fulltext/ajpbs-v3-id1053.php,DB14509
L5858,New Zealand Drug Data Sheet: Lithium Carbonate,https://medsafe.govt.nz/Profs/datasheet/l/Lithiumcarbonatecap.pdf,DB14509
L9560,FDA Approved Drug Products: Asmanex Mometasone Furoate Inhalation Powder,"https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021067s026,s028lbl.pdf",DB14512
L9563,FDA Approved Drug Products: Nasonex Mometasone Furoate Nasal Spray,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020762s053lbl.pdf,DB14512
L9566,FDA Approved Drug Products: Elocon Mometasone Furoate Lotion,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019796s029lbl.pdf,DB14512
L9569,FDA Approved Drug Products: Sinuva Mometasone Furoate Sinus Implant,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209310s001lbl.pdf,DB14512
L9590,FDA Approved Drug Products: Elocon Mometasone Furoate Ointment,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019543s028lbl.pdf,DB14512
L10349,Citroma Magnesium Citrate DailyMed label,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a58a14bf-3e49-4216-a8c8-cee53a620c80,DB14513
L10355,"Magnesium Sulfate Injection, USP 50%",https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019316s024lbl.pdf,DB14513
L2601,"NIH document, Magnesium",https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/,DB14513
L9926,FDA Approved Drug Products: Auryxia (ferric citrate) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205874s013lbl.pdf,DB14520
L14291,Spectrum Chemical: Ferric Citrate MSDS,https://www.spectrumchemical.com/MSDS/F3120.pdf,DB14520
L1981,"CHROMIUM, ELEMENTAL - National Library of Medicine HSDB ... - Toxnet - NIH",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+910,DB14526
L1982,CHROMIUM COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6999,DB14526
L1983,Chromium Toxicological Overview - Health Protection Agency - Gov.uk,https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/338694/Chromium_toxicological_overview.pdf,DB14526
L1986,Dietary Supplement Fact Sheet: Chromium,https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/,DB14526
L1990,Dailymed Label: DIVISTA - chromium picolinate capsule ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06c485cd-ee30-44f2-be63-bb98f8d1a907,DB14526
L1981,"CHROMIUM, ELEMENTAL - National Library of Medicine HSDB ... - Toxnet - NIH",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+910,DB14527
L1982,CHROMIUM COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6999,DB14527
L1983,Chromium Toxicological Overview - Health Protection Agency - Gov.uk,https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/338694/Chromium_toxicological_overview.pdf,DB14527
L1986,Dietary Supplement Fact Sheet: Chromium,https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/,DB14527
L1990,Dailymed Label: DIVISTA - chromium picolinate capsule ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06c485cd-ee30-44f2-be63-bb98f8d1a907,DB14527
L1981,"CHROMIUM, ELEMENTAL - National Library of Medicine HSDB ... - Toxnet - NIH",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+910,DB14528
L1982,CHROMIUM COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6999,DB14528
L1983,Chromium Toxicological Overview - Health Protection Agency - Gov.uk,https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/338694/Chromium_toxicological_overview.pdf,DB14528
L1986,Dietary Supplement Fact Sheet: Chromium,https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/,DB14528
L1990,Dailymed Label: DIVISTA - chromium picolinate capsule ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06c485cd-ee30-44f2-be63-bb98f8d1a907,DB14528
L1981,"CHROMIUM, ELEMENTAL - National Library of Medicine HSDB ... - Toxnet - NIH",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+910,DB14529
L1982,CHROMIUM COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6999,DB14529
L1983,Chromium Toxicological Overview - Health Protection Agency - Gov.uk,https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/338694/Chromium_toxicological_overview.pdf,DB14529
L1986,Dietary Supplement Fact Sheet: Chromium,https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/,DB14529
L1990,Dailymed Label: DIVISTA - chromium picolinate capsule ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06c485cd-ee30-44f2-be63-bb98f8d1a907,DB14529
L1981,"CHROMIUM, ELEMENTAL - National Library of Medicine HSDB ... - Toxnet - NIH",https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+910,DB14530
L1982,CHROMIUM COMPOUNDS - National Library of Medicine HSDB ... - Toxnet - NIH,https://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+6999,DB14530
L1983,Chromium Toxicological Overview - Health Protection Agency - Gov.uk,https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/338694/Chromium_toxicological_overview.pdf,DB14530
L1986,Dietary Supplement Fact Sheet: Chromium,https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/,DB14530
L1990,Dailymed Label: DIVISTA - chromium picolinate capsule ,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06c485cd-ee30-44f2-be63-bb98f8d1a907,DB14530
L14183,Fisher Scientific: Zinc Chloride MSDS,https://fscimage.fishersci.com/msds/25350.htm,DB14533
L14186,Medsafe New Zealand Approved Drug Products: Zinc Chloride Solution for Injection,https://www.medsafe.govt.nz/profs/Datasheet/d/dblzincchlorideinj.pdf,DB14533
L14189,Dailymed: Zinc Chloride Injection,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9a1914a0-e195-4233-c1be-bc2075580eb8,DB14533
L12888,FDA Approved Drug Products: Zinc Sulfate Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209377s000lbl.pdf,DB14548
L12705,FDA Approved Drug Products: Gallium Citrate Ga 67 Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017478s016lbl.pdf,DB14550
L3725,"DailyMed Label: ANDEXXA- andexanet alfa injection, powder, lyophilized, for solution",https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7f0c50-ff2d-49e5-8e10-4efa861556e6,DB14562
L3741,andexanet alfa | Ligand page | IUPHAR/BPS Guide to Pharmacology,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=structure&ligandId=7576,DB14562
L3768,FDA Press Release Ivosidenib Approval,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm614115.htm,DB14568
L11232,FDA Approved Products: Sivextro (tedizolid phosphate) tablet and injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205435s000lbl.pdf,DB14569
L4565,APTIOM ® (eslicarbazepine acetate,https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022416s000lbl.pdf,DB14575
L4220,FDA Announcement: Patisiran,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm616518.htm,DB14582
L4246,FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System - Drugs.com,https://www.drugs.com/newdrugs/fda-approves-annovera-segesterone-acetate-ethinyl-estradiol-vaginal-contraceptive-4796.html,DB14583
L4537,FDA news,https://www.fda.gov/Drugs/DrugSafety/ucm618261.htm,DB14597
L4538,Globalnews,https://globenewswire.com/news-release/2018/08/27/1557233/0/en/Shire-Announces-FDA-Approval-of-TAKHZYRO-lanadelumab-flyo-a-First-of-its-Kind-mAb-Preventive-Treatment-for-Hereditary-Angioedema.html,DB14597
L4541,NIH,https://drugs.ncats.io/substance/2372V1TKXK,DB14597
L12774,FDA Approved Drug Products: Edetate Calcium Disodium Intravenous or Intramuscular Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/008922s016lbl.pdf,DB14598
L14222,Dailymed: Endrate Edetate Disodium Anhydrous Intravenous Injection (Discontinued),https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=290c3e9c-c0c6-440a-1a9c-46e3e2b07a77,DB14600
L14234,Medsafe New Zealand Approved Drug Products: Edetate Disodium Injection,https://www.medsafe.govt.nz/Profs/Datasheet/e/EdetateDisodiumUSPinj.pdf,DB14600
L9437,FDA Approved Drug Products: Pediapred Prednisolons Sodium Phosphate Oral Solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019157s021lbl.pdf,DB14631
L9440,FDA Approved Drug Products: Orapred Prednisolone Sodium Phosphate Orally Disintegrating Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021959s004lbl.pdf,DB14631
L14144,FDA Approved Drug Products: Inflamase Prednisolone Sodium Phosphate Ophthalmic Drops (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=080751,DB14631
L72,Trimesta,http://www.syntheticbiologics.com/trimesta,DB14641
L13284,FDA Approved Drug Products: Solu-Medrol (methylprednisolone sodium succinate) for injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011856s133lbl.pdf,DB14644
L14318,RECOVERY trial news release: dexamethasone,https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf,DB14649
L10695,FDA Approved Drug Products: Decadron Dexamethasone Oral Tablet (Discontinued),https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=011664,DB14649
L14348,Chemocare: dexamethasone acetate,http://chemocare.com/chemotherapy/drug-info/dexamethasone-acetate.aspx,DB14649
L10701,FDA Approved Drug Products: Dexamethasone Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/40572s002lbledt.pdf,DB14649
L11994,FDA Approved Drug Products: Celestone Soluspan (betamethasone sodium phosphate and betamethasone acetate) injectable suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/014602s062lbl.pdf,DB14669
L14309,British Pharmacopoeia: Betamethasone Sodium Phosphate MSDS,https://www.pharmacopoeia.com/Catalogue/Preview?uri=%2Fcontent%2Ffile%2Fproducts%2Fhealthandsafety%2FCat_041_GB.pdf,DB14669
L232,Monograph,http://www.robholland.com/Nursing/Drug_Guide/data/monographframes/C012.html,DB14684
L233,webmd,http://www.webmd.com/drugs/2/drug-6278/calcium-polycarbophil-oral/details,DB14684
L4576,Pharmatimes: Bayer files long-acting haemophilia therapy in the US,http://www.pharmatimes.com/news/bayer_files_long-acting_haemophilia_therapy_in_the_us_1209901,DB14700
L4577,A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A (PROTECT-VIII),https://clinicaltrials.gov/ct2/show/NCT01580293,DB14700
L4579,EMA: Damoctagog Alfa,http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2011/03/human_orphan_000897.jsp&mid=WC0b01ac058001d12b,DB14700
L4615,FDA Approves Libtayo,https://www.drugs.com/newdrugs/fda-approves-libtayo-cemiplimab-rwlc-advanced-cutaneous-squamous-cell-carcinoma-4827.html,DB14707
L4616,"Libtayo, Regeneron",https://www.regeneron.com/libtayo-injection,DB14707
L12747,"FDA Approved Drug Products: ACAM2000 (Smallpox (Vaccinia) Vaccine, Live) for percutaneous administration",https://www.fda.gov/media/75792/download,DB14711
L4654,Rare DR,https://www.raredr.com/news/fda-approves-elapegademase-treatment-adascid-in-pediatric-adult-patients,DB14712
L4655,Globe News Wire,https://globenewswire.com/news-release/2015/03/30/720127/10126746/en/Sigma-Tau-Pharmaceuticals-Inc-Receives-Orphan-Drug-Designation-for-EZN-2279-for-Treatment-of-Adenosine-deaminase-Deficient-Severe-Combined-Immunodeficiency-Disease.html,DB14712
L4656,NIH,https://ghr.nlm.nih.gov/condition/adenosine-deaminase-deficiency#genes,DB14712
L11758,FDA Approved Drug Products: Revcovi (elapegademase-lvlr) for intramuscular injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761092s000lbl.pdf,DB14712
L11761,FDA Approved Drug Products: Tegsedi (inotersen) for subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211172s004lbl.pdf,DB14713
L4741,NCI Drug Dictionary,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/sting-agonist-mk-1454,DB14721
L4742,ChemieTek ADU-S100 Entry,http://www.chemietek.com/adu-s100--miw815-details.aspx,DB14722
L4847,Larotrectinib FDA Approval Press Release,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626710.htm,DB14723
L4840,FDA news,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm626263.htm,DB14724
L4841,Clinical trials,https://clinicaltrials.gov/ct2/show/NCT01818492,DB14724
L4845,NHS,http://www.io.nihr.ac.uk/wp-content/uploads/2018/02/8727-Emapalumab-for-primary-HLH-V1.0-FEB2018-NON-CONF.pdf,DB14724
L4846,American Society of Hematology,http://www.hematology.org/Thehematologist/Mini-Review/8257.aspx,DB14724
L4890,Asparlas Approval History,https://www.drugs.com/history/asparlas.html,DB14730
L4891,NCI: Calaspargase Pegol,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/calaspargase-pegol,DB14730
L4892,Blood Journal: Randomized Study of Pegaspargase (SS-PEG) and Calaspargase Pegol (SPC-PEG) in Pediatric Patients with Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: Results of DFCI ALL Consortium Protocol 11-001,http://www.bloodjournal.org/content/128/22/175?sso-checked=true,DB14730
L4893,FDA news,https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm629020.htm,DB14731
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB14731
L4895,Oncology nursing news,https://www.oncnursingnews.com/web-exclusives/fda-approves-tagraxofusperzs-for-blastic-plasmacytoid-dendritic-cell-neoplasm,DB14731
L4896,Stemline therapeutics news,https://ir.stemline.com/news-releases/news-release-details/stemline-therapeutics-announces-presentation-elzonristm,DB14731
L4897,Blood journal,http://www.bloodjournal.org/content/124/3/385?sso-checked=true,DB14731
L4898,NHS reports,http://www.io.nihr.ac.uk/wp-content/uploads/2018/09/12136-Tagraxofusp-for-BPDCN-V1.0-SEP2018-NON-CONF.pdf,DB14731
L5083,The Human Metabolome Database: Queuine Profile,http://www.hmdb.ca/metabolites/HMDB0001495,DB14732
L5503,American Society of Hematology Blood: Efficacy of an Extended Half-Life GlycoPEGylated rFVIII (N8-GP): Pooled Analysis of ABR (Results from Two Clinical Trials),http://www.bloodjournal.org/content/132/Suppl_1/1177?sso-checked=true&utm_source=TrendMD&utm_medium=cpc&utm_campaign=Blood_TrendMD_0,DB14738
L1104,FiercePharma,https://www.fiercepharma.com/pharma/novoeight%C2%AE-turoctocog-alfa-receives-approval-from-fda,DB14738
L13338,FDA Approved Drug Products: Vitrase Hyaluronidase Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021640s025lbl.pdf,DB14740
L14510,FDA News Release: FDA Approves Breast Cancer Treatment That Can Be Administered At Home By Health Care Professional,https://www.fda.gov/news-events/press-announcements/fda-approves-breast-cancer-treatment-can-be-administered-home-health-care-professional,DB14740
L12246,SteriMax Inc: Polymyxin B for Injection USP Monograph,http://sterimaxinc.com/wp-content/uploads/2016/03/1.3.1-SteriMax-English-PM-February-8-201612.pdf,DB00781
L5722,FDA Drug Approval Package for Mecaserim Rinfabate,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021884_s000_IplexTOC.cfm,DB14751
L11,Link,http://newdruginformation.com/Hydroxystilbamidine_Isethionate.htm,DB14753
L12174,NIH: Clinical Trial NCT04252664,https://clinicaltrials.gov/ct2/show/NCT04252664,DB14761
L12177,NIH: Clinical Trial NCT04257656,https://clinicaltrials.gov/ct2/show/NCT04257656,DB14761
L13236,FDA: Emergency Use Authorization For Remdesivir,https://www.fda.gov/media/137564/download,DB14761
L12609,FDA: Emergency Use Authorization Information,https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization,DB14761
L13239,FDA: Fact Sheet For Health Care Providers EUA of Remdesivir,https://www.fda.gov/media/137566/download,DB14761
L9623,Vumerity FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211855s000lbl.pdf,DB14783
L9626,Biogen and Alkermes Announce FDA Approval of VUMERITY™ (diroximel fumarate) for Multiple Sclerosis,https://www.prnewswire.com/news-releases/biogen-and-alkermes-announce-fda-approval-of-vumerity-diroximel-fumarate-for-multiple-sclerosis-300947775.html,DB14783
L9629,FDA Clears More Tolerable Diroximel Fumarate (Vumerity) for MS,https://www.medscape.com/viewarticle/920574,DB14783
L9632,Drugs.com: FDA approves Vumerity,https://www.drugs.com/newdrugs/fda-approves-vumerity-diroximel-fumarate-multiple-sclerosis-5096.html,DB14783
L9638,Dimethyl fumarate FDA Label,https://www.tecfidera.com/content/dam/commercial/tecfidera/pat/en_us/pdf/full-prescribing-info.pdf,DB14783
L12099,FDA Approved Drug Products: Sarclisa (isatuximab-irfc) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761113s000lbl.pdf,DB14811
L12102,FDA News Release: Isatuximab Approval,https://www.fda.gov/news-events/press-announcements/fda-approves-new-therapy-patients-previously-treated-multiple-myeloma,DB14811
L13769,"FDA Approved Drug Products: QINLOCK (ripretinib) tablets, for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213973s000lbl.pdf,DB14840
L13778,FDA Approves First Drug for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors,https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-fourth-line-treatment-advanced-gastrointestinal-stromal-tumors,DB14840
L13811,GIST Support International: Switch Pocket Kinase Inhibitors,https://www.gistsupport.org/ask-the-professional/switch-pocket-kinase-inhibitors/,DB14840
L13841,Deciphera phase 1 study results,https://www.deciphera.com/wp-content/uploads/2018/10/ESMO-2018-George-et-al.-for-submission-to-ESMO-final.pdf,DB14840
L13859,Deciphera phase 3 study results,https://www.deciphera.com/wp-content/uploads/2019/11/CTOS-2019-INVICTUS-Oral-Presentation-FINAL_Nov-15.pdf,DB14840
L9089,FDA Approved Drug Products: Brolucizumab Intravitreal Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761125s000lbl.pdf,DB14864
L9104,Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration,https://clinicaltrials.gov/ct2/show/results/NCT02507388,DB14864
L10875,ChemSpider: Cefiderocol,http://www.chemspider.com/Chemical-Structure.52084902.html?rid=8fe73583-cb45-43bd-9b2f-128a26660d6e&page_num=0,DB14879
L10893,FDA Press Release Cefiderocol,https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibacterial-drug-treat-complicated-urinary-tract-infections-part-ongoing-efforts,DB14879
L14114,FDA Approved Drug Products: Tauvid (flortaucipir F-18) injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212123s000lbl.pdf,DB14914
L10842,"FDA Approved Drug Products: ENHERTU (fam-trastuzumab deruxtecan-nxki) for injection, for intravenous use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761139s000lbl.pdf,DB14962
L10845,FDA approves new treatment option for patients with HER2-positive breast cancer who have progressed on available therapies,https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-option-patients-her2-positive-breast-cancer-who-have-progressed-available,DB14962
L10397,FDA Approved Drug Products: Oxbrytatm (voxelotor) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213137s000lbl.pdf,DB14975
L10400,FDA approves novel treatment to target abnormality in sickle cell disease,https://www.fda.gov/news-events/press-announcements/fda-approves-novel-treatment-target-abnormality-sickle-cell-disease,DB14975
L10403,FDA approves Global Blood Therapeutics sickle cell disease drug,https://www.reuters.com/article/us-global-blood-theraprutics-fda/fda-approves-global-blood-therapeutics-sickle-cell-disease-drug-idUSKBN1XZ2E5,DB14975
L10406,"Absorption, Metabolism and Excretion of GBT440, a Novel Hemoglobin S (HbS) Polymerization Inhibitor for the Treatment of Sickle Cell Disease (SCD), in Healthy Male Subjects",https://ashpublications.org/blood/article/128/22/2487/98674/Absorption-Metabolism-and-Excretion-of-GBT440-a,DB14975
L12078,World Health Organization: Landscape analysis of therapeutics as of February 17 2020,https://www.who.int/blueprint/priority-diseases/key-action/Table_of_therapeutics_Appendix_17022020.pdf?ua=1,DB14999
L12081,FDA approved products: Extravia (interferon beta-1b) subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/125290s067lbl.pdf,DB14999
L12012,Nature Biotechnology: Coronavirus puts drug repurposing on the fast track,https://www.nature.com/articles/d41587-020-00003-1,DB14999
L12093,Product monograph: Avonex pen (interferon beta 1a),https://www.wellrx.com/avonex%20pen/monographs/,DB14999
L12096,FDA approved products: Betaseron (interferon beta 1b) subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/103471s5193lbl.pdf,DB14999
L12105,EMD Serono MSDS: Interferon beta 1a,https://imgcdn.mckesson.com/CumulusWeb/Click_and_learn/MSDS_9SERO_REBIF_SYR_%2044MCG.pdf,DB14999
L12111,ThPDB: Interferon beta1a,http://crdd.osdd.net/raghava/thpdb/display_thppid_sub.php?details=Th1049,DB14999
L12120,DailyMed: Avonex (interferon beta1a) solution for injection,https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d70a39cc-de15-4c12-a1ec-8063b69ea0e1,DB14999
L10163,FDA Approved Drug Products: Brukinsa (zanubrutinib) capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213217s000lbl.pdf,DB15035
L10166,FDA grants accelerated approval to zanubrutinib for mantle cell lymphoma,https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-zanubrutinib-mantle-cell-lymphoma,DB15035
L10169,Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know,https://www.astrazeneca-us.com/media/astrazeneca-us-blog/2018/clinical-trial-endpoints-in-cancer-research-four-terms-you-should-know-09242018.html,DB15035
L10202,FDA Approved Drug Products: Givlaari subcutaneous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/0212194s000lbl.pdf,DB15066
L10896,"FDA Approved Drug Products: Rinvoq (upadacitinib) extended-release tablets, for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211675s000lbl.pdf,DB15091
L10899,AbbVie Receives European Commission Approval of RINVOQ™ (upadacitinib) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis,https://news.abbvie.com/news/press-releases/abbvie-receives-european-commission-approval-rinvoq-upadacitinib-for-treatment-adults-with-moderate-to-severe-active-rheumatoid-arthritis.htm,DB15091
L10905,Upadacitinib Summary Review - FDA,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211675Orig1s000SumR.pdf,DB15091
L10911,Upadacitinib Safety Data Sheet - EZSolution,https://www.biovision.com/documentation/sds/B2486_SDS.pdf,DB15091
L10914,Upadacitinib Clinical Pharmacology and Biopharmaceutics Review(s) - FDA,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/211675Orig1s000ClinPharmR.pdf,DB15091
L13050,"FDA Approved Drug Products: PEMAZYRE (pemigatinib) tablets, for oral use",https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213736s000lbl.pdf,DB15102
L13068,FDA Resources for Information | Approved Drugs: FDA grants accelerated approval to pemigatinib for cholangiocarcinoma with an FGFR2 rearrangement or fusion,https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-pemigatinib-cholangiocarcinoma-fgfr2-rearrangement-or-fusion,DB15102
L11136,FDA Approved Drug Products: Avapritinib Oral Tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf,DB15233
L10097,FDA Approved Drug Products: Adakveo Crizanlizumab-TMCA Intravenous Injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761128s000lbl.pdf,DB15271
L12615,BiopharmaDive: 5 FDA Approval Decisions to Watch in the 2nd Quarter,https://www.biopharmadive.com/news/5-fda-approval-decisions-to-watch-2nd-quarter/575058/,DB15305
L10926,FDA Approved Drug Products: Ubrelvy (ubrogepant) oral tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211765s000lbl.pdf,DB15328
L10959,FDA News Release: Ubrogepant approval,https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-adults-migraine,DB15328
L9389,FDA News Release: Trikafta Approval,https://www.fda.gov/news-events/press-announcements/fda-approves-new-breakthrough-therapy-cystic-fibrosis,DB15444
L9395,"FDA Approved Drug Products: Trikafta (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets)",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212273s000lbl.pdf,DB15444
L4894,FDA Approved Drug Products: Apadaz (benzhydrocodone and acetaminophen) tablets,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208653s002s003lbl.pdf,DB15465
L7859,KemPharm: Apadaz approval announcement,http://investors.kempharm.com/news-releases/news-release-details/kempharm-announces-fda-approval-apadaztm-benzhydrocodone-and,DB15465
L7862,Drugs@FDA: Apadaz,https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process,DB15465
L8219,ZW25 Anti-HER2 x HER2 Bispecific Overview,https://www.zymeworks.com/our-pipeline/zw25,DB15471
L8234,ZW49 Anti-HER2 x HER2 ADC Overview,https://www.zymeworks.com/our-pipeline/zw49,DB15472
L8570,Med Chem Express: Cambinol Product Data Sheet,https://file.medchemexpress.com/batch_PDF/HY-100732/Cambinol-DataSheet-MedChemExpress.pdf,DB15493
L8597,FDA Approved Drug Products: Gallium Dotatoc GA 68,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210828s000lbl.pdf,DB15494
L8603,EMA Assessment Report: SomaKit TOC,https://www.ema.europa.eu/en/documents/assessment-report/somakit-toc-epar-public-assessment-report_en.pdf,DB15494
L9049,Cancer.gov Mps1 inhibitor BOS172722 definition,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/794872,DB15498
L9194,ZOLGENSMA® (onasemnogene abeparvovec-xioi) FDA Label,https://www.fda.gov/media/126109/download,DB15528
L9209,SMN1 gene - Genetics Home Reference - NIH,https://ghr.nlm.nih.gov/gene/SMN1,DB15528
L9449,FDA Approved Drug Products: Prednisolone Acetate Oral Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022067s007lbl.pdf,DB15566
L9452,FDA Approved Drug Products: Prednisolone Acetate Ophthalmic Suspension,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017100s045lbl.pdf,DB15566
L9455,FDA Approved Drug Products: Prednisolone Acetate Ophthalmic Suspension 1%,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/017011s050lbl.pdf,DB15566
L9476,Greenstone LLC: Prednisolone Acetate Ophthalmic Suspension MSDS,https://www.greenstonellc.com/sites/default/files/pdfs/MSDS/PREDNISOLONE%20ACETATE%20OPHTHALMIC%20SUSPENSION%2C%20USP%201MSDS_0.pdf,DB15566
L9470,"Patent: Epigenetic silencing of NMT2 (2018, Pacylex Pharmaceuticals, Inc.)",https://patents.google.com/patent/US20180208990A1/en?q=PCLX-001&oq=PCLX-001,DB15567
L9875,NCI Drug Dictionary - Definition of CCR4 inhibitor FLX475,https://www.cancer.gov/publications/dictionaries/cancer-drug/def/796771,DB15570
L10139,"BioPharma Dive: First look at CRISPR, Vertex gene-editing therapy hints at treatment potential",https://www.biopharmadive.com/news/crispr-vertex-gene-editing-data-sickle-cell-beta-thalassemia/567557/,DB15572
L10755,FDA grants accelerated approval to first targeted treatment for rare Duchenne muscular dystrophy mutation,https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-targeted-treatment-rare-duchenne-muscular-dystrophy-mutation,DB15593
L10758,"FDA label, Golodirsen",https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211970s000lbl.pdf,DB15593
L10764,Muscular dystrophy UK,https://www.musculardystrophyuk.org/progress-in-research/background-information/what-is-exon-skipping-and-how-does-it-work/,DB15593
L10767,MSDS: Golodirsen,https://www.novachemistry.com/index.php/Index/product_info/pid/334067,DB15593
L10773,Eteplirsen FDA label,https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/206488lbl.pdf,DB15593
L10830,Brilliant Blue G Opthalmic solution,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/209569s000lbl.pdf,DB15594
L10839,"Brilliant Blue G MSDS, Cayman Chem",https://www.caymanchem.com/msdss/14320m.pdf,DB15594
L10854,"ERVEBO® (Ebola Zaire Vaccine, Live) - FDA Label",https://www.fda.gov/media/133748/download,DB15595
L10857,"ERVEBO, INN-Ebola Zaire Vaccine - Summary of Product Characteristics - EMA",https://www.ema.europa.eu/en/documents/product-information/ervebo-epar-product-information_en.pdf,DB15595
L10866,How the new Ebola vaccine was made in Canada - CBC News,https://www.cbc.ca/news/health/second-opinion-ebola-vaccine-1.4672807,DB15595
L10884,2014-2016 Ebola Outbreak in West Africa | History | Ebola (Ebola Virus Disease) | CDC,https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/index.html,DB15595
L10974,FDA Approved Drug Products: Accrufer Ferric Maltol Oral Capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212320Orig1s000lbl.pdf,DB15598
L11010,EMA Summary of Product Characteristics: Feraccru,https://www.ema.europa.eu/en/documents/product-information/feraccru-epar-product-information_en.pdf,DB15598
L11013,Crystalline Ferric Maltol Patent,https://patentimages.storage.googleapis.com/5f/36/38/437858f5844c0c/WO2016066555A1.pdf,DB15598
L11100,EPA Insight: NNZ-2591 patent granted in Europe to 2034 for neurodevelopmental disorders,https://www.epa-insight.com/post/nnz-2591-patent-granted-in-europe-to-2034-for-neurodevelopmental-disorders,DB15601
L11103,"BusinessWire: FDA Grants Orphan Drug Designation for Neuren's NNZ-2591 to Treat Angelman, Phelan-McDermid and Pitt Hopkins Syndromes",https://www.businesswire.com/news/home/20191017005361/en,DB15601
L11106,Neuren Pharmaceuticals: Product Development,http://www.neurenpharma.com/irm/content/the-science-behind-neuren-s-products1.aspx?RID=304&RedirectCount=1,DB15601
L11581,FDA Approved Products: MONOFERRIC (ferric derisomaltose) for injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/208171s000lbl.pdf,DB15617
L11587,EMPR: Monoferric injection approved for iron deficiency anemia,https://www.empr.com/home/news/monoferric-injection-approved-for-iron-deficiency-anemia/,DB15617
L11617,Auspar: Monofer (ferric derisomaltose),https://www.tga.gov.au/sites/default/files/auspar-ferric_derisomaltose-181105-pi.pdf,DB15617
L11620,EMC: Monofer 100mg/ml solution for injection/infusion,https://www.medicines.org.uk/emc/medicine/23669,DB15617
L11635,Canadian Monograph: Venofer (iron sucrose),https://pdf.hres.ca/dpd_pm/00018889.PDF,DB15617
L12087,RT Question More: China tests Russian anti-viral drug which might treat coronavirus as Moscow warns of possible 'mass outbreak',https://www.rt.com/russia/480037-china-tests-russian-drug-coronavirus/,DB15622
L12165,Triazavirin,http://www.triazavirin.ru,DB15622
L12045,NIH AIDSinfo: TMC-310911 Pharmacology,https://aidsinfo.nih.gov/drugs/549/tmc-310911/0/professional,DB15623
L12012,Nature Biotechnology: Coronavirus puts drug repurposing on the fast track,https://www.nature.com/articles/d41587-020-00003-1,DB15623
L12645,Pharmaceutical Business Review: Moderna's mRNA-1273 vaccine,https://www.pharmaceutical-business-review.com/news/moderna-mrna-1273-coronavirus-trial/,DB15654
L12660,Clinical Trials: Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection,https://clinicaltrials.gov/ct2/show/NCT04283461,DB15654
L12675,Chinese Clinical Trial Register: A phase I clinical trial for recombinant novel coronavirus (2019-COV) vaccine (adenoviral vector),http://www.chictr.org.cn/showprojen.aspx?proj=51154,DB15655
L12678,Antibody Society: COVID-19 Archives,https://www.antibodysociety.org/covid-19/,DB15655
L12669,Clinical Trials: A Study of a Candidate COVID-19 Vaccine (COV001),https://www.clinicaltrials.gov/ct2/show/NCT04324606,DB15656
L12672,TrialSite News: University of Oxford Commences Clinical Trial for Vaccine Candidate (ChAdOx1 nCoV-19) Targeting COVID-19,https://www.trialsitenews.com/university-of-oxford-commences-clinical-trial-for-vaccine-candidate-chadox1-ncov-19-targeting-covid-19-2/,DB15656
L12717,DC Chemicals: EIDD-2081 MSDS,http://www.dcchemicals.com/usr/uploads/gene/2020326/MSDS_12096_DC27035_2349386-89-4.pdf,DB15661
L12891,Sunovion Pharmaceuticals,https://www.sunovion.ca,DB15665
L13604,FDA Approved Drug Products: Retevmo (selpercatinib) capsules,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213246s000lbl.pdf,DB15685
L13239,FDA: Fact Sheet For Health Care Providers EUA of Remdesivir,https://www.fda.gov/media/137566/download,DB15686
L13775,European Patent Specification: 1'-substituted carba-nucleoside analogs for antiviral treatment,https://patentimages.storage.googleapis.com/4b/84/70/16d3c8634171ba/EP2937350B1.pdf,DB15686
L13874,NIH: Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection (NCT04374032),https://clinicaltrials.gov/ct2/show/NCT04374032,DB15687
L13877,Bosna Lijek: Enkorten Metenkefalin and Tridecactide Injection,http://www.bosnalijek.com/products-L2e?c=ign&ign=metenkefalin%20%2B%20tridecactide,DB15687
L13868,NIH: Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen (NCT04346615),https://clinicaltrials.gov/ct2/show/NCT04346615,DB15688
L13886,"Practical Neurology: Vazegepant, Investigational Drug Being Studied for Migraine, to Enter Phase 2 Trial for COVID-19 Treatment",https://practicalneurology.com/news/vazegepant-investigational-drug-being-studied-for-migraine-to-enter-phase-2-trial-for-covid-19-treatment,DB15688
L14096,FDA Approved Drug Products: Cerianna (fluoroestradiol F 18) for intravenous injection,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212155s000lbl.pdf,DB15690
L14117,"Applied Radiology News Release: PETNET, Zionexa Announce FDA Approval of Cerianna (Fluoroestradiol F 18)",https://www.appliedradiology.com/articles/petnet-zionexa-announce-fda-approval-of-cerianna-fluoroestradiol-f-18,DB15690
L14303,"Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19",https://clinicaltrials.gov/ct2/show/NCT04426695?term=REGN10933&draw=2&rank=2,DB15691
L14306,Regeneron: Regeneron begins first clinical trials of antibody-antiviral cocktail REGN-COV-2 for the treatment and prevention of COVID-19,https://investor.regeneron.com/news-releases/news-release-details/regeneron-begins-first-clinical-trials-anti-viral-antibody,DB15691
L14333,FDA recommendations for investigational COVID-19 convalescent plasma,https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma,DB15692
L14372,INO-4800 Phase I clinical trial NCT04336410,https://clinicaltrials.gov/ct2/show/NCT04336410,DB15693
L14375,INOVIO Press release phase 1/2 clinical trial,http://ir.inovio.com/news-releases/news-releases-details/2020/INOVIO-and-IVI-Partner-with-Seoul-National-University-Hospital-to-Start-Phase-12-Clinical-Trial-of-INOVIOs-COVID-19-DNA-Vaccine-INO-4800-in-South-Korea/default.aspx,DB15693
